<?xml version="1.0" encoding="UTF-8"?>
<experiments version="01020304" total="233">
    <experiment textidx="0">
        <id>1807015948</id>
        <accession>E-MEXP-2376</accession>
        <name>Global transcriptional response of pig brain and lung to natural infection by
            Pseudorabies virus</name>
        <releasedate>2009-10-01</releasedate>
        <species>Sus scrofa</species>
        <samples>12</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>Age</category>
            <value>2 to 4 days</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>normal</value>
            <value>pseudorabies virus infected</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Sus scrofa</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>brain</value>
            <value>lung</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>unknown_sex</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>normal</value>
            <value>pseudorabies virus infected</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>brain</value>
            <value>lung</value>
        </experimentalfactor>
        <user>1807113606</user>
        <user>1807113608</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1339206443</id>
            <accession>A-MEXP-693</accession>
            <name>CMR HsRefSet</name>
            <count>20</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1807032895</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2376.A-MEXP-693.1.FeatureDimension</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>20</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Global transcriptional response of pig brain and lung to natural infection by
                Pseudorabies virus</title>
        </bibliography>
        <provider>
            <contact>Peter Ellis</contact>
            <email>pjie2@cam.ac.uk, ec294@cam.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>disease state</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <description>
            <id>1807015984</id>
            <text>Six piglets (age 2-4 days) suffering from pseudorabies virus were identified
                during at outbreak at a commercial farm. RNA was extracted from lung (n=4) and brain
                (n=6) of the infected pigs, and compared to lung/brain RNA from a control pool of
                three uninfected piglets. Expression profiling used a human oligonucleotide
                geneset.</text>
        </description>
        <description>
            <id>1807058695</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 12 samples of
                species [Sus scrofa], using 20 arrays of array design [CMR HsRefSet], producing 20
                raw data files and 0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="1">
        <id>1805652259</id>
        <accession>E-MEXP-2374</accession>
        <name>Transcription profiling of human embryonic stem cells in response to valproic acid and
            valproic acid analogs</name>
        <releasedate>2009-09-30</releasedate>
        <species>Homo sapiens</species>
        <samples>17</samples>
        <assays>17</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>SA002</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>embryonic stem cell</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>2-ethyl-4-methyl-pentanoic acid</value>
            <value>3-Propyl heptanoic acid</value>
            <value>dimethyl sulfoxide</value>
            <value>S-2-pentyl-4-pentynoic acid</value>
            <value>VPA</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DOSE</name>
            <value>0.1</value>
            <value>0.25</value>
            <value>0.5</value>
            <value>1</value>
        </experimentalfactor>
        <user>1321836195</user>
        <user>1805662060</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>649816155</id>
            <accession>A-GEHB-1</accession>
            <name>GE Healthcare/Amersham Biosciences CodeLink Human Whole Genome Bioarray</name>
            <count>17</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1805652681</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2374.A-GEHB-1.1.FeatureDimension</name>
            <bioassaydatacubes>17</bioassaydatacubes>
            <arraydesignprovider>GEHB</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>17</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Mans Jergil</contact>
            <email>Mans.Jergil@farmbio.uu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <description>
            <id>1805652268</id>
            <text>Transcriptional profiling of valproic acid and valproic acid analogs in human
                embryonic stem cells.</text>
        </description>
        <description>
            <id>1805652865</id>
            <text>(Generated description) Experiment with 17 hybridizations, using 17 samples of
                species [Homo sapiens], using 17 arrays of array design [GE Healthcare/Amersham
                Biosciences CodeLink Human Whole Genome Bioarray], producing 17 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="2">
        <id>1805653642</id>
        <accession>E-TABM-811</accession>
        <name>Transcription profiling of human malignant pheochromocytoma vs normal tissue from the
            adrenal medulla</name>
        <releasedate>2009-09-30</releasedate>
        <species>Homo sapiens</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>malignant pheochromocytoma</value>
            <value>normal</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>adrenal medulla</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>malignant pheochromocytoma</value>
            <value>normal</value>
        </experimentalfactor>
        <user>1805654694</user>
        <user>1805654737</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>2</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1805653671</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Robin Andersson</contact>
            <email>robin.andersson@lcb.uu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>disease state</experimentdesign>
        <description>
            <id>1805653648</id>
            <text>Integrative epigenomic and genomic analysis of malignant pheochromocytoma</text>
        </description>
        <description>
            <id>1805653692</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Homo sapiens], using 2 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 2 raw data files and 0 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="3">
        <id>1805668273</id>
        <accession>E-TABM-812</accession>
        <name>Chromatin immunoprecipitation of human malignant pheochromocytoma tissue with H3K27me3
            and H3K4me3</name>
        <releasedate>2009-09-30</releasedate>
        <species>Homo sapiens</species>
        <samples>1</samples>
        <assays>42</assays>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>malignant pheochromocytoma</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>adrenal medulla</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Immunoprecipitate</name>
            <value>H3K27me3</value>
            <value>H3K4me3</value>
            <value>input_DNA</value>
        </experimentalfactor>
        <user>1805654694</user>
        <user>1805674418</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1466410368</id>
            <accession>A-AFFY-91</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R A Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1467331302</id>
            <accession>A-AFFY-92</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R B Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1467818303</id>
            <accession>A-AFFY-93</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R C Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1471135352</id>
            <accession>A-AFFY-94</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R D Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1471396419</id>
            <accession>A-AFFY-95</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R E Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1471544026</id>
            <accession>A-AFFY-96</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R F Array</name>
            <count>6</count>
        </arraydesign>
        <arraydesign>
            <id>1471565960</id>
            <accession>A-AFFY-97</accession>
            <name>Affymetrix GeneChip Human Tiling 2.0R G Array</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1805668396</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P01R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668384</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P02R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668392</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P03R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668412</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P04R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668430</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P05R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668402</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P06R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1805668407</id>
            <name>Affymetrix:FeatureDimension:Hs35b_P07R_v01</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Robin Andersson</contact>
            <email>robin.andersson@lcb.uu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>binding site identification</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <description>
            <id>1805668279</id>
            <text>Integrative epigenomic and genomic analysis of malignant pheochromocytoma</text>
        </description>
        <description>
            <id>1805669081</id>
            <text>(Generated description) Experiment with 42 hybridizations, using 1 samples of
                species [Homo sapiens], using 42 arrays of array design [Affymetrix GeneChip Human
                Tiling 2.0R C Array, Affymetrix GeneChip Human Tiling 2.0R D Array, Affymetrix
                GeneChip Human Tiling 2.0R F Array, Affymetrix GeneChip Human Tiling 2.0R B Array,
                Affymetrix GeneChip Human Tiling 2.0R E Array, Affymetrix GeneChip Human Tiling 2.0R
                A Array, Affymetrix GeneChip Human Tiling 2.0R G Array], producing 42 raw data files
                and 0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="4">
        <id>1804906305</id>
        <accession>E-MEXP-2370</accession>
        <name>Transcription profiling of Mus Musculus embryonic stem cell line R1 exposures to
            Valproic acid and VPA analogs to investigate VPA as a potent inducer of neural tube
            defects</name>
        <releasedate>2009-09-28</releasedate>
        <species>Mus musculus</species>
        <samples>15</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>R1</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>mESC</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>R1</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Compound</name>
            <value>2-ethyl-4-methyl-pentanoic acid</value>
            <value>dimethyl sulfoxide</value>
            <value>S-2-pentyl-4-pentynoic acid</value>
            <value>Valproic acid</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DOSE</name>
            <value>0.1</value>
            <value>0.25</value>
            <value>0.5</value>
            <value>1</value>
        </experimentalfactor>
        <user>1321836195</user>
        <user>1804907144</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1159774382</id>
            <accession>A-GEHB-3</accession>
            <name>GE Healthcare CodeLink Mouse Whole Genome Bioarray</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804906502</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2370.A-GEHB-3.1.FeatureDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>GEHB</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>M ns Jergil</contact>
            <email>Mans.Jergil@farmbio.uu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <description>
            <id>1804906313</id>
            <text>Valproic acid (VPA) is a potent inducer of neural tube defects (ntd:s) in both
                human and mouse, but its mechanism of teratogenicity is not know. The mouse
                embryonic stem cell line R1, may be relevant as an in vitro model of teratogenicity
                and was evaluated with exposures to VPA,and the two VPA anlogs
                (S)-2-pentyl-4-pentynoic acid, and 2-ethyl-4-methyl-pentanoic acid to profile the
                gene expression response. Those profiles may reveal biomarkers of teratogenic
                exposures in an in vitro system as well as give mechanistic input of the
                teratogenicity of VPA.</text>
        </description>
        <description>
            <id>1804906616</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 15 samples of
                species [Mus musculus], using 15 arrays of array design [GE Healthcare CodeLink
                Mouse Whole Genome Bioarray], producing 15 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="5">
        <id>1804908545</id>
        <accession>E-GEOD-17990</accession>
        <name>Transcriptomic and proteomic analyses of colon inflammation in interleukin-10
            gene-deficient mice</name>
        <releasedate>2009-09-28</releasedate>
        <species>Mus musculus</species>
        <samples>30</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1658154094</user>
        <user>1804910119</user>
        <secondaryaccession>GSE17990</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>387186944</id>
            <accession>A-AGIL-13</accession>
            <name>Agilent Whole Mouse Genome 012694 G4122A</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804909110</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17990.A-AGIL-13.1.ReporterDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Alan Francis McCulloch</contact>
            <email>alan.mcculloch@agresearch.co.nz</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1804908552</id>
            <text>A total of 30 male IL10-/- (B6.129P2-Il10&lt;tm1Cgn&gt;/J) and 30 male C57
                control (C57BL/6J) mice were obtained from The Jackson Laboratory (Bar Harbor,
                Maine, USA). All mice were between 28 and 35 days of age at the start of the study.
                For convenience and consistency in reporting, their age was defined as 35 days or 5
                weeks of age. The mice were housed individually in standard shoebox size cages
                containing untreated wood shavings and maintained in an air-conditioned animal room
                with a 12-h light-dark cycle. Animals had free access to water and were fed an
                AIN-76A standard powder diet prepared in-house. This study was approved by the
                AgResearch Ruakura Animal Ethics Committee in Hamilton, New Zealand according to the
                Animal Protection Act (1960) and Animal Protection Regulations (1987) and
                amendments. Four days after arrival, all mice were inoculated orally with a mixture
                of Enterococcus faecalis strains and bacteria commonly found in the intestinal lumen
                to obtain a more consistent and reproducible intestinal inflammation. Mice were
                randomly assigned to five sampling groups (7, 8.5, 10, 12 and 14 weeks of age).
                Experiment Overall Design: For the comparison of gene expression levels, colonic RNA
                of IL10-/- and C57 at 7 and 12 weeks of age were compared because of a low HIS
                variability in the colon within those time points. A reference design with 15 arrays
                was used, where each individual RNA sample was hybridized with a reference sample
                onto the array, in a total of 3 or 4 biological replicates per treatment. Reference
                RNA was prepared by pooling equal amounts of purified total RNA extracted from small
                intestine, colon, kidney, liver and fetuses from normal, healthy Swiss mice.</text>
        </description>
        <description>
            <id>1804909321</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 30 samples of
                species [Mus musculus], using 15 arrays of array design [Agilent Whole Mouse Genome
                012694 G4122A], producing 0 raw data files and 15 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="6">
        <id>1804913171</id>
        <accession>E-GEOD-16334</accession>
        <name>Expression data from normal and Fanconi anemia low density bone marrow cells</name>
        <releasedate>2009-09-28</releasedate>
        <species>Homo sapiens</species>
        <samples>32</samples>
        <assays>32</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1804915047</user>
        <user>1804915048</user>
        <secondaryaccession>GSE16334</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>32</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804913654</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>32</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>32</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804913697</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16334.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>32</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>32</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Grover Bagby MD</contact>
            <email>grover@ohsu.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1804913178</id>
            <text>Fanconi anemia (FA) is a rare inherited disease complicated by aplastic anemia.
                There is evidence that hematopoietic stem cells have lost self replicative capacity
                and undergo apoptosis when exposed to inhibitory cytokines including interferon
                gamma and tumor necrosis factor-alpha. We used gene expression microarrays to
                identify transcriptomal differences between bone marrow cells from normal volunteers
                and from children and adults with Fanconi anemia Experiment Overall Design: Fanconi
                anemia patients were identified using mitomycin C and/or diepoxybutane chromosomal
                breakage analysis. Eleven normal volunteers and 21 FA patients were studied. All FA
                patients with cytogenetic evidence of clonal evolution were excluded. All FA
                patients with acute leukemia were excluded. RNA was prepared from freshly obtained
                low density mononuclear cell fractions.</text>
        </description>
        <description>
            <id>1804913947</id>
            <text>(Generated description) Experiment with 32 hybridizations, using 32 samples of
                species [Homo sapiens], using 32 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 32 raw data files and 32 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="7">
        <id>1804915403</id>
        <accession>E-TABM-805</accession>
        <name>Transcription profiling of human bone tumours to evaluate four commercial
            high-resolution oligonucleotide microarray platforms.</name>
        <releasedate>2009-09-28</releasedate>
        <species>Homo sapiens</species>
        <samples>3</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>ATCC</value>
            <value>Promega</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>Cell line</value>
            <value>Control</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>Ewing's sarcoma</value>
            <value>normal</value>
            <value>Osteosarcoma</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
        </sampleattribute>
        <experimentalfactor>
            <name>BioSourceProvider</name>
            <value>ATCC</value>
            <value>Promega</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>CellLine</name>
            <value>Cell line</value>
            <value>Control</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>normal</value>
            <value>Tumour</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Organism</name>
            <value>Homo sapiens</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Sex</name>
            <value>female</value>
            <value>male</value>
        </experimentalfactor>
        <user>1199386009</user>
        <user>1804916570</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1762080794</id>
            <accession>A-AFFY-142</accession>
            <count>4</count>
        </arraydesign>
        <arraydesign>
            <id>1762253514</id>
            <accession>A-MEXP-1598</accession>
            <name>NimbleGen HG18 CGH 385k WG tiling v1.0</name>
            <count>4</count>
        </arraydesign>
        <arraydesign>
            <id>1762512492</id>
            <accession>A-MEXP-1597</accession>
            <name>Agilent Human Genome CGH Microarray 244A 014693</name>
            <count>4</count>
        </arraydesign>
        <arraydesign>
            <id>1762512503</id>
            <accession>A-MEXP-1605</accession>
            <name>Illumina HumanExon510s-duo</name>
            <count>4</count>
        </arraydesign>
        <bibliography/>
        <provider>
            <contact>Stine Kresse</contact>
            <email>stinek@radium.uio.no</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>array platform variation</experimentdesign>
        <experimentdesign>comparative genome hybridization</experimentdesign>
        <experimentdesign>genotyping</experimentdesign>
        <experimentdesign>individual genetic characteristics</experimentdesign>
        <description>
            <id>1804915409</id>
            <text>Evaluation of four commercial high-resolution oligonucleotide microarray
                platforms, Affymetrix Genome-Wide Human SNP Array 6.0, Agilent Human Genome CGH
                244A, Illumina HumanExon510s-duo and Nimblegen HG18 CGH 385k WG tiling v1.0, for
                genomic profiling of bone tumours.</text>
        </description>
        <description>
            <id>1804915565</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 3 samples of
                species [Homo sapiens], using 16 arrays of array design [Affymetrix GeneChip
                Genome-Wide Human SNP 6.0 [GenomeWideSNP_6], Illumina HumanExon510s-duo, NimbleGen
                HG18 CGH 385k WG tiling v1.0, Agilent Human Genome CGH Microarray 244A 014693],
                producing 20 raw data files and 0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="8">
        <id>1804951775</id>
        <accession>E-TABM-807</accession>
        <name>Transcription profiling of blackcurrant (Ribes nigrum cv Ben Hope) bud tissue during
            dormancy and bud-break.</name>
        <releasedate>2009-09-28</releasedate>
        <species>Ribes nigrum</species>
        <samples>8</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Ribes nigrum</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf bud</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Ribes nigrum cv Ben Hope</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Time</name>
            <value>0</value>
            <value>12</value>
            <value>14</value>
            <value>16</value>
            <value>2</value>
            <value>4</value>
            <value>43</value>
            <value>8</value>
        </experimentalfactor>
        <user>1561220012</user>
        <user>1804951960</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1802014473</id>
            <accession>A-MEXP-1694</accession>
            <name>SCRI Ribes nigrum 4k v1</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804951820</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-807.A-MEXP-1694.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>BMC Genomics</publication>
            <authors>Peter E Hedley, Joanne R Russell, Linzi Jorgensen, Jenny A Morris, Sandra
                Gordon, Linda Milne, Christine Hackett and Rex Brennan</authors>
            <title>Identification of candidate genes associated with bud dormancy in blackcurrant
                (Ribes nigrum)</title>
        </bibliography>
        <provider>
            <contact>Pete Hedley</contact>
            <email>pete.hedley@scri.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <description>
            <id>1804951781</id>
            <text>Transcriptional analysis of staged leaf bud tissue during dormancy and bud-break
                in blackcurrant using SCRI custom Ribes 4k arrays</text>
        </description>
        <description>
            <id>1804951872</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 8 samples of
                species [Ribes nigrum], using 12 arrays of array design [SCRI Ribes nigrum 4k v1],
                producing 12 raw data files and 0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="9">
        <id>1802253422</id>
        <accession>E-TABM-798</accession>
        <name>Transcription profiling of juvenile Daphnia manga following exposure to various doses
            of Lufenuron, a benzoylphenylurea growth inhibitor (no RNA amplification)</name>
        <releasedate>2009-09-25</releasedate>
        <species>Daphnia magna</species>
        <samples>30</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Age</category>
            <value>&lt; 24</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>University of Reading</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>juvenile</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Daphnia magna</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>whole_organism</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>hours</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>Lufenuron</value>
            <value>none</value>
            <value>reference pool (all treated samples)</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>0</value>
            <value>0.15</value>
            <value>0.33</value>
            <value>0.65</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose(ug_per_L)</name>
            <value>0.15 - 0.65</value>
        </experimentalfactor>
        <user>1799581524</user>
        <user>1802274509</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1231885224</id>
            <accession>A-MAXD-9</accession>
            <name>Reading University Daphnia magna 14K V2.3</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802256839</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-798.A-MAXD-9.1.FeatureDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>MAXD</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Amanda Callaghan Christopher Hill</contact>
            <email>c.j.hill@reading.ac.uk, a.callaghan@reading.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <description>
            <id>1802253436</id>
            <text>Juvenile (&lt;24hr old) Daphnia magna populations (n=250) were exposed (24hr)
                to Benzoylphenylurea growth inhibitor (14C labeled) lufenuron. Treatments were 0.15
                ug/L, 0.33 ug/L, 0.65 ug/L lufenuron solvent control was 100 ul/L acetone carrier .
                Transcriptomic responses were screened using a D.magna cDNA microarray and the
                regulation of gene expression via log fold-change in transcript abundance, assessed.
                Genes involved in the synthesis of chitin were expected to respond to lufenuron,
                given the mode of action</text>
        </description>
        <description>
            <id>1802264682</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 30 samples of
                species [Daphnia magna], using 15 arrays of array design [Reading University -
                Daphnia magna 14455 - V2.3], producing 15 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="10">
        <id>1802512922</id>
        <accession>E-MEXP-2169</accession>
        <name>E2F ChIP on chip</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>8</samples>
        <assays>13</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Chip-antibody</name>
            <value>E2f2 #sc-633 (Santa Cruz)</value>
            <value>E2f4 #sc-1082 (Santa Cruz)</value>
            <value>input_DNA</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DevelopmentalStage</name>
            <value>late G1</value>
            <value>s phase</value>
            <value>S phase</value>
            <value>unsynchronized</value>
        </experimentalfactor>
        <user>1344330149</user>
        <user>1762016923</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1802237812</id>
            <accession>A-MEXP-1574</accession>
            <name>MIT_Human_19K_v4.03</name>
            <count>13</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802513035</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2169.A-MEXP-1574.1.FeatureDimension</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>11</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802513041</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2169.A-MEXP-1574.1.FeatureDimension</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Shlomit Farkash-Amar</contact>
            <email>shlomitf@md.huji.ac.il</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>binding site identification</experimentdesign>
        <experimentdesign>cell cycle</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <description>
            <id>1802512930</id>
            <text>ChIp on chip with E2F2 or E2F4 antibodies on BJ-T cells.</text>
        </description>
        <description>
            <id>1802513193</id>
            <text>(Generated description) Experiment with 13 hybridizations, using 8 samples of
                species [Homo sapiens], using 13 arrays of array design [MIT_Human_19K_v4.03],
                producing 13 raw data files and 0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="11">
        <id>1802517858</id>
        <accession>E-MEXP-2366</accession>
        <name>Transcription profiling of Zea mays leaves from MON810 (Helen Bt) and its
            near-isogenic couterpart (Helen) grown in agricultural fields</name>
        <releasedate>2009-09-25</releasedate>
        <species>Zea mays</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>vegetative tasseling</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>CMV 35S promoter + maize HSP70 intron (partial) + Bacillus thuringensis CRYIA(b)
                insecticidal protein (truncated).</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Helen</value>
            <value>Helen Bt</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>Helen</value>
            <value>Helen Bt</value>
        </experimentalfactor>
        <user>1591136548</user>
        <user>1802519298</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1287164335</id>
            <accession>A-AFFY-77</accession>
            <name>Affymetrix GeneChip Maize Genome Array [Maize]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802518056</id>
            <name>Affymetrix:FeatureDimension:Maize</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802518078</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2366.A-AFFY-77.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Natural variation explains most transcriptomic changes among maize plants of
                different MON810 and comparable non-GM varieties subjected to two N fertilization
                farming practices</title>
        </bibliography>
        <provider>
            <contact>Maria Pla</contact>
            <email>maria.pla@udg.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>strain or line</experimentdesign>
        <description>
            <id>1802518254</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Zea mays], using 6 arrays of array design [Affymetrix GeneChip Maize Genome
                Array [Maize]], producing 6 raw data files and 6 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1802517867</id>
            <text>Comparison of the transcriptome profiles of a widely commercialized maize MON810
                variety and its non-GM near-isogenic counterpart grown in agricultural fields. The
                Helen variety was commercialized by Limagrain Iberica. Variety Helen B was obtained
                by Advanta; authorized the 11/08/2005; now commercialized by Limagrain Iberica. The
                insert integrated into the maize genome contains: Cauliflower Mosaic Virus 35S
                promoter + maize HSP70 intron (partial) + synthetic sequence coding for the Bacillus
                thuringensis CRYIA(b) insecticidal protein (truncated).</text>
        </description>
    </experiment>
    <experiment textidx="12">
        <id>1802518484</id>
        <accession>E-MEXP-2367</accession>
        <name>Transcription profiling of Zea mays leaves from variety Helen grown in agricultural
            fields at 2 levels of nitrogen fertilization</name>
        <releasedate>2009-09-25</releasedate>
        <species>Zea mays</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>vegetative tasseling</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Helen</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GrowthCondition</name>
            <value>nitrogen fertilization</value>
            <value>no added nitrogen</value>
        </experimentalfactor>
        <user>1591136548</user>
        <user>1802519299</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1287164335</id>
            <accession>A-AFFY-77</accession>
            <name>Affymetrix GeneChip Maize Genome Array [Maize]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802518714</id>
            <name>Affymetrix:FeatureDimension:Maize</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802518742</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2367.A-AFFY-77.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Natural variation explains most transcriptomic changes among maize plants of
                different MON810 and comparable non-GM varieties subjected to two N fertilization
                farming practices</title>
        </bibliography>
        <provider>
            <contact>Maria Pla</contact>
            <email>maria.pla@udg.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1802518493</id>
            <text>Comparison of the transcriptome profiles of a widely commercialized maize variety
                (Helen) at two levels of nitrogen fertilization. Conventional nitrogen fertilization
                compared to not nitrogen fertilization during the season.</text>
        </description>
        <description>
            <id>1802519051</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Zea mays], using 6 arrays of array design [Affymetrix GeneChip Maize Genome
                Array [Maize]], producing 6 raw data files and 6 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="13">
        <id>1802519063</id>
        <accession>E-MEXP-2368</accession>
        <name>Transcription profiling of Zea mays leaves from variety MON810 (Helen Bt) grown in
            agricultural fields at 2 levels of nitrogen fertilization</name>
        <releasedate>2009-09-25</releasedate>
        <species>Zea mays</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>vegetative tasseling</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>CMV 35S promoter + maize HSP70 intron (partial) + Bacillus thuringensis CRYIA(b)
                insecticidal protein (truncated).</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Helen Bt</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GrwothCondition</name>
            <value>nitrogen fertilization</value>
            <value>no added nitrogen</value>
        </experimentalfactor>
        <user>1591136548</user>
        <user>1802519472</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1287164335</id>
            <accession>A-AFFY-77</accession>
            <name>Affymetrix GeneChip Maize Genome Array [Maize]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802519180</id>
            <name>Affymetrix:FeatureDimension:Maize</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802519190</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2368.A-AFFY-77.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Natural variation explains most transcriptomic changes among maize plants of
                different MON810 and comparable non-GM varieties subjected to two N fertilization
                farming practices</title>
        </bibliography>
        <provider>
            <contact>Maria Pla</contact>
            <email>maria.pla@udg.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1802519072</id>
            <text>Comparison of the transcriptome profiles of a widely commercialized MON810 maize
                variety (HelenBt) at two levels of nitrogen fertilization. Variety Helen Bt;
                obtained by Advanta; authorized the 11/08/2005; now commercialized by Limagrain
                Iberica. Conventional nitrogen fertilization compared to not nitrogen fertilization
                during the season.</text>
        </description>
        <description>
            <id>1802519258</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Zea mays], using 6 arrays of array design [Affymetrix GeneChip Maize Genome
                Array [Maize]], producing 6 raw data files and 6 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="14">
        <id>1802524289</id>
        <accession>E-MEXP-2369</accession>
        <name>Transcription profiling of Saccharomyces cerevisiae genomic DNA, nucleosomal DNA and
            the yeast strain to analyse diversity of eukaryotic DNA replication origins revealed by
            genome-wide analysis of chromatin structure</name>
        <releasedate>2009-09-25</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>3</samples>
        <assays>5</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>MATa leu2-3,112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15</value>
            <value>W303-1A His3MX6-UASGal-orc2-1 URA3::GFP-TUB1</value>
        </sampleattribute>
        <sampleattribute>
            <category>nucleic acid</category>
            <value>genomic DNA</value>
            <value>nucleosomal</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>mating_type_alpha</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>GALorc2-1</value>
            <value>W303-1A</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Nucleic acid</name>
            <value>genomic DNA</value>
            <value>nucleosomal</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>GALorc2-1</value>
            <value>W303-1A</value>
        </experimentalfactor>
        <user>1802529623</user>
        <user>1802529628</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1620687160</id>
            <accession>A-AFFY-116</accession>
            <name>Affymetrix Custom Array - S. cerevisiae Tiling Steinmetz</name>
            <count>5</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802524655</id>
            <name>Affymetrix:FeatureDimension:Scerevisiae_tlg</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>5</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Diversity of Eukaryotic DNA Replication Origins Revealed by Genome-wide Analysis
                of Chromatin Structure</title>
        </bibliography>
        <provider>
            <contact>Nicolas Berbenetz</contact>
            <email>nick.berbenetz@utoronto.ca</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>organism status</experimentdesign>
        <experimentdesign>tiling path</experimentdesign>
        <description>
            <id>1802524304</id>
            <text>Genomic DNA from Saccharomyces cerevisiae W303-1A was isolated along with
                nucleosomal DNA from W303-1A and the yeast strain GAL:orc2-1. Nucleosomal DNA was
                isolated following a 2h release from a nocodazole block in which the medium was
                changed from galactose (YPAG) to glucose (YPAD).</text>
        </description>
        <description>
            <id>1802525629</id>
            <text>(Generated description) Experiment with 5 hybridizations, using 3 samples of
                species [Saccharomyces cerevisiae], using 5 arrays of array design [Affymetrix
                Custom Array - S. cerevisiae Tiling Steinmetz], producing 5 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="15">
        <id>1802567083</id>
        <accession>E-TABM-800</accession>
        <name>Transcription profiling of Drosophila melanogaster females head+thorax vs abdomen
            organism parts and high mating pressure vs low mating pressure to investigate the
            genomic transcriptional signature of mating costs</name>
        <releasedate>2009-09-25</releasedate>
        <species>Drosophila melanogaster</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Age</category>
            <value>10</value>
        </sampleattribute>
        <sampleattribute>
            <category>biological_replicate</category>
            <value>1</value>
            <value>2</value>
            <value>3</value>
            <value>4</value>
        </sampleattribute>
        <sampleattribute>
            <category>EnvironmentalHistory</category>
            <value>High mating pressure</value>
            <value>Low mating pressure</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Drosophila melanogaster</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>Abdomen</value>
            <value>Head, Thorax</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>stage</category>
            <value>Adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Dahomey</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>days post eclosion</value>
        </sampleattribute>
        <experimentalfactor>
            <name>EnvironmentalHistory</name>
            <value>High mating pressure</value>
            <value>Low mating pressure</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>Abdomen</value>
            <value>Head, Thorax</value>
        </experimentalfactor>
        <user>1802578774</user>
        <user>1802578777</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1792938173</id>
            <accession>A-AFFY-146</accession>
            <count>16</count>
        </arraydesign>
        <bibliography>
            <authors>Dave T. Gerrard, Dylan R. Edwards, Tracey Chapman</authors>
            <title>Genomic responses to the cost of mating in female fruit flies.</title>
        </bibliography>
        <provider>
            <contact>Dave Gerrard</contact>
            <email>davetgerrard@gmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1802567093</id>
            <text>In this study we examined the genomic transcriptional signature of mating costs in
                female fruitflies in which mating rate was elevated 3-4 fold. We conducted 4-fold
                biological replication and randomly sampled cohorts of females before the major
                mortality effects of the elevated mating appeared (to avoid the potentially biasing
                effects of lineage selection). We then assayed differential gene expression, in two
                different body parts (abdomen versus head+thorax), using genome wide
                microarrays.</text>
        </description>
        <description>
            <id>1802571464</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Drosophila melanogaster], using 16 arrays of array design [Affymetrix
                GeneChip Drosophila Tiling 2.0R Array [Dm_tiling2_MR]], producing 16 raw data files
                and 2 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="16">
        <id>1802712479</id>
        <accession>E-GEOD-2250</accession>
        <name>Effects of irradiation on mouselung</name>
        <releasedate>2009-09-25</releasedate>
        <samples>0</samples>
        <assays>0</assays>
        <user/>
        <secondaryaccession>GSE2250</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <provider>
            <contact>Christina Kathleen Haston</contact>
            <email>christina.haston@mcgill.ca</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802712638</id>
            <text>(Generated description) Experiment with 0 hybridizations, using 0 samples of
                species [], using 0 arrays of array design [], producing 0 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1802712492</id>
            <text>Total right lung RNA from mouse at different points in time after 18 Gy whole
                thorax irradiation. Experiment Overall Design: treated vs. control in 3
                strains</text>
        </description>
    </experiment>
    <experiment textidx="17">
        <id>1802713615</id>
        <accession>E-TABM-804</accession>
        <name>Transcription profiling of Dictyostelium discoideum strains lacking the DimB or MybE
            transcriptions factors in response to treatment with the polyketide DIF-1</name>
        <releasedate>2009-09-25</releasedate>
        <species>Dictyostelium discoideum</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Dictyostelium discoideum</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Ax2</value>
            <value>dimB-</value>
            <value>mybE-</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>DIF-1</value>
            <value>none</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>Ax2</value>
            <value>dimB-</value>
            <value>mybE-</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Time</name>
            <value>10</value>
            <value>9</value>
        </experimentalfactor>
        <user>1571506098</user>
        <user>1802751329</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1215757285</id>
            <accession>A-SGRP-3</accession>
            <name>Sanger Pathogens Dictyostelium discoideum 8579</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802719913</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-804.A-SGRP-3.1.FeatureDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>SGRP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802721760</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-804.A-SGRP-3.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>SGRP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Gareth Bloomfield</contact>
            <email>gb2@sanger.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>genetic modification</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1802713623</id>
            <text>The prototypic prestalk-specific gene ecmA is inducible by the polyketide DIF-1.
                The DimB and MybE transcription factors bind to sites in the ecmA promoter and DIF-1
                induction of ecmA in a monolayer assay is greatly diminished in null strains for
                either of the two factors. We perform genome-wide micro-array analyses, on parental
                (Ax2), mybE- and dimB- cells, and identify many additional genes that depend on MybE
                and DimB for their DIF-1 inducibility. Surprisingly, an even larger number of genes
                are only DIF-inducible in mybE- cells, some genes are only inducible in DimB- cells
                and some are inducible when either transcription factor is absent. Thus in monolayer
                assay, where MybE and DimB function as inducers of ecmA, many other genes fall under
                negative control by the same two transcription factors. There is presumably
                therefore a partially or wholly alternate DIF-1 activation pathway for the latter
                genes.</text>
        </description>
        <description>
            <id>1802736125</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Dictyostelium discoideum], using 18 arrays of array design [Sanger
                Pathogens Dictyostelium discoideum 8579], producing 18 raw data files and 1
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="18">
        <id>1802715320</id>
        <accession>E-GEOD-18003</accession>
        <name>Skin Electrovaccination: Effects on Transgene Expression, DNA Persistence and Local
            Tissue Environment</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>7</samples>
        <assays>7</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE18003</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>25874048</id>
            <accession>A-AFFY-6</accession>
            <name>Affymetrix GeneChip Murine Genome U74Av2 [MG_U74Av2]</name>
            <count>7</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802725963</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18003.MG_U74Av2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>7</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>JAMIE TIMMONS</contact>
            <email>Jamie.Timmons@gmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802715341</id>
            <text>Background: The use of electrical pulses to enhance uptake of molecules into
                living cells have been used for decades. This technique, often referred to as
                electroporation, has become an increasingly popular method to enhance in vivo DNA
                delivery for both gene. therapy applications as well as for delivery of vaccines
                against both infectious diseases and cancer. In vivo electrovaccination is currently
                being investigated in several clinical trials, including DNA delivery to healthy
                volunteers. However, the mode of action at molecular level is not yet fully
                understood. Methodology/Principal Findings: This study investigates intradermal DNA
                electrovaccination in detail and describes the effects on expression of the vaccine
                antigen, plasmid persistence and the local tissue environment. Gene profiling of the
                vaccination site is currently being evaluated in clinical trials, the data provided
                will be of high significance.. Conclusions/Significance: This study provides
                important insights to how DNA delivery by intradermal electrovaccination affects the
                local immunological responses of the skin, transgene expression and clearance of the
                plasmid. As the described vaccination approach showed that the combination of DNA
                and electroporation induced a significant up-regulation of pro-inflammatory genes.
                In vivo imaging of luciferase activity after electrovaccination demonstrated a rapid
                onset (minutes) and a long duration (months) of transgene expression. However, when
                the more immunogenic prostate specific antigen (PSA) was co-administered,
                PSA-specific T cells were induced and concurrently the luciferase expression became
                undetectable. Electroporation did not affect the long-term persistence of the
                PSA-expressing plasmid. Experiment Overall Design: untreated mice (n=4), and mice
                subjected to DNA vaccination followed by electroporation (n=3)</text>
        </description>
        <description>
            <id>1802730425</id>
            <text>(Generated description) Experiment with 7 hybridizations, using 7 samples of
                species [Mus musculus], using 7 arrays of array design [Affymetrix GeneChip Murine
                Genome U74Av2 [MG_U74Av2]], producing 0 raw data files and 7 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="19">
        <id>1802716191</id>
        <accession>E-GEOD-18037</accession>
        <name>Expression data from early response of Saccharomyces cerevisiae to the antimalarial
            drug quinine</name>
        <releasedate>2009-09-25</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <user>1802736920</user>
        <user>1802736954</user>
        <secondaryaccession>GSE18037</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>119528504</id>
            <accession>A-AFFY-27</accession>
            <name>Affymetrix GeneChip Yeast Genome S98 [YG_S98]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802728745</id>
            <name>Affymetrix:FeatureDimension:YG_S98</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802729226</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18037.YG_S98.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sandra Santos</contact>
            <email>ss.santos@ist.utl.pt</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802716205</id>
            <text>In this study, we used the eukaryotic model Saccharomyces cerevisiae to better
                understand quinine s mode of action and the mechanisms underlying the cell response
                to the drug. We performed a transcriptional profiling of the yeast response to a
                quinine concentration that exerted a very slight effect over cellular growth.
                Experiment Overall Design: Four arrays, corresponding to two replicates of each
                condition under study, were analysed.</text>
        </description>
        <description>
            <id>1802734020</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Saccharomyces cerevisiae], using 4 arrays of array design [Affymetrix
                GeneChip Yeast Genome S98 [YG_S98]], producing 4 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="20">
        <id>1802716540</id>
        <accession>E-GEOD-18026</accession>
        <name>Analysis of chronic lymphocytic leukemia CLL cells and normal B cells</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>7</samples>
        <assays>7</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE18026</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>7</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802742188</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18026.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>7</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sanjai Sharma</contact>
            <email>sasharma@mednet.ucla.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802716551</id>
            <text>We have analyzed 2 normal B cells isolated from peripheral blood and 5 CLL
                specimens with affy 133A microarray for expression. We used microarrays to analyze
                gene expression in normal B cells and CLL cells. Experiment Overall Design:
                Hybridize RNA to the chip for the above mentioned total 5 samples</text>
        </description>
        <description>
            <id>1802743814</id>
            <text>(Generated description) Experiment with 7 hybridizations, using 7 samples of
                species [Homo sapiens], using 7 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 0 raw data files and 7 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="21">
        <id>1802719179</id>
        <accession>E-GEOD-17300</accession>
        <name>Overexpression of USF1 in HEK293T cells</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17300</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802746818</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802747008</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17300.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19750004</accession>
            <authors>Christopher L Plaisier, Steve Horvath, Adriana Huertas-Vazquez, Ivette
                Cruz-Bautista, Miguel F Herrera, Teresa Tusie-Luna, Carlos Aguilar-Salinas, P ivi
                Pajukanta</authors>
            <title>A systems genetics approach implicates USF1, FADS3, and other causal candidate
                genes for familial combined hyperlipidemia.</title>
        </bibliography>
        <provider>
            <contact>Christopher Plaisier</contact>
            <email>plaisier@ucla.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802747652</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1802719200</id>
            <text>Overexpression of USF1 in HEK293T cells in vitro to ascertain the genes downstream
                of USF1. Will identify direct targets as well as indirect targets of USF1.
                Experiment Overall Design: Cloned USF1 from cDNA and transiently transfected into
                HEK293T cells. Total RNA collected 48 hours after transfection. Empty vector used as
                control. Expression of USF1 was validated using western blot, and qRT-PCR was used
                to validate differential expression.</text>
        </description>
    </experiment>
    <experiment textidx="22">
        <id>1802720423</id>
        <accession>E-GEOD-14335</accession>
        <name>Whole genome profiling of fibroblasts from Diamond-Blackfan Anemia patients</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>10</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14335</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>458263473</id>
            <accession>A-AFFY-37</accession>
            <name>Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2]</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802749117</id>
            <name>Affymetrix:FeatureDimension:HG-U133A_2</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802749290</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14335.HG-U133A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Paola Roncaglia</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802751326</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 10 samples of
                species [Homo sapiens], using 10 arrays of array design [Affymetrix GeneChip Human
                Genome U133A 2.0 [HG-U133A_2]], producing 10 raw data files and 10 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1802720438</id>
            <text>Diamond-Blackfan Anemia (DBA) is a rare inherited red cell hypoplasia
                characterized by a defect in the maturation of erythroid progenitors and is in some
                cases associated to malformations. Patients have an increased risk of solid tumors.
                Mutations have been found in several ribosomal protein (RP) genes. Studies in
                hematopoietic progenitors from patients show that the haploinsufficiency of an RP
                impairs rRNA processing and ribosome biogenesis. DBA lymphocytes and fibroblasts
                show reduced protein synthesis, and the latter display abnormal rRNA processing and
                impaired proliferation. To evaluate the involvement of non-hematopoietic tissues in
                DBA, we have analyzed global gene expression in fibroblasts from DBA patients
                compared to healthy controls. Microarray expression profiling using Affymetrix
                GeneChip Human Genome U133A 2.0 Arrays revealed that 421 genes are statistically
                significantly differentially expressed in DBA patients' fibroblasts relative to
                controls. These genes include a large cluster of ribosomal proteins and factors
                involved in protein synthesis and amino acid metabolism, as well as genes with roles
                in cell death, cancer and tissue development. Our results report for the first time
                into abnormal expression in a non-hematopoietic cell type in DBA, and support the
                hypothesis that DBA may be due to a defect in general or specific protein synthesis.
                Experiment Overall Design: Analyzed samples include fibroblasts from 4 DBA patients
                and 6 healthy controls.</text>
        </description>
    </experiment>
    <experiment textidx="23">
        <id>1802720945</id>
        <accession>E-GEOD-15050</accession>
        <name>Bacterial Adrenergic signaling</name>
        <releasedate>2009-09-25</releasedate>
        <species>Escherichia coli</species>
        <samples>11</samples>
        <assays>11</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Escherichia coli</value>
        </sampleattribute>
        <user>1802741943</user>
        <user>1802741964</user>
        <secondaryaccession>GSE15050</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>897002315</id>
            <accession>A-AFFY-56</accession>
            <name>Affymetrix GeneChip E.coli Genome 2.0 Array [E_coli_2]</name>
            <count>11</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802727148</id>
            <name>Affymetrix:FeatureDimension:E_coli_2</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>11</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802727986</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15050.E_coli_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>11</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19696934</accession>
            <authors>David T Hughes, Marcie B Clarke, Kaneyoshi Yamamoto, David A Rasko, Vanessa
                Sperandio</authors>
            <title>The QseC adrenergic signaling cascade in Enterohemorrhagic E. coli
                (EHEC).</title>
        </bibliography>
        <provider>
            <contact>David Rasko</contact>
            <email>drasko@som.umaryland.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802720963</id>
            <text>The ability to respond to stress is at the core of an organism s survival. The
                hormones epinephrine and norepinephrine play a central role in stress responses in
                mammals, which require the synchronized interaction of the whole neuroendocrine
                system. Bacteria also sense and respond to epinephrine and norepinephrine as a means
                to gauge the metabolic and immune state of the host. Mammalian adrenergic receptors
                are G-coupled protein receptors (GPCRs), bacteria, however, sense these hormones
                through histidine sensor kinases (HKs). HKs autophosphorylate in response to
                multiple signals and transfer this phosphate to response regulators (RRs). Two
                bacterial adrenergic receptors have been identified in EHEC, QseC and QseE, with
                QseE being downstream of QseC in this signaling cascade. We mapped the QseC
                signaling cascade in the deadly pathogen enterohemorrhagic E. coli (EHEC), which
                exploits this signaling system to promote disease. Through QseC, EHEC activates
                expression of metabolic, virulence and stress response genes, synchronizing the cell
                response to these stress hormones. Coordination of these responses is achieved by
                QseC phosphorylating three of the thirty two EHEC RRs. The QseB RR, which is QseC s
                cognate RR, activates the flagella regulon which controls bacteria motility and
                chemotaxis. The QseF RR, which is phosphorylated by the QseE adrenergic sensor,
                coordinates expression of virulence genes involved in formation of lesions in the
                intestinal epithelia by EHEC, and the bacterial SOS stress response. The third RR,
                KdpE, controls potassium uptake, osmolarity response, and also the formation of
                lesions in the intestine. Adrenergic regulation of bacterial gene expression shares
                several parallels with mammalian adrenergic signaling having profound effects in the
                whole organism. Understanding adrenergic regulation of a bacterial cell is a
                powerful approach to study the underlying mechanisms of stress and cellular
                survival. Experiment Overall Design: Microarray comparisons reveal some trends with
                respect to signaling cascades. Comparative methods were used to identify
                networks.</text>
        </description>
        <description>
            <id>1802735644</id>
            <text>(Generated description) Experiment with 11 hybridizations, using 11 samples of
                species [Escherichia coli], using 11 arrays of array design [Affymetrix GeneChip
                E.coli Genome 2.0 Array [E_coli_2]], producing 11 raw data files and 11 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="24">
        <id>1802720951</id>
        <accession>E-GEOD-17995</accession>
        <name>Role of ICOS:ICOSL interaction in acute GVHD</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>7</samples>
        <assays>7</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17995</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>447429329</id>
            <accession>A-AFFY-36</accession>
            <name>Affymetrix GeneChip Mouse Genome 430A 2.0 [Mouse430A_2]</name>
            <count>7</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802735746</id>
            <name>Affymetrix:FeatureDimension:MOE430A</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>7</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802735917</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17995.Mouse430A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>7</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Guenther HS Richter</contact>
            <email>guenther.richter@lrz.tum.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802720967</id>
            <text>Inducible co-stimulator (ICOS) interaction with its ligand (ICOSL) is involved in
                several T cell effector functions. While blockade of ICOS:ICOSL interaction in
                chronic graft versus host disease (GVHD) seems benefi cial, results for acute GVHD
                remain controversial. To further elucidate its role in acute GVHD, C57BL / 6 mice
                were lethally irradiated and reconstituted with allogeneic spleen cells in the
                absence or presence of ICOSL-blocking mAb. Mice reconstituted with allogeneic spleen
                cells experienced severe GVHD and died untreated within 6 9 days after
                transplantation. Mice treated with an anti-ICOSL mAb starting from day 3 after
                transplantation gained weight again and survived for at least additional 12 days,
                although the treatment was already stopped at day 11 after transplantation. In
                contrast, the anti-ICOSL treatment starting from day 0 did not prevent GVHD. The
                diff erence between therapeutic (day 3) and prophylactic (day 0) anti-ICOSL
                treatment was independent of CD25 + CD4 + regulatory T cells since their depletion
                did not abrogate the therapeutic eff ect of ICOSL blockade. Microarray analysis
                revealed IFN- and chemokine up-regulation in spleen cells of prophylactically
                treated mice, emphasizing kinetic dependence of acute GVHD modulation via blockade
                of ICOS:ICOSL interaction. Experiment Overall Design: B6 recipients were irradiated
                with 10.0 Gray, administered from a 137 Cs source. Splenocytes from C3H mice were
                prepared as single cell suspensions in PBS, depleted of red blood cells and counted.
                2 3 10^7 C3H splenocytes in a volume of 200 l were transplanted into B6 recipients
                via tail vein injection (4 mice per group per experiment) 4 6 h after irradiation.
                Mice in the treatment group with anti-ICOSL mAb and their respective controls,
                received 500 g mAb i. p starting at day 0 or day 3, followed by subsequent
                injections of 200 g of mAb every other day. At day 4 after transplantation RNA of
                spleen cells was prepared and subjected to microarray analysis. Combined RNA from
                allogeneic transplanted mice was hybridized onto 2 independent arrays.</text>
        </description>
        <description>
            <id>1802737618</id>
            <text>(Generated description) Experiment with 7 hybridizations, using 7 samples of
                species [Mus musculus], using 7 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430A 2.0 [Mouse430A_2]], producing 7 raw data files and 7 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="25">
        <id>1802733232</id>
        <accession>E-GEOD-18071</accession>
        <name>Chloroplast polynucleotide phosphorylase null mutant (pnp1-1) and phosphate
            starvation</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1802773602</user>
        <user>1802773606</user>
        <secondaryaccession>GSE18071</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802761789</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802762794</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18071.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19710229</accession>
            <authors>Yehudai-Resheff Marchive, Fei Germain, Judkins Jiang, Fernie Wu, Stern
                Fait</authors>
            <title>Abnormal physiological and molecular mutant phenotypes link chloroplast
                polynucleotide phosphorylase to the phosphorus deprivation response in
                Arabidopsis.</title>
        </bibliography>
        <provider>
            <contact>Chloe Marchive</contact>
            <email>cm363@cornell.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802733258</id>
            <text>A prominent enzyme in organellar RNA metabolism is the exoribonuclease
                polynucleotide phosphorylase (PNPase), whose reversible activity is governed by the
                nucleotides diphosphate-inorganic phosphate ratio. In Chlamydomonas reinhardtii,
                PNPase regulates chloroplast transcript accumulation in response to phosphorus (P)
                starvation, and PNPase expression is repressed by the response regulator PSR1 under
                these conditions. Here, we investigated the role of PNPase in the Arabidopsis
                (Arabidopsis thaliana) P deprivation response by comparing wild-type and pnp mutant
                plants with respect to their morphology, metabolite profiles, and transcriptomes. We
                found that P-deprived pnp mutants develop aborted clusters of lateral roots, which
                are characterized by decreased auxin responsiveness and cell division, and exhibit
                cell death at the root tips. Electron microscopy revealed that the collapse of root
                organelles is enhanced in the pnp mutant under P deprivation and occurred with low
                frequency under P-replete conditions. Global analyses of metabolites and transcripts
                were carried out to understand the molecular bases of these altered P deprivation
                responses. We found that the pnp mutant expresses some elements of the deprivation
                response even when grown on a full nutrient medium, including altered transcript
                accumulation, although its total and inorganic P contents are not reduced. The pnp
                mutation also confers P status-independent responses, including but not limited to
                stress responses. Taken together, our data support the hypothesis that the activity
                of the chloroplast PNPase is involved in plant acclimation to P availability and
                that it may help maintain an appropriate balance of P metabolites even under normal
                growth conditions. Experiment Overall Design: For each timepoints (3h and one week),
                we compared WT and pnp1-1 on +P and on -P, so a total of eight conditions For each
                condition, three biological replicates of at least 4 seedlings (without roots) were
                analyzed.</text>
        </description>
        <description>
            <id>1802767287</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Arabidopsis thaliana], using 24 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 24 raw data files and 24 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="26">
        <id>1802734482</id>
        <accession>E-GEOD-18042</accession>
        <name>Erythroid differentiation: G1E model</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1802887314</user>
        <user>1802887331</user>
        <secondaryaccession>GSE18042</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802779014</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802780624</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18042.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ross Hardison</contact>
            <email>rch8@psu.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802734502</id>
            <text>Analysis of erythroid differentiation using Gata1 gene-disrupted G1E ER4 clone
                cells. Estradiol addition activates an ectopically expressed Gata-1-estrogen
                receptor fusion protein, triggering synchronous differentiation. 30 hour time course
                corresponds roughly to late burst-forming unit-erythroid stage (t=0 hrs) through
                orthochromatic erythroblast stage (t=30 hrs). Experiment Overall Design: G1E ER4
                cells cultured in G1E medium were treated at 6 time points with estradiol to
                initiate erythroid differentiation by activating Gata1 transcription factor and
                total RNAs from treated cells were extracted for microarray experiment. The
                erythroid differentiation status was confirmed by cell pellet color and expression
                of microRNA miR451. The design was similar to an earlier studies (Welch, J. J.,
                Watts, J. A., Vakoc, C. R., Yao, Y., Wang, H., Hardison, R. C., Blobel, G. A.,
                Chodosh, L. A., and Weiss, M. J. (2004)). Global regulation of erythroid gene
                expression by transcription factor GATA-1. Blood 104, 3136-3147), except that a more
                recent version of Affymetric chip was used to acheive greater transcriptome
                coverage.</text>
        </description>
        <description>
            <id>1802796442</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Mus musculus], using 18 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 18 raw data files and 18 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="27">
        <id>1802735324</id>
        <accession>E-GEOD-17994</accession>
        <name>Expression Profiling of brain samples from wt and SCA3 tg animals after CCI-779 and
            placebo treatment</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>19</samples>
        <assays>19</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17994</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>19</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802779053</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>19</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>19</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802780756</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17994.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>19</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>19</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Michael Bonin</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802796449</id>
            <text>(Generated description) Experiment with 19 hybridizations, using 19 samples of
                species [Mus musculus], using 19 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 19 raw data files and 19 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1802735334</id>
            <text>Spinocerebellar ataxia type 3 is a neurodegenerative disorder caused by the
                expansion of the polyglutamine repeat region within the ataxin-3 protein. The mutant
                protein forms intracellular aggregates in the brain. However, the cellular
                mechanisms causing toxicity are still poorly understood and there are currently no
                effective treatments. In this study we show that administration of a rapamycin
                ester, CCI-779, improves motor performance in a transgenic mouse model of SCA3.
                CCI-779 inhibits mammalian target of rapamycin (mTOR) and hence upregulates protein
                degradation by autophagy. CCI-779 reduces the number of aggregates seen in the
                brains of transgenic mice and decreases levels of cytosolic soluble mutant ataxin-3,
                while endogenous wild-type protein levels remain unaffected. CCI-779 is designed for
                long-term use in patients and therefore represents a possible therapeutic strategy
                for the treatment of SCA3. Using this disease model and treatment paradigm we
                employed a microarray approach to investigate transcriptional changes that might be
                important in the pathogenesis of SCA3. This approach identified Usp15, which showed
                expression changes at both the mRNA and protein level. Usp15 levels were also
                changed in mice expressing another mutant polyglutamine protein, huntingtin. In
                total we identified 16 transcripts that were decreased in transgenic ataxin-3 mice
                that were normalised following CCI-779 treatment, as the number of transcripts
                changed was low and the magnitude of these changes was small we suggest that
                transcriptional dysregulation may not be an important step in the primary
                pathogenesis of SCA3. Experiment Overall Design: We analyzed 19 brain samples in
                total. 4 samples from wt animals after placebo treatment. 5 samples from wt animals
                after CCI-779 treatment. 5 samples from SCA3 tg animals after placebo treatment. 5
                samples from SCA3 tg animals after CCI-779 treatment.</text>
        </description>
    </experiment>
    <experiment textidx="28">
        <id>1802737226</id>
        <accession>E-GEOD-18047</accession>
        <name>Classical and/or alternative NF-kB pathway activation in multiple myeloma
            pathogenesis</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1802892932</user>
        <user>1802892936</user>
        <secondaryaccession>GSE18047</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802785072</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802787926</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18047.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Oleg Konstantin Glebov</contact>
            <email>glebovo@mail.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802737243</id>
            <text>Mutations involving the NFKB pathway are present in at least 17% of multiple
                myeloma (MM) tumors and 40% of MM cell lines (MMCL). These mutations, which are
                thought to be progression events, enable MM tumors to become less dependent on
                extrinsic bone marrow signals that activate NFKB. Studies on a panel of 50 MMCL
                provide some clarification of the mechanisms through which these mutations act and
                the significance of classical vs alternative activation of NFKB. First, only one
                mutation (NFKB2) selectively activates the alternative pathway, whereas several
                mutations (CYLD, NFKB1, TACI) selectively activate the classical pathway. However,
                most mutations affecting NIK level (NIK, TRAF2, TRAF3, cIAP1&amp;2, CD40)
                activate the alternative but often both pathways. Second, we confirm the critical
                role of TRAF2 in regulating NIK degradation, whereas TRAF3 enhances but is not
                essential for cIAP1/2-mediated proteosomal degradation of NIK in MM. Third, using
                transfection to selectively activate the classical or alternative NFKB pathways, we
                show virtually identical changes in gene expression in one MMCL, whereas the changes
                are similar albeit non-identical in a second MMCL. Together, our results suggest
                that MM tumors can achieve increased autonomy from the bone marrow microenvironment
                by mutations that activate either NFKB pathway. Experiment Overall Design: Total RNA
                was isolated from both H929 and SACHI cell lines at 3 consecutive time points after
                infection with retroviruses containing NIK-gene, IKKB-gene, or no gene of interest,
                providing 3 replicate RNA samples for each cell line and infection variant. These
                RNA samples were processed and hybridized according to Affymetrix protocols. In
                total, 2(cell lines) x 3 (infection variants) x 3(time points) = 18 arrays were
                hybridized and analyzed.</text>
        </description>
        <description>
            <id>1802870965</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Homo sapiens], using 18 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 18 raw data files and 18
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="29">
        <id>1802738350</id>
        <accession>E-GEOD-14395</accession>
        <name>Gender-specific gene repression of PPAR-alpha KO mice in liver and heart</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1681015336</user>
        <user>1802891224</user>
        <secondaryaccession>GSE14395</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802779250</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802781274</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14395.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19729835</accession>
            <authors>Pradervand Leuenberger, Wahli</authors>
            <title>Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver
                from estrogen-induced toxicity in mice.</title>
        </bibliography>
        <provider>
            <contact>Sylvain Pradervand</contact>
            <email>Sylvain.Pradervand@unil.ch</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802738368</id>
            <text>Most metabolic studies are conducted in male animals; thus, the molecular
                mechanism controlling gender-specific pathways has been neglected, including
                sex-dependent responses to peroxisome proliferator-activated receptors (PPARs). Here
                we show that PPARalpha has broad female-dependent repressive actions on hepatic
                genes involved in steroid metabolism and inflammation. In males, this effect is
                reproduced by the administration of synthetic PPARalpha ligand. Using the steroid
                hydroxylase gene Cyp7b1 as a model, we elucidated the molecular mechanism of this
                PPARalpha-dependent repression. Initial sumoylation of the ligand-binding domain of
                PPARalpha triggers the interaction of PPARalpha with the GA-binding protein alpha
                bound to the target promoter. Histone deacetylase is then recruited, and histones
                and adjacent Sp1-binding site are methylated. These events result in the loss of
                Sp1-stimulated expression, and thus the down-regulation of Cyp7b1. Physiologically,
                this repression confers protection against estrogen-induced intrahepatic
                cholestasis, paving the way for a novel therapy against the most common hepatic
                disease during pregnancy. Experiment Overall Design: Expression profile difference
                between male and female PPARalpha wild-type and knock-out mice in liver and heart (3
                pools of 4 animals in each group). Wild-type (12 males and 12 females) and knock-out
                PPARalpha SV129 mice (12 males and 12 females) approximately 10 to 12 weeks of age
                were killed at ZT14 and their livers and hearts quickly removed and frozen.</text>
        </description>
        <description>
            <id>1802833663</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Mus musculus], using 24 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 24 raw data files and 24 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="30">
        <id>1802738701</id>
        <accession>E-GEOD-12748</accession>
        <name>Weighted Gene Coexpression Network Analysis Identifies Biomarkers in Glycerol Kinase
            Deficient Mice</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>7</samples>
        <assays>7</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12748</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>7</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802778533</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>7</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802779415</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12748.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>7</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Nicole Kim MacLennan</contact>
            <email>nmaclennan@mednet.ucla.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802738717</id>
            <text>Symptomatic glycerol kinase deficiency (GKD) is associated with episodic metabolic
                and central nervous system deterioration. We report here the first application of
                Weighted Gene Co-Expression Network Analysis (WGCNA) to investigate a knockout (KO)
                murine model of a human genetic disease. WGCNA identified networks and key hub
                transcripts from liver mRNA of glycerol kinase (Gyk) KO and wild type (WT) mice. Day
                of life 1 (dol1) samples from KO mice contained a network module enriched for
                organic acid metabolism before Gyk KO mice develop organic acidemia and die on
                dol3-4 and the module containing Gyk was enriched with apoptotic genes. Roles for
                the highly connected Acot, Psat and Plk3 transcripts were confirmed in cell cultures
                and subsequently validated by causality testing. We provide evidence that GK may
                have an apoptotic moonlighting role that is lost in GKD. This systems biology
                strategy has improved our understanding of GKD pathogenesis and suggests possible
                treatments. Experiment Overall Design: Male WT and KO mouse pups were sacrificed on
                day of life (dol) 1 and each liver was harvested. Total RNA from 4 KO and 3 WT
                livers was isolated individually. Affymetrix mus 430 2.0 GeneChips were used to
                analyze differences in liver gene expression between KO and WT mice. Dol1 and 3 Gyk
                KO mice represent different disease states. Dol 1 was chosen because mice are
                phenotypically asymptomatic with respect to Glycerol Kinase Deficiency (GKD) and
                allowed us to look at alterations that occur before the overt disease state. Dol 3
                mice are phenotypically symptomatic with respect to GKD.</text>
        </description>
        <description>
            <id>1802783141</id>
            <text>(Generated description) Experiment with 7 hybridizations, using 7 samples of
                species [Mus musculus], using 7 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 7 raw data files and 7 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="31">
        <id>1802742158</id>
        <accession>E-GEOD-18000</accession>
        <name>Gene expression comparison of drug-resistant Panc1/mock cells and Panc1 cells
            expressing wildtype syk</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE18000</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>2</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802784514</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18000.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>2</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jian-Liang Li</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802742180</id>
            <text>We recently identified the nonreceptor tyrosine kinase syk as a tumor suppressor
                in pancreatic ductal adenocarcinoma cells. Reintroduction of syk into Panc1 cells
                promoted a more differentiated phenotype and retarded invasion and tumorigenic
                growth. Gene array analysis identified over 2,000 transcripts differentially
                expressed at FDR&lt;0.01. Among these were members of the MMP2 axis, which were
                subsequently shown to regulate Panc1 invasion. Experiment Overall Design: Affymetrix
                global gene arrays were used to analyse differences in gene expression patterns in
                Panc1 cells stably reexpressing syk, or vector-only mock controls. RNA was harvested
                from cells grown under identical conditions in standard culture.</text>
        </description>
        <description>
            <id>1802786520</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Homo sapiens], using 2 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 2 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="32">
        <id>1802745170</id>
        <accession>E-GEOD-17967</accession>
        <name>RMA expression data for liver samples from subjects with HCV cirrhosis with and
            without concomitant HCC</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>63</samples>
        <assays>63</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1718051884</user>
        <user>1802787968</user>
        <secondaryaccession>GSE17967</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>458263473</id>
            <accession>A-AFFY-37</accession>
            <name>Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2]</name>
            <count>63</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802767869</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17967.HG-U133A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>63</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>63</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Kellie Archer</contact>
            <email>kjarcher@vcu.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802745190</id>
            <text>In this study, we used the Affymetrix HG-U133A 2.0 GeneChip for deriving a
                multigenic classifier capable of predicting HCV+cirrhosis with vs without
                concomitant HCC. We studied gene expression in cirrhotic tissues with (N=16) and
                without (N=47) HCC. Experiment Overall Design: Liver tissue samples were obtained
                from patients waiting for liver transplantation. For each sample, RNA was extracted
                and hybridized to an Affymetrix GeneChip.</text>
        </description>
        <description>
            <id>1802775754</id>
            <text>(Generated description) Experiment with 63 hybridizations, using 63 samples of
                species [Homo sapiens], using 63 arrays of array design [Affymetrix GeneChip Human
                Genome U133A 2.0 [HG-U133A_2]], producing 0 raw data files and 63 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="33">
        <id>1802746212</id>
        <accession>E-GEOD-14561</accession>
        <name>Expression data of murine GPI-deficient bone marrow cells in a mouse model of targeted
            Pig-a deletion</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>17</samples>
        <assays>17</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14561</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>17</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802778971</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>17</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>17</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802780528</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14561.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>17</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>17</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Valeria Visconte</contact>
            <email>viscontev@mail.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802746231</id>
            <text>Somatic mutation in the X-linked phosphatidylinositol glycan class A (PIG-A) gene
                causes glycosylphosphatidylinositol (GPI) anchor deficiency in humans with
                Paroxysmal Nocturnal Hemoglobinuria (PNH). Clinically, patients with PNH have
                intravascular hemolysis, venous thrombosis and bone marrow failure. We produced a
                conditional Pig-a knock-out mouse model specifically inactivating the Pig-a gene in
                hematopoietic cells to study the role of PIG-A deficiency in PNH pathophysiology. We
                used Affymetrix Mouse Genome 430 2.0 chips to investigate the gene expression
                pattern in the mouse model of targeted Pig-a deletion. Experiment Overall Design: We
                performed microarray analysis on 3 pools of sorted GPI-deficient (GPI-) and GPI
                normal (GPI+) bone marrow cells derived from the same Pig-a knock-out animals, and
                identified 1275/669 genes of the 45,101 transcripts potentially available for
                screening using 2-fold change, &lt;10% false discovery rate (FDR) and percentage
                of present calls as selection criteria. The major representative genes belong to the
                category of immune response. We tested whether the molecular differences between
                GPI- and GPI+ bone marrow cells could be preserved when GPI- cells were transplanted
                in lethally-irradiated wild type mice (C57BL/6). Microarray analysis was performed
                using sorted bone marrow cells from 4 animals transplanted with GPI-deficient bone
                marrow cells (T-GPI-) from Pig-a knock-out donors, 3 animals transplanted with
                GPI-normal bone marrow cells from C57BL/6 donors (T-GPI+), and GPI-normal bone
                marrow cells from 4 wild-type C57BL/6 mice (WT-GPI+). We found 296 probesets with
                2-fold change cutoff, of which T-GPI- cells had 145 up-regulated genes in comparison
                to WT-GPI+ cells, and had 123 genes differentially expressed when compared to T-GPI+
                cells. The gene expression of the GPI-deficient cells was very similar between the
                two sets of microarray experiments affirming the maintenance of the phenotype before
                and after bone marrow cell transplantation.</text>
        </description>
        <description>
            <id>1802795978</id>
            <text>(Generated description) Experiment with 17 hybridizations, using 17 samples of
                species [Mus musculus], using 17 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 17 raw data files and 17 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="34">
        <id>1802749988</id>
        <accession>E-GEOD-18007</accession>
        <name>Genome-wide analysis of TOC1-ox transcriptional networks</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1802774206</user>
        <user>1802774226</user>
        <secondaryaccession>GSE18007</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802772411</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18007.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Paloma Mas</contact>
            <email>pmmgmc@cid.csic.es</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802750016</id>
            <text>To gain insights into the mechanisms of TOC1 function in the Arabidopsis circadian
                clock we performed transcriptional profiling of Wild-Type (WT) and and TOC1
                overexpressor plants (TOC1-ox). Experiment Overall Design: Comparisons of WT and
                TOC1-ox. Three biological replicates synchronized under 12-hour light:12-hour dark
                (LD) cycles for 12 days. Samples were collected at Zeitgeber Time 15 (ZT15).</text>
        </description>
        <description>
            <id>1802772840</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Arabidopsis thaliana], using 6 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 0 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="35">
        <id>1802754353</id>
        <accession>E-GEOD-18043</accession>
        <name>Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast
            differentiation and osteogenesis</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE18043</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802794661</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802796444</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18043.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Thomas H upl</contact>
            <email>thomas.haeupl@charite.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802754367</id>
            <text>Human adult mesenchymal stromal cells (hMSC) have the potential to differentiate
                into chondrogenic, adipogenic or osteogenic lineages, providing a potential source
                for tissue regeneration. An important issue for efficient bone regeneration is to
                identify factors that can be targeted to promote the osteogenic potential of hMSCs.
                Using transcriptomic analysis, we found that integrin alpha5 (ITGA5) expression is
                upregulated during dexamethasone-induced hMSCs osteoblast differentiation.
                Gain-of-function studies showed that ITGA5 promotes the expression of osteoblast
                phenotypic markers as well as in vitro osteogenesis in hMSCs. Downregulation of
                endogenous ITGA5 using shRNA blunted osteoblast marker expression and osteogenic
                differentiation. Pharmacological and molecular analyses showed that the enhanced
                hMSCs osteoblast differentiation induced by ITGA5 was mediated by activation of
                FAK/ERK1/2-MAPKs and PI3K signaling pathways. Remarkably, activation of ITGA5 using
                a specific antibody that primes the integrin or a peptide that specifically
                activates ITGA5 was sufficient to enhance ERK1/2-MAPKs and PI3K signaling and to
                promote osteoblast differentiation and osteogenic capacity of hMSCs. We also
                demonstrate that hMSCs engineered to over-express ITGA5 exhibited a marked increase
                in their osteogenic potential in vivo. These findings not only reveal that ITGA5 is
                required for osteoblast differentiation of adult human MSCs but also provide a novel
                targeted strategy using ITGA5 agonists to promote the osteogenic capacity of hMSCs,
                which may be used for tissue regeneration in bone disorders where the recruitment or
                capacity of MSCs is compromised. Experiment Overall Design: Gene expression profiles
                were generated from bone marrow MSC before and 1, 3 and 7 days after stimulation
                with 10E-7M dexamethasone to study the early molecular processes of osteogenic
                differentiation. 3 replicates per timepoint.</text>
        </description>
        <description>
            <id>1802885413</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Homo sapiens], using 12 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 12 raw data files and 12
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="36">
        <id>1802754477</id>
        <accession>E-GEOD-12842</accession>
        <name>Gene expression in grapevine in response to Bois noir infection</name>
        <releasedate>2009-09-25</releasedate>
        <species>Vitis vinifera</species>
        <samples>10</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Vitis vinifera</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802766165</user>
        <secondaryaccession>GSE12842</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1293425370</id>
            <accession>A-AFFY-78</accession>
            <name>Affymetrix GeneChip Vitis vinifera (Grape) Genome Array [Vitis_Vinifera]</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802756819</id>
            <name>Affymetrix:FeatureDimension:Vitis_Vinifera</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802757369</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12842.Vitis_Vinifera.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>PLEXdb Curator Sudhansu Dash</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802754490</id>
            <text>Transcriptional changes in field-grown plants of Vitis Vinifera cultivars
                'Chardonnay' and 'Incrocio Manzoni' naturally infected with Bois Noir phytoplasma,
                compared to healthy samples. SUBMITTER_CITATION: Albertazzi G., Caffagni A., Milc
                J.A., Francia E., Roncaglia E., Ferrari F., Tagliafico E., Stefani E., Pecchioni N.
                (2009) Gene expression in grapevine cultivars in response to Bois Noir phytoplasma
                infection. Plant Science 176: 792-804. ****[PLEXdb(http://www.plexdb.org) has
                submitted this series at GEO on behalf of the original contributor, Nicola
                Pecchioni. The equivalent experiment is VV14 at PLEXdb.] Experiment Overall Design:
                genotype: Chardonnay - disease type: Bois Noir infected(3-replications); genotype:
                Chardonnay - disease type: Healthy(3-replications); genotype: Incrocio Manzoni -
                disease type: Bois Noir infected(2-replications); genotype: Incrocio Manzoni -
                disease type: Healthy(2-replications)</text>
        </description>
        <description>
            <id>1802760456</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 10 samples of
                species [Vitis vinifera], using 10 arrays of array design [Affymetrix GeneChip Vitis
                vinifera (Grape) Genome Array [Vitis_Vinifera]], producing 10 raw data files and 10
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="37">
        <id>1802755267</id>
        <accession>E-GEOD-14334</accession>
        <name>Transcriptomic analysis of human lung development</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>38</samples>
        <assays>38</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14334</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>38</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802796168</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>38</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>38</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802828627</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14334.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>38</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>38</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Alvin Kho</contact>
            <email>alvin_kho@hms.harvard.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802892953</id>
            <text>(Generated description) Experiment with 38 hybridizations, using 38 samples of
                species [Homo sapiens], using 38 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 38 raw data files and 38
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1802755278</id>
            <text>We decompose the genome-wide expression patterns in 38 embryonic human lung
                (53-154 days post conception/dpc) into their independent, dominant directions of
                transcriptomic sample variation in order togain global insight of the developing
                human lung transcriptome.The characteristic genes and their corresponding bio
                ontologic attribute profile for the latter were identified. We noted the over
                representation of lung specific attributes (e.g., surfactant proteins) traditionally
                associated with later developmental stages, and highly ranked attributes (e.g.,
                chemokine immunologic processes) not previously reported nor immediately apparent in
                an early lung development context. We defined the 3,223 gene union of the
                characteristic genes of the 3 most dominant sources of variation as the developing
                lung characteristic sub transcriptome (DLCS). It may be regarded as the minimal gene
                set describing the essential biology of this process. The developing lung series in
                this transcriptomic variation perspectiveform a contiguous trajectory with critical
                time points that both correlate with the 2 traditional morphologic stages
                overlapping -154 dpc and suggest the existence of 2 novel phases within the
                pseudoglandular stage. To demonstrate that this characterization is robust, we
                showed that the model could be used to estimate the gestational age of independent
                human lung tissue samples with a median absolute error of 5 days, based on the DLCS
                of their lung profile alone. Repeating this procedure on the homologous
                transcriptome profiles of developing mouse lung 14 19 dpc, we were able to recover
                their correct developmental chronology. Whole human fetal lung gene expression
                profiling from estimated gestational ages 53 to 154 days post conception. Experiment
                Overall Design: Time series with biological replicates.</text>
        </description>
    </experiment>
    <experiment textidx="38">
        <id>1802757572</id>
        <accession>E-GEOD-12930</accession>
        <name>Induction of the IL-6/signal transducer and activator of transcription pathway in the
            lungs of mice exposed to tobacco</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>78</samples>
        <assays>39</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802787487</user>
        <secondaryaccession>GSE12930</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1285385262</id>
            <accession>A-AGIL-23</accession>
            <name>Agilent Mouse Oligo Microarray (V2) 013326 G4121B</name>
            <count>39</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802768100</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768600</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802767959</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802767983</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768019</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768046</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768074</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768107</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768118</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768170</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768212</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768234</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768252</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768288</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768307</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768319</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768344</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768371</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768394</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768410</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768434</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768448</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768465</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768486</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768512</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768532</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768568</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768624</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768673</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768699</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768719</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768755</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768804</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768841</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768860</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768890</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768909</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768925</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802768947</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12930.A-AGIL-23.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19698101</accession>
            <authors>Sabina Halappanavar, Marsha Russell, Martin R Stampfli, Andrew Williams, Carole
                L Yauk</authors>
            <title>Induction of the interleukin 6/ signal transducer and activator of transcription
                pathway in the lungs of mice sub-chronically exposed to mainstream tobacco
                smoke.</title>
        </bibliography>
        <provider>
            <contact>Andrew Williams</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802775333</id>
            <text>(Generated description) Experiment with 39 hybridizations, using 78 samples of
                species [Mus musculus], using 39 arrays of array design [Agilent Mouse Oligo
                Microarray (V2) 013326 G4121B], producing 0 raw data files and 39 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1802757583</id>
            <text>We have examined the impact of subchronic levels of tobacoo smoke on murine lungs.
                We have used high density DNA microarray and analysed lung tissues from mice exposed
                to mainstream tobacco smoke (MTS). Our results reveal induction of inflammatory
                cytokine interleukin-6 (IL-6) and its antagonist suppressor of cytokine signalling
                (SOCS3) mRNA in smoking group. We also show that these changes are transient and are
                reversed completely after a period of cessation of smoking. Experiment Overall
                Design: Male C57B1/CBA mice were exposed to MTS from two cigarettes daily, 5
                days/week for 6 or 12 weeks. Mice were sacrificed immediately, or six weeks
                following the last cigarette. Left lung lobes were removed and flash frozen. Total
                RNA was isolated from a small part of the frozen lung and was hybridized against
                universal mouse reference RNA to Agilent Oligo DNA microarrays (Agilent
                Technologies) containing 22,000 transcripts. Microarrays were normalized using a
                global LOWESS approach and analyzed by MAANOVA 2.0 and SAM. Microarray results were
                validated by real time RT-PCR. Impact of alteration in expression of select genes
                was further validated by analysing their total protein levels in lung tissue
                homogenates.</text>
        </description>
    </experiment>
    <experiment textidx="39">
        <id>1802764252</id>
        <accession>E-GEOD-17170</accession>
        <name>A systems genetics approach implicates USF1, FADS3 and other causal candidate genes
            for familial combined hyperlipidemia</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>70</samples>
        <assays>70</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17170</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>70</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802773135</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>70</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>70</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802775036</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17170.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>70</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>70</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19750004</accession>
            <authors>Christopher L Plaisier, Steve Horvath, Adriana Huertas-Vazquez, Ivette
                Cruz-Bautista, Miguel F Herrera, Teresa Tusie-Luna, Carlos Aguilar-Salinas, P ivi
                Pajukanta</authors>
            <title>A systems genetics approach implicates USF1, FADS3, and other causal candidate
                genes for familial combined hyperlipidemia.</title>
        </bibliography>
        <provider>
            <contact>Christopher Plaisier</contact>
            <email>plaisier@ucla.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802888915</id>
            <text>(Generated description) Experiment with 70 hybridizations, using 70 samples of
                species [Homo sapiens], using 70 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 70 raw data files and 70
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1802764265</id>
            <text>Assessment of mRNA expression levels in fat biopsies from subcutaneous adipose
                tissue from unrelated individuals. Experiment Overall Design: Subcutaneous adipose
                tissue from 70 unrelated individuals.</text>
        </description>
    </experiment>
    <experiment textidx="40">
        <id>1802766524</id>
        <accession>E-GEOD-15169</accession>
        <name>Repertoire and evolution of miRNA genes in four divergent nematode species</name>
        <releasedate>2009-09-25</releasedate>
        <species>Caenorhabditis briggsae</species>
        <species>Caenorhabditis elegans</species>
        <species>Caenorhabditis remanei</species>
        <species>Pristionchus pacificus</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Caenorhabditis briggsae</value>
            <value>Caenorhabditis elegans</value>
            <value>Caenorhabditis remanei</value>
            <value>Pristionchus pacificus</value>
        </sampleattribute>
        <user>1797360001</user>
        <user>1804908659</user>
        <secondaryaccession>GSE15169</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1802764191</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-15169.VirtualArrayDesign</accession>
            <count>4</count>
        </arraydesign>
        <provider>
            <contact>Eugene Berezikov</contact>
            <email>e.berezikov@niob.knaw.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802766535</id>
            <text>We have performed small RNA sequencing in the nematodes Caenorhabditis elegans, C.
                briggsae, C. remanei and Pristionchus pacificus, which have diverged up to 400
                million years ago, to establish the repertoire and evolutionary dynamics of miRNAs
                in these species. In addition to previously known miRNA genes from C. elegans and C.
                briggsae we demonstrate expression of many of their homologs in C. remanei and P.
                pacificus, and identified in total more than 100 novel expressed miRNA genes, the
                majority of which belong to P. pacificus. More than half of all identified miRNA
                genes were found to be conserved at the seed level in all four nematode species,
                whereas only a few miRNAs appear to be species-specific. In our compendium of miRNAs
                we observed evidence for known mechanisms of miRNA evolution, including antisense
                transcription and arm switching, as well as miRNA family expansion through gene
                duplication. In addition, we identified a novel mode of miRNA evolution, termed
                hairpin shifting , in which an alternative hairpin is formed with up- or downstream
                sequences, leading to shifting of the hairpin and creation of novel miRNA* species.
                Finally, we identified 21U-RNAs in all four nematodes, including P. pacificus, where
                the upstream 21U-RNA motif is more diverged. However, the genomic distribution of
                21U-RNA clusters in P. pacificus appears more scattered throughout the genome as
                compared to C. elegans. The identification and systematic analysis of small RNA
                repertoire in four nematode species described here provides a valuable resource for
                understanding the evolutionary dynamics of miRNA-mediated gene regulation.
                Experiment Overall Design: Small RNAs were cloned from mixed stage animals.
                Sequencing was performed using the 454 GS FLX platform.</text>
        </description>
        <description>
            <id>1802767461</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Caenorhabditis elegans, Caenorhabditis briggsae, Pristionchus pacificus,
                Caenorhabditis remanei], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-15169], producing 0 raw data files and 12 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="41">
        <id>1802770036</id>
        <accession>E-GEOD-18225</accession>
        <name>Expression data from early anther</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1802832044</user>
        <user>1802832330</user>
        <secondaryaccession>GSE18225</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>9</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802783963</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>9</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802785027</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18225.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>9</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Xuan Ma</contact>
            <email>xxm108@psu.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802794736</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Arabidopsis thaliana], using 9 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 9 raw data files and 9 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1802770050</id>
            <text>We performed microarray experiments with RNAs from dissected immature anthers
                (stages 4-7) from wild-type, dyt1 and ams mutant plants, using the Affymetrix ATH1
                chip. Experiment Overall Design: Anthers from Arabidopsis thaliana were selected at
                4-7 stages of early development for RNA extraction and hybridization on Affymetrix
                microarrays. Samples from two mutants and wild-type anther.</text>
        </description>
    </experiment>
    <experiment textidx="42">
        <id>1802772984</id>
        <accession>E-GEOD-13130</accession>
        <name>Langerhans cells from aryl hydrocarbon receptor deficient mice</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1759694197</user>
        <user>1802797828</user>
        <secondaryaccession>GSE13130</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>447429329</id>
            <accession>A-AFFY-36</accession>
            <name>Affymetrix GeneChip Mouse Genome 430A 2.0 [Mouse430A_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802783802</id>
            <name>Affymetrix:FeatureDimension:MOE430A</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802784072</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13130.Mouse430A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19454665</accession>
            <authors>Bettina Jux, Stephanie Kadow, Charlotte Esser</authors>
            <title>Langerhans cell maturation and contact hypersensitivity are impaired in aryl
                hydrocarbon receptor-null mice.</title>
        </bibliography>
        <provider>
            <contact>Charlotte Esser</contact>
            <email>chesser@uni-duesseldorf.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802773002</id>
            <text>The arylhydrocarbon receptor is a ligand inducible transcription factor. Known to
                control xenobiotic metabolizing enzymes, it also affects - depending on the cell
                type - numerous other genes, either directly or indirectly. With respect to the
                immune system, persistent activation leads to immunosuppression. We asked how the
                AhR is involved in Langerhans cells. These antigen presenting cells of the skin are
                responsible for allergies against chemicals (thus xenobiotic metabolism might be
                relevant) and a recently detected endogenous ligand, FICZ made by UVB radiation from
                tryptophane, is particularly abundant in the skin. Experiment Overall Design: ear
                skin epidermal sheets from AhR exon2 deficient mice and wildtype C57BL/6 mice were
                isolated and cultivated for 16 hours in standard medium. Tissues were then
                homogenized and Langerhans cells isolated via BSA gradient and cell sorting to
                greater 95% purity. RNA was preparedand amplified prior to chip-hybridization using
                the MessageAmp Kit of Ambion (Woodward St. Austin, USA). RNA was biotinylated (Enzo
                Bio Array HighYield RNA transcript labeling kit (Affymetrix, High Wycombe, UK)) and
                purified. RNA was hybridized to MOE430A gene chips (Affymetrix).</text>
        </description>
        <description>
            <id>1802788175</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Mus musculus], using 4 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430A 2.0 [Mouse430A_2]], producing 4 raw data files and 4 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="43">
        <id>1802776953</id>
        <accession>E-GEOD-15258</accession>
        <name>Whole blood transcript profiling of rheumatoid arthritis patients</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>86</samples>
        <assays>86</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1802912704</user>
        <user>1802912706</user>
        <secondaryaccession>GSE15258</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>86</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802893493</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>86</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>86</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802899067</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15258.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>86</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>86</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19699293</accession>
            <authors>Dagin Bienkowska, Allaire Batliwalla, Gregersen Roubenoff, Carulli</authors>
            <title>Convergent random forest predictor: Methodology for predicting drug response from
                genome-scale data applied to anti-TNF response.</title>
        </bibliography>
        <provider>
            <contact>Jadwiga Bienkowska</contact>
            <email>jadwiga.bienkowska@biogenidec.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802776971</id>
            <text>The whole blood was collected pre-treatment from rheumatoid arthritis patients
                starting the anti_TNF therapy. All patients were na ve to anti_TNFs. The disease
                activity was measured using the DAS28 score at the pre-treatment visit1 (DAS28_v1)
                and 14 weeks after treatment visit3 (DAS28_v3). The response to the therapy was
                evaluated using the EULAR [European League Against Rheumatism] definition of the
                response. The objective of the data analysis was to identify gene expression
                coorelating with response as well as to identify genes that differentiate responders
                versus non-responders pre-treatment. The results of this investigation identified 8
                trainscripts that predict responders vs. non-responders with 89% accuracy.
                Experiment Overall Design: Patients' response to anti-TNF was assessed using EULAR
                score and patients were classified as responders, moderate responders and
                non-responders. Genes correlating with the response status have been
                identified.</text>
        </description>
        <description>
            <id>1802905274</id>
            <text>(Generated description) Experiment with 86 hybridizations, using 86 samples of
                species [Homo sapiens], using 86 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 86 raw data files and 86
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="44">
        <id>1802780337</id>
        <accession>E-GEOD-18195</accession>
        <name>Effects of bevacizumab (avastin) in mouse model of endometrial cancer</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802895353</user>
        <secondaryaccession>GSE18195</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802891810</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802891970</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18195.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Gavin Pickett</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802780352</id>
            <text>Microarrays were used to determine the efficacy of bevacizumab (a monoclonal
                antibody against the vascular endothelial growth factor and its receptors.) on
                endometrial cancer cells. Endometrial cancer is the most frequent gynecologic cancer
                in women. Long term outcomes for patients with advanced stage or recurrent disease
                are poor. Targeted molecular therapy against the vascular endothelial growth factor
                (VEGF) and its receptors constitute a new therapeutic option for these patients. The
                goal of our work was to assess the potential effectiveness of inhibition of
                VEGF/VEGFR signaling in a xenograft model of endometrial cancer using bevacizumab
                (Avastin, a humanized antibody against VEGFA). We also aimed to identify molecular
                markers of sensitivity or resistance to this agent. We show that bevacizumab retards
                tumor growth in athymic mice by inhibiting molecular components of signaling
                pathways that sustain cell survival and proliferation. We also demonstrate that
                resistance to bevacizumab may involve up-regulation of antiapoptotic genes and
                certain proto-oncogenes. Experiment Overall Design: Human xenografts produced from
                endometrial cell line, grown in athymic mice, were treated in vivo with
                bevacizumab.</text>
        </description>
        <description>
            <id>1802893809</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 4 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="45">
        <id>1802781947</id>
        <accession>E-GEOD-12134</accession>
        <name>The transcription factor AP2 regulates the number of basal progenitors</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802899500</user>
        <secondaryaccession>GSE12134</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802891546</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802891760</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12134.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19749747</accession>
            <authors>Drechsel Pinto, Ninkovic Schmid, Brill Irmler, Gianfranceschi Restani, Weber
                Cerri, Baer Tarabykin, Beckers Guillemot, Dehay Zecevic, Schorle Caleo, G
                tz</authors>
            <title>AP2gamma regulates basal progenitor fate in a region- and layer-specific manner
                in the developing cortex.</title>
        </bibliography>
        <provider>
            <contact>Magdalena Goetz</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802895493</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 12 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1802781964</id>
            <text>Understanding the mechanisms that specify neuronal subtypes is important to
                unravel the complex mechanisms of neuronal circuit assembly. Here we have identified
                a novel role for the transcription factor AP2 in progenitor and neuronal subtype
                specification in the cerebral cortex. Conditional deletion of AP2 causes
                misspecification of basal progenitors starting at; mid-neurogenesis and
                gain-of-function experiments show that AP2 directly regulates the expression of
                several genes characteristic for basal progenitors, such as Math3 and Tbr2. The
                misspecification of basal progenitors upon loss of AP2 resulted in their increased
                death and; the ultimate reduction of callosal layer II/III projection neurons. This
                had pronounced effects on visual performance with a strong reduction of visual
                acuity. Thus, we have identified a novel regulator of basal progenitor fate
                regulating the number of layer II/III neurons in an area-specific manner and
                revealing their importance for accurate function of the visual cortex. Experiment
                Overall Design: We analysed 12 samples from the cortex (rostral and caudal) of
                AP2gamma k.o. mice and control mice. For each of the 4 groups (caudal ko, caudal wt,
                rostral ko, rostral wt) three biological replicates were analysed.</text>
        </description>
    </experiment>
    <experiment textidx="46">
        <id>1802785231</id>
        <accession>E-GEOD-17906</accession>
        <name>Gene expression down-regulation in prostate tumor-associated stromal cells involves
            organ-specific genes</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>25</samples>
        <assays>25</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1804909742</user>
        <secondaryaccession>GSE17906</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>25</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910961</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>25</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>25</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804910999</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17906.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>25</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>25</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19737398</accession>
            <authors>Laura E Pascal, Young Ah Goo, Ricardo Zn V ncio, Laura S Page, Amber A
                Chambers, Emily S Liebeskind, Thomas K Takayama, Lawrence D True, Alvin Y
                Liu</authors>
            <title>Gene expression down-regulation in CD90+ prostate tumor-associated stromal cells
                involves potential organ-specific genes.</title>
        </bibliography>
        <provider>
            <contact>Ricardo V ncio</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802785241</id>
            <text>The prostate stroma is a key mediator of epithelial differentiation and
                development, and potentially plays a role in the initiation and progression of
                prostate cancer. Isolation and characterization of viable populations of the
                constituent cell types of prostate tumors could provide valuable insight into the
                biology of cancer. The CD90+ stromal fibromuscular cells from tumor specimens were
                isolated by cell-sorting and analyzed by DNA microarray. Dataset analysis was used
                to compare gene expression between normal and tumor-associated reactive stromal
                cells. Reactive stroma is characterized by smooth muscle differentiation, prostate
                down-regulation of SPOCK3, MSMB, CXCL13, and PAGE4, bladder down-regulation of
                TRPA1, HSD17B2, IL24, and SALL1, and an up-regulation of CXC-chemokines. This study
                identified a group of differentially expressed genes in CD90+ reactive stromal cells
                that are potentially involved in organ development and smooth muscle cell
                differentiation. Experiment Overall Design: A total of 15 arrays were run for the
                following sample types obtained from 10 patients: Experiment Overall Design: 2 CD90+
                prostate tumor-associated stromal: Experiment Overall Design: Patient 1:
                CP_Str_08-028_CD90posi Experiment Overall Design: Patient 2:
                08-032_CP_strom_CD90posi Experiment Overall Design: 2 CD13+ normal bladder stromal:
                Experiment Overall Design: Patient 3: 06-125_NB_CD13posi Experiment Overall Design:
                Patient 4: 06-070_NB_str_CD13posi Experiment Overall Design: 1 CD13+ bladder
                tumor-associated stromal: Experiment Overall Design: Patient 5:
                07-008_CB_str_CD13posi Experiment Overall Design: 5 whole tissue prostate cancer and
                5 normal tissue from matched pairs: Experiment Overall Design: Patient 6:
                05-206_CaP, 05-206_NP Experiment Overall Design: Patient 7: 05-213_CaP, 05-213_NP
                Experiment Overall Design: Patient 8: 05-214_CaP, 05-214_NP Experiment Overall
                Design: Patient 9: 05-218_CaP, 05-218_NP Experiment Overall Design: Patient 10:
                05-220_CaP, 05-220_NP Experiment Overall Design: Additionally, 8 arrays were run for
                the following sample types obtained from 7 patients: Experiment Overall Design: 5
                CD49a+ normal prostate stromal (PMID 16638148): Experiment Overall Design: Patient
                1: CD49a_01-26-04 Experiment Overall Design: Patient 2: CD49a_03-23-04 Experiment
                Overall Design: Patient 3: CD49a_03-04-04 Experiment Overall Design: Patient 4:
                CD49a-1_06-02-04 Experiment Overall Design: Patient 5: CD49a-4_06-02-04 Experiment
                Overall Design: 3 CD26+ prostate cancer (2 biological replicates, 1 sample run
                twice): Experiment Overall Design: Patient 6: 05-179_CD26t Experiment Overall
                Design: Patient 6: 05-179_CD26t_2 Experiment Overall Design: Patient 7:
                08-032_CP_epi_CD26posi Experiment Overall Design: The following two prostate cancer
                samples were also included in the analyses: Experiment Overall Design: CD26+ cancer
                cell, replicate 1 Experiment Overall Design: CD26+ cancer cell, replicate 2
                Experiment Overall Design: The tissue samples consisted of prostate tissue specimens
                obtained from patients undergoing radical prostatectomy under approval by the
                University of Washington Institutional Review Board. The same approach was used for
                both cancer-free and cancer-enriched (where at least 85% of the cells in the
                corresponding frozen section were of cancer) samples. To obtain bladder stromal
                cells for analysis, tissue specimens were obtained from cystoprostatectomy
                surgeries. For cell sorting, the collected specimens were processed within hours.
                Cell types were sorted using monoclonal antibodies specific for tumor-associated
                prostate stromal cells (CD90), tumor-associated bladder stromal cells (CD13) and
                normal bladder stromal cells (CD13) with MACS.</text>
        </description>
        <description>
            <id>1804911229</id>
            <text>(Generated description) Experiment with 25 hybridizations, using 25 samples of
                species [Homo sapiens], using 25 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 25 raw data files and 25
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="47">
        <id>1802790710</id>
        <accession>E-GEOD-18179</accession>
        <name>Gene profiling of intermediolateral column, medial, and lateral motoneuron after
            spinal cord transection</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>62</samples>
        <assays>62</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1802904047</user>
        <user>1802904048</user>
        <secondaryaccession>GSE18179</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>25874048</id>
            <accession>A-AFFY-6</accession>
            <name>Affymetrix GeneChip Murine Genome U74Av2 [MG_U74Av2]</name>
            <count>62</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802858833</id>
            <name>Affymetrix:FeatureDimension:MG_U74Av2</name>
            <bioassaydatacubes>62</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>62</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802887774</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18179.MG_U74Av2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>62</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>62</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Dapeng Cui</contact>
            <email>bio_cuidp@hotmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802790724</id>
            <text>To determine spinal cord injury (SCI) induced changes in gene expression, laser
                capture microscopy (LCM) and Affymetrix microarrays were used to profiles three
                distinct populations of motor neurons (MNs) in five sets of littermates. In each
                set, one littermate received a lamenectomy (sham operated), and the other received a
                complete spinal cord transection. Each MN population was caudal to the transection
                and not axotomized. Thus, MNs in transected animals were responding to two major
                insults: deafferentation and changing microenvironments due to spreading immune and
                inflammatory responses. A total of 30 expression profiles from sham operated control
                animals have been uploaded to GEO database with accession number GSE2595. The
                current series contains 32 motoneuron expression profiles from spinalized mice. All
                chips (30 sham + 32 transection) were generated together using RMA in 2004.
                Experiment Overall Design: In this study we determine SCI induced changes in gene
                expression in lateral motoneurons (LMN), medial motoneurons (MMN) and
                intermediolateral column motoneurons (IML). Five sets of male littermates were used
                in these experiments (sets a-e). In each set, one littermate received a lamenectomy
                (sham operated), and the other received a complete spinal cord transection. Four of
                the sets (a-d) consisted of one transect and one littermate sham operated control.
                The fifth set (e) had an additional transect. All surgeries were performed on
                postnatal day (P) 24. Three weeks later (P45), the animals were sacrificed and their
                spinal cords were removed and sectioned for LCM. Each of the three cell types was
                captured from every animal. The expression profiles of the three classes of MNs were
                obtained using Affymetrix microarrays.</text>
        </description>
        <description>
            <id>1802901105</id>
            <text>(Generated description) Experiment with 62 hybridizations, using 62 samples of
                species [Mus musculus], using 62 arrays of array design [Affymetrix GeneChip Murine
                Genome U74Av2 [MG_U74Av2]], producing 62 raw data files and 62 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="48">
        <id>1802795112</id>
        <accession>E-GEOD-13027</accession>
        <name>Endometrial receptivity</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>7</samples>
        <assays>7</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802896701</user>
        <secondaryaccession>GSE13027</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>7</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802891838</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>7</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802892260</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13027.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>7</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>7</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19176542</accession>
            <authors>Inge Van Vaerenbergh, Leentje Van Lommel, Vanessa Ghislain, Peter In't Veld,
                Frans Schuit, Human Mousavi Fatemi, Paul Devroey, Claire Bourgain</authors>
            <title>In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on
                the day of oocyte retrieval correlates with altered gene expression.</title>
        </bibliography>
        <provider>
            <contact>Inge Van Vaerenbergh</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802795123</id>
            <text>In GnRH-antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on
                the day of oocyte retrieval correlates with altered gene expression Experiment
                Overall Design: Endometrial biopsies taken on the day of oocyte retrieval in
                stimulated IVF cycles with 1 or 2 embryos replaced on day 3 in the same cycle.
                Endometrial dating was performed according to Noyes' criteria. All endometria taken
                on the day of oocyte retrieval showed an advanced maturation, ranging from +d2 to
                +d4. The patients with a subsequent clinical pregnancy all showed a histological
                dating corresponding to +d2 or +d3. Gene expression of histologically more advanced
                endometria, as assessed by Noyes' criteria, (n=3, +d4) was compared with matched
                less advanced endometria (n=4,+d2-3).</text>
        </description>
        <description>
            <id>1802894788</id>
            <text>(Generated description) Experiment with 7 hybridizations, using 7 samples of
                species [Homo sapiens], using 7 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 7 raw data files and 7 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="49">
        <id>1802796348</id>
        <accession>E-GEOD-18161</accession>
        <name>Washing scaling of microarray expression</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1804909808</user>
        <secondaryaccession>GSE18161</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910126</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18161.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Knut Krohn</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802796355</id>
            <text>Post-hybridization washing is an essential part of microarray experiments. Both,
                the quality of the experimental washing protocol and the adequate consideration of
                washing in intensity calibration ultimately affect the quality of the expression
                estimates extracted from the microarray intensities. We conducted experiments on
                GeneChip microarrays with altered protocols for washing, scanning and staining to
                study the probe-level intensity changes as a function of washing cycles.
                Particularly, three Affymetrix GeneChip HGU133plus2 arrays were hybridized and
                equilibrated for 16 hours in the hybridization oven. For one of the three arrays
                washing and staining was performed according to the manufacturer s instructions. For
                another array the first scan was done immediately after low stringent wash and
                staining without intermitting stringent washing. Then, the array was stringently
                washed and scanned in alternating order three more times where each washing step
                consists of a definite number of washing cycles. The third array was low stringently
                washed followed by two stringent washing cycles and staining before the first scan.
                Subsequently it was analogously processed as array A. All three chips are repeatedly
                processed in a second series of alternating wash/scan-cycles which was performed
                using the same protocol for each chip as in the first series as described above. As
                in the first series the arrays were also stained a second time to compensate for any
                loss of bleached fluorescent dye. Analysis of the washing kinetics shows that the
                signal-to-noise ratio doubles roughly every ten stringent washing cycles. Washing
                can be characterized by time-dependent rate constants which reflect the
                heterogeneous character of target binding to microarray probes. We propose an
                empirical washing function which estimates the survival of probe bound targets. The
                washing function allows calibrating probe intensities for the effect of washing. On
                a relative scale, proper calibration for washing markedly increases expression
                measures especially in the limit of small and large values. Experiment Overall
                Design: The aim of the study was to understand the probe-level intensity changes as
                a function of washing cycles. For this experiment RNA was prepared from a cancer
                cell line and used for probe synthesis. Hybridisation to three Affymetrix
                microarrays was identically performed with aliquotes of one hybridization mix from a
                single RNA sample. The protocols for washing, scanning and staining were
                altered.</text>
        </description>
        <description>
            <id>1804910400</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Homo sapiens], using 18 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 18
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="50">
        <id>1802832772</id>
        <accession>E-GEOD-16642</accession>
        <name>Illumina mRNA-Seq of control and hnRNP H knockdown in 293T cells</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1804909510</user>
        <user>1804909511</user>
        <secondaryaccession>GSE16642</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1802712793</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-16642.VirtualArrayDesign</accession>
            <count>2</count>
        </arraydesign>
        <provider>
            <contact>Xinshu Xiao</contact>
            <email>gxxiao@ucla.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802849966</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-16642], producing 0 raw data files and 2 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1802832800</id>
            <text>Pre-mRNA splicing is regulated through combinatorial activity of RNA motifs
                including splice sites and splicing regulatory elements (SREs). Here, we show that
                the activity of a major class of mammalian SREs is highly sensitive to the strength
                of the adjacent 5' splice site (5'ss) sequence, and that this has important
                functional and evolutionary implications. Activity of G-run SREs was higher for
                intermediate strength 5'ss by ~4-fold relative to weak 5'ss, and by ~1.3-fold
                relative to strong 5'ss. The dependence on 5'ss strength was supported both by
                comparative genomics and by microarray and Illumina mRNA-Seq analyses of splicing
                changes following RNAi against the splicing factor heterogeneous nuclear
                ribonucleoprotein (hnRNP) H, which binds G-runs. This dependence implies that the
                responsiveness of exons to changes in hnRNP H levels is a bivariate function of both
                SRE abundance and 5'ss strength; this relationship may hold also for other splicing
                factors. This pattern of activity enables G-runs and hnRNP H to buffer the effects
                of 5'ss mutations, augmenting both the frequency of 5'ss polymorphism and the
                evolution of new splicing patterns. Experiment Overall Design: Examine mRNA
                expression in 293T cells following hnRNP H or control siRNA knockdown</text>
        </description>
    </experiment>
    <experiment textidx="51">
        <id>1802859041</id>
        <accession>E-GEOD-17661</accession>
        <name>Modulation of gene expression by rapamycin in hepatic cell lines, WB-F344 and
            WB311</name>
        <releasedate>2009-09-25</releasedate>
        <species>Rattus norvegicus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1802900482</user>
        <user>1802900483</user>
        <secondaryaccession>GSE17661</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802894866</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17661.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jennifer Ann Sanders</contact>
            <email>Jennifer_Sanders@brown.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802859069</id>
            <text>Two rat hepatic cell lines, WB-F344 and WB311, were characterized for the effect
                of rapamycin on gene expression. The WB311 cell line, which is tumorigenic and
                resistant to the growth inhibitory effects of rapamycin, was originally derived from
                the WB-F344 parental hepatic epithelial cell line. The goal of this experiment was
                to identify genes that responded to rapamycin in the sensitive cells but not the
                resistant cells, thereby providing insight into the mechanism of rapamycin
                resistance. Experiment Overall Design: Total RNA for each of four experimental
                groups was prepared and analyzed in triplicate: WB-F344, vehicle control; WB-F344,
                rapamycin; WB311, vehicle control; WB311, rapamycin.</text>
        </description>
        <description>
            <id>1802899640</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Rattus norvegicus], using 12 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 0 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="52">
        <id>1802888435</id>
        <accession>E-GEOD-17262</accession>
        <name>S. pombe acetyltransferase mutants identifies redundant pathways of gene regulation,
            Affymetrix dataset</name>
        <releasedate>2009-09-25</releasedate>
        <species>Schizosaccharomyces pombe</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Schizosaccharomyces pombe</value>
        </sampleattribute>
        <user>1802898852</user>
        <user>1802898856</user>
        <secondaryaccession>GSE17262</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>486625854</id>
            <accession>A-AFFY-47</accession>
            <name>Affymetrix GeneChip Yeast Genome 2.0 Array [Yeast_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802888917</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17262.Yeast_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Susan Forsburg</contact>
            <email>forsburg@usc.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802888443</id>
            <text>Analysis of histone acetyl transferases (HATs) from the MYST and GNAT families in
                S. pombe to identify functional differences or overlap with regard to gene
                expression. Mutations were made to Elp3 and Gcn5 (GNAT family), and to Mst2 (MYST
                family). Mutants showed distinct phenotypes which were repressed or enhanced by
                mutant combinations. Experiment Overall Design: Mutations were made to Elp3 and Gcn5
                (GNAT family), and to Mst2 (MYST family) in S. pombe. RNA was extracted from the
                various mutants and hybridized on Affymetrix arrays.</text>
        </description>
        <description>
            <id>1802895006</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Schizosaccharomyces pombe], using 24 arrays of array design [Affymetrix
                GeneChip Yeast Genome 2.0 Array [Yeast_2]], producing 0 raw data files and 24
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="53">
        <id>1802889398</id>
        <accession>E-GEOD-17250</accession>
        <name>Comparative analysis of gene regulation by the transcription factor PPAR _mouse</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1656112518</user>
        <user>1802903243</user>
        <secondaryaccession>GSE17250</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802896483</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802898756</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17250.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19710929</accession>
            <authors>Maryam Rakhshandehroo, Guido Hooiveld, Michael M ller, Sander Kersten</authors>
            <title>Comparative analysis of gene regulation by the transcription factor PPARalpha
                between mouse and human.</title>
        </bibliography>
        <provider>
            <contact>Guido Hooiveld</contact>
            <email>guido.hooiveld@wur.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802889405</id>
            <text>Studies in mice have shown that PPAR is an important regulator of hepatic lipid
                metabolism and the acute phase response. However, little information is available on
                the role of PPAR in human liver. Here we set out to compare the function of PPAR in
                mouse and human hepatocytes via analysis of target gene regulation. Primary
                hepatocytes from 6 human and 6 mouse donors were treated with PPAR agonist Wy14643
                and gene expression profiling was performed using Affymetrix GeneChips followed by a
                systems biology analysis. Baseline PPAR expression was similar in human and mouse
                hepatocytes. Depending on species and time of exposure, Wy14643 significantly
                induced the expression of 362-672 genes. Surprisingly minor overlap was observed
                between the Wy14643-regulated genes from mouse and human, although more substantial
                overlap was observed at the pathway level. Xenobiotics metabolism and apolipoprotein
                synthesis were specifically regulated by PPAR in human hepatocytes, whereas
                glycolysis-gluconeogenesis was regulated specifically in mouse hepatocytes. Most of
                the genes commonly regulated in mouse and human were involved in lipid metabolism
                and many represented known PPAR targets, including CPT1A, HMGCS2, FABP, ACSL, and
                ADFP. Several genes were identified that were specifically induced by PPAR in human
                (MBL2, ALAS1, CYP1A1, TSKU) or mouse (Fbp2, lgals4, Cd36, Ucp2, Pxmp4). Furthermore,
                several putative novel PPAR targets were identified that were commonly regulated in
                both species, including CREB3L3, KLF10, KLF11 and MAP3K8. Our results suggest that
                PPAR activation has a major impact on gene regulation in human hepatocytes.
                Importantly, the role of PPAR as master regulator of hepatic lipid metabolism is
                generally well-conserved between mouse and human. Overall, however, PPAR regulates a
                mostly divergent set of genes in mouse and human hepatocytes. Experiment Overall
                Design: Primary hepatocytes from 6 mice from 6 different strains were treated with
                the PPAR agonist Wy14643 for 6 and 24 hours, and gene expression profiling was
                performed using Affymetrix GeneChips. Mouse primary hepatocytes were isolated by
                two-step collagenase perfusion from 6 different strains of mouse; NMRI, SV129, FVB,
                DBA, BALB/C and C57BL/6J. Cells were plated on collagen-coated six-well plates.
                Viability was determined by Trypan Blue exclusion, and was at least 75%. Hepatocytes
                were suspended in William's E medium (Lonza Bioscience, Verviers, Belgium)
                supplemented with 10% (v/v) fetal calf serum, 20 m-units/mL insulin, 10 nM
                dexamethasone, 100 U/mL penicillin, 100 g/mL of streptomycin, 0.25 g/mL fungizone
                and 50 g/mL gentamycin. After four hours the medium was discarded and replaced with
                fresh medium. The next day, cells were incubated in fresh medium in the presence or
                absence of Wy14643 (10 microM) dissolved in DMSO for 6 and 24 hours, followed by RNA
                isolation. A 5-fold lower concentration of Wy14643 was used in mouse primary
                hepatocytes to take into account the higher affinity of Wy14643 for mouse PPAR
                compared to human PPAR .</text>
        </description>
        <description>
            <id>1802901484</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Mus musculus], using 24 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 24 raw data files and 24 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="54">
        <id>1802889637</id>
        <accession>E-GEOD-17251</accession>
        <name>Comparative analysis of gene regulation by the transcription factor PPAR _human</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1656112518</user>
        <user>1802904020</user>
        <secondaryaccession>GSE17251</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802899143</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802899743</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17251.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19710929</accession>
            <authors>Maryam Rakhshandehroo, Guido Hooiveld, Michael M ller, Sander Kersten</authors>
            <title>Comparative analysis of gene regulation by the transcription factor PPARalpha
                between mouse and human.</title>
        </bibliography>
        <provider>
            <contact>Guido Hooiveld</contact>
            <email>guido.hooiveld@wur.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802889644</id>
            <text>Studies in mice have shown that PPAR is an important regulator of hepatic lipid
                metabolism and the acute phase response. However, little information is available on
                the role of PPAR in human liver. Here we set out to compare the function of PPAR in
                mouse and human hepatocytes via analysis of target gene regulation. Primary
                hepatocytes from 6 human and 6 mouse donors were treated with PPAR agonist Wy14643
                and gene expression profiling was performed using Affymetrix GeneChips followed by a
                systems biology analysis. Baseline PPAR expression was similar in human and mouse
                hepatocytes. Depending on species and time of exposure, Wy14643 significantly
                induced the expression of 362-672 genes. Surprisingly minor overlap was observed
                between the Wy14643-regulated genes from mouse and human, although more substantial
                overlap was observed at the pathway level. Xenobiotics metabolism and apolipoprotein
                synthesis were specifically regulated by PPAR in human hepatocytes, whereas
                glycolysis-gluconeogenesis was regulated specifically in mouse hepatocytes. Most of
                the genes commonly regulated in mouse and human were involved in lipid metabolism
                and many represented known PPAR targets, including CPT1A, HMGCS2, FABP, ACSL, and
                ADFP. Several genes were identified that were specifically induced by PPAR in human
                (MBL2, ALAS1, CYP1A1, TSKU) or mouse (Fbp2, lgals4, Cd36, Ucp2, Pxmp4). Furthermore,
                several putative novel PPAR targets were identified that were commonly regulated in
                both species, including CREB3L3, KLF10, KLF11 and MAP3K8. Our results suggest that
                PPAR activation has a major impact on gene regulation in human hepatocytes.
                Importantly, the role of PPAR as master regulator of hepatic lipid metabolism is
                generally well-conserved between mouse and human. Overall, however, PPAR regulates a
                mostly divergent set of genes in mouse and human hepatocytes. Experiment Overall
                Design: Primary hepatocytes from 6 human subjects were treated with the PPAR agonist
                Wy14643 for 6 and 24 hours, and gene expression profiling was performed using
                Affymetrix GeneChips. Human hepatocytes and Hepatocyte Culture Medium Bulletkit were
                purchased from Lonza Bioscience (Verviers, Belgium). Primary hepatocytes were
                isolated from surgical liver biopsies obtained from six individual donors who
                underwent surgery after informed consent was obtained for surgery with subsequent
                use of samples in experiments. Hepatocytes were isolated with two-step collagenase
                perfusion method and the viability of the cells was over 80%. Cells were plated on
                collagen-coated six-well plates and filled with maintenance medium. Upon arrival of
                the cells, the medium was discarded and was replaced by Hepatocyte Culture Medium
                (HCM) with additives. The additives included Gentamicin sulphate/Amphotercin-B,
                Bovine serum albumin (Fatty acid free), Transferrin, Ascorbic acid, Insulin,
                Epidermal growth factor, Hydrocortisone hemisuccinate. The next day, cells were
                incubated in fresh medium in the presence or absence of Wy14643 (50 microM)
                dissolved in DMSO for 6 and 24 hours, followed by RNA isolation.</text>
        </description>
        <description>
            <id>1802902063</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Homo sapiens], using 24 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 24 raw data files and 24
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="55">
        <id>1802890813</id>
        <accession>E-GEOD-18112</accession>
        <name>Seed maturation/ drying of altered Lys metabolism genotype</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1804909916</user>
        <user>1804909917</user>
        <secondaryaccession>GSE18112</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910181</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18112.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ruthie Ruthie</contact>
            <email>ruthie.angelovici@weizmann.ac.il</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802890820</id>
            <text>In order to elucidate transcriptional and metabolic networks associated with Lys
                metabolism, we utilized developing seeds as a system in which Lys synthesis could be
                stimulated developmentally without application of chemicals and coupled this to a
                T-DNA insertion knockout mutation impaired in Lys catabolism. This seed-specific
                metabolic perturbation stimulated Lys accumulation starting from the initiation of
                storage reserve accumulation. Our results revealed that the response of seed
                metabolism to the inducible alteration of Lys metabolism was relatively minor,
                however, that which was observable operated in a modular manner. They also
                demonstrated that Lys metabolism is strongly associated with the operation of the
                TCA cycle, whilst largely disconnected from other metabolic networks. In contrast,
                the inducible alteration of Lys metabolism was strongly associated with gene
                networks, stimulating the expression of hundreds of genes controlling anabolic
                processes that are associated with plant performance and vigor, whilst suppressing a
                small number of genes associated with plant stress interactions. The most pronounced
                effect of the developmentally-inducible alteration of Lys metabolism was an
                induction of expression of a large set of genes encoding ribosomal proteins as well
                as genes encoding translation initiation and elongation factors, all of which are
                associated with protein synthesis. With respect to metabolic regulation, the
                inducible alteration of Lys metabolism was primarily associated with altered
                expression of genes belonging to networks of amino acids and sugar metabolism. The
                combined data are discussed within the context of network interactions both between
                and within metabolic and transcriptional control systems. Experiment Overall Design:
                Arabidopsis thaliana (WS) seeds of the WT and KD genotype (Zhu and Galili, 2003)were
                germinated on soil and grown in the greenhouse (23oC). Flowers were marked and at
                given time intervals following flowering (14DAF to Dry ). Maturing siliques were
                collected, then seeds were dissected from siliques . Mature seeds were collected at
                the end of the desiccation period and stored at 4 C. Two repeats were collected from
                each time point. Three to five thousands seeds were harvested for each
                extraction.</text>
        </description>
        <description>
            <id>1804910371</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Arabidopsis thaliana], using 12 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 0 raw data files and 12 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="56">
        <id>1802891598</id>
        <accession>E-GEOD-18148</accession>
        <name>Microarray analysis of Cbfb-deficient regulatory T cells</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1802900109</user>
        <secondaryaccession>GSE18148</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802895811</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802896458</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18148.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Akihiko Kitoh</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802891605</id>
            <text>Gene expression profiles of Cbfb-deficient and control Treg cells were compared.
                Abstract: Naturally arising regulatory T (Treg) cells express the transcription
                factor FoxP3, which critically controls the development and function of Treg cells.
                FoxP3 interacts with another transcription factor Runx1 (also known as AML1). Here
                we showed that Treg cell-specific deficiency of Cbf , a cofactor for all Runx
                proteins, or that of Runx1, but not Runx3, induced lymphoproliferation, autoimmune
                disease, and hyper-production of IgE. Cbfb-deleted Treg cells exhibited impaired
                suppressive function in vitro and in vivo, with altered gene expression profiles
                including attenuated expression of FoxP3 and high expression of interleukin-4. The
                Runx complex bound to more than 3000 gene loci in Treg cells, including the Foxp3
                regulatory regions and the Il4 silencer. In addition, knockdown of RUNX1 showed that
                RUNX1 is required for the optimal regulation of FoxP3 expression in human T cells.
                Taken together, our results indicate that the Runx1-Cbf heterodimer is indispensable
                for in vivo Treg cell function, in particular, suppressive activity and optimal
                expression of FoxP3. Experiment Overall Design: CD4+CD25hi cells, most of which were
                Foxp3+ Treg cells, were isolated from Cbfb-flox/flox: Foxp3-ires-Cre (n = 3) and
                control Cbfb-flox/wt: Foxp3-ires-Cre (n = 3) mice. Total RNA was extracted from
                those purified Cbfb-deficient or control Treg cells.</text>
        </description>
        <description>
            <id>1802899184</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Mus musculus], using 6 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 6 raw data files and 6 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="57">
        <id>1802891976</id>
        <accession>E-GEOD-18146</accession>
        <name>Conjugated and non-conjugated androgen differentially modulate gene expression in
            breast cancer cell lines.</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1742560538</user>
        <user>1802901082</user>
        <secondaryaccession>GSE18146</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802899029</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802899174</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18146.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>George Notas</contact>
            <email>gnotas@med.uoc.gr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802891988</id>
            <text>The role of androgen in breast cancer development is not fully understood although
                androgen receptors (AR) have been identified in breast cancer clinical samples and
                cell lines. However the whole spectra of androgen actions cannot be accounted to the
                classic AR mode of action and the possible existence of a cell surface AR has been
                suggested. Indeed androgens like all steroids have been reported to trigger membrane
                initiated signaling activity and exert specific actions. Androgens acting on the
                membrane can rapidly activate kinase signaling pathways and ultimately could affect
                gene expression. However, the molecular nature of membrane androgen binding sites
                represents another major persisting question. In the present study, we investigated
                early transcriptional effects of testosterone and the impermeable testosterone-BSA
                conjugate, in two breast cancer cell lines, in an attempt to decipher specific genes
                modified in each case, providing evidences about specific membrane initiating
                actions. Our data indicate that the two agents tested affect the expression of
                several genes. A group of genes were commonly affected while others were uniquely
                modified by each agent. In MDA-MB-231 cells, that are AR negative, the majority of
                genes affected by testosterone were also affected by testosterone-BSA indicating a
                membrane action. Subsequent analysis revealed that the two agents trigger different
                molecular pathways and cellular/molecular functions, suggestive of a molecular
                heterogeneity of membrane and intracellular AR. In addition, the phenotypic
                interactions of membrane-acting androgen with growth factor were verified at the
                transcriptomic level. Finally an interesting interplay between membrane-acting
                androgen with inflammation-related molecules, with potential clinical implications
                was revealed. Experiment Overall Design: Cell lines and culture conditions
                Experiment Overall Design: The hormone-sensitive breast cancer cell line T47D
                (expressing ER , ER and AR) and the hormone insensitive breast cancer cell line
                MDA-MB-231 (expressing only ER ) were purchased from the European Collection of Cell
                Cultures (Salisbury, UK). T47D cells and MDA-MB-231 were cultured in RPMI-1640
                medium, supplemented with 10% charcoal treated fetal bovine serum (FBS), in a
                humidified atmosphere of 5% CO2 in air, at 37 C. Culture media and serum were from
                Gibco BRL (Life Technologies, Paisley, UK). Experiment Overall Design: Treatment-
                Gene expression assay Experiment Overall Design: Cells were serum starved for 6
                hours and then treated with 10-7M Testosterone or charcoal-treated Testosterone-BSA,
                for 3 hours. Total RNA was isolated using Nucleospin II columns (Macheray-Nagel, D
                ren, Germany), labeled and hybridized according to the Affymetrix protocol
                (Affymetrix Gene-Chip Expression Analysis Technical Manual), using the HGU133A plus
                2 chip, analyzing a total of 54675 transcripts. Signals were detected by an
                Affymetrix microarray chip reader.</text>
        </description>
        <description>
            <id>1802900054</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="58">
        <id>1802893236</id>
        <accession>E-GEOD-17610</accession>
        <name>Gene expression in response to AGL15 during somatic embryogenesis</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1802900659</user>
        <user>1802900663</user>
        <secondaryaccession>GSE17610</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>9</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802896354</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>9</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802897262</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17610.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>9</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sharyn Perry</contact>
            <email>sperr2@uky.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802893247</id>
            <text>Transcript accumulation was measured using the Affymetrix Arabidopsis ATH1 Genome
                Array [ATH1-121501] to document changes in response to the MADS-domain transcription
                factor AGAMOUS-Like 15 during somatic embryogenesis. A somatic embryo system was
                used where mature seed is allowed to complete germination in liquid MS media
                containing 2,4-D and seedlings produce somatic embryos from the shoot apical
                meristem (SAM) region. The frequency with which these embryos are produced directly
                correlates with AGL15 accumulation. Experiment Overall Design: Wild type Arabidopsis
                (Columbia ecotype) with normal amounts of AGL15 were compared to (1) 35S:AGL15 that
                constitutively expresses AGL15 and produces more somatic embryos from the shoot
                apical region than wild type and (2) agl15 agl18 double loss-of-function mutants
                that produce less somatic embryos from the shoot apical region than wild
                type.</text>
        </description>
        <description>
            <id>1802899895</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Arabidopsis thaliana], using 9 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 9 raw data files and 9 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="59">
        <id>1802894132</id>
        <accession>E-GEOD-17933</accession>
        <name>Transcriptional Biomarkers to Predict Female Mouse Lung Tumors in Rodent Cancer
            Bioassays - A 26 Chemical Set</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>191</samples>
        <assays>191</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1756236021</user>
        <user>1802931405</user>
        <secondaryaccession>GSE17933</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>191</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802901387</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>191</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>191</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1802903561</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17933.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>191</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>191</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Russell Scott Thomas</contact>
            <email>rthomas@thehamner.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802894140</id>
            <text>The process for evaluating chemical safety is inefficient, costly, and animal
                intensive. There is growing consensus that the current process of safety testing
                needs to be significantly altered to improve efficiency and reduce the number of
                untested chemicals. In this study, the use of short-term gene expression profiles
                was evaluated for predicting the increased incidence of mouse lung tumors. Animals
                were exposed to a total of 26 diverse chemicals with matched vehicle controls over a
                period of three years. Upon completion, significant batch-related effects were
                observed. Adjustment for batch effects significantly improved the ability to predict
                increased lung tumor incidence. For the best statistical model, the estimated
                predictive accuracy under honest five-fold cross-validation was 79.3% with a
                sensitivity and specificity of 71.4 and 86.3%, respectively. A learning curve
                analysis demonstrated that gains in model performance reached a plateau at 25
                chemicals, indicating that the size of the current data set was sufficient to
                provide a robust classifier. The classification results showed a small subset of
                chemicals contributed disproportionately to the misclassification rate. For these
                chemicals, the misclassification was more closely associated with genotoxicity
                status than efficacy in the original bioassay. Statistical models were also used to
                predict dose-response increases in tumor incidence for methylene chloride and
                naphthalene. The average posterior probabilities for the top models matched the
                results from the bioassay for methylene chloride. For naphthalene, the average
                posterior probabilities for the top models over-predicted the tumor response, but
                the variability in predictions were significantly higher. The study provides both a
                set of gene expression biomarkers for predicting chemically-induced mouse lung
                tumors as well as a broad assessment of important experimental and analysis criteria
                for developing microarray-based predictors of safety-related endpoints. Experiment
                Overall Design: Five-week-old female B6C3F1 mice were exposed for 13 weeks to 26
                chemicals. The chemical and dose information are provided with the individual sample
                annotations. With each chemical treatment, a matched vehicle control group was run
                concurrently with the exposure. A subset of two chemicals, methylene chloride and
                naphthalene, were performed in a five-point dose response with a matched purified
                air control group. The concentrations for these exposures overlapped those in the
                original cancer bioassay. Gavage exposures were administered 5 days per week and
                feed exposures were provided 7 days per week. For inhalation exposures, mice were
                exposed 6 hr per day, 5 days per week. After 13 weeks, animals were euthanized and
                lungs were collected. The right lobe was used for microarray analysis. Microarray
                analysis was performed on the lungs of three to four mice per treatment
                group.</text>
        </description>
        <description>
            <id>1802911222</id>
            <text>(Generated description) Experiment with 191 hybridizations, using 191 samples of
                species [Mus musculus], using 191 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 191 raw data files and 191 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="60">
        <id>1802894728</id>
        <accession>E-GEOD-18153</accession>
        <name>Effect of deuterium oxide on Arabidopsis gene expression</name>
        <releasedate>2009-09-25</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>15</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1804909961</user>
        <user>1804909962</user>
        <secondaryaccession>GSE18153</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910204</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-18153.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>William Gray</contact>
            <email>grayx051@tc.umn.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802894735</id>
            <text>2H2O has a long history as a protein or amino acid labeling techinique, and such
                labeling systems have proven effective for many different types of studies. A
                disadvantage of a 2H2O labeling system is that plant growth is inhibited as the
                percentage of deuterium in the medium increases. However the molecular effects of
                2H2O on plant growth has not previoulsly been investigated. To assist with the
                experimental design of proteomic 2H2O labeling studies, we used microarrays to
                determine the global effects of 2H2O on gene expression and to indentify genes which
                genes are effected by 2H2O treatment. Experiment Overall Design: RNA was prepared
                from Arabidopsis seedlings grown for seven days on either H2O control media or 30%
                2H2O to examine the long-term effects of 2H2O treatment,and from seedlings shifted
                from H2O media to either 2H2O or H2O for 4 h to examine short-term effects on gene
                expression, and seedlings shifted from 2H2O to H2O for 4 h to examine recovery
                effects on gene expression.</text>
        </description>
        <description>
            <id>1804910428</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 15 samples of
                species [Arabidopsis thaliana], using 15 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 0 raw data files and 15 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="61">
        <id>1802896144</id>
        <accession>E-GEOD-16754</accession>
        <name>Comparative transcriptional profiling of organs of the barley spike</name>
        <releasedate>2009-09-25</releasedate>
        <species>Hordeum vulgare</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Hordeum vulgare</value>
        </sampleattribute>
        <user>1802900865</user>
        <user>1802900873</user>
        <secondaryaccession>GSE16754</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>287590865</id>
            <accession>A-AFFY-31</accession>
            <name>Affymetrix GeneChip Barley Genome [Barley1]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1802898683</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16754.Barley1.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Tilahun Abebe</contact>
            <email>Tilahun.Abebe@uni.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802900277</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Hordeum vulgare], using 12 arrays of array design [Affymetrix GeneChip
                Barley Genome [Barley1]], producing 0 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1802896161</id>
            <text>The lemma, the palea and the awn of a barley spike are photosynthetic organs and
                supply the developing seed with carbohydrates. In addition, the lemma and the palea
                cover the seed and protect it from pathogens and insects. In this study, we compared
                gene expression among the lemma, the palea, the awn and the developing seed of
                barley at the grain-filling stage (Zadok scale 83) using the Barley1 Genome Array in
                order to identify genes that determine the primary function of these organs.
                Experiment Overall Design: Lemma, palea, awn and seed were collected at
                grain-filling stage (Zadok scale 83) to compare differences in gene expression. For
                each organ three biological replications were collected on three different dates. On
                each of the three dates, one replication of each organ was collected from plants
                grown in separate pots using a randomized complete block design (RCBD). In ths
                design, organ type was the treatment effect and date of sample collection
                (replication) was the block. To get enough tissue for RNA extraction, each
                replication for each organ was collected from four plants in the same pot. RNA from
                each replicate sample was hybridized to individual Barley1 GeneChips. Thus, for four
                organs with three replications (blocks), a total of 12 Barley1 GeneChips were
                used.</text>
        </description>
    </experiment>
    <experiment textidx="62">
        <id>1802897234</id>
        <accession>E-GEOD-15860</accession>
        <name>Caloric restriction modified anxiety- and depressive-like behavior and gene expression
            change in the mouse amygdala</name>
        <releasedate>2009-09-25</releasedate>
        <species>Mus musculus</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1804909867</user>
        <user>1804909868</user>
        <secondaryaccession>GSE15860</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1354819483</id>
            <accession>A-MEXP-724</accession>
            <name>Agilent Whole Mouse Genome Microarray 4x44K 014868 G4122F</name>
            <count>9</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910157</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15860.A-MEXP-724.1.ReporterDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804910149</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15860.A-MEXP-724.2.ReporterDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804910158</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15860.A-MEXP-724.3.ReporterDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19737990</accession>
            <authors>Tanahashi Yamamoto, Chikahisa Kawai, Nishida Katsuura, Sei Teshima-Kondo,
                Rokutan</authors>
            <title>Changes in behavior and gene expression induced by caloric restriction in C57BL/6
                mice.</title>
        </bibliography>
        <provider>
            <contact>Yuta Yamamoto</contact>
            <email>pomme@basic.med.tokushima-u.ac.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802897241</id>
            <text>Moderate caloric restriction (CR) and weight loss are beneficial for the promotion
                of health; however, there is controversy regarding the effects of dieting regimens
                on behavior. In this study, we investigated two different dieting regimens: repeated
                fasting and refeeding (RFR) and daily feeding of half the amount of food consumed by
                RFR mice (CR). Mice in both regimens were subjected to 20% reduction in food intake
                and transiently reduced their body weights during the first 12 days of the study.
                Open field, light-dark transition, elevated plus maze, and forced swimming tests
                indicated that CR, but not RFR, reduced anxiety- and depressive-like behaviors, with
                a peak on day 8. Using a mouse whole genome microarray, we analyzed gene expression
                in the prefrontal cortex, amygdala, and hypothalamus. In addition to the caloric
                restriction-responsive genes commonly modified by RFR and CR, each regimen
                differentially changed the expression of distinct genes in each region. The most
                profound change was observed in the amygdala of CR mice: 884 genes were specifically
                up-regulated. Ingenuity pathway analysis showed that these 884 genes significantly
                modified 9 canonical pathways in the amygdala. alpha-adrenergic and dopamine
                receptor signaling were the two top-scoring pathways. Quantitative real-time RT-PCR
                confirmed the up-regulation of 6 genes in these pathways. Ppp1r1b encoded Darpp-32
                including dopamine receptor signaling, and the increased protein was specific for CR
                mice. Our results suggest that moderate CR may modify anxiety- and depressive-like
                behaviors and alter gene expression especially in the mouse amygdala. Experiment
                Overall Design: We tested three feeding regimens. One group of mice had ad libitum
                (AD) access to food, and was used as a control group. The repeated fasting and
                refeeding (RFR) group of mice were fasted on day 0 and allowed to feed ad libitum on
                day 1. Amounts of food consumed by the three mice on day 1 were measured. The half
                amount of food consumed by the RFR mice was given to three mice in another cage for
                two days (days 0 and 1) (CR group). The fasting followed by refeeding (RFR) and the
                restriction of food (CR) were repeated up to day 16. Body weights and consumed chow
                were measured at 20:00 every day, and then the fasting or feeding period was
                started. In RFR mice, fasting was started on day 0.Total RNA was prepared from the
                prefrontal cortex, hypothalamus, and amygdala in the mice of each group on day 8. An
                equal amount of RNA from 4 mice in each group was pooled and used for microarray
                analysis.</text>
        </description>
        <description>
            <id>1804910291</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Mus musculus], using 9 arrays of array design [Agilent Whole Mouse Genome
                Microarray 4x44K 014868 G4122F], producing 0 raw data files and 9 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="63">
        <id>1802898572</id>
        <accession>E-GEOD-13367</accession>
        <name>Genome-wide gene expression analysis of mucosal colonic biopsies and isolated
            colonocytes...</name>
        <releasedate>2009-09-25</releasedate>
        <species>Homo sapiens</species>
        <samples>56</samples>
        <assays>56</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1641024105</user>
        <user>1804910076</user>
        <secondaryaccession>GSE13367</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>56</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804910901</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13367.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>56</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>56</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Morten Hansen</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1802898579</id>
            <text>Background &amp; Aims: Genome-wide gene expression (GWGE) profiles of mucosal
                colonic biopsies have suggested the existence of a continuous inflammatory state in
                quiescent ulcerative colitis (UC). The aim of this study was to use DNA
                microarray-based GWGE profiling of mucosal colonic biopsies and isolated colonocytes
                from UC patients and controls in order to identify the cell types responsible for
                the continuous inflammatory state. Methods: Adjacent mucosal colonic biopsies were
                obtained endoscopically from the descending colon in patients with active UC (n=8),
                quiescent UC (n=9), and with irritable bowel syndrome (controls, n=10). After
                isolation of colonocytes and subsequent extraction of total RNA, GWGE data were
                acquired using Human Genome U133 Plus 2.0 GeneChip Array (Affymetrix, Santa Clara,
                CA). Data analysis was carried out by principal component analysis and projection to
                latent structure-discriminant analysis using the SIMCA-P11 software (Umetrics, Ume ,
                Sweden). Results: A clear separation between active UC, quiescent UC and control
                biopsies were found, whereas the model for the colonocytes was unable to distinguish
                between quiescent UC and controls. The differentiation between quiescent UC and
                control biopsies was governed by unique profiles containing gene expressions with
                significant fold changes. These primarily belonged to the family of homeostatic
                chemokines revealing a plausible explanation to the abnormal regulated innate immune
                response seen in patients with UC. Conclusion: This study has demonstrated the
                presence of a continuous inflammatory state in quiescent UC, which seems to reflect
                an altered gene expression profile of lamina propria cells. Experiment Overall
                Design: Adjacent mucosal colonic biopsies were attained endoscopically from the
                descending colon in patients with active UC (n=8), quiescent UC (n=9), and in
                controls (n=10). After extraction of total RNA, genome-wide gene expression data
                were acquired using Human Genome U133 Plus 2.0 GeneChip Array (Affymetrix, Santa
                Clara, CA). Amplification was required to obtain sufficient amounts of labelled
                complementary RNA (cRNA) target for analysis with arrays. Data analysis was carried
                out by principal component analysis and projection to latent structure-discriminant
                analysis using the SIMCA-P11 software (Umetrics, Ume , Sweden).</text>
        </description>
        <description>
            <id>1802905147</id>
            <text>(Generated description) Experiment with 56 hybridizations, using 56 samples of
                species [Homo sapiens], using 56 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 56
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1804911379</id>
            <text>(Generated description) Experiment with 56 hybridizations, using 56 samples of
                species [Homo sapiens], using 56 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 56
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="64">
        <id>1801801994</id>
        <accession>E-GEOD-13524</accession>
        <name>Transcription profiling of rat nucleus accumbens of alcohol-preferring animals
            following chronic ethanol consumption</name>
        <releasedate>2009-09-24</releasedate>
        <species>Rattus norvegicus</species>
        <samples>29</samples>
        <assays>29</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>ethanol</value>
            <value>water</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>continuous</value>
            <value>limited</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE13524</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>29</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801851096</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>29</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801855626</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13524.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>29</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Mark William Kimpel</contact>
            <email>mkimpel@iupui.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <description>
            <id>1801802012</id>
            <text>This study investigated changes in gene expression associated with ethanol
                drinking in adult male P rats under the following conditions for 8 weeks: continuous
                access (24 hr/day, 7 days/week), multiple scheduled access (three 1-hr sessions
                during the dark cycle/day, 5 days/week) and ethanol-naive (water). The objective of
                this study was to investigate changes in gene expression associated with ethanol
                drinking. Adult male alcohol-preferring (P) rats were given Ethanol in their
                home-cages under continuous access (CA; 24 hr/day, 7 days/week) or multiple
                scheduled access (MSA; three 1-hr sessions during the dark cycle/day, 5 days/week)
                conditions for 8 weeks. A third group was ethanol-na ve (W group). Average ethanol
                intakes, across the 8 weeks, for the CA and MSA groups were approximately 9.5 and
                6.5 g/kg/day, respectively. Fifteen hr after the last ethanol drinking episode, rats
                were euthanized, the brains rapidly extracted, and the nucleus accumbens (ACB)
                dissected. RNA was extracted and purified for microarray analysis. The only
                significant differences, overall, were between the CA and W groups (p &lt; 0.01;
                Storey false discovery rate = 0.15); there were 374 significant differences in
                unique named genes between these 2 groups. There were 20 significant Gene Ontology
                (GO) biological processes categories, which included negative regulation of protein
                kinase activity , anti-apoptosis , and regulation of G-protein-coupled receptor
                protein signaling pathway . Ingenuity analysis indicated a network of transcription
                factors, involving oncogenes (Fos, Jun, Junb had higher expression levels in the ACB
                of the CA than W group), suggesting increased neuronal activity in the CA group.
                There were 13 genes (Hspa5, Stom, Lcn7, Tceb3, Cdc42, Rap1ga1, Ece1, Dhrs3, Plod1,
                Kif1b, Nmnat1, Srpr, Esam) significantly different between the CA and W groups
                located within both mouse and rat ethanol QTLs, suggesting that these genes may
                contribute to ethanol drinking behavior. In conclusion, the robust differences in
                gene expression found between the CA and W groups, but not observed between the MSA
                and W groups, may be a result of the higher daily ethanol intakes of the CA group,
                and/or its initial ethanol withdrawal. Experiment Overall Design: 10 samples each of
                control, continuous ethanol and limited access ethanol</text>
        </description>
        <description>
            <id>1801882243</id>
            <text>(Generated description) Experiment with 29 hybridizations, using 29 samples of
                species [Rattus norvegicus], using 29 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 29 raw data files and 29 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="65">
        <id>1801900733</id>
        <accession>E-TABM-795</accession>
        <name>Transcription profiling of human macrophage-like cell line RAW264.7. to investigate
            two Toll-interacting protein isoforms: full length isoform (Tollip FL) and novel 220
            amino acid isoform (Tollip ASV-1), which lacks the Ub-binding domain</name>
        <releasedate>2009-09-24</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>27</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>RAW264.7.</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>none</value>
            <value>Tollip ASV-1</value>
            <value>Tollip FL</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>immune cells</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>none</value>
            <value>Tollip ASV-1</value>
            <value>Tollip FL</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Time</name>
            <value>0</value>
            <value>120</value>
            <value>30</value>
        </experimentalfactor>
        <user>1641024105</user>
        <user>1801955151</user>
        <user>1801980630</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1801360049</id>
            <accession>A-MEXP-1693</accession>
            <name>Illumina MouseRef-8 v1 Expression BeadChip 24613</name>
            <count>27</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801914670</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-795.A-MEXP-1693.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Yu-Lan-Sandra Lo</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1801900748</id>
            <text>Pathogen recognition via the Toll-like receptor (TLR) signaling pathways leads to
                inflammatory responses by innate immune cells. The Toll-interacting protein (Tollip)
                is an ubiquitin-binding protein which negatively regulates TLR signaling. We have
                previously described extensive alternative splicing of Tollip in human and mouse
                macrophages. In the current study we examined the role of two mouse Tollip isoforms
                in innate immune responses: the canonical full-length form (Tollip.a), and a novel
                220 amino acid isoform (Tollip.b), which lacks the Ub-binding domain. We
                hypothesized that alternative splicing of this negative regulator contributes to the
                diversification of macrophage responses to pathogens. The function of the two Tollip
                isoforms was studied by over-expressing the variants in the macrophage-like cell
                line, RAW264.7.</text>
        </description>
        <description>
            <id>1801924974</id>
            <text>(Generated description) Experiment with 27 hybridizations, using 4 samples of
                species [Homo sapiens], using 27 arrays of array design [Illumina MouseRef-8 v1
                Expression BeadChip 24613], producing 1 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="66">
        <id>1801992000</id>
        <accession>E-TABM-796</accession>
        <name>Genotyping of human family trios using placental cDNA, placental genomic DNA (gDNA)
            and gDNA from both parents to find new imprinted genes</name>
        <releasedate>2009-09-24</releasedate>
        <species>Homo sapiens</species>
        <samples>72</samples>
        <assays>142</assays>
        <sampleattribute>
            <category>FamilyRelationship</category>
            <value>child of I_103</value>
            <value>child of I_143</value>
            <value>child of I_158</value>
            <value>child of I_160</value>
            <value>child of I_182</value>
            <value>child of I_201</value>
            <value>child of I_218</value>
            <value>child of I_246</value>
            <value>child of I_255</value>
            <value>child of I_266</value>
            <value>child of I_268</value>
            <value>child of I_273</value>
            <value>child of I_274</value>
            <value>child of I_289</value>
            <value>child of I_294</value>
            <value>child of I_301</value>
            <value>child of I_306</value>
            <value>child of I_308</value>
            <value>child of I_40</value>
            <value>child of I_59</value>
            <value>child of I_66</value>
            <value>child of I_87</value>
            <value>child of I_N44</value>
            <value>child of I_N69</value>
            <value>father of I_103</value>
            <value>father of I_143</value>
            <value>father of I_158</value>
            <value>father of I_160</value>
            <value>father of I_182</value>
            <value>father of I_201</value>
            <value>father of I_218</value>
            <value>father of I_246</value>
            <value>father of I_255</value>
            <value>father of I_266</value>
            <value>father of I_268</value>
            <value>father of I_273</value>
            <value>father of I_274</value>
            <value>father of I_294</value>
            <value>father of I_301</value>
            <value>father of I_306</value>
            <value>father of I_308</value>
            <value>father of I_40</value>
            <value>father of I_59</value>
            <value>father of I_66</value>
            <value>father of I_87</value>
            <value>father of I_N44</value>
            <value>father of I_N69</value>
            <value>mother of I_103</value>
            <value>mother of I_143</value>
            <value>mother of I_158</value>
            <value>mother of I_160</value>
            <value>mother of I_182</value>
            <value>mother of I_201</value>
            <value>mother of I_218</value>
            <value>mother of I_246</value>
            <value>mother of I_255</value>
            <value>mother of I_266</value>
            <value>mother of I_268</value>
            <value>mother of I_273</value>
            <value>mother of I_274</value>
            <value>mother of I_294</value>
            <value>mother of I_301</value>
            <value>mother of I_306</value>
            <value>mother of I_308</value>
            <value>mother of I_40</value>
            <value>mother of I_59</value>
            <value>mother of I_66</value>
            <value>mother of I_87</value>
            <value>mother of I_N44</value>
            <value>mother of I_N69</value>
            <value>unrelated with I_289</value>
        </sampleattribute>
        <sampleattribute>
            <category>MaterialType</category>
            <value>genomic_DNA</value>
            <value>total_RNA</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>Peripheral blood</value>
            <value>Placenta</value>
        </sampleattribute>
        <experimentalfactor>
            <name>FamilyRelationship</name>
            <value>child of I_103</value>
            <value>child of I_143</value>
            <value>child of I_158</value>
            <value>child of I_160</value>
            <value>child of I_182</value>
            <value>child of I_201</value>
            <value>child of I_218</value>
            <value>child of I_246</value>
            <value>child of I_255</value>
            <value>child of I_266</value>
            <value>child of I_268</value>
            <value>child of I_273</value>
            <value>child of I_274</value>
            <value>child of I_289</value>
            <value>child of I_294</value>
            <value>child of I_301</value>
            <value>child of I_306</value>
            <value>child of I_308</value>
            <value>child of I_40</value>
            <value>child of I_59</value>
            <value>child of I_66</value>
            <value>child of I_87</value>
            <value>child of I_N44</value>
            <value>child of I_N69</value>
            <value>father of I_103</value>
            <value>father of I_143</value>
            <value>father of I_158</value>
            <value>father of I_160</value>
            <value>father of I_182</value>
            <value>father of I_201</value>
            <value>father of I_218</value>
            <value>father of I_246</value>
            <value>father of I_255</value>
            <value>father of I_266</value>
            <value>father of I_268</value>
            <value>father of I_273</value>
            <value>father of I_274</value>
            <value>father of I_294</value>
            <value>father of I_301</value>
            <value>father of I_306</value>
            <value>father of I_308</value>
            <value>father of I_40</value>
            <value>father of I_59</value>
            <value>father of I_66</value>
            <value>father of I_87</value>
            <value>father of I_N44</value>
            <value>father of I_N69</value>
            <value>mother of I_103</value>
            <value>mother of I_143</value>
            <value>mother of I_158</value>
            <value>mother of I_160</value>
            <value>mother of I_182</value>
            <value>mother of I_201</value>
            <value>mother of I_218</value>
            <value>mother of I_246</value>
            <value>mother of I_255</value>
            <value>mother of I_266</value>
            <value>mother of I_268</value>
            <value>mother of I_273</value>
            <value>mother of I_274</value>
            <value>mother of I_294</value>
            <value>mother of I_301</value>
            <value>mother of I_306</value>
            <value>mother of I_308</value>
            <value>mother of I_40</value>
            <value>mother of I_59</value>
            <value>mother of I_66</value>
            <value>mother of I_87</value>
            <value>mother of I_N44</value>
            <value>mother of I_N69</value>
            <value>unrelated with I_289</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>MaterialType</name>
            <value>genomic_DNA</value>
            <value>total_RNA</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>Peripheral blood</value>
            <value>Placenta</value>
        </experimentalfactor>
        <user>1799600357</user>
        <user>1801995339</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799589571</id>
            <accession>A-MEXP-1677</accession>
            <name>Illumina Human Custom GoldenGate 1536 SNPs</name>
            <count>142</count>
        </arraydesign>
        <bibliography>
            <authors>Caroline Daelemans, Matthew E. Ritchie, Guillaume Smits, Sayeda Abu-Amero, Ian
                M. Sudbery, Matthew S. Forrest, Susana Campino, Taane G. Clark, Philip Stanier,
                Dominic Kwiatkowski, Panos Deloukas, Emmanouil T. Dermitzakis, Simon Tavare, Gudrun
                E. Moore, Ian Dunham</authors>
            <title>High-throughput analysis of candidate imprinted genes and allele-specific gene
                expression in the human term placenta</title>
        </bibliography>
        <provider>
            <contact>Matthew Ritchie</contact>
            <email>mritchie@wehi.edu.au</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>genotyping</experimentdesign>
        <experimentdesign>imprinting</experimentdesign>
        <description>
            <id>1801992008</id>
            <text>Twenty-three family trios of placental cDNA, placental genomic DNA (gDNA) and gDNA
                from both parents were tested using Illumina SNP arrays to find new imprinted genes
                to ascertain the extent of allele specific expression in this tissue.</text>
        </description>
        <description>
            <id>1801993702</id>
            <text>(Generated description) Experiment with 142 hybridizations, using 72 samples of
                species [Homo sapiens], using 142 arrays of array design [Illumina Human Custom
                GoldenGate 1536 SNPs], producing 142 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="67">
        <id>1801242338</id>
        <accession>E-TABM-797</accession>
        <name>Transcription profiling of juvenile Daphnia manga following exposure to various doses
            of Lufenuron, a benzoylphenylurea growth inhibitor (using Message Amp II)</name>
        <releasedate>2009-09-23</releasedate>
        <species>Daphnia magna</species>
        <samples>32</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Age</category>
            <value>&lt; 24</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>University of Reading</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>juvenile</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Daphnia magna</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>whole_organism</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>hours</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>Lufenuron</value>
            <value>none</value>
            <value>reference pool (all treated samples)</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>0</value>
            <value>0.15</value>
            <value>0.33</value>
            <value>0.65</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose(ug_per_L)</name>
            <value>0.15 - 0.65</value>
        </experimentalfactor>
        <user>1799581524</user>
        <user>1801244185</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1231885224</id>
            <accession>A-MAXD-9</accession>
            <name>Reading University Daphnia magna 14K V2.3</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801242614</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-797.A-MAXD-9.1.FeatureDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>MAXD</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Amanda Callaghan Christopher Hill</contact>
            <email>c.j.hill@reading.ac.uk, a.callaghan@reading.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <description>
            <id>1801243294</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 32 samples of
                species [Daphnia magna], using 16 arrays of array design [Reading University -
                Daphnia magna 14455 - V2.3], producing 16 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1801242345</id>
            <text>Juvenile (&lt;24hr old) Daphnia magna populations (n=25) were exposed (24hr)
                to 0.00ug, 0.15ug, 0.33ug, 0.65ug lufenuron Benzoylphenylurea growth inhibitor.
                Transcriptomic responses were screened using a D.magna cDNA microarray and the
                regulation of gene expression via log fold-change in transcript abundance, assessed.
                Genes involved in the synthesis of chitin were expected to respond to lufenuron,
                given the mode of action. Extracted total RNA was amplified (400ng/sample) prior to
                hybridisation with the expectation that this would increase the abundance of
                significantly responding genes.</text>
        </description>
    </experiment>
    <experiment textidx="68">
        <id>1801257790</id>
        <accession>E-TABM-803</accession>
        <name>Transcription profiling of Dictyostelium discoideum strains during growth and early
            development</name>
        <releasedate>2009-09-23</releasedate>
        <species>Dictyostelium discoideum</species>
        <samples>2</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Dictyostelium discoideum</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Ax2</value>
            <value>lrrB-</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>Ax2</value>
            <value>lrrB-</value>
        </experimentalfactor>
        <user>1571506098</user>
        <user>1801274639</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1215757285</id>
            <accession>A-SGRP-3</accession>
            <name>Sanger Pathogens Dictyostelium discoideum 8579</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801258492</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-803.A-SGRP-3.1.FeatureDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>SGRP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801258537</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-803.A-SGRP-3.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>SGRP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Gareth Bloomfield</contact>
            <email>gb2@sanger.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <description>
            <id>1801259137</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 2 samples of
                species [Dictyostelium discoideum], using 6 arrays of array design [Sanger Pathogens
                Dictyostelium discoideum 8579], producing 6 raw data files and 1 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1801257799</id>
            <text>Dictyostelium discoideum is an ideal organism to study SH2-domain mediated signal
                transduction because not only does it provide relatively simple model cell
                biological and developmental processes, but also possesses a highly streamlined
                repertoire of SH2-containing proteins. We studied one such novel protein, LrrB, by
                gene deletion and protein interaction experiments. A DNA microarray experiment
                carried out on growing cells reveals misregulation of a small set of vegetative
                genes in the lrrB knockout strain when compared to the parent, Ax2. Real time PCR
                experiments described in the accompanying manuscript extend these observations to
                show how this affects gene expression during early development, and that knockouts
                in another SH2 protein that interacts with LrrB show misregulation of some of the
                same genes, suggesting that these proteins may form part of a novel adaptor complex
                that regulates gene expression during Dictyostelium growth and early
                development.</text>
        </description>
    </experiment>
    <experiment textidx="69">
        <id>1801280100</id>
        <accession>E-MEXP-2365</accession>
        <name>Transcription profiling of zebrafish wild type and prion protein prp2-morphants
            injected early embryos.</name>
        <releasedate>2009-09-23</releasedate>
        <species>Danio rerio</species>
        <samples>8</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Age</category>
            <value>24 hours</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>ClinicalHistory</category>
            <value>Only 1x Danieau solution (58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO4, 0.6 mM Ca (NO3)2,
                5 mM HEPES, pH 7.6) are injected</value>
            <value>The MO stock solutions were diluted to working concentrations of 0.15 mM in 1
                Danieau solution</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>embryo</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>morpholino</value>
            <value>whild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>Emberyo pool control- 1</value>
            <value>Emberyo pool control- 2</value>
            <value>Emberyo pool control- 3</value>
            <value>Emberyo pool control- 4</value>
            <value>Emberyo pool Morpholino- 1</value>
            <value>Emberyo pool Morpholino- 2</value>
            <value>Emberyo pool Morpholino- 3</value>
            <value>Emberyo pool Morpholino- 4</value>
        </sampleattribute>
        <sampleattribute>
            <category>InitialTimePoint</category>
            <value>24 hours post fertilizide</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Danio rerio</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>whole_organism</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>Zebrafish embryos</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>morpholino</value>
            <value>whild_type</value>
        </experimentalfactor>
        <user>1801304904</user>
        <user>1801304917</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1583433260</id>
            <accession>A-MEXP-1048</accession>
            <name>NMC 16k Zebrafish oligo array v3.0</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801288763</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2365.A-MEXP-1048.1.FeatureDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801289286</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2365.A-MEXP-1048.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Rasoul Nourizadeh</contact>
            <email>rasoul.nouri@veths.no</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <experimentdesign>transcript identification</experimentdesign>
        <description>
            <id>1801280113</id>
            <text>Four independent pools of zebrafish embryo were injected with prp2 morphants and
                after 24 hours post fertilization, gene expression profiles were compared to their
                respective controls, using microarray. A dye swap design experiment using four
                microarray slides were conducted.</text>
        </description>
        <description>
            <id>1801292605</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 8 samples of
                species [Danio rerio], using 4 arrays of array design [NMC 16k Zebrafish oligo array
                v3.0], producing 4 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="70">
        <id>1801447563</id>
        <accession>E-GEOD-6614</accession>
        <name>Transcription profiling of mouse brains following nicotine-induced seizures</name>
        <releasedate>2009-09-23</releasedate>
        <species>Mus musculus</species>
        <samples>28</samples>
        <assays>28</assays>
        <sampleattribute>
            <category>Age</category>
            <value>6 weeks</value>
            <value>7 weeks</value>
            <value>8 weeks</value>
            <value>9 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>ClinicalTreatment</category>
            <value>1 hour following nicotine-induced seizures</value>
            <value>untreated</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6J</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>nicotine</value>
            <value>none</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Genotype</name>
            <value>Alpha7 L250T heterozygous</value>
            <value>Alpha7 nAChR subunit L250T heterozygous</value>
            <value>Beta4 nAChR subunit null</value>
            <value>wild_type</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE6614</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>25874048</id>
            <accession>A-AFFY-6</accession>
            <name>Affymetrix GeneChip Murine Genome U74Av2 [MG_U74Av2]</name>
            <count>28</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801460420</id>
            <name>Affymetrix:FeatureDimension:MG_U74Av2</name>
            <bioassaydatacubes>28</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>28</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801464790</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-6614.MG_U74Av2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>28</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>28</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>17456735</accession>
            <authors>Merav Kedmi, Avi Orr-Urtreger</authors>
            <title>Expression changes in mouse brains following nicotine-induced seizures: the
                modulation of transcription factor networks.</title>
        </bibliography>
        <provider>
            <contact>Avi Orr-Urtreger</contact>
            <email>aviorr@tasmc.health.gov.il</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1801447580</id>
            <text>Nicotine, acting through the neuronal nicotinic acetylcholine receptors (nAChR),
                can induce seizures in mice. We aimed to study brain transcriptional response to
                seizure and to identify genes whose expression is altered after nicotine-induced
                seizures. Whole brains of untreated mice were compared to brains one hour after
                seizure activity, using Affymetrix U74Av2 microaarays. Experimental groups included
                wild-type mice and both nicotine-induced seizures sensitive and resistant nAChR
                mutant mice. Each genotype group received different nicotine doses to generate
                seizures. This approach allowed the identification of significantly changed genes
                whose expression was dependent on seizure activity, nicotine administration or both,
                but not on the type of nAChR subunit mutation or the amount of nicotine injected.
                Significant expression changes were detected in 62 genes (p &lt; 0.05, FDR
                correction). Among them, GO functional annotation analysis determined that the most
                significantly over-represented categories were of genes encoding MAP kinase
                phosphatases, regulators of transcription and nucleosome assembly proteins.
                In-silico bioinformatic analysis of the promoter regions of the 62 changed genes
                detected the significant enrichments of 16 transcription regulatory elements (TREs),
                creating a network of transcriptional regulatory responses to seizures. The TREs for
                ATF and SRF were most significantly enriched, supporting their association with
                seizure activity. Our data suggest that nicotine-induced seizure in mice is a useful
                model to study seizure activity and its global brain transcriptional response. The
                differentially expressed genes detected here can help understand the molecular
                mechanisms underlying seizures in animal models, and may also serve as candidate
                genes to study epilepsy in humans. Experiment Overall Design: Whole brain expression
                profiles were determined in two experimental groups of mice, sixteen mice that were
                not treated with nicotine and twelve mice one hour after experiencing
                nicotine-induced seizure. The untreated group included six wild-type mice, five
                alpha7+/T and five beta4-/- mice. The group of mice that underwent nicotine-induced
                seizures included three wild-types, five alpha7+/T and four beta4-/- mice. Different
                doses of nicotine were injected intraperitoneally (i.p.) to each genotype group of
                mice in order to achieve a similar seizure score in all three genotypes.</text>
        </description>
        <description>
            <id>1801485614</id>
            <text>(Generated description) Experiment with 28 hybridizations, using 28 samples of
                species [Mus musculus], using 28 arrays of array design [Affymetrix GeneChip Murine
                Genome U74Av2 [MG_U74Av2]], producing 28 raw data files and 28 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="71">
        <id>1801495506</id>
        <accession>E-MEXP-2337</accession>
        <name>Transcription profiling of Vitis vinifera cv. Cabernet-Sauvignon leaves obtained from
            plants grown in different enviroments and infected with vascular ascomycete fungus
            Eutypa lata.</name>
        <releasedate>2009-09-23</releasedate>
        <species>Vitis vinifera</species>
        <samples>24</samples>
        <assays>26</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>frozen_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>E. lata infected plant with symptoms</value>
            <value>E. lata infected plant without symptoms</value>
            <value>normal</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Vitis vinifera</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>E. lata infected plant with symptoms</value>
            <value>E. lata infected plant without symptoms</value>
            <value>normal</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>GrowthCondition</name>
            <value>greenhouse</value>
            <value>vineyard</value>
        </experimentalfactor>
        <user>1741181380</user>
        <user>1801562607</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1742671957</id>
            <accession>A-MEXP-1536</accession>
            <name>INRA Vitis vinifera oligo array 15K v3</name>
            <count>26</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801515275</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.1.FeatureDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801515632</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.1.FeatureDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801515913</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.1.FeatureDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801522146</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.1.ReporterDimension</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>26</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801524435</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801525552</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801527631</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801531140</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801533202</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801536217</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2337.A-MEXP-1536.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Christian Kappel</contact>
            <email>christian.kappel@bordeaux.inra.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>disease state</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <description>
            <id>1801495530</id>
            <text>Eutypa dieback is a vascular disease that may severely affect vineyards throughout
                the world. In the present work, microarrays analysis were made in order (i) to
                improve our knowledge of grapevine (Vitis vinifera cv. Cabernet-Sauvignon) responses
                to Eutypa lata, the causal agent of Eutypa dieback and (ii) to identify genes that
                may prevent symptom development. Qiagen/Operon grapevine microarrays bearing 14,500
                probes were used to compare between three experimental conditions (in vitro,
                greenhouse, vineyard), foliar material of infected symptomatic plants (S+R+),
                infected asymptomatic plants (S-R+), and healthy plants (S-R-). These plants were
                characterized by symptoms notation after natural (vineyard) or experimental (in
                vitro, greenhouse) infection, re-isolation of the fungus located in the lignified
                parts, and the formal identification of E. lata mycelium by PCR. Semi-quantitative
                RT-PCR experiments were run to confirm the expression of some genes of interest in
                response to E. lata. Their expression profiles were also studied in response to
                other grapevine pathogens (E. necator, P. viticola, B. cinerea). (i) Five functional
                categories including metabolism, defense reactions, interaction with environment,
                transport and transcription were up-regulated in S+R+ plants compared to S-R-
                plants. These genes, which cannot prevent infection and symptom development, are not
                specific since they were also upregulated after infection by powdery mildew, downy
                mildew and black rot. (ii) Most of the genes that may prevent symptom development
                are associated with the light phase of photosynthesis. This finding is discussed in
                the context of previous data on the mode of action of eutypin and Eutypa secreted
                polypeptide fraction.</text>
        </description>
        <description>
            <id>1801561692</id>
            <text>(Generated description) Experiment with 26 hybridizations, using 24 samples of
                species [Vitis vinifera], using 26 arrays of array design [INRA Vitis vinifera oligo
                array 15K v3], producing 26 raw data files and 32 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="72">
        <id>1801564363</id>
        <accession>E-MEXP-2118</accession>
        <name>Transcription profiling of Bos indicus blood from animals kept at sea level or at high
            altitude to determine hypobaric hypoxia induced transcriptional changes</name>
        <releasedate>2009-09-23</releasedate>
        <species>Bos indicus</species>
        <samples>2</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Age</category>
            <value>4 to 5 years</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>ClinicalHistory</category>
            <value>Healthy</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>None</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>Control</value>
            <value>HA</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Bos indicus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>blood</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <experimentalfactor>
            <name>EnvironmentalHistory</name>
            <value>Altitude 11000 ft</value>
            <value>Altitude Sea level</value>
        </experimentalfactor>
        <user>1755732393</user>
        <user>1755732394</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1660325748</id>
            <accession>A-AFFY-128</accession>
            <name>Affymetrix GeneChip Bovine Genome Array Bovine</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801564572</id>
            <name>Affymetrix:FeatureDimension:Bovine</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801564631</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2118.A-AFFY-128.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>qadar pasha</contact>
            <email>qpasha@igib.res.in</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>all pairs</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dose response</experimentdesign>
        <description>
            <id>1801564661</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 2 samples of
                species [Bos indicus], using 4 arrays of array design [Affymetrix GeneChip Bovine
                Genome Array [Bovine]], producing 4 raw data files and 1 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1801564371</id>
            <text>Hypobaric Hypoxia Induced Transcriptional profiling of Bovine (Bos indicus)</text>
        </description>
    </experiment>
    <experiment textidx="73">
        <id>1801564859</id>
        <accession>E-TABM-781</accession>
        <name>ChIP-chip profiling of human malignant pleural mesothelioma cell lines to investigate
            H3K27me3 targets on the CpG promoters</name>
        <releasedate>2009-09-23</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>3</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>MPM</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>MPM</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Immunoprecipitate</name>
            <value>Input</value>
            <value>K27</value>
        </experimentalfactor>
        <user>1800363177</user>
        <user>1801565950</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1800651684</id>
            <accession>A-MEXP-1691</accession>
            <name>KShinjo Custom Agilent Human Array 44K15550</name>
            <count>3</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801565216</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-781.A-MEXP-1691.1.FeatureDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801565224</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-781.A-MEXP-1691.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>Cancer Research</publication>
            <authors>Yasuhiro Goto; Keiko Shinjo; Yutaka Kondo</authors>
            <title>Epigenetic profiles distinguish malignant pleural mesothelioma from lung
                adenocarcinoma</title>
            <year>2009</year>
        </bibliography>
        <provider>
            <contact>Keiko Shinjo</contact>
            <email>kshinjo@aichi-cc.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>binding site identification</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>individual genetic characteristics</experimentdesign>
        <description>
            <id>1801565268</id>
            <text>(Generated description) Experiment with 3 hybridizations, using 6 samples of
                species [Homo sapiens], using 3 arrays of array design [KShinjo Custom Agilent Human
                Array 44K15550], producing 3 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1801564865</id>
            <text>To examine H3K27me3 targets on the CpG promoters in MPM cell lines.</text>
        </description>
    </experiment>
    <experiment textidx="74">
        <id>1800057022</id>
        <accession>E-GEOD-13793</accession>
        <name>Transcription profiling of rat cerebellum and hippocampus following exposure to
            neurotoxicant Aroclor 1254</name>
        <releasedate>2009-09-22</releasedate>
        <species>Rattus norvegicus</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>cerebellum</value>
            <value>hippocampus</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Long Evans</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>Aroclor 1254</value>
            <value>none</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DevelopmentalStage</name>
            <value>P14</value>
            <value>P7</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>6 mg/kg/day</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>cerebellum</value>
            <value>hippocampus</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE13793</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>232122446</id>
            <accession>A-AFFY-25</accession>
            <name>Affymetrix GeneChip Rat Expression Array RAE230A [RAE230A]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800370592</id>
            <name>Affymetrix:FeatureDimension:RAE230A</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800370628</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13793.RAE230A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jennifer Fostel</contact>
            <email>fostel@niehs.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <description>
            <id>1800370860</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Rattus norvegicus], using 24 arrays of array design [Affymetrix GeneChip
                Rat Expression Array RAE230A [RAE230A]], producing 24 raw data files and 24
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1800057030</id>
            <text>Pregnant rats (Long-Evans) were dosed perinatally with 0 or 6 mg/kg/day of Aroclor
                1254 from gestation day 6 through postnatal day (PND) 21. Gene expression in
                cerebellum and hippocampus from PND7 and PND14 animals was analyzed with an emphasis
                on developmental aspects. Changes in gene expression (&gt;= 1.5 fold) in control
                animals identified normal developmental changes. These basal levels of expression
                were compared to data from Aroclor 1254-treated animals to determine the impact of
                gestational PCB exposure on developmental parameters. The results indicate that the
                expression of a number of developmental genes related to cell cycle, synaptic
                function, cell maintenance, and neurogenesis is significantly altered from PND7 to
                PND14. Aroclor 1254 treatment appears to dampen the overall growth-related gene
                expression levels in both regions with the effect being more pronounced in the
                cerebellum. Functional analysis suggests that Aroclor 1254 delays maturation of the
                developing nervous system, with the consequences dependent on the ontological state
                of the brain area and the functional role of the individual gene. Experiment Overall
                Design: Pregnant rats (Long-Evans) were dosed perinatally with 0 or 6 mg/kg/day of
                Aroclor 1254 from gestation day 6 through postnatal day (PND) 21. Gene expression in
                cerebellum and hippocampus from PND7 and PND14 animals was analyzed with an emphasis
                on developmental aspects.</text>
        </description>
        <description>
            <id>1800060888</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Rattus norvegicus], using 24 arrays of array design [Affymetrix GeneChip
                Rat Expression Array RAE230A [RAE230A]], producing 24 raw data files and 24
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="75">
        <id>1800124655</id>
        <accession>E-GEOD-8150</accession>
        <name>Transcription profiling of mouse brain to identify age-related transcriptional changes
            and the effect of dietary supplementation of vitamin E</name>
        <releasedate>2009-09-22</releasedate>
        <species>Mus musculus</species>
        <samples>20</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>Age</category>
            <value>30 months</value>
            <value>5 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>neocortex</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>B6/C3H F1 hybrid</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Age</name>
            <value>30 months</value>
            <value>5 months</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Compound</name>
            <value>alpha-tocopherol</value>
            <value>alpha-tocopherol + gamma-tocopherol</value>
            <value>none</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE8150</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>20</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800317131</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>20</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800326646</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-8150.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>20</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sang-Kyu Park</contact>
            <email>sangkyu@colorado.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <description>
            <id>1800362536</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 20 samples of
                species [Mus musculus], using 20 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 20 raw data files and 20 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1800124667</id>
            <text>We established the transcriptional profile of brain aging and examine the global
                effects of vitamin E supplementation on age-related alterations in expression in the
                aged mouse brain. Experiment Overall Design: Gene expression profiles were obtained
                from the neocortex tissues of 5-month-old controls, 30-month-old controls and
                30-month old B6C3F1 mice with middle age-onset supplementation of -tocopherol or a
                mixture of - and -tocopherol (500mg/kg of each tocopherol).</text>
        </description>
    </experiment>
    <experiment textidx="76">
        <id>1800140323</id>
        <accession>E-GEOD-4773</accession>
        <name>Transcription profiling of human SK-N-MC cell line model of Parkinson's disease</name>
        <releasedate>2009-09-22</releasedate>
        <species>Homo sapiens</species>
        <samples>21</samples>
        <assays>21</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>SK-N-MC</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>C1A_e1_le1</value>
            <value>C1B_e1_le1</value>
            <value>C1C_e1_le1</value>
            <value>C2A_e1_le1</value>
            <value>C2B_e1_le1</value>
            <value>C2C_e1_le1</value>
            <value>C4A_e1_le1</value>
            <value>C4B_e1_le1</value>
            <value>C4C_e1_le1</value>
            <value>R1A_e1_le1</value>
            <value>R1B_e1_le1</value>
            <value>R1C_e1_le1</value>
            <value>R2A_e1_le1</value>
            <value>R2A_e1_le2</value>
            <value>R2C_e1_le1</value>
            <value>R4A_e1_le1</value>
            <value>R4B_e1_le1</value>
            <value>R4C_e1_le1</value>
            <value>UTA_e1_le1</value>
            <value>UTB_e1_le1</value>
            <value>UTC_e1_le1</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>brain</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>none</value>
            <value>rotenone</value>
            <value>vehicle - control</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Individual</name>
            <value>C1A_e1_le1</value>
            <value>C1B_e1_le1</value>
            <value>C1C_e1_le1</value>
            <value>C2A_e1_le1</value>
            <value>C2B_e1_le1</value>
            <value>C2C_e1_le1</value>
            <value>C4A_e1_le1</value>
            <value>C4B_e1_le1</value>
            <value>C4C_e1_le1</value>
            <value>R1A_e1_le1</value>
            <value>R1B_e1_le1</value>
            <value>R1C_e1_le1</value>
            <value>R2A_e1_le1</value>
            <value>R2A_e1_le2</value>
            <value>R2C_e1_le1</value>
            <value>R4A_e1_le1</value>
            <value>R4B_e1_le1</value>
            <value>R4C_e1_le1</value>
            <value>UTA_e1_le1</value>
            <value>UTB_e1_le1</value>
            <value>UTC_e1_le1</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Time</name>
            <value>1 week</value>
            <value>2 weeks</value>
            <value>4 weeks</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE4773</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>21</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800158610</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>20</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800158639</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-4773.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>21</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>21</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Elizabeth Salomon</contact>
            <email>esalomon@tgen.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1800140335</id>
            <text>Parkinson's disease is a prevalent neurodegenerative disorder for which there is
                no cure. The cause of PD symptoms is loss of dopamine neurons in the midbrain, but
                it is not known why these neurons die. Pesticide exposure is epidemiologically
                associated with PD, and administration of the organic pesticide rotenone to rats
                recapitulates most of the behavioral, neurochemical, and neuropathological findings
                in PD, including specific death of dopamine neurons. We have developed an in vitro
                model of rotenone toxicity using a dopaminergic cell line (SK-N-MC neuroblastoma
                cells) that mimics many of the cellular changes seen with in vivo rotenone toxicity
                and with PD, such as alpha-synuclein aggregation and oxidative damage. We are
                currently using this simple model to explore mechanisms of dopaminergic
                neurodegeneration, with our ultimate goal being the discovery of novel mechanisms
                for dopaminergic neuroprotection in PD. We will examine gene expression profiles of
                cultured SK-N-MC cells at several time points during rotenone exposure to determine
                pathways involved in rotenone toxicity and dopaminergic degeneration. We will
                compare these profiles to baseline profiles of rodent dopaminergic neurons that we
                have already obtained, as well as to profiles of dopamine neurons from
                rotenone-treated rats that we will obtain in the near future. We will also compare
                these data to published results from SN neurons from human PD patients. This
                technique will not only help us to detect gene expression changes relevant to
                dopaminergic neurodegeneration in PD, but it will allow us to determine if the
                SK-N-MC system can be reliably used to screen for neuroprotective therapies for PD.
                We anticipate that SK-N-MC cells will show a relevant subset of the gene changes
                seen in dopamine neurons in vivo and that this will guide us in the sorts of
                mechanisms and drugs that can be screened in this system. Chronic exposure to low
                levels of rotenone causes changes in gene expression in SK-N-MC cells that sensitize
                the cells to toxic insults. We also hypothesize that there are several compensatory
                protective pathways that are stimulated by chronic rotenone, although these pathways
                are ultimately ineffective at preventing damage. We anticipate that gene expression
                profiling of rotenone-treated cells over time will suggest several novel strategies
                for neuroprotective intervention. SK-N-MC cells will be grown in three different
                media: media only, vehicle (EtOH), and rotenone (5 nM). All current experimental
                evidence in our lab indicates that vehicle-treated cells are indistinguishable from
                media-only cells. Rotenone-treated cellls have a stereotypical response in culture.
                At one week, the only noticed change is an increase in alph-synuclein aggregation.
                At two weeks, evidence of increased oxidative stress appears (increased protein
                carbonyls and lipid peroxidation). At four weeks, the cells are markedly sensitized
                to oxidative challenge with H2O2. Therefore, we will examine gene expression at
                baseline, and during 1, 2, and 4 weeks of rotenone treatment. Three experiments will
                be performed, each lasting 4 weeks. For each experiment, three separate dishes of
                vehicle-treated, and rotenone-treated cells will be harvested at 1, 2, and 4 weeks
                (18 independent samples). Untreated, media-only cells will be harvested after 1 week
                in vitro to serve as baseline cells. Total RNA will be isolated. An equal amount of
                RNA from one dish per experiment per group will be used to compose the final
                samples. Therefore, each independent sample will consist of RNA from 3 separate
                experiments. This will allow us to take advantage of a pooling strategy, yet not
                sacrifice technical and biological replication. 21 samples will be sent to the
                Consortium. Three will be from untreated cells. Nine will be vehicle-treated at 1,
                2, and 4 weeks (3 each). Nine will be rotenone-treated at 1, 2 , and 4 weeks (3
                each). Each sample will be labeled and hybridized to one Affymetrix Human Genome
                U133 Plus 2.0 Gene Chip. With assistance of the consortium, we will analyze the data
                using the Signifiance Analysis of Microarrays (SAM) program and self-organizing map
                algorithms.</text>
        </description>
        <description>
            <id>1800158795</id>
            <text>(Generated description) Experiment with 21 hybridizations, using 21 samples of
                species [Homo sapiens], using 21 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 20 raw data files and 21
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="77">
        <id>1800368609</id>
        <accession>E-GEOD-10748</accession>
        <name>Transcription profiling of rat brain treated with D-serine</name>
        <releasedate>2009-09-22</releasedate>
        <species>Rattus norvegicus</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Age</category>
            <value>11-12 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>brain</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Fischer 344</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>D-serine</value>
            <value>none</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>20 mg/kg</value>
            <value>200 mg/kg</value>
            <value>5 mg/kg</value>
            <value>50 mg/kg</value>
            <value>500 mg/kg</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Individual</name>
            <value>Animal #243</value>
            <value>Animal #244</value>
            <value>Animal #245</value>
            <value>Animal #246</value>
            <value>Animal #247</value>
            <value>Animal #248</value>
            <value>Animal #249</value>
            <value>Animal #251</value>
            <value>Animal #253</value>
            <value>Animal #254</value>
            <value>Animal #255</value>
            <value>Animal #256</value>
            <value>Animal #257</value>
            <value>Animal #258</value>
            <value>Animal #259</value>
            <value>Animal #261</value>
            <value>Animal #262</value>
            <value>Animal #263</value>
            <value>Animal #265</value>
            <value>Animal #266</value>
            <value>Animal #267</value>
            <value>Animal #269</value>
            <value>Animal #270</value>
            <value>Animal #271</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE10748</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800369726</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800369766</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-10748.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Molly Davidson</contact>
            <email>molly.davidson@wpafb.af.mil</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <description>
            <id>1800369993</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Rattus norvegicus], using 24 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 24 raw data files and 24 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1800368616</id>
            <text>D-serine is naturally present throughout the human body. It is also used as add-on
                therapy for treatment-refractory schizophrenia. D-serine interacts with the
                strychnine-insensitive glycine binding site of NMDA receptor, and this interaction
                could lead to potentially toxic activity (i.e., excitotoxicity) in brain tissue. The
                transcriptomic changes that occur in the brain after D-serine exposure have not been
                fully explored. Affymetrix microarray technology was used to determine differential
                gene expression resulting from D-serine exposure. Experiment Overall Design: Male
                Fisher 344 rats aged 11-12 weeks were treated with various doses (0, 5, 20, 50, 200
                &amp; 500 mg/kg) of D-serine and terminally sacrificed 96 hours post-exposure.
                An approximate 30mg-section of the forebrain was processed for total RNA
                isolation.</text>
        </description>
    </experiment>
    <experiment textidx="78">
        <id>1800369643</id>
        <accession>E-BUGS-84</accession>
        <name>Comparative genomic hybridization of S. aureus to examine Genetic Diversity in CC398
            Methicillin-Resistant Staphylococcus aureus of Different Geographic Origin.</name>
        <releasedate>2009-09-22</releasedate>
        <species>Mycobacterium tuberculosis</species>
        <samples>5</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Genotype</category>
            <value>t034-ST398, cc398, PVL +</value>
            <value>t034-ST398, CC398, PVL +</value>
            <value>t034-ST398, CC398, PVL -</value>
            <value>t034-ST398, CC398, PVL-</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mycobacterium tuberculosis</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Staphylococcus aureus 40555</value>
            <value>Staphylococcus aureus 45009</value>
            <value>Staphylococcus aureus 50148</value>
            <value>Staphylococcus aureus 51726</value>
            <value>Staphylococcus aureus MRSA252</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>40555</value>
            <value>45009</value>
            <value>50148</value>
            <value>51726</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>616482310</id>
            <accession>A-BUGS-17</accession>
            <name>BuG@S S.aureus 9248 SAv1_1_0</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1801983491</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/FeatureDimension:27</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801983492</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/FeatureDimension:27</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801983497</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:35192</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1801983499</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:35701</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19681955</accession>
        </bibliography>
        <experimentdesign>reference</experimentdesign>
        <experimentdesign>strain or line</experimentdesign>
        <description>
            <id>1800369646</id>
            <text>Abstract Staphylococcus aureus of sequence type 398 has emerged in Europe, North
                America and Asia and has typically been associated with livestock and their human
                contacts. We analysed two PVL-negative t034-ST398 isolates from humans in contact
                with pigs, and two t034-ST398 PVL-positive isolates from two unrelated adopted
                Chinese children using multi-strain microarrays to determine the genomic
                variability. The ST398 isolates clearly belong to the same lineage when compared to
                other clonal lineages. However, the four isolates cluster into two distinct groups
                corresponding to differences in epidemiology based on mobile genetic elements and
                resistance patterns, suggesting the two groups are epidemiologically
                distinct.</text>
        </description>
        <description>
            <id>1800369650</id>
            <text>Data is also available from &lt;ahref="http://bugs.sgul.ac.uk/E-BUGS-84"
                target="_blank"&gt;BuG@Sbase&lt;/a&gt;</text>
        </description>
        <description>
            <id>1800369830</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 5 samples of
                species [Staphylococcus aureus, Mycobacterium tuberculosis], using 4 arrays of array
                design [BuG@S S.aureus 9248 SAv1_1_0], producing 8 raw data files and 8 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1801983518</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 5 samples of
                species [Staphylococcus aureus, Mycobacterium tuberculosis], using 4 arrays of array
                design [BuG@S S.aureus 9248 SAv1_1_0], producing 8 raw data files and 8 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="79">
        <id>1800373127</id>
        <accession>E-MEXP-2359</accession>
        <name>Transcription profiling of human pre-implantation development</name>
        <releasedate>2009-09-22</releasedate>
        <species>Homo sapiens</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>frozen_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>embryo</value>
        </sampleattribute>
        <sampleattribute>
            <category>InitialTimePoint</category>
            <value>day 2</value>
            <value>germinal vescicle</value>
            <value>metaphase 1</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>embryo</value>
            <value>germinal vescicle</value>
            <value>oocyte</value>
        </sampleattribute>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>embryo</value>
            <value>germinal vescicle</value>
            <value>oocyte</value>
        </experimentalfactor>
        <user>1800377076</user>
        <user>1800377077</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800375513</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800375561</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2359b.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Transcriptome profiling of human pre-implantation development</title>
        </bibliography>
        <provider>
            <contact>Marco Zucchelli</contact>
            <email>marco.zucchelli@ki.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>development or differentiation</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <description>
            <id>1800373135</id>
            <text>Transcriptome profiling of human pre-implantation development</text>
        </description>
        <description>
            <id>1800375745</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Homo sapiens], using 12 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 12 raw data files and 12
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="80">
        <id>1800381335</id>
        <accession>E-TABM-756</accession>
        <name>Transcription profiling of mouse liver after partial hepatectomy in time course</name>
        <releasedate>2009-09-22</releasedate>
        <species>Mus musculus</species>
        <samples>366</samples>
        <assays>366</assays>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>DNA</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>PCR_amplicon</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>liver</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Time</name>
            <value>12</value>
            <value>20</value>
            <value>30</value>
            <value>4</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797441144</id>
            <accession>A-MEXP-1645</accession>
            <name>UW_CEA_MOUSE_OD1</name>
            <count>184</count>
        </arraydesign>
        <arraydesign>
            <id>1797469562</id>
            <accession>A-MEXP-1646</accession>
            <name>UW_CEA_MOUSE_OD2</name>
            <count>182</count>
        </arraydesign>
        <bibliography>
            <accession>19700759</accession>
            <publication>Am J Pathol</publication>
            <authors>Li J, Campbell JS, Mitchell C, McMahan RS, Yu X, Riehle KJ, Bumgarner RE,
                Fausto N</authors>
            <title>Relationships between deficits in tissue mass and transcriptional programs after
                partial hepatectomy in mice</title>
            <year>2009</year>
            <volume>175</volume>
            <issue>3</issue>
            <pages>947-57</pages>
        </bibliography>
        <provider>
            <contact>Jiangning Li</contact>
            <email>jl2@fhcrc.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1800381341</id>
            <text/>
        </description>
        <description>
            <id>1800383166</id>
            <text>(Generated description) Experiment with 366 hybridizations, using 366 samples of
                species [Mus musculus], using 366 arrays of array design [UW_CEA_MOUSE_OD2,
                UW_CEA_MOUSE_OD1], producing 0 raw data files and 6 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="81">
        <id>1800394546</id>
        <accession>E-GEOD-6285</accession>
        <name>Transcription profiling of brains of mice fed four different diets for a 2-week
            duration</name>
        <releasedate>2009-09-22</releasedate>
        <species>Mus musculus</species>
        <samples>24</samples>
        <assays>24</assays>
        <sampleattribute>
            <category>Age</category>
            <value>8 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>brain</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>NMR-1</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GrowthCondition</name>
            <value>chimpanzee diet</value>
            <value>fast food diet</value>
            <value>human caf diet</value>
            <value>pellet diet</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE6285</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800396580</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>24</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1800396641</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-6285.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Mehmet Somel</contact>
            <email>somel@eva.mpg.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>growth condition</experimentdesign>
        <description>
            <id>1800394553</id>
            <text>Beyond the DNA sequence difference between humans and closely related apes, there
                are large differences in the environments that these species experience. One
                prominent example for this is diet. The human diet diverges from those of other
                primates in various aspects, such as having a high calorie and protein content, as
                well as being cooked. Here, we used a laboratory mouse model to identify gene
                expression differences related to dietary differences. Experiment Overall Design: We
                fed four groups of six genetically identical 8-week-old female NMR1 mice one of four
                diets ad libidum: (1) a diet consisting of vegetables, fruit and yogurt identical to
                the diet fed to chimpanzees in our ape facility ('Chimpanzee'); (2) a diet
                consisting exclusively of McDonalds. fast food ('FastFood'); (3) a diet consisting
                of cooked food eaten by our staff in the Institute cafeteria ('HumanCafe'); (4) the
                mouse pellet diet on which they were raised ('Pellet'). At the end of a 2-week
                period, mice were euthanized by cervical dislocation and both liver and brain (right
                cerebral hemisphere) tissue were dissected. RNA was extracted from the 24 liver and
                brain samples as per established lab protocols and processed in two batches
                (containing equal numbers of individuals from all groups).</text>
        </description>
        <description>
            <id>1800397016</id>
            <text>(Generated description) Experiment with 24 hybridizations, using 24 samples of
                species [Mus musculus], using 24 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 24 raw data files and 24 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="82">
        <id>1799974201</id>
        <accession>E-TABM-799</accession>
        <name>Transcription profiling of Ectocarpus siliculosus wild type and morphogenesis mutant
            Etoile</name>
        <releasedate>2009-09-21</releasedate>
        <species>Ectocarpus siliculosus</species>
        <samples>2</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Genotype</category>
            <value>ETL_MUTANT</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>MaterialType</category>
            <value>total_RNA</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Ectocarpus siliculosus</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>ETL_MUTANT</value>
            <value>wild_type</value>
        </experimentalfactor>
        <user>1799974226</user>
        <user>1799974227</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1682254989</id>
            <accession>A-MEXP-1445</accession>
            <name>Nimblegen E.siliculosus Gene Expression v1 </name>
            <count>8</count>
        </arraydesign>
        <bibliography/>
        <provider>
            <contact>Aude Le Bail</contact>
            <email>lebail@sb-roscoff.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>individual genetic characteristics</experimentdesign>
        <description>
            <id>1799974216</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 2 samples of
                species [Ectocarpus siliculosus], using 8 arrays of array design [Nimblegen
                E.siliculosus Gene Expression v1 ], producing 8 raw data files and 9 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1799974207</id>
            <text>Comparison between transcriptome of wild type and etl mutant</text>
        </description>
    </experiment>
    <experiment textidx="83">
        <id>1799975791</id>
        <accession>E-MEXP-2364</accession>
        <name>Transcription profiling of Zea mays leafs of MON810 (Helen Bt) and near-isogenic
            commercial varieties (Helen) gorwn in low nitrogen conditions</name>
        <releasedate>2009-09-21</releasedate>
        <species>Zea mays</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>vegetative tasseling</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>none</value>
            <value>transformed</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>+CRYIA(b) insecticidal protein</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Helen</value>
            <value>Helen Bt</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>Helen</value>
            <value>Helen Bt</value>
        </experimentalfactor>
        <user>1591136548</user>
        <user>1799980477</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1287164335</id>
            <accession>A-AFFY-77</accession>
            <name>Affymetrix GeneChip Maize Genome Array [Maize]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799976606</id>
            <name>Affymetrix:FeatureDimension:Maize</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799976320</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2364.A-AFFY-77.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Natural variation explains most transcriptomic changes among maize plants of
                different MON810 and comparable non-GM varieties subjected to two N fertilization
                farming practices</title>
        </bibliography>
        <provider>
            <contact>Maria Pla</contact>
            <email>maria.pla@udg.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>strain or line</experimentdesign>
        <description>
            <id>1799975799</id>
            <text>Comparison of the transcriptome profiles of a widely commercialized maize MON810
                variety and its non-GM near-isogenic counterpart subjected to low N fertilization
                farming practices</text>
        </description>
        <description>
            <id>1799976966</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Zea mays], using 6 arrays of array design [Affymetrix GeneChip Maize Genome
                Array [Maize]], producing 6 raw data files and 6 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="84">
        <id>1799977784</id>
        <accession>E-TABM-794</accession>
        <name>Transcription profiling of human prostate cancer</name>
        <releasedate>2009-09-21</releasedate>
        <species>Homo sapiens</species>
        <samples>102</samples>
        <assays>102</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>freshly frozen</value>
        </sampleattribute>
        <sampleattribute>
            <category>ClinicalInformation</category>
            <value>LN norm</value>
            <value>LN PCa</value>
            <value>NAP</value>
            <value>PCa</value>
            <value>TURP normal</value>
            <value>TURP PCa</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>normal</value>
            <value>prostate carcinoma</value>
            <value>prostate carcinoma lymph node metastasis</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>lymphnode</value>
            <value>prostate</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <experimentalfactor>
            <name>ClinicalInformation</name>
            <value>LN norm</value>
            <value>LN PCa</value>
            <value>NAP</value>
            <value>PCa</value>
            <value>TURP normal</value>
            <value>TURP PCa</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>normal</value>
            <value>prostate carcinoma</value>
            <value>prostate carcinoma lymph node metastasis</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>lymphnode</value>
            <value>prostate</value>
        </experimentalfactor>
        <user>1799988249</user>
        <user>1799988250</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1780657333</id>
            <accession>A-MEXP-1663</accession>
            <name>Agilent Human miRNA G4470B (019118)</name>
            <count>102</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799978656</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-794.A-MEXP-1663.1.FeatureDimension</name>
            <bioassaydatacubes>102</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>102</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <authors>E.S. Martens-Uzunova, S.E. Jalava, N.F. Dits, J. Trapman, C.H. Bangma, T.
                Litman, T. Visakorpi, G. Jenster</authors>
            <title>profiling of the small transcriptome in prostate cancer</title>
        </bibliography>
        <provider>
            <contact>Sanni Jalava</contact>
            <email>sanni.jalava@uta.fi</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>disease state</experimentdesign>
        <experimentdesign>ex vivo</experimentdesign>
        <description>
            <id>1799983149</id>
            <text>(Generated description) Experiment with 102 hybridizations, using 102 samples of
                species [Homo sapiens], using 102 arrays of array design [Agilent Human miRNA G4470B
                (019118)], producing 102 raw data files and 0 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1799977791</id>
            <text>miRNA expression profiling of 102 patient samples</text>
        </description>
    </experiment>
    <experiment textidx="85">
        <id>1799981193</id>
        <accession>E-MEXP-2360</accession>
        <name>Transcription profiling of human memory B cells to plasma cells differentiation time
            course</name>
        <releasedate>2009-09-21</releasedate>
        <species>Homo sapiens</species>
        <samples>25</samples>
        <assays>25</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>activated B cells</value>
            <value>bone marrow plasma cells</value>
            <value>memory B cells</value>
            <value>plasma cells</value>
            <value>plasmablasts</value>
        </sampleattribute>
        <sampleattribute>
            <category>Time</category>
            <value>Time</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellType</name>
            <value>activated B cells</value>
            <value>bone marrow plasma cells</value>
            <value>memory B cells</value>
            <value>plasma cell</value>
            <value>plasmablasts</value>
        </experimentalfactor>
        <user>1799985220</user>
        <user>1799985229</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>25</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799983627</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>25</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>25</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799983663</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2360.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>25</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>25</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>AN IN VITRO MODEL OF DIFFERENTIATION OF MEMORY B CELLS INTO PLASMABLASTS AND
                PLASMA CELLS INCLUDING DETAILED PHENOTYPIC AND MOLECULAR CHARACTERIZATION</title>
        </bibliography>
        <provider>
            <contact>Michel Jourdan</contact>
            <email>michel.jourdan@inserm.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <description>
            <id>1799983867</id>
            <text>(Generated description) Experiment with 25 hybridizations, using 25 samples of
                species [Homo sapiens], using 25 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 25 raw data files and 25
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1799981201</id>
            <text>In vitro model of differentiation of memory B cells into plasmablasts and plasma
                cells.</text>
        </description>
    </experiment>
    <experiment textidx="86">
        <id>1799983501</id>
        <accession>E-TABM-783</accession>
        <name>Transcription profiling of human non anaplastic T-cell lymphoma</name>
        <releasedate>2009-09-21</releasedate>
        <samples>35</samples>
        <assays>35</assays>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>from lymph node</value>
            <value>lymph node</value>
            <value>n/a</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organsim</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
            <value>n/a</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Age</name>
            <value>21</value>
            <value>32</value>
            <value>35</value>
            <value>42</value>
            <value>45</value>
            <value>50</value>
            <value>53</value>
            <value>54</value>
            <value>56</value>
            <value>57</value>
            <value>59</value>
            <value>62</value>
            <value>63</value>
            <value>64</value>
            <value>65</value>
            <value>66</value>
            <value>67</value>
            <value>68</value>
            <value>69</value>
            <value>71</value>
            <value>74</value>
            <value>75</value>
            <value>77</value>
            <value>81</value>
            <value>83</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Age(years)</name>
            <value>n/a</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseStage</name>
            <value>1</value>
            <value>3</value>
            <value>4</value>
            <value>n/a</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>angioimmunoblastic T-cell lymphoma</value>
            <value>peripheral T-cell lymphoma, not otherwise specified</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>SampleType</name>
            <value>sorted cells</value>
            <value>tissue</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>35</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799983925</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>35</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>35</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799983974</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-783.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>35</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>17284527</accession>
            <publication>Blood</publication>
            <authors>Laurence de Leval, David S. Rickman, Caroline Thielen, Aurelien de Reynies,
                Yen-Lin Huang, Georges Delsol, Laurence Lamant, Karen Leroy, Josette Briere, Thierry
                Molina, Fran oise Berger, Christian Gisselbrecht, Luc Xerri, and Philippe
                Gaulard</authors>
            <title>The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a
                molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular
                helper T (TFH) cells.</title>
            <year>2007</year>
            <volume>109</volume>
            <issue>11</issue>
            <pages>4952-4963</pages>
        </bibliography>
        <provider>
            <contact>Aurelien de Reynies</contact>
            <email>reyniesa@ligue-cancer.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <description>
            <id>1799984191</id>
            <text>(Generated description) Experiment with 35 hybridizations, using 35 samples of
                species [], using 35 arrays of array design [Affymetrix GeneChip Human Genome U133
                Plus 2.0 [HG-U133_Plus_2]], producing 35 raw data files and 1 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1799983507</id>
            <text>A Cartes d Identite des Tumeurs (CIT) project from the french Ligue Nationale
                Contre le Cancer (http://cit.ligue-cancer.net) | Affymetrix HG-U133 Plus 2.0 : 17
                AITL biopsies, 2 AITL sorted cells, 16 PTCL NOS biopsies | The molecular alterations
                underlying the pathogenesis of angioimmunoblastic T-cell lymphoma (AITL) and
                peripheral T-cell lymphoma, unspecified (PTCL-u) are largely unknown. In order to
                characterize the ontogeny and molecular differences between both entities, a series
                of AITLs (n = 18) and PTCLs-u (n = 16) was analyzed using gene expression profiling.
                Unsupervised clustering correlated with the pathological classification and with
                CD30 expression in PTCL-u. The molecular profile of AITLs was characterized by a
                strong microenvironment imprint (overexpression of B-cell- and follicular dendritic
                cell-related genes, chemokines, and genes related to extracellular matrix and
                vascular biology), and overexpression of several genes characteristic of normal
                follicular helper T (T(FH)) cells (CXCL13, BCL6, PDCD1, CD40L, NFATC1). By gene set
                enrichment analysis, the AITL molecular signature was significantly enriched in
                published T(FH)-specific genes. The enrichment was higher for sorted AITL cells than
                for tissue samples. Overexpression of several T(FH) genes was validated by
                immunohistochemistry in AITLs. A few cases with molecular T(FH)-like features were
                identified among CD30(-) PTCLs-u. Our findings strongly support that T(FH) cells
                represent the normal counterpart of AITL, and suggest that the AITL spectrum may be
                wider than suspected, as a subset of CD30(-) PTCLs-u may derive from or be related
                to AITL.| Submitter : Aurelien de Reynies &lt;reyniesa@ligue-cancer.fr&gt; |
                Project leader : Philippe Gaulard
                &lt;philippe.gaulard@hmn.aphp.fr&gt;</text>
        </description>
    </experiment>
    <experiment textidx="87">
        <id>1800000487</id>
        <accession>E-TABM-555</accession>
        <name>Transcription profiling of rat to investigate technical and biological variability on
            the Agilent platform</name>
        <releasedate>2009-09-21</releasedate>
        <species>Rattus norvegicus</species>
        <samples>36</samples>
        <assays>96</assays>
        <sampleattribute>
            <category>Age</category>
            <value>7-8</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>rat 1</value>
            <value>rat 2</value>
            <value>rat 3</value>
            <value>rat 4</value>
            <value>rat 5</value>
            <value>rat 6</value>
            <value>rat Pool 1-3</value>
            <value>rat Pool 1-6</value>
            <value>rat Pool 4-6</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>25% liver, 75% kidney</value>
            <value>75% liver, 25% kidney</value>
            <value>kidney</value>
            <value>liver</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Sprague Dawley Crl:CD(SD)</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>weeks</value>
        </sampleattribute>
        <experimentalfactor>
            <name>AmpLabelingInputMass</name>
            <value>200</value>
            <value>400</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>HybOperator</name>
            <value>A</value>
            <value>B</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Individual</name>
            <value>rat 1</value>
            <value>rat 2</value>
            <value>rat 3</value>
            <value>rat 4</value>
            <value>rat 5</value>
            <value>rat 6</value>
            <value>rat Pool 1-3</value>
            <value>rat Pool 1-6</value>
            <value>rat Pool 4-6</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>25% liver, 75% kidney</value>
            <value>75% liver, 25% kidney</value>
            <value>kidney</value>
            <value>liver</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>SamplePreparationUser</name>
            <value>A</value>
            <value>B</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1431203323</id>
            <accession>A-MEXP-784</accession>
            <name>Agilent Whole Rat Genome Microarray 4x44K 014879 G4131F</name>
            <count>96</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1800000787</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-555.A-MEXP-784.1.FeatureDimension</name>
            <bioassaydatacubes>96</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>96</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Anne Bergstrom Lucas</contact>
            <email>anne_lucas@agilent.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>array platform variation</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>organism part comparison</experimentdesign>
        <description>
            <id>1800000493</id>
            <text>In this experiment, there are replicate measurements of gene expression in a group
                of similarly treated animals measured in such a way as to provide data for
                comparison of technical variation with biological variability. The data are twelve
                microarray measurements on each of six rats that were subject to the same
                control-group treatment. The twelve measurements encompass triplicate measures of
                RNA from the liver, from the kidney, and from two mixtures of both RNAs.</text>
        </description>
        <description>
            <id>1800001376</id>
            <text>(Generated description) Experiment with 96 hybridizations, using 36 samples of
                species [Rattus norvegicus], using 96 arrays of array design [Agilent Whole Rat
                Genome Microarray 4x44K 014879 G4131F], producing 96 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="88">
        <id>1799933855</id>
        <accession>E-MTAB-144</accession>
        <name>Methylation profiling of human pediatric acute lymphoblastic leukemia</name>
        <releasedate>2009-09-18</releasedate>
        <species>Homo sapiens</species>
        <samples>20</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>frozen_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>ETV6/RUNX1</value>
            <value>high hyperdiploid</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>blood</value>
            <value>bone marrow</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Chip-antibody</name>
            <value>input_DNA</value>
            <value>mouse monoclonal anti-5-methylcytidine</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Genotype</name>
            <value>ETV6/RUNX1</value>
            <value>high hyperdiploid</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1791929925</id>
            <accession>A-MEXP-1673</accession>
            <name>Nimblegen 2006-11-02_HG18_CpG_Promo</name>
            <count>20</count>
        </arraydesign>
        <bibliography>
            <title>The DNA methylome of peediatric acute lymphoblastic leukemia</title>
        </bibliography>
        <provider>
            <contact>Josef Davidsson</contact>
            <email>josef.davidsson@med.lu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>binding site identification</experimentdesign>
        <experimentdesign>individual genetic characteristics</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <description>
            <id>1799933865</id>
            <text>Samples from 20 children with B-cell precursor ALL, comprising ten with high
                hyperdiploidy and ten with the ETV6/RUNX1 fusion, were included in the study. Four g
                of methylated and input fraction DNA were analyzed with a classic MeDIP assay and
                subsequent microarray hybridization using the NimbleGen CpG Island-Plus-Promoter
                Array (Roche NimbleGen, Madison, WI).&lt;br&gt;&lt;br&gt;This array
                platform covers all 28,226 UCSC-annotated CpG islands and promoter regions for all
                RefSeq genes, including 385,000 probes of 50-75mer length per array, with an
                upstream and downstream promoter tiling of 800 bp and 200 bp, respectively. Signal
                intensity data were extracted from the scanned images. Each feature on the array has
                a corresponding log2 ratio, which is the ratio of the input signals for the
                methylated DNA and the input fraction DNA. The log2 ratio was scaled in order to
                center the ratio data around zero by subtracting the bi-weight mean for the log2
                ratio values for all features on the array from each log2 ratio value. A modified
                ACME algorithm, where a fixed-length window (750 bp) is placed around each
                consecutive probe, and the one-sided Kolmogorov-Smirnov test were then applied on
                the scaled log2 ratio data to determine whether the probes were drawn from a
                significantly more positive distribution (peak) of intensity log2 ratios than the
                other probes in the array. The resulting score for each probe is the -log10 p-value
                from the windowed Kolmogorov-Smirnov test around that probe. Peak data were
                generated by searching for probes above a p-value minimum cut-off (-log10) of
                2.&lt;br&gt;&lt;br&gt;Peaks within 500 bp of each other were merged.
                Each annotated gene was subsequently searched for peaks appearing in a specified
                promoter region around the transcription start site. The region searched was
                design-specific, spanning from 5 kb upstream to 1 kb downstream of the transcription
                start site. Genes that had at least two probes with peaks above the p-value minimum
                cut-off were considered to have significant CpG island methylation scores for
                hypermethylation.</text>
        </description>
        <description>
            <id>1799934641</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 20 samples of
                species [Homo sapiens], using 20 arrays of array design [Nimblegen
                2006-11-02_HG18_CpG_Promo], producing 40 raw data files and 21 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="89">
        <id>1799936307</id>
        <accession>E-MEXP-2363</accession>
        <name>Transcription profiling of Drosophila embryos with differenct ewg transcription factor
            isoforms identifies a subset of differentially regulated genes important for synaptic
            growth regulation</name>
        <releasedate>2009-09-18</releasedate>
        <species>Drosophila melanogaster</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Age</category>
            <value>16 to 18 hours</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>embryo</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>induced_mutation</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>DJ</value>
            <value>ewgl1</value>
            <value>NS1</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>InitialTimePoint</category>
            <value>egg_laying</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Drosophila melanogaster</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>DJ</value>
            <value>ewgl1</value>
            <value>NS1</value>
            <value>wild_type</value>
        </experimentalfactor>
        <user>1533987698</user>
        <user>1799937433</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>106254051</id>
            <accession>A-AFFY-17</accession>
            <name>Affymetrix GeneChip Drosophila Genome [DrosGenome1]</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799936400</id>
            <name>Affymetrix:FeatureDimension:DrosGenome1</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799936456</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2363.A-AFFY-17.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Matthias Soller</contact>
            <email>m.soller@bham.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <description>
            <id>1799936319</id>
            <text>comparison of different ewg isoforms</text>
        </description>
        <description>
            <id>1799936647</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Drosophila melanogaster], using 16 arrays of array design [Affymetrix
                GeneChip Drosophila Genome [DrosGenome1]], producing 16 raw data files and 1
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="90">
        <id>1799939743</id>
        <accession>E-MEXP-2327</accession>
        <name>Transcription profiling of Francisella tularensis to spermine</name>
        <releasedate>2009-09-18</releasedate>
        <species>Francisella tularensis</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Francisella tularensis</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>LVS</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>spermine</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DOSE</name>
            <value>0</value>
            <value>200</value>
        </experimentalfactor>
        <user>1773127241</user>
        <user>1799941377</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799674886</id>
            <accession>A-MEXP-1690</accession>
            <name>Francisella custom 82_192</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799940134</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2327.A-MEXP-1690.1.FeatureDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799940165</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2327.A-MEXP-1690.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Global transcriptional response to spermine, a component of the intra-macrophage
                environment, reveals regulation of Francisella gene expression through insertion
                sequence elements.</title>
        </bibliography>
        <provider>
            <contact>Paul Carlson</contact>
            <email>pecarl@umich.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <description>
            <id>1799939752</id>
            <text>Francisella tularensis LVS was grown in MH broth in the presence or absence of
                200uM spermine. RNA was harvasted from overnight (16 hour) cultures and processed
                for microarray hybridization.</text>
        </description>
        <description>
            <id>1799940642</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Francisella tularensis], using 6 arrays of array design [Francisella custom
                82_192], producing 6 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="91">
        <id>1799940664</id>
        <accession>E-MEXP-2338</accession>
        <name>Transcription profiling of mouse thymus glandwfrom normal and ollagen induced
            arthritis animals</name>
        <releasedate>2009-09-18</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3 to 4 months</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>mTEC 3.10 line</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>collagen induced arthritis</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>DBA-1J_1</value>
            <value>DBA-1J_2</value>
            <value>DBA-1J_3</value>
            <value>DBA-1J_4</value>
            <value>DBA-2J_1</value>
            <value>DBA-2J_2</value>
            <value>DBA-2J_3</value>
            <value>DBA-2J_4</value>
            <value>mTEC1</value>
            <value>mTEC2</value>
            <value>mTEC3</value>
            <value>mTEC4</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>thymus</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6</value>
            <value>DBA-1/J</value>
            <value>DBA-2/J</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>medullary thymic epithelial cell</value>
            <value>thymic stroma</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>mTEC 3.10 line</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>CellType</name>
            <value>medullary thymic epithelial cell</value>
            <value>thymic stroma</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>collagen induced arthritis</value>
        </experimentalfactor>
        <user>1759941528</user>
        <user>1799943097</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1759865161</id>
            <accession>A-MEXP-1583</accession>
            <name>GIM M musculus 4608genes</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799940837</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2338.A-MEXP-1583.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799940912</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2338.A-MEXP-1583.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Geraldo Passos</contact>
            <email>passos@rge.fmrp.usp.br</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <description>
            <id>1799940672</id>
            <text>DBA/1J and DBA-2/J mice (12-14 weeks old) weighing 18 22 g were housed in
                temperature-controlled rooms (22 25 C) in the animal facility of the School of
                Medicine of Ribeir o Preto, University of S o Paulo, S o Paulo, Brazil, and received
                water and food ad libitum. DBA/1J and DBA-2/J male mice were used in type II
                collagen immunizations. For CIA, at day zero, DBA/1J males were intradermally
                injected at the base of the tail with 200 g of bovine type II collagen (CII) (Sigma)
                in 100 l of 0.05 M acetic acid emulsified with equal volume of complete Freund s
                adjuvant (Chondrex, Redmond, WA). On day 21, a second injection of CII (200 g in
                acetic acid) was given intraperitoneally (i.p). DBA/2J males were also immunized
                with CII and served as controls. A caliper was used to determine the paw diameter
                and swelling was determined as the increase in diameter compared to day zero of
                immunization. The thymic stroma was separated from the whole thymus. The mTEC 3.10
                medullary thymic epithelial cell line was established from C57BL/6 mice, and the
                original medullary phenotype was confirmed by immunostaining with anti-cytokeratin
                monoclonal antibodies. In addition, the CD80+ phenotype was confirmed using
                fluorescent activated cell sorting (FACS) analysis. Cells were cultured in 10% fetal
                bovine serum-supplemented RPMI 1640 medium at 37oC and 5% CO2. Total RNA was
                extracted from 1x107 stromal cells and from 1x107 mTEC 3.10 cells using Trizol
                Reagent and following the manufacturer s instructions (Invitrogen, Carlsbad, CA,
                USA). RNA preparations were confirmed to be free of proteins and phenol using UV
                spectrophotometry and the state of degradation was assessed using agarose gel
                electrophoresis (ethidium bromide staining).</text>
        </description>
        <description>
            <id>1799941587</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [GIM M musculus 4608genes],
                producing 12 raw data files and 12 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="92">
        <id>1799941543</id>
        <accession>E-MEXP-2339</accession>
        <name>Transcription profiling of mouse thymus gland from pre-diabetic and diabetic
            animals.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Age</category>
            <value>18 to 22 weeks</value>
            <value>6 to 10 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>mTEC 3.10 line</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>pre diabetic</value>
            <value>type 1 diabetes mellitus (DM-1)</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>Diabetic 1</value>
            <value>Diabetic 2</value>
            <value>Diabetic 3</value>
            <value>Diabetic 4</value>
            <value>mTECs 1</value>
            <value>mTECs 2</value>
            <value>mTECs 3</value>
            <value>mTECs 4</value>
            <value>Pre diabetic 1</value>
            <value>Pre diabetic 2</value>
            <value>Pre diabetic 3</value>
            <value>Pre diabetic 4</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>thymus</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6</value>
            <value>NOD (non-obese diabetic)</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>medullary thymic epithelial cell</value>
            <value>thymic stroma</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellType</name>
            <value>medullary thymic epithelial cell</value>
            <value>thymic stroma</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>pre diabetic</value>
            <value>type 1 diabetes mellitus (DM-1)</value>
        </experimentalfactor>
        <user>1759941528</user>
        <user>1799943672</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1759865161</id>
            <accession>A-MEXP-1583</accession>
            <name>GIM M musculus 4608genes</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799941749</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2339.A-MEXP-1583.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799941868</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2339.A-MEXP-1583.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Geraldo Passos</contact>
            <email>passos@rge.fmrp.usp.br</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <description>
            <id>1799941552</id>
            <text>Female NOD mice were born in specific pathogen free (SPF) conditions at the
                CEMIB-UNICAMP animal facility (University of Campinas, S o Paulo, Brazil) and
                maintained in SPF mini-isolators in our laboratory at the University of S o Paulo,
                Campus of Ribeir o Preto, Brazil. We studied both pre-diabetic (8 2 week-old) and
                diabetic (20 2 week-old) animals. Diabetes was confirmed by blood glucose levels
                (?250 mg glucose/dL) using the Accu Check Active Kit (Roche Diagn stica Brasil, S o
                Paulo, Brazil). The thymic stroma was separated from the whole thymus. The mTEC 3.10
                medullary thymic epithelial cell line was established from C57BL/6 mice, and the
                original medullary phenotype was confirmed by immunostaining with anti-cytokeratin
                monoclonal antibodies. In addition, the CD80+ phenotype was confirmed using
                fluorescent activated cell sorting (FACS) analysis. Cells were cultured in 10% fetal
                bovine serum-supplemented RPMI 1640 medium at 37oC and 5% CO2. Total RNA was
                extracted from 1x107 stromal cells (from pre-diabetic and diabetic animals) and
                1x107 mTEC 3.10 cells using Trizol Reagent and following the manufacturer s
                instructions (Invitrogen, Carlsbad, CA, USA). RNA preparations were confirmed to be
                free of proteins and phenol using UV spectrophotometry and the state of degradation
                was assessed using agarose gel electrophoresis (ethidium bromide staining).</text>
        </description>
        <description>
            <id>1799942907</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [GIM M musculus 4608genes],
                producing 12 raw data files and 12 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="93">
        <id>1799942617</id>
        <accession>E-MEXP-2354</accession>
        <name>Transcription profiling of Saccharomyces cerevisiae Gis1 overexpression time
            course</name>
        <releasedate>2009-09-18</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>10</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Genotype</category>
            <value>CML376 (MATa ura3 leu2 his3 trp1::tTA GAL2 CMVp(tetR'-SSN6
                )::LEU2)/pCM190-GIS1</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>0h doxycycline plus 1</value>
            <value>0h doxycycline plus 2</value>
            <value>3h doxycycline minus 7</value>
            <value>3h doxycycline minus 8</value>
            <value>3h doxycycline plus 4</value>
            <value>3h doxycycline plus3</value>
            <value>6h doxycycline minus 10</value>
            <value>6h doxycycline plus 5</value>
            <value>6h doxycycline plus 6</value>
            <value>6h doxycycline plus 9</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>CML376</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DOSE</name>
            <value>0</value>
            <value>20</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>TIME</name>
            <value>0</value>
            <value>3</value>
            <value>6</value>
        </experimentalfactor>
        <user>1799946191</user>
        <user>1799946192</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>119528504</id>
            <accession>A-AFFY-27</accession>
            <name>Affymetrix GeneChip Yeast Genome S98 [YG_S98]</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799943835</id>
            <name>Affymetrix:FeatureDimension:YG_S98</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799943921</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2354.A-AFFY-27.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Nianshu Zhang</contact>
            <email>nz228@cam.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dose response</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1799942634</id>
            <text>The change of genome-wide transcription profiles as a result of Gis1
                overexpression is monitored by comparing the transcriptomes isolated from cells
                where Gis1 overexpression is switched on or off. GIS1 was cloned into pCM190 vector
                under the control of the tetO7 promoter. The promoter is switched on when there is
                no doxycycline but off with doxycycline (20ug/ml). Cells were grown in medium with
                doxycycline, harvested, washes twice in sterile water, resuspended in the same
                medium with doxycycline (Dox+) or without doxycycline (dox-) and grown for
                additional 6 hours. Samples were taken for each condition at 3 and 6 hours. Time 0
                sample was taken before resuspension.</text>
        </description>
        <description>
            <id>1799944434</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 10 samples of
                species [Saccharomyces cerevisiae], using 10 arrays of array design [Affymetrix
                GeneChip Yeast Genome S98 [YG_S98]], producing 10 raw data files and 1 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="94">
        <id>1799942789</id>
        <accession>E-MEXP-2356</accession>
        <name>Transcription profiling of Lycopersicon esculentum roots in wild-type and
            ABA-deficient, control and Glomus intraradices inoculated plants to characterise
            variations in mycorrhization.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Lycopersicon esculentum</species>
        <samples>4</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>50 days growing</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>ABA-deficient mutant</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Lycopersicon esculentum</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>root</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Solanum lycopersicum ABA-deficient mutant sitiens (Accession LA0575)</value>
            <value>Solanum lycopersicum wild-type Rheinlands Ruhm (Accession LA0535)</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>ABA-deficient mutant</value>
            <value>wild_type</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>ProtocolType</name>
            <value>control</value>
            <value>mycorrhizal</value>
        </experimentalfactor>
        <user>1799945361</user>
        <user>1799945366</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1448776545</id>
            <accession>A-AFFY-87</accession>
            <name>Affymetrix GeneChip Tomato Genome Array [Tomato]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799943088</id>
            <name>Affymetrix:FeatureDimension:Tomato</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799943263</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2356.A-AFFY-87.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Variations in the mycorrhization characteristics in roots of wild-type and
                ABA-deficient tomatoes are accompanied by specific transcriptomic
                alterations</title>
        </bibliography>
        <provider>
            <contact>Jose Garcia</contact>
            <email>josemanuel.garcia@eez.csic.es</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>array platform variation</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>transcript identification</experimentdesign>
        <description>
            <id>1799942797</id>
            <text>Abscisic acid (ABA) determines mycorrhiza functionality and arbuscule development.
                Transcriptome analysis in response to different mycorrhization status according to
                the ABA concentration in the root was performed to identify genes that may play a
                role in arbuscule functionality. Tomato Affymetrix GeneChip (around 10,000 probes)
                allowed us to detect and compare the transcriptional root profiling of tomato
                (Solanum lycopersicum) wild-type and ABA-deficient sitiens plants colonized by the
                arbuscular mycorrhizal fungus Glomus intraradices.
                &lt;br&gt;&lt;br&gt;</text>
        </description>
        <description>
            <id>1799943582</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 4 samples of
                species [Lycopersicon esculentum], using 12 arrays of array design [Affymetrix
                GeneChip Tomato Genome Array [Tomato]], producing 12 raw data files and 1
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="95">
        <id>1799943566</id>
        <accession>E-TABM-790</accession>
        <name>Transcription profiling of B. thuringiensis 407 nprA::lacZ and an isogenic
            delta-nprR-nprX strain</name>
        <releasedate>2009-09-18</releasedate>
        <species>Bacillus thuringiensis Bt407</species>
        <samples>8</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>3.5 h</value>
            <value>5.5 h</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>nprA::lacZ</value>
            <value>nprA::lacZ delta-nprRnprX</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Bacillus thuringiensis Bt407</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>AH1440</value>
            <value>AH1441</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Age</name>
            <value>3.5</value>
            <value>5.5</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>nprA::lacZ</value>
            <value>nprA::lacZ delta-nprRnprX</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>AH1440</value>
            <value>AH1441</value>
        </experimentalfactor>
        <user>1799947047</user>
        <user>1799947053</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1224751402</id>
            <accession>A-MEXP-587</accession>
            <name>UiO anthrax oligo 8k array</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799945023</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.FeatureDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799945183</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799945261</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799945328</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799945416</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799945466</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-790.A-MEXP-587.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Karoline Faegri</contact>
            <email>karolinf@farmasi.uio.no</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1799943574</id>
            <text>Comparison of gene expression in B. thuringiensis 407 nprA::lacZ and an isogenic
                delta-nprR-nprX strain</text>
        </description>
        <description>
            <id>1799946124</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 8 samples of
                species [Bacillus thuringiensis Bt407], using 6 arrays of array design [UiO anthrax
                oligo 8k array], producing 6 raw data files and 5 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="96">
        <id>1799945335</id>
        <accession>E-MEXP-2358</accession>
        <name>Transcript profiling of Arabidopsis thaliana trasngenic seedlings constitutively
            overexpressing UGT74E2 (35S::UGT74E2).</name>
        <releasedate>2009-09-18</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Age</category>
            <value>1.04 days</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>stage 1.04</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>gene_knock_in</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>35S::UGT74E2</value>
            <value>Col-0</value>
        </sampleattribute>
        <sampleattribute>
            <category>InitialTimePoint</category>
            <value>3 day stratification</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>35S::UGT74E2</value>
            <value>Col-0</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799951698</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951717</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951721</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951726</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951732</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951736</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799951739</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2358.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Perturbation of indole-3-butyric acid homeostasis by UDP-glucosyltransferase
                UGT74E2 modulates Arabidopsis architecture and water stress tolerance</title>
        </bibliography>
        <provider>
            <contact>Olivier Van Aken</contact>
            <email>olake@cyllene.uwa.edu.au</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>development or differentiation</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <description>
            <id>1799951826</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Arabidopsis thaliana], using 6 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1799945349</id>
            <text>Transcript profiling of transgenic Arabidopsis thaliana seedlings constitutively
                overexpressing UGT74E2 (35S::UGT74E2).</text>
        </description>
    </experiment>
    <experiment textidx="97">
        <id>1799947200</id>
        <accession>E-MEXP-2355</accession>
        <name>Transcription profiling of Arabidopsis thaliana wild type and knock-out mutants of
            subclass III SnRK2 protein kinases after 6h of treatment with dehydration stress.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>11</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>Age</category>
            <value>2 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>frozen_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>gene_knock_out</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>srk2d</value>
            <value>srk2de</value>
            <value>srk2e</value>
            <value>srk2ei</value>
            <value>srk2i</value>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>CS60000_dry6h</value>
            <value>srk2d_single mutant_dry6h_1</value>
            <value>srk2d_single mutant_dry6h_2</value>
            <value>srk2de_double mutant_dry6h_1</value>
            <value>srk2de_double mutant_dry6h_2</value>
            <value>srk2e_single mutant_dry6h_1</value>
            <value>srk2e_single mutant_dry6h_2</value>
            <value>srk2ei_double mutant_dry6h_1</value>
            <value>srk2ei_double mutant_dry6h_2</value>
            <value>srk2i_single mutant_dry6h_1</value>
            <value>srk2i_single mutant_dry6h_2</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>srk2d</value>
            <value>srk2de</value>
            <value>srk2e</value>
            <value>srk2ei</value>
            <value>srk2i</value>
            <value>wild_type</value>
        </experimentalfactor>
        <user>1242535197</user>
        <user>1799954924</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1576876585</id>
            <accession>A-MEXP-1038</accession>
            <name>Agilent Arabidopsis 3 Oligo Microarray 4x44K 015059 G2519F</name>
            <count>20</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799949667</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2355.A-MEXP-1038.1.FeatureDimension</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>20</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Kyonoshin Maruyama</contact>
            <email>kyonosin@jircas.affrc.go.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1799951702</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 11 samples of
                species [Arabidopsis thaliana], using 20 arrays of array design [Agilent Arabidopsis
                3 Oligo Microarray 4x44K 015059 G2519F], producing 20 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1799947208</id>
            <text>Effect of single or double knock-out mutation of subclass III SnRK2 protein
                kinases in Arabidopsis after 6 h of treatment with dehydration stress.</text>
        </description>
    </experiment>
    <experiment textidx="98">
        <id>1799951601</id>
        <accession>E-BUGS-79</accession>
        <name>Transcription profiling of Staphylococcus aureus to subinhibitory concentrations of a
            sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine dimer.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Staphylococcus aureus</species>
        <samples>2</samples>
        <assays>30</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Staphylococcus aureus</value>
        </sampleattribute>
        <sampleattribute>
            <category>Phenotype</category>
            <value>methicillin resistant</value>
        </sampleattribute>
        <experimentalfactor>
            <name>ComplexAction</name>
            <value>log phase 15 min control</value>
            <value>log phase 15 min ELB-21</value>
            <value>log phase 5 min control</value>
            <value>log phase 5 min ELB-21</value>
            <value>log phase 60 min control</value>
            <value>log phase 60 min ELB-21</value>
            <value>stationary phase 300 min control</value>
            <value>stationary phase 300 min ELB-21</value>
            <value>stationary phase 60 min control</value>
            <value>stationary phase 60 min ELB-21</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>616482310</id>
            <accession>A-BUGS-17</accession>
            <name>BuG@S S.aureus 9248 SAv1_1_0</name>
            <count>30</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799952279</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/FeatureDimension:27</name>
            <bioassaydatacubes>30</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>30</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952282</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/FeatureDimension:27</name>
            <bioassaydatacubes>30</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>30</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952392</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33208</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952400</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33209</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952404</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33210</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952410</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33211</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952415</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33212</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952419</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33213</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952424</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33214</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952430</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33215</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952436</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33216</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952440</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33217</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952444</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33218</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952448</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33219</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952451</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33220</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952455</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33221</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952461</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33222</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952469</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33223</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952473</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33224</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952476</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33225</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952481</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33226</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952486</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33227</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952489</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33228</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952495</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33229</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952498</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33230</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952502</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33231</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952507</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33232</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952513</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33233</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952518</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33234</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952524</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33235</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952531</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33236</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952535</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33237</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952540</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:33238</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952648</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:34806</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799952667</id>
            <name>bugs.sgul.ac.uk:BuG@Sbase/ReporterDimension:34807</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19744983</accession>
            <publication>J Antimicrob Chemother</publication>
            <authors>Doyle M, Feuerbaum EA, Fox KR, Hinds J, Thurston DE, Taylor PW</authors>
            <title>Response of Staphylococcus aureus to subinhibitory concentrations of a
                sequence-selective, DNA minor groove cross-linking pyrrolobenzodiazepine
                dimer</title>
            <year>2009</year>
            <uri>http://dx.doi.org/10.1093/jac/dkp325</uri>
        </bibliography>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <description>
            <id>1799951604</id>
            <text>Objectives ELB-21 is a pyrrolo[2,1-c][1,4]benzodiazepine dimer with potent
                antistaphylococcal activity; it binds covalently to guanine residues on opposing
                strands of duplex DNA, interfering with regulatory proteins and transcription
                elongation in a sequence-selective manner. Transcriptional and proteomic alterations
                induced by exposure of Staphylococcus aureus clinical isolate EMRSA-16 to ELB-21
                were determined in order to define more precisely the bactericidal mechanism of the
                drug. Methods DNase I footprinting was used to identify high-affinity DNA binding
                sites. Microarrays and gel electrophoresis were used to assess the ELB-21-induced
                phenotype. Results High-affinity interstrand binding sites in which guanine residues
                were separated by 4 bp, and also some intrastrand cross-linking sites of variable
                length were identified. Exposure of EMRSA-16 to 0.015 mg/L ELB-21 elicited a 2-fold
                or greater up-regulation of 168 genes in logarithmic phase and 181 genes in
                stationary phase; the majority of genes affected were associated with resident
                prophages Sa2 and Sa3, pathogenicity island SaPI4 and DNA damage repair. ELB-21
                induced a marked increase in the number of viable phage particles in culture
                supernatants. The expression of only a limited number of genes showed a &gt;50%
                reduction. Sixteen extracellular and four intracellular proteins were differentially
                expressed during logarithmic and stationary phases, including RecA, proteins
                associated with staphylococcal pathogenesis (IsaA, CspA), cell division and wall
                synthesis. Conclusions ELB-21 kills S. aureus by forming multiple interstrand and
                intrastrand DNA cross-links, resulting in induction of the DNA damage response,
                derepression of resident prophages and modulation of a limited number of genes
                involved with cell wall synthesis.</text>
        </description>
        <description>
            <id>1799951610</id>
            <text>Data is also available from &lt;ahref="http://bugs.sgul.ac.uk/E-BUGS-79"
                target="_blank"&gt;BuG@Sbase&lt;/a&gt;</text>
        </description>
        <description>
            <id>1799953439</id>
            <text>(Generated description) Experiment with 30 hybridizations, using 2 samples of
                species [Staphylococcus aureus], using 30 arrays of array design [BuG@S S.aureus
                9248 SAv1_1_0], producing 60 raw data files and 42 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="99">
        <id>1799955768</id>
        <accession>E-TABM-789</accession>
        <name>Methylation profiling of mouse pluripotent stem cells by D-REAM</name>
        <releasedate>2009-09-18</releasedate>
        <species>Mus musculus</species>
        <samples>21</samples>
        <assays>21</assays>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>Kyoto University, Japan</value>
            <value>RIKEN, Japan</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>103C-1</value>
            <value>103C-2</value>
            <value>38D-1</value>
            <value>38D-2</value>
            <value>38D-3</value>
            <value>B6-1</value>
            <value>B6-2</value>
            <value>EG12.5</value>
            <value>EG8.5</value>
            <value>Hepatocytes</value>
            <value>MEF</value>
            <value>MS12</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellType</category>
            <value>embryonic fibroblasts</value>
            <value>embryonic stem cell</value>
            <value>hepatocyte</value>
            <value>induced pluripotent stem cell from hepatocyte</value>
            <value>induced pluripotent stem cell from MEF</value>
            <value>somatic tissue</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>brain</value>
            <value>liver</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6NCrj</value>
            <value>C57BL6/129</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>103C-1</value>
            <value>103C-2</value>
            <value>38D-1</value>
            <value>38D-2</value>
            <value>38D-3</value>
            <value>B6-1</value>
            <value>B6-2</value>
            <value>EG12.5</value>
            <value>EG8.5</value>
            <value>Hepatocytes</value>
            <value>MEF</value>
            <value>MS12</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>CellType</name>
            <value>embryonic fibroblasts</value>
            <value>embryonic stem cell</value>
            <value>hepatocyte</value>
            <value>induced pluripotent stem cell from hepatocyte</value>
            <value>induced pluripotent stem cell from MEF</value>
            <value>somatic tissue</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>brain</value>
            <value>liver</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>C57BL/6NCrj</value>
            <value>C57BL6/129</value>
        </experimentalfactor>
        <user>1799964290</user>
        <user>1799969164</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>2</count>
        </arraydesign>
        <arraydesign>
            <id>1660377995</id>
            <accession>A-AFFY-129</accession>
            <name>Affymetrix GeneChip Mouse Promoter 1.0R Array Mm_PromPR_v02-1_NCBIv36</name>
            <count>19</count>
        </arraydesign>
        <bibliography/>
        <provider>
            <contact>Shinya Sato</contact>
            <email>aa67135@mail.ecc.u-tokyo.ac.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>all pairs</experimentdesign>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>tiling path</experimentdesign>
        <description>
            <id>1799955774</id>
            <text>Genome-wide DNA methylation profiling of embryonic stem cells, embryonic germ
                cells, induced pluripotent stem cells, and their progenitors (MEF, hepatocytes)
                analyzed by D-REAM</text>
        </description>
        <description>
            <id>1799956788</id>
            <text>(Generated description) Experiment with 21 hybridizations, using 21 samples of
                species [Mus musculus], using 21 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2], Affymetrix GeneChip Mouse Promoter 1.0R Array
                [Mm_PromPR_v02-1_NCBIv36]], producing 21 raw data files and 21 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="100">
        <id>1799957994</id>
        <accession>E-TABM-792</accession>
        <name>Transcription profiling of human CD34+ cells from familial platelet disorder</name>
        <releasedate>2009-09-18</releasedate>
        <species>Homo sapiens</species>
        <samples>8</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>Dr. Bluteau, Institut Gustave Roussy, INSERM U790, 39 rue camille desmoulins,
                F-94805, Villejuif, France</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>cell</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellType</category>
            <value>CD34+ cells</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>Familial Platelet Disorder (FPD) - RUNX1_R139stop</value>
            <value>Familial Platelet Disorder (FPD) - RUNX1_R174Q</value>
            <value>normal</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>Familial Platelet Disorder (FPD) - RUNX1_R139stop</value>
            <value>Familial Platelet Disorder (FPD) - RUNX1_R174Q</value>
            <value>normal</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>ProtocolType</name>
            <value>Amp</value>
            <value>NAmp</value>
        </experimentalfactor>
        <user>397405481</user>
        <user>1799964881</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1316855037</id>
            <accession>A-AGIL-28</accession>
            <name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532
                rows)</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799960876</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-792.A-AGIL-28.1.FeatureDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>NR4A3, a novel RUNX1 target, is involved in deregulation of hematopoiesis leading
                to preleukemic state in FPD/AML.</title>
        </bibliography>
        <provider>
            <contact>Hugues RIPOCHE</contact>
            <email>hripoche@igr.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>disease state</experimentdesign>
        <experimentdesign>in vivo</experimentdesign>
        <description>
            <id>1799958000</id>
            <text>Characterize the genes deregulated in CD34 positive cells from peripheral blood of
                FPD/AML patients harbouring two different RUNX1 mutations. RUNX1 (also called AML1),
                a DNA-binding subunit of the CBF transcription factor family, is a master regulatory
                gene in hematopoiesis and acts as a tumour suppressor. Heterozygous germ line
                alterations in RUNX1 lead to a familial platelet disorder with a propensity to
                develop acute myeloid leukemia (FPD/AML). Although RUNX1 abnormalities per se are
                not sufficient to induce full-blown leukemia in FPD, this pathology represents a
                valuable model to understand how RUNX1 germ line mutations predispose to acquisition
                of additional genetic changes leading to leukemia transformation. To investigate how
                RUNX1 may predispose to leukemia, we performed a comparative study between two
                pedigrees harbouring different RUNX1 mutations, one associated with only
                thrombocytopenia (R139stop) and the other leading to thrombocytopenia and leukemic
                predisposition (R174Q).</text>
        </description>
        <description>
            <id>1799961004</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 8 samples of
                species [Homo sapiens], using 4 arrays of array design [Agilent Whole Human Genome
                Microarray 4x44K 014850 G4112F (85 cols x 532 rows)], producing 4 raw data files and
                0 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="101">
        <id>1799960767</id>
        <accession>E-MEXP-2361</accession>
        <name>Transcription profiling of human lymphocyte proliferation of peripheral blood
            mononuclear cells (PBMCs) in vitro time course.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Homo sapiens</species>
        <samples>21</samples>
        <assays>21</assays>
        <sampleattribute>
            <category>Age</category>
            <value>45 to 56 years</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>blood</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>peripheral blood mononuclear cell</value>
        </sampleattribute>
        <experimentalfactor>
            <name>TIME</name>
            <value>0</value>
            <value>1</value>
            <value>3</value>
            <value>5</value>
            <value>7</value>
        </experimentalfactor>
        <user>1230670489</user>
        <user>1799963572</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1762083787</id>
            <accession>A-AFFY-143</accession>
            <count>21</count>
        </arraydesign>
        <bibliography>
            <title>The comparison of different pre- and post- analysis filters for determination of
                exon level alternative splicing events using Affymetrix arrays.</title>
        </bibliography>
        <provider>
            <contact>Toni Whistler</contact>
            <email>TAW6@CDC.GOV</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>growth condition</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <description>
            <id>1799960778</id>
            <text>In vitro lymphocyte proliferation of human PBMCs examined using Affymetrix exon
                arrays to examine alternative splicing events</text>
        </description>
        <description>
            <id>1799961315</id>
            <text>(Generated description) Experiment with 21 hybridizations, using 21 samples of
                species [Homo sapiens], using 21 arrays of array design [Affymetrix GeneChip Human
                Exon 1.0 ST], producing 21 raw data files and 21 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="102">
        <id>1799963984</id>
        <accession>E-MEXP-2340</accession>
        <name>Transcription profiling of human neuroblastoma cell line SHEP expressing Tet21N
            MYC.</name>
        <releasedate>2009-09-18</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>SHEP</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>child</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>transfection</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>unknown_sex</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>SHEP-Tet21N</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>neuroblastoma</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>Tet21N minus MYCN</value>
            <value>Tet21N MYCN</value>
        </experimentalfactor>
        <user>1604579882</user>
        <user>1799965884</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799964662</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799964679</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2340.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>p53 is a direct transcriptional target of MYCN in neuroblastoma</title>
        </bibliography>
        <provider>
            <contact>Dan Swan</contact>
            <email>d.c.swan@ncl.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <description>
            <id>1799963992</id>
            <text>MYCN is an oncogene amplified in approximately 20% of all neuroblastomas and 50%
                of high risk neuroblastoma. It is a transcription factor regulating the expression
                of genes involved in proliferation and apoptosis.We would like to identify genes
                potentially regulated by MYCN in a conditional MYCN exression system. The SHEP
                Tet21N system is a conditional, tetracycline-regulated MYCN expression system
                established in the MYCN non-amplified SHEP neuroblastoma cell line (Lutz et al.,
                1996). Expression of MYCN is switched off by the addition of tetracycline to the
                growth medium. Levels of MYCN protein and RNA in the absence of tetracycline are
                comparable with those present in MYCN amplified cell lines (Bell et al.,
                2006).&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;By
                performing microarray analyses on the Tet21n cell lines in the presence and absence
                of MYCN we hope to identify genes whose expression had been altered by MYCN either
                upregulated or downregulated and may be potential MYCN targets. The altered
                expression of some of these genes will then be validated using quantitative RTPCR
                and a selection will be further investigated to determine if they are MYCN
                transcriptional targets and may be potential candidates for anti-MYCN therapies for
                neuroblastoma&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;Specific
                objectives&lt;br&gt;&lt;br&gt;1) To investigate genes which are
                altered by 2 fold or more in the presence of or absence of MYCN in Tet21N
                cells.&lt;br&gt;&lt;br&gt;&lt;br&gt;&lt;br&gt;Refs:&lt;br&gt;&lt;br&gt;Bell,
                E., Premkumar, R., Carr, J., Lu, X., Lovat, P.E., Kees, U.R., Lunec, J. &amp;
                Tweddle, D.A. (2006). The role of MYCN in the failure of MYCN amplified
                neuroblastoma cell lines to G1 arrest after DNA damage. Cell Cycle, 5,
                2639-47.&lt;br&gt;&lt;br&gt;Lutz, W., Stohr, M., Schurmann, J.,
                Wenzel, A., Lohr, A. &amp; Schwab, M. (1996). Conditional expression of N-myc in
                human neuroblastoma cells increases expression of alpha-prothymosin and ornithine
                decarboxylase and accelerates progression into S-phase early after mitogenic
                stimulation of quiescent cells. Oncogene, 13, 803-12.</text>
        </description>
        <description>
            <id>1799964766</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 1 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="103">
        <id>1799580620</id>
        <accession>E-TABM-793</accession>
        <name>Transcription profiling of juvenile Daphnia manga following exposure to the pesticides
            methomyl and propanil</name>
        <releasedate>2009-09-17</releasedate>
        <species>Daphnia magna</species>
        <samples>30</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Age</category>
            <value>&lt; 24</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceProvider</category>
            <value>University of Reading</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>juvenile</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Daphnia magna</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>whole_organism</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>hours</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>methomyl</value>
            <value>methomyl and propanil</value>
            <value>none</value>
            <value>propanil</value>
            <value>reference pool (treated and untreated)</value>
        </experimentalfactor>
        <user>1799581524</user>
        <user>1799581527</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1231885224</id>
            <accession>A-MAXD-9</accession>
            <name>Reading University Daphnia magna 14K V2.3</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799580701</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-793.A-MAXD-9.1.FeatureDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>MAXD</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Amanda Callaghan Christopher Hill</contact>
            <email>c.j.hill@reading.ac.uk, a.callaghan@reading.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799580626</id>
            <text>Juvenile daphnia magna (&lt;24hrs old, n=25 / test vessel) were exposed to
                methomyl (M) a carbamate insecticide (10.52ug/l), propanil (P), an analide herbicide
                (363ug/l), an independent action (IA) mixture of M (10.52ug/l and P (363ug/l)
                representing effect concentration 1 (EC1) for each chemical, based on standard
                immobility assay (OECD) or to control (untreated medium). All exposures were carried
                out in reconstituted water (see protocol GROWTH). Treated vessels were spiked with
                stock solutions of pesticides dissolved directly into reconstituted water. Test
                vessels were 1L glass beakers arranged in a randomised block design. Transcriptomic
                screening was used to assess the mechanism of toxicity of the two single pesticides
                and to explain (in part) the interaction of methomyl and propanil in an independent
                action (IA) EC1 mixture.</text>
        </description>
        <description>
            <id>1799580840</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 30 samples of
                species [Daphnia magna], using 15 arrays of array design [Reading University -
                Daphnia magna 14455 - V2.3], producing 15 raw data files and 0 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="104">
        <id>1799338729</id>
        <accession>E-MEXP-2343</accession>
        <name>Transcription profiling of human colorectal carcinoma cells retrotransfected by Cox2
            to analyse gene alteration</name>
        <releasedate>2009-09-16</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>Culture</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>HT29</value>
        </sampleattribute>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>Retrotransfected by Cox2 Vector</value>
            <value>Retrotransfected by Empty Vector</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>Control</value>
            <value>Cox2</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>Colon</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>Control</value>
            <value>Cox2</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799339537</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799339551</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2343.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799339591</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2343.A-AFFY-44.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Expression of Cox-2 in human colorectal carcinoma cells leads to enhanced growth,
                migration and metastasis</title>
        </bibliography>
        <provider>
            <contact>Ricardo L pez P rez</contact>
            <email>riclopez@apointech.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799338737</id>
            <text>Analysis of gene alteration in HT29 cell line due to PTGS2 overexpression</text>
        </description>
        <description>
            <id>1799340266</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 4 raw data files and 2 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="105">
        <id>1799356178</id>
        <accession>E-MEXP-2362</accession>
        <name>Transcription profiing of a yeast strain containing 2 extra copies of Abf2p compared
            to its wild type counterpart</name>
        <releasedate>2009-09-16</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Genotype</category>
            <value>MATa trp1 ade2-1 ura3-52 cit1::LEU2 leu2-3,112 ?+</value>
            <value>MATa trp1 ade2-1 ura3-52 ura3::YIp356/ABF2 trp1::YIp356/ABF2 cit1::LEU2
                leu2-3,112 ?+</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>mating_type_a</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>14ww</value>
            <value>3xABF2</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>MATa trp1 ade2-1 ura3-52 cit1::LEU2 leu2-3,112 ?+</value>
            <value>MATa trp1 ade2-1 ura3-52 ura3::YIp356/ABF2 trp1::YIp356/ABF2 cit1::LEU2
                leu2-3,112 ?+</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>486625854</id>
            <accession>A-AFFY-47</accession>
            <name>Affymetrix GeneChip Yeast Genome 2.0 Array [Yeast_2]</name>
            <count>2</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799364152</id>
            <name>Affymetrix:FeatureDimension:Yeast_2</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Sulfur metabolism actively promotes initiation of cell division in yeast</title>
        </bibliography>
        <provider>
            <contact>MICHAEL POLYMENIS</contact>
            <email>POLYMENIS@TAMU.EDU</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>all pairs</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799356186</id>
            <text>We compared the RNA expression profile from a Saccharomyces cerevisiae yeast
                strain (3xABF2) containing two (2) extra copies of Abf2p, a mtDNA maintenance
                factor, to the signal from its wild type counterpart (14ww). The two strains used
                have been described in Genetics 148: 1763-1776.</text>
        </description>
        <description>
            <id>1799367388</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Saccharomyces cerevisiae], using 2 arrays of array design [Affymetrix
                GeneChip Yeast Genome 2.0 Array [Yeast_2]], producing 2 raw data files and 0
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="106">
        <id>1799357967</id>
        <accession>E-GEOD-12297</accession>
        <name>Re-sequencing of human post mortem cerebellum reveals altered synaptic vesicular
            transport in</name>
        <releasedate>2009-09-16</releasedate>
        <species>Homo sapiens</species>
        <samples>20</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>Age</category>
            <value>27 years</value>
            <value>31 years</value>
            <value>32 years</value>
            <value>33 years</value>
            <value>37 years</value>
            <value>38 years</value>
            <value>42 years</value>
            <value>43 years</value>
            <value>45 years</value>
            <value>46 years</value>
            <value>47 years</value>
            <value>48 years</value>
            <value>49 years</value>
            <value>50 years</value>
            <value>53 years</value>
            <value>59 years</value>
            <value>62 years</value>
            <value>69 years</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>reference</value>
            <value>schizophrenia</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>1</value>
            <value>11S</value>
            <value>17</value>
            <value>18</value>
            <value>1S</value>
            <value>2</value>
            <value>2S</value>
            <value>31</value>
            <value>35</value>
            <value>36</value>
            <value>39</value>
            <value>3S</value>
            <value>40</value>
            <value>41</value>
            <value>42</value>
            <value>5</value>
            <value>5S</value>
            <value>6S</value>
            <value>7S</value>
            <value>8S</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>cerebellar cortex</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismStatus</category>
            <value>postmortem</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>reference</value>
            <value>schizophrenia</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Individual</name>
            <value>1</value>
            <value>11S</value>
            <value>17</value>
            <value>18</value>
            <value>1S</value>
            <value>2</value>
            <value>2S</value>
            <value>31</value>
            <value>35</value>
            <value>36</value>
            <value>39</value>
            <value>3S</value>
            <value>40</value>
            <value>41</value>
            <value>42</value>
            <value>5</value>
            <value>5S</value>
            <value>6S</value>
            <value>7S</value>
            <value>8S</value>
        </experimentalfactor>
        <user>1</user>
        <user>1798649589</user>
        <user>1798649590</user>
        <secondaryaccession>GSE12297</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799357372</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12297.VirtualArrayDesign</accession>
            <count>20</count>
        </arraydesign>
        <bibliography>
            <accession>18985160</accession>
            <authors>Joann Mudge, Neil A Miller, Irina Khrebtukova, Ingrid E Lindquist, Gregory D
                May, Jim J Huntley, Shujun Luo, Lu Zhang, Jennifer C van Velkinburgh, Andrew D
                Farmer, Sharon Lewis, William D Beavis, Faye D Schilkey, Selene M Virk, C Forrest
                Black, M Kathy Myers, Lar C Mader, Ray J Langley, John P Utsey, Ryan W Kim,
                Rosalinda C Roberts, Sat Kirpal Khalsa, Meredith Garcia, Victoria Ambriz-Griffith,
                Richard Harlan, Wendy Czika, Stanton Martin, Russell D Wolfinger, Nora I
                Perrone-Bizzozero, Gary P Schroth, Stephen F Kingsmore</authors>
            <title>Genomic convergence analysis of schizophrenia: mRNA sequencing reveals altered
                synaptic vesicular transport in post-mortem cerebellum.</title>
        </bibliography>
        <provider>
            <contact>Stephen Kingsmore</contact>
            <email>sfk@ncgr.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>disease state</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799357974</id>
            <text>Schizophrenia (SCZ) is a common, disabling mental illness with high heritability
                but complex, poorly understood genetic etiology. As the first phase of a genomic
                convergence analysis of SCZ, we generated 16.7 billion nucleotides of short read,
                shotgun sequences of cDNA from post-mortem cerebellar cortices of 14 patients and
                six matched controls. A rigorous analysis pipeline was developed for analysis of
                digital gene expression studies. Sequences aligned to approximately 33,200
                transcripts in each sample, with average coverage of 450 reads per gene. Following
                adjustments for confounding clinical, sample and experimental sources of variation,
                215 genes differed significantly in expression between cases and controls. Golgi
                apparatus, vesicular transport, membrane association, Zinc binding and regulation of
                transcription were over-represented among differentially expressed genes. Twenty
                three genes with altered expression and involvement in presynaptic vesicular
                transport, Golgi function and GABAergic neurotransmission define a unifying
                molecular hypothesis for dysfunction in cerebellar cortex in SCZ. Experiment Overall
                Design: 16.7 billion nucleotides of shotgun, full length cDNA sequence data were
                generated using Illumina Genome Analyzer platforms with sequencing-by-synthesis
                (SBS) chemistry from 20 mRNA samples (Lister et al., 2008; Morin et al.,
                2008)(Mortazvi et al., 2008). mRNA samples were isolated post-mortem from the
                lateral hemispheres of the cerebellar cortices of 14 patients with SCZ and 6 control
                individuals (Paz et al., 2006; Bullock et al., In Press)(Table 1). Unrelated
                subjects were chosen to facilitate sampling of genetic heterogeneity (Freimer and
                Sabatti, 2004; McClellan et al., 2007). Cases and controls were approximately
                matched for age (cases, 45.2 + 11.8 years; controls 41.3 + 9.2 years), sex (all
                male), race, post-mortem interval (cases, 12.2 + 5.0 hours; controls 17.7 + 3.3
                hours), cause of death, autopsy brain pH (cases, 6.54 + 0.19; controls 6.46 + 0.10)
                and RNA integrity number (cases, 8.06 + 0.53; controls, 7.87 + 0.41) (Table 1). 12.5
                38.7 million, high quality sequences of length 32 36 bp were generated per sample
                (Table 2). Sequences were aligned to the human genome and RefSeq transcript
                databases using the algorithm GMAP, which allowed &lt; 2 (&lt; 6%)
                mismatches (Wu and Watanabe, 2005). There was little intra-sample variability in the
                number of sequences aligned to each locus from run-to-run or
                instrument-to-instrument (Fig. 1A; all source coefficient of variation 3.4%). 43.5 +
                6.7% of sequences aligned to a transcript and 69.4 + 9.6% to the genome, evidence
                that annotation of mRNA isoforms in Homo sapiens is incomplete (Birney et al., 2007)
                (Table 2). 91% of alignments were unique (Table 2). Reads aligning to more than one
                location contained repetitive, paralogous, polymorphic or low complexity sequences
                and primarily mapped to untranslated regions or highly polymorphic gene families,
                such as major histocompatibility genes (Sugarbaker et al., 2008). Unmapped sequences
                did not align to mitochondrial or 1879 viral genomes, offering negative evidence of
                chronic viral etiology for SCZ in these patients.</text>
        </description>
        <description>
            <id>1799358669</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 20 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12297], producing 0 raw data files and 20 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="107">
        <id>1799360082</id>
        <accession>E-GEOD-12346</accession>
        <name>ChIP-Seq of mouse Stat5a and Stat5b with an IgG control reveals priming for Th2
            differentiation requires IL-2-mediated induction of IL-4 receptor alpha chain
            expression</name>
        <releasedate>2009-09-16</releasedate>
        <species>Mus musculus</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12346</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799357946</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12346.VirtualArrayDesign</accession>
            <count>9</count>
        </arraydesign>
        <bibliography>
            <accession>18820682</accession>
            <authors>Wei Liao, Dustin E Schones, Jangsuk Oh, Yongzhi Cui, Kairong Cui, Tae-Young
                Roh, Keji Zhao, Warren J Leonard</authors>
            <title>Priming for T helper type 2 differentiation by interleukin 2-mediated induction
                of interleukin 4 receptor alpha-chain expression.</title>
        </bibliography>
        <provider>
            <contact>Dustin Schones</contact>
            <email>schonesde@mail.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799360089</id>
            <text>Th2 cells enable humoral immunity and host-defense to parasites. Whereas IL-4
                drives Th2 differentiation and IL-2 is important later in this process by augmenting
                IL4 chromatin accessibility, we demonstrate that IL-2 serves an essential early role
                in regulating IL-4R expression by inducing binding of Stat5a and Stat5b to the IL4ra
                locus, with sustained binding during Th2 differentiation. Although IL-4 induces
                IL-4R expression, TCR-induced IL-4R expression was unexpectedly normal in ILr-/- but
                profoundly diminished in IL2-/- T cells. Remarkably, enforced IL-4R expression
                rescued Th2 differentiation in IL2-/- cells. These results reveal a novel function
                for IL-2, with IL-2 via Stat5 providing an early signal for IL4ra induction, thereby
                priming cells for Th2 differentiation and promoting/maintaining IL-4R expression in
                Th2-committed cells. ChIP-seq experiments for Stat5a and Stat5b with an IgG control
                experiment for 8hr, 13hr and 2 rounds of Th2 differentiation. Experiment Overall
                Design: ChIP-seq experiments for Stat5a and Stat5b with an IgG control experiment
                for 8hr, 13hr and 2 rounds of Th2 differentiation. There are a total of 22 lanes of
                data for the three samples across the three time points.</text>
        </description>
        <description>
            <id>1799360515</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Mus musculus], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12346], producing 0 raw data files and 15 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="108">
        <id>1799366550</id>
        <accession>E-TABM-654</accession>
        <name>Transcription profiling of yeast deletion mutants of putative protein complex
            members</name>
        <releasedate>2009-09-16</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>57</samples>
        <assays>56</assays>
        <sampleattribute>
            <category>Genotype</category>
            <value>bud22-del</value>
            <value>cdk8-del</value>
            <value>cycC-del</value>
            <value>ecm30-del</value>
            <value>efg1-del</value>
            <value>med15-del</value>
            <value>med18-del</value>
            <value>med2-del</value>
            <value>med20-del</value>
            <value>med3-del</value>
            <value>med31-del</value>
            <value>nce102-del</value>
            <value>oca1-del</value>
            <value>oca2-del</value>
            <value>oca4-del</value>
            <value>oca5-del</value>
            <value>oca6-del</value>
            <value>pet112-del</value>
            <value>refpool</value>
            <value>rtg1-del</value>
            <value>rtg3-del</value>
            <value>siw14-del</value>
            <value>tus1-del</value>
            <value>ubp15-del</value>
            <value>vac8-del</value>
            <value>yll032c-del</value>
            <value>yml119w-del</value>
            <value>ymr293c-del</value>
            <value>ypl066w-del</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>BY4742</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Genotype</name>
            <value>bud22-del</value>
            <value>cdk8-del</value>
            <value>cycC-del</value>
            <value>ecm30-del</value>
            <value>efg1-del</value>
            <value>med15-del</value>
            <value>med18-del</value>
            <value>med2-del</value>
            <value>med20-del</value>
            <value>med3-del</value>
            <value>med31-del</value>
            <value>nce102-del</value>
            <value>oca1-del</value>
            <value>oca2-del</value>
            <value>oca4-del</value>
            <value>oca5-del</value>
            <value>oca6-del</value>
            <value>pet112-del</value>
            <value>refpool</value>
            <value>rtg1-del</value>
            <value>rtg3-del</value>
            <value>siw14-del</value>
            <value>tus1-del</value>
            <value>ubp15-del</value>
            <value>vac8-del</value>
            <value>yll032c-del</value>
            <value>yml119w-del</value>
            <value>ymr293c-del</value>
            <value>ypl066w-del</value>
        </experimentalfactor>
        <user>1730700173</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1607097985</id>
            <accession>A-UMCU-10</accession>
            <name>UMC Utrecht S. cerevisiae 16K array, version 1.3</name>
            <count>56</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799367364</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-654.A-UMCU-10.1.FeatureDimension</name>
            <bioassaydatacubes>56</bioassaydatacubes>
            <arraydesignprovider>UMCU</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>56</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799367772</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-654.A-UMCU-10.1.FeatureDimension</name>
            <bioassaydatacubes>56</bioassaydatacubes>
            <arraydesignprovider>UMCU</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>56</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <authors>Joris Benschop;Nathalie Brabers;Dik van Leenen;Linda Bakker;Hanneke van
                Deutekom;Philip Lijnzaad;Nevan Krogan;Frank Holstege;Patrick Kemmeren</authors>
            <title>A comprehensive consensus map of protein complexes in Saccharomyces
                cerevisiae</title>
        </bibliography>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>genetic modification</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799366558</id>
            <text>A number of putative protein complexes have been selected for experimental
                validation by gene expression profiling of the individual deletion mutants of the
                respective protein complex members.</text>
        </description>
        <description>
            <id>1799370943</id>
            <text>(Generated description) Experiment with 56 hybridizations, using 57 samples of
                species [Saccharomyces cerevisiae], using 56 arrays of array design [UMC Utrecht S.
                cerevisiae 16K array, version 1.3], producing 56 raw data files and 56 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="109">
        <id>1799370198</id>
        <accession>E-GEOD-11974</accession>
        <name>Re-sequencing of rice seed</name>
        <releasedate>2009-09-16</releasedate>
        <species>Oryza sativa</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Oryza sativa</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE11974</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799370158</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-11974.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <bibliography>
            <accession>19103661</accession>
            <authors>Liang-Jiao Xue, Jing-Jing Zhang, Hong-Wei Xue</authors>
            <title>Characterization and expression profiles of miRNAs in rice seeds.</title>
        </bibliography>
        <provider>
            <contact>Hongwei Xue</contact>
            <email>hwxue@sibs.ac.cn</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799370205</id>
            <text>Small RNAs are common and effective modulators of gene expression in eukaryotic
                organisms. To characterize the small RNAs expressed during rice seed development,
                massively parallel signature sequencing (MPSS) was performed, resulting in the
                obtainment of 22-nt sequence signatures. Through integrative analysis,novel miRNAs
                were identified mostly based on the miRNA* accumulation. Experiment Overall Design:
                Total RNA was isolated separately from rice seeds collected at 3, 6, 9 and 12 days
                after anthesis (DAA), then mixed into a library and separated on denatured
                polyacrylamide gel electrophoresis (PAGE). The fraction of 18-26 nt small RNA was
                recovered by small RNA gel extraction Kit.</text>
        </description>
        <description>
            <id>1799370307</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Oryza sativa], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-11974], producing 0 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="110">
        <id>1799371710</id>
        <accession>E-GEOD-17454</accession>
        <name>ChIP-Seq of C. elegans to identify transcription factor CEH-14 binding sites -
            ModEncode</name>
        <releasedate>2009-09-16</releasedate>
        <species>Caenorhabditis elegans</species>
        <samples>3</samples>
        <assays>3</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Caenorhabditis elegans</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17454</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799370627</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-17454.VirtualArrayDesign</accession>
            <count>3</count>
        </arraydesign>
        <provider>
            <contact>Michael Wilson</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>ChIP-seq</experimenttype>
        <description>
            <id>1799371717</id>
            <text>We, being members of modENCODE consortium, have established an experimetal
                pipeline in C.elegans that allows global identification of the binding sites for
                transcription factors using chromatin immunoprecipitation followed by illumina
                high-throughput sequencing (ChIP-seq). In current study, we identified the binding
                sites for CEH-14 at L2 stage, which is required for specification of the AFD
                thermosensory neurons and for normal thermotactic behavior. For data usage terms and
                conditions, please refer to http://www.genome.gov/27528022 and
                http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf
                Experiment Overall Design: CEH-14 was tagged with a dual GFP:3xFLAG tag at the
                carboxy terminus, whose expression pattern was confirmed through both fluorescence
                imaging and immunoblot analysis. The binding sites were determined using ChIP-seq.
                Two biological replicates were used in this study, but replicate1 is at a later L2
                stage. Only one Input sample (non-immunoprecipitated chromatin (input) from
                replicate2 was used as a control. The concordance between two replicates is just
                above 50% when p-value is 0.05.</text>
        </description>
        <description>
            <id>1799371861</id>
            <text>(Generated description) Experiment with 3 hybridizations, using 3 samples of
                species [Caenorhabditis elegans], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-17454], producing 0 raw data files and 5 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="111">
        <id>1799372620</id>
        <accession>E-GEOD-14600</accession>
        <name>ChIP-Seq of Arabidopsis to identify target genes of the MADS transcription factor
            SEPALLATA3</name>
        <releasedate>2009-09-16</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>5</samples>
        <assays>5</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14600</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799370848</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-14600.VirtualArrayDesign</accession>
            <count>5</count>
        </arraydesign>
        <bibliography>
            <accession>19385720</accession>
            <authors>Kerstin Kaufmann, Jose M Mui o, Ruy Jauregui, Chiara A Airoldi, Cezary
                Smaczniak, Pawel Krajewski, Gerco C Angenent</authors>
            <title>Target genes of the MADS transcription factor SEPALLATA3: integration of
                developmental and hormonal pathways in the Arabidopsis flower.</title>
        </bibliography>
        <provider>
            <contact>Gerco Angenent</contact>
            <email>gerco.angenent@wur.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>ChIP-seq</experimenttype>
        <description>
            <id>1799372627</id>
            <text>The molecular mechanisms by which floral homeotic genes act as major developmental
                switches to specify the identity of floral organs, are still largely unknown. Floral
                homeotic genes encode transcription factors of the MADS-box family, which are
                supposed to assemble in a combinatorial fashion into organ-specific multimeric
                protein complexes. Major mediators of protein interactions are MADS-domain proteins
                of the SEPALLATA subfamily, which play a crucial role in the development of all
                types of floral organs. In order to characterize the roles of the SEPALLATA3
                transcription factor complexes at the molecular level, we analyzed genome-wide the
                direct targets of SEPALLATA3. We used chromatin immunoprecipitation followed by
                ultrahigh-throughput sequencing or hybridization to whole-genome tiling arrays to
                obtain genome-wide DNA-binding patterns of SEPALLATA3. The results demonstrate that
                SEPALLATA3 binds to thousands of sites in the genome. Most potential target sites
                that were strongly bound in wild-type inflorescences, are also bound in the floral
                homeotic agamous mutant, which displays only the perianth organs, sepals and petals.
                Characterization of the target genes shows that SEPALLATA3 integrates and modulates
                different growth-related and hormonal pathways in a combinatorial fashion with other
                MADS-box proteins and possibly with non-MADS transcription factors. In particular,
                the results suggest multiple links between SEPALLATA3 and auxin signaling pathways.
                Our gene expression analyses link the genomic binding site data with the phenotype
                of plants expressing a dominant repressor version of SEPALLATA3, suggesting that it
                modulates auxin response to facilitate floral organ outgrowth and morphogenesis.
                Furthermore, the binding of the SEPALLATA3 protein to cis-regulatory elements of
                other MADS-box genes and expression analyses reveal that this protein is a key
                component in the regulatory transcriptional network underlying the formation of
                floral organs. Experiment Overall Design: ChIP experiments were performed on
                Arabidopsis wildtype and agamous mutant inflorescences using an antibody raised
                against a C-terminal peptide of SEP3. As control, ChIP experiments were performed on
                the sep3 mutant.</text>
        </description>
        <description>
            <id>1799372770</id>
            <text>(Generated description) Experiment with 5 hybridizations, using 5 samples of
                species [Arabidopsis thaliana], using 1 arrays of array design [Virtual Array Design
                for E-GEOD-14600], producing 0 raw data files and 5 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="112">
        <id>1799375586</id>
        <accession>E-GEOD-13750</accession>
        <name>Re-sequencing of yeast ribosomally bound sequences</name>
        <releasedate>2009-09-16</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13750</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799370547</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-13750.VirtualArrayDesign</accession>
            <count>8</count>
        </arraydesign>
        <bibliography>
            <accession>19213877</accession>
            <authors>Nicholas T Ingolia, Sina Ghaemmaghami, John R S Newman, Jonathan S
                Weissman</authors>
            <title>Genome-wide analysis in vivo of translation with nucleotide resolution using
                ribosome profiling.</title>
        </bibliography>
        <provider>
            <contact>Nicholas Ingolia</contact>
            <email>nick@ingolia.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799375593</id>
            <text>Techniques for systematically monitoring protein translation have lagged far
                behind methods for measuring mRNA levels. Here we present a ribosome profiling
                strategy, based on deep sequencing of ribosome protected mRNA fragments, that
                enables genome-wide investigation of translation with sub-codon resolution. We used
                this technique to monitor translation in budding yeast under both rich and
                starvation conditions. These studies defined the protein sequences being translated
                and found extensive translational control both for determining absolute protein
                abundance and for responding to environmental stress. We also observed distinct
                phases during translation involving a large decrease in ribosome density going from
                early to late peptide elongation as well as wide-spread, regulated initiation at
                non-AUG codons. Ribosome profiling is readily adaptable to other organisms, making
                high-precision investigation of protein translation experimentally accessible.
                Experiment Overall Design: Examine replicates of ribosome footprints and mRNA
                abundance in biological replicates of log-phase growth and acute amino acid
                starvation</text>
        </description>
        <description>
            <id>1799375850</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Saccharomyces cerevisiae], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-13750], producing 0 raw data files and 32 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="113">
        <id>1799376005</id>
        <accession>E-GEOD-16916</accession>
        <name>Re-sequencing of maize tip and base of a developing</name>
        <releasedate>2009-09-16</releasedate>
        <species>Zea mays</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16916</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799370228</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-16916.VirtualArrayDesign</accession>
            <count>2</count>
        </arraydesign>
        <provider>
            <contact>Lalit Ponnala</contact>
            <email>lp257@cornell.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799376012</id>
            <text>We have generated over 80 million 32 nt reads generated from RNA samples isolated
                from the tip and base of a developing Mo17 leaf. A comparision of these data with
                the maize AGP resulted in the confirmation of approximately 88% of the maize
                filtered gene set Experiment Overall Design: Examination of two different RNA
                samples from two different segments of a developing 3rd leaf</text>
        </description>
        <description>
            <id>1799376084</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Zea mays], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-16916], producing 0 raw data files and 4 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="114">
        <id>1799394330</id>
        <accession>E-GEOD-14605</accession>
        <name>Re-sequencing of mouse single cell - wild-type oocytes, two single Dicer knockout
            oocyte, and one single Ago2 knockout oocyte</name>
        <releasedate>2009-09-16</releasedate>
        <species>Mus musculus</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14605</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799382618</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-14605.VirtualArrayDesign</accession>
            <count>6</count>
        </arraydesign>
        <bibliography>
            <accession>19349980</accession>
            <authors>Fuchou Tang, Catalin Barbacioru, Yangzhou Wang, Ellen Nordman, Clarence Lee,
                Nanlan Xu, Xiaohui Wang, John Bodeau, Brian B Tuch, Asim Siddiqui, Kaiqin Lao, M
                Azim Surani</authors>
            <title>mRNA-Seq whole-transcriptome analysis of a single cell.</title>
        </bibliography>
        <provider>
            <contact>Catalin Barbacioru</contact>
            <email>catalin@appliedbiosystems.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1799394342</id>
            <text>Here we modified a single cell whole transcriptome amplification method to make it
                capable of amplifying cDNAs as long as 3kb efficiently and unbiasedly. We combined
                this modified single cell cDNA amplification method with Applied Biosystems next
                generation sequencing SOLiD System to set up a single cell whole transcriptome
                assay. The modified amplification strategy allows us to amplify full-length cDNAs
                for most of the expressed genes. We show that it is feasible to get digital gene
                expression profiles at single cell resolution. This allows us to ask fundamental
                biological questions that could not be addressed previously, especially in the early
                embryonic development field, and to understand transcriptome complexity at the
                resolution of a single cell. Experiment Overall Design: gene expression profiling
                from two single wild-type oocytes, two single Dicer knockout oocyte, and one single
                Ago2 knockout oocyte</text>
        </description>
        <description>
            <id>1799396411</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Mus musculus], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-14605], producing 0 raw data files and 50 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="115">
        <id>1799417461</id>
        <accession>E-GEOD-15922</accession>
        <name>Methylation profiling of Arabidopsis endosperm</name>
        <releasedate>2009-09-16</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15922</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1799385117</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-15922.VirtualArrayDesign</accession>
            <count>4</count>
        </arraydesign>
        <bibliography>
            <accession>19520962</accession>
            <authors>Tzung-Fu Hsieh, Christian A Ibarra, Pedro Silva, Assaf Zemach, Leor
                Eshed-Williams, Robert L Fischer, Daniel Zilberman</authors>
            <title>Genome-wide demethylation of Arabidopsis endosperm.</title>
        </bibliography>
        <provider>
            <contact>Pedro Silva</contact>
            <email>psilva@nature.berkeley.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>methylation profiling</experimenttype>
        <description>
            <id>1799417472</id>
            <text>Parent-of-origin-specific (imprinted) gene expression is regulated in Arabidopsis
                thaliana endosperm by cytosine demethylation of the maternal genome mediated by the
                DNA glycosylase DEMETER, but the extent of the methylation changes is not known.
                Here we show that virtually the entire endosperm genome is demethylated, coupled
                with extensive local non-CG hypermethylation of siRNA-targeted sequences. Mutation
                of DEMETER partially restores endosperm CG methylation to levels found in other
                tissues, indicating that CG demethylation is specific to maternal sequences.
                Endosperm demethylation is accompanied by CHH hypermethylation of embryo
                transposable elements. Our findings demonstrate extensive reconfiguration of the
                endosperm methylation landscape that likely reinforces transposon silencing in the
                embryo. Experiment Overall Design: Examination of DNA methylation in four
                Arabidopsis tissues Experiment Overall Design: Description of processed data and raw
                data file contents can be found in the attached README.txt file</text>
        </description>
        <description>
            <id>1799417679</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Arabidopsis thaliana], using 1 arrays of array design [Virtual Array Design
                for E-GEOD-15922], producing 0 raw data files and 26 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="116">
        <id>1799053859</id>
        <accession>E-MEXP-2350</accession>
        <name>Transcription profiling of Arabidopsis thaliana AP1::AtIPT4 transformants vs wild type
            plants to identify the candidate genes responsive to cytokinin</name>
        <releasedate>2009-09-15</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>AP1::AtIPT4</value>
            <value>none</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>Columbia</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>inflorescence</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>AP1::AtIPT4</value>
            <value>none</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Genotype</name>
            <value>Columbia</value>
        </experimentalfactor>
        <user>1799056539</user>
        <user>1799056542</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799055224</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799055249</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2350.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799055281</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2350.A-AFFY-2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <title>Cytokinin-Regulated Floral Development at Least Partially Mediated by CUC2 and
                CUC3 in Arabidopsis</title>
        </bibliography>
        <provider>
            <contact>Xian Sheng Zhang</contact>
            <email>zhangxs@sdau.edu.cn</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>all pairs</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>transcript identification</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799053869</id>
            <text>The aim of this experiment is to identify the candidate genes responsive to
                cytokinin in Arabidopsis floral development. For this purpose, AtIPT4 gene under the
                control of the AP1 promoter was transformed into wild type plants of Arabidopsis.
                The transcriptional profiles of the young inflorescence of AP1::AtIPT4 transformants
                and wild-type plants are compared.</text>
        </description>
        <description>
            <id>1799055426</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Arabidopsis thaliana], using 6 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 6 raw data files and 7 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="117">
        <id>1799067283</id>
        <accession>E-NCMF-30</accession>
        <name>Transcription profiling of human radiation associated breast cancers reveals distinct
            subtypes</name>
        <releasedate>2009-09-15</releasedate>
        <species>Homo sapiens</species>
        <samples>43</samples>
        <assays>84</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Protocol</name>
            <value>Tissue</value>
        </experimentalfactor>
        <user>1312020402</user>
        <user>1799078784</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1309244695</id>
            <accession>A-NCMF-2</accession>
            <name>NCMF Human HO.35k</name>
            <count>84</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799067530</id>
            <name>NCMF:DED:37631:D7</name>
            <bioassaydatacubes>84</bioassaydatacubes>
            <arraydesignprovider>NCMF</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>84</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799067892</id>
            <name>NCMF:DED:37631:D7</name>
            <bioassaydatacubes>84</bioassaydatacubes>
            <arraydesignprovider>NCMF</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>84</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799068101</id>
            <name>NCMF:DED:COMBREP:D7</name>
            <bioassaydatacubes>42</bioassaydatacubes>
            <arraydesignprovider>NCMF</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>42</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <authors>Annegien Broeks , Linde M. Braaf, Lodewyk F.A.Wessels, Marc van de Vijver,
                Marie L. De Bruin, Marilyn Stovall, Nicola S. Russel</authors>
            <title>Radiation-associated breast tumors display a distinct gene expression
                profile</title>
            <year>2010-09-09</year>
        </bibliography>
        <provider>
            <contact>Daoud Sie</contact>
            <email>d.sie@nki.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>dye swap</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799067287</id>
            <text>BfHL's, spor zonder BfNHL's en BfHL4</text>
        </description>
        <description>
            <id>1799070662</id>
            <text>(Generated description) Experiment with 84 hybridizations, using 43 samples of
                species [Homo sapiens], using 84 arrays of array design [NCMF Human HO.35k],
                producing 84 raw data files and 126 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="118">
        <id>1799072762</id>
        <accession>E-TABM-791</accession>
        <name>Comparative genomic hybridization of human nasal NK/T-cell Lymphoma (8 tumor samples,
            2 cell lines)</name>
        <releasedate>2009-09-15</releasedate>
        <samples>11</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Age</category>
            <value>25</value>
            <value>52</value>
            <value>58</value>
            <value>62</value>
            <value>64</value>
            <value>67</value>
            <value>72</value>
            <value>n/a</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>extranodal NK/T-Cell Lymphoma derived cell line</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>extranodal NK/T-Cell Lymphoma</value>
            <value>extranodal NK/T-Cell Lymphoma derived cell line</value>
            <value>normal</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>bone marrow</value>
            <value>n/a</value>
            <value>nasopharyngeal region</value>
            <value>skin</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organsim</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>female</value>
            <value>male</value>
            <value>n/a</value>
        </sampleattribute>
        <sampleattribute>
            <category>TimeUnit</category>
            <value>n/a</value>
            <value>years</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Age</name>
            <value>25</value>
            <value>52</value>
            <value>58</value>
            <value>62</value>
            <value>64</value>
            <value>67</value>
            <value>72</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Age(years)</name>
            <value>n/a</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>extranodal NK/T-Cell Lymphoma</value>
            <value>extranodal NK/T-Cell Lymphoma derived cell line</value>
            <value>normal</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>bone marrow</value>
            <value>n/a</value>
            <value>nasopharyngeal region</value>
            <value>skin</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Sex</name>
            <value>female</value>
            <value>male</value>
            <value>n/a</value>
        </experimentalfactor>
        <user>1466277950</user>
        <user>1798659392</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1798744934</id>
            <accession>A-MEXP-1687</accession>
            <name>CIT-aCGH-V6-4.4K</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799073166</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-791.A-MEXP-1687.1.FeatureDimension</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799073225</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-791.A-MEXP-1687.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>Blood</publication>
            <authors>Yen-Lin Huang, Aurelien de Reynies, Laurence de Leval, Bouchra Ghazi, Nadine
                Martin-Garcia, Jacques Bosq, Josette Briere, Barbara Petit, Emilie Thomas, Paul
                Coppo, Teresa Marafioti, Christian Schmitt, Philippe Gaulard</authors>
            <title>Gene expression profiling identifies emerging oncogenic pathways operating in
                extranodal NK/T-cell lymphoma, nasal type</title>
            <year>2009</year>
        </bibliography>
        <provider>
            <contact>Aurelien de Reynies</contact>
            <email>reyniesa@ligue-cancer.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimenttype>comparative genomic hybridization</experimenttype>
        <description>
            <id>1799072770</id>
            <text>A Cartes d Identite des Tumeurs (CIT) project from the french Ligue Nationale
                Contre le Cancer (http://cit.ligue-cancer.net ) | Human genome-wide CIT-aCGH-V6-4.4K
                : 8 NKTCL biopsies, 2 NKTCL cell lines. Biopsies and cell lines of NK/T-cell
                lymphoma, nasal-type (NKTCL) were subject to combined gene expression profiling (see
                E-TABM-702) and array-based comparative genomic hybridization analyses. | Submitter
                : Aurelien de Reynies &lt;reyniesa@ligue-cancer.fr&gt; | Project leader :
                Philippe Gaulard &lt;philippe.gaulard@hmn.aphp.fr&gt;</text>
        </description>
        <description>
            <id>1799073486</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 11 samples of
                species [], using 10 arrays of array design [CIT-aCGH-V6-4.4K], producing 10 raw
                data files and 1 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="119">
        <id>1799084003</id>
        <accession>E-MTAB-146</accession>
        <name>Transcription profiling of mouse HA specific T regulatory cells cultured in the
            presence of HA-pulsed dendritic cells and rhIL-2 with or without HA-specific T effector
            cells</name>
        <releasedate>2009-09-15</releasedate>
        <species>Mus musculus</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>CellType</category>
            <value>HA specific-CD4 positive T cell</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>TCR-HA</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GrowthCondition</name>
            <value>co-cultured with HA-specific Teff</value>
            <value>cultured alone</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1635059174</id>
            <accession>A-MEXP-1175</accession>
            <name>Illumina MouseWG-6 v2.0 Expression BeadChip</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799085895</id>
            <name>ebi.ac.uk:MAGETabulator:E-MTAB-146.A-MEXP-1175.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799085867</id>
            <name>ebi.ac.uk:MAGETabulator:E-MTAB-146.A-MEXP-1175.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Eliane Piaggio</contact>
            <email>elianepiaggio@yahoo.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799084008</id>
            <text>Expanded HA-specific Thy-1.1 Tregs were cultured in the presence of HA-pulsed
                dendritic cells and rhIL-2 with or without HA-specific Teffs. After 5 days, Tregs
                were sorted by flow cytometry, based on the expression of the Thy-1.1 congeneic
                marker. Two biological duplicates were hybridized to the Sentrix BeadChips Array
                mouse WG-6 v2 (Illumina, USA). Data extraction and normalization was performed using
                Quantile normalization in the BeadStudio software.</text>
        </description>
        <description>
            <id>1799086140</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Mus musculus], using 8 arrays of array design [Illumina MouseWG-6 v2.0
                Expression BeadChip], producing 0 raw data files and 2 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="120">
        <id>1799085601</id>
        <accession>E-GEOD-4734</accession>
        <name>Transcription profiling of mouse brain regions (bed nucleus of the stria terminalis,
            hippocampus, hypothalamus, periaqueductal gray, and pituitary gland) in six mouse
            strains (129S6/SvEvTac, A/J, C57BL/6J, C3H/HeJ, DBA/2J, and FVB/NJ)</name>
        <releasedate>2009-09-15</releasedate>
        <species>Mus musculus</species>
        <samples>61</samples>
        <assays>61</assays>
        <sampleattribute>
            <category>Age</category>
            <value>8 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>wild_type</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>bed nucleus of the stria terminalis</value>
            <value>hippocampus</value>
            <value>hypothalamus</value>
            <value>periaqueductal gray</value>
            <value>pituitary gland</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>male</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>129S6/SvEvTac</value>
            <value>A/J</value>
            <value>C3H/HeJ</value>
            <value>C57BL/6J</value>
            <value>DBA/2J</value>
            <value>FVB/NJ</value>
        </sampleattribute>
        <experimentalfactor>
            <name>OrganismPart</name>
            <value>bed nucleus of the stria terminalis</value>
            <value>hippocampus</value>
            <value>hypothalamus</value>
            <value>periaqueductal gray</value>
            <value>pituitary gland</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>129S6/SvEvTac</value>
            <value>A/J</value>
            <value>C3H/HeJ</value>
            <value>C57BL/6J</value>
            <value>DBA/2J</value>
            <value>FVB/NJ</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE4734</secondaryaccession>
        <secondaryaccession>GDS2917</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>61</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799089916</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-4734.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>61</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>61</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>17324278</accession>
            <authors>Iiris Hovatta, Matthew A Zapala, Ron S Broide, Eric E Schadt, Ondrej Libiger,
                Nicholas J Schork, David J Lockhart, Carrolee Barlow</authors>
            <title>DNA variation and brain region-specific expression profiles exhibit different
                relationships between inbred mouse strains: implications for eQTL mapping
                studies.</title>
        </bibliography>
        <provider>
            <contact>Carrolee Barlow</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>organism part comparison</experimentdesign>
        <experimentdesign>strain or line</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1799085609</id>
            <text>Gene expression patterns were determined from five brain regions (bed nucleus of
                the stria terminalis, hippocampus, hypothalamus, periaqueductal gray, and pituitary
                gland) in six mouse strains (129S6/SvEvTac, A/J, C57BL/6J, C3H/HeJ, DBA/2J, and
                FVB/NJ). At least two replicate samples per brain region/strain were analyzed using
                Affymetrix Mouse Genome 430 2.0 arrays. Experiment Overall Design: six mouse strains
                and five brain regions were analyzed</text>
        </description>
        <description>
            <id>1799091273</id>
            <text>(Generated description) Experiment with 61 hybridizations, using 61 samples of
                species [Mus musculus], using 61 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 0 raw data files and 61 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="121">
        <id>1799086772</id>
        <accession>E-TABM-653</accession>
        <name>siRNA profiling of human synovial fibroblasts depleted for clusterin</name>
        <releasedate>2009-09-15</releasedate>
        <species>Homo sapiens</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>CellType</category>
            <value>synoviocytes</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>rheumatoid arthritis</value>
        </sampleattribute>
        <sampleattribute>
            <category>Individual</category>
            <value>Control 1</value>
            <value>Control 2</value>
            <value>patient De</value>
            <value>patient NA</value>
            <value>patient Si</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Compound</name>
            <value>none</value>
            <value>tumor necrosis factor alpha</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>0</value>
            <value>48</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Individual</name>
            <value>Control 1</value>
            <value>Control 2</value>
            <value>patient De</value>
            <value>patient NA</value>
            <value>patient Si</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>RNAi</name>
            <value>none</value>
            <value>siRNA C2</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Time</name>
            <value>0</value>
            <value>24</value>
            <value>48</value>
        </experimentalfactor>
        <user>1799087787</user>
        <user>1799087791</user>
        <secondaryaccession>Transcription profiling of human synoviocytes cells form patients
            suffering of Rheumatoid arthritis and depleted for clusterin by siRNA
            knockdown</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1549642516</id>
            <accession>A-MEXP-931</accession>
            <name>Illumina HumanRef-8 v2 Expression BeadChip</name>
            <count>16</count>
        </arraydesign>
        <bibliography>
            <publication>Arthitis Research Therapy</publication>
            <title>Implication of clusterin in TNFalpha response of rheumatoid synovitis: lessons
                from in vitro knock-down of clusterin in human synovial fibroblast cells</title>
        </bibliography>
        <provider>
            <contact>Geraldine Falgarone</contact>
            <email>g.falgarone@avc.aphp.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cellular modification</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <experimenttype>RNAi</experimenttype>
        <description>
            <id>1799086778</id>
            <text>Analysis of synoviocytes cell form patients suffering of Rheumatoid arthritis and
                depleted for clusterin by siRNA knockdown</text>
        </description>
        <description>
            <id>1799087522</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Homo sapiens], using 16 arrays of array design [Illumina HumanRef-8 v2
                Expression BeadChip], producing 1 raw data files and 0 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="122">
        <id>1799087942</id>
        <accession>E-MEXP-2308</accession>
        <name>Methylation profiling of human cancer cells promoter vs normal cells.</name>
        <releasedate>2009-09-15</releasedate>
        <species>Homo sapiens</species>
        <samples>8</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>H226</value>
            <value>H520</value>
            <value>MRC5</value>
            <value>WI38</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>H226</value>
            <value>H520</value>
            <value>MRC5</value>
            <value>WI38</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Chip-antibody</name>
            <value>MAP</value>
            <value>none</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1762937483</id>
            <accession>A-MEXP-1607</accession>
            <name>Nimblegen HG18 50-75mer - 385k - Human promoter array - Stancheva</name>
            <count>12</count>
        </arraydesign>
        <bibliography/>
        <provider>
            <contact>Jose de las Heras</contact>
            <email>j.delasheras@ed.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>binding site identification</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <experimentdesign>physiological process</experimentdesign>
        <experimenttype>methylation profiling</experimenttype>
        <description>
            <id>1799087950</id>
            <text>Genomic DNA from two normal lung cell lines (MRC5 and WI38) and two non-small cell
                lung carcinoma cell lines (H226 and H520) was fragmented, and affinity purified
                using the MBD domain from MeCP2, which binds to methylated CpG dinucleotides. This
                allows enrichment of a methylated fraction of DNA. Promoter arrays were used to look
                for methylated promoters by hybridising the enriched fraction and total genomic DNA
                simultaneously. The process is similar to ChIP-on-chip.</text>
        </description>
        <description>
            <id>1799088482</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 8 samples of
                species [Homo sapiens], using 12 arrays of array design [Nimblegen HG18 50-75mer -
                385k - Human promoter array - Stancheva], producing 24 raw data files and 1
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="123">
        <id>1798651082</id>
        <accession>E-GEOD-12585</accession>
        <name>Transcription profiling of human healthy smokers lymphocytes</name>
        <releasedate>2009-09-14</releasedate>
        <species>Homo sapiens</species>
        <samples>23</samples>
        <assays>23</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12585</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>23</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798651353</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>23</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>23</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798651363</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12585.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>23</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>23</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jinguo Chen</contact>
            <email>jinguochen@yahoo.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798651089</id>
            <text>Little is known about alteration of the global gene expression by cigarette smoke
                (CS) and few biomarkers for smoking-related harm are available. We used Affymetrix
                HG-U133A GeneChips to measure the transcriptomes in lymphocytes of 23 current
                healthy smokers. When heavy smokers were compared with light smokers, 311 genes
                demonstrated a significant difference in mRNA expression of their blood lymphocytes.
                Experiment Overall Design: The goals of this study were to evaluate novel gene
                expression profiles and pathways affected by cigarette smoking, and to identify
                potential biomarkers for cigarette smoke exposure and harm. To this end, we isolated
                the PBMC from 10 heavy and 13 light smokers, determined their gene expression
                profiles with Affymetrix microarray and analyzed their relationship with cigarette
                smoking.</text>
        </description>
        <description>
            <id>1798651395</id>
            <text>(Generated description) Experiment with 23 hybridizations, using 23 samples of
                species [Homo sapiens], using 23 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 23 raw data files and 23 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="124">
        <id>1798651305</id>
        <accession>E-GEOD-8908</accession>
        <name>Transcritpion profiling of hronically inflamed human peri-implant and periodontal
            ligament cells in vivo</name>
        <releasedate>2009-09-14</releasedate>
        <species>Homo sapiens</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE8908</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>458263473</id>
            <accession>A-AFFY-37</accession>
            <name>Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2]</name>
            <count>2</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798651397</id>
            <name>Affymetrix:FeatureDimension:HG-U133A_2</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798651398</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-8908.HG-U133A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>2</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Robert Geffers</contact>
            <email>robert.geffers@helmholtz-hzi.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798651313</id>
            <text>The goal of this study was to compare the gene expression profiles of chronically
                inflamed human peri-implant and chronically inflamed human periodontal tissues in
                order to elucidate potential changes at the molecular level. Cells out of the pocket
                depth of the inflamed peri-implant and periodontal ligament as well as from the
                middle third of healthy periodontal ligament were applied. Genome-wide gene
                expression was compared with the help of microarray analysis, and the data were
                validated by real-time RT-PCR. The expression rates of 14,239 genes were
                investigated and 2,079 of them were found differentially expressed by at least
                two-fold; the expression rates of 1,093 genes were significantly up-regulated and
                the expression rates of 986 genes were significantly down-regulated in inflamed
                peri-implant cells compared to inflamed periodontal cells. We focused on genes
                coding for extracellular matrix components and those that degrade them. Only genes
                of non-fibril-forming collagens (types IV, VI, VII, and XVII) were increased in
                inflamed peri-implant tissue, whereas only the genes of two fibril-forming collagens
                (types III and XVII) were decreased, suggesting that peri-implant tissue re-models
                faster than periodontal tissue. Furthermore, cathepsin D and cathepsin S might
                participate to a greater extent in connective tissue destruction of peri-implant
                tissue. The present investigation demonstrated that, despite their clinical
                similarities, periimplantitis and periodontitis are two different diseases at the
                genetic level. Experiment Overall Design: The peri-implant tissue was scraped of the
                implant and the periodontal tissue was scraped off the roots of the teeth. Both
                tissue probes were treated with the RNeasy mini Kit (Qiagen, Hilden, Germany) to
                isolate total RNA from chronically inflamed peri-implant and chronically inflamed
                PDL cells, according to the manufacturer s instructions. Healthy PDL cells were
                taken from the middle third of the root clearly avoiding sampling the gingiva. The
                chronically inflamed peri-implant and periodontal cells were taken directly out of
                the depth of the pocket again avoiding the ingrown gingiva. Quality control and
                quantitation of total RNA samples were determined prior to the microarray
                experiments (Agilent 2100 Bioanalyzer, Agilent Technologies, Palo Alto, CA, USA).
                Equal amounts of total RNA were pooled into an inflamed peri-implant and an inflamed
                and healthy periodontal cell pool. To monitor the relative abundance of mRNA for
                full-length human genes, the Affymetrix GeneChip HG_U133A was used, representing
                22,283 probe sets (14,239 unique human genes). Labelled cRNA, fragmented to an
                average size of 100 150 bases, was hybridized to the GeneChips. For each pool of
                cRNA, two GeneChips were hybridized. Experiment Overall Design: Chronically inflamed
                peri-implant as well as healthy and chronically inflamed periodontal tissue was
                collected from 48 patients at the Dental Medical School of the University of
                Goettingen (21 men, 27 women, aged between 18 and 72 years) from March 2005 to
                August 2006, as already described by Gersdorff et al. (2007). The peri-implant
                tissue probes were taken from endosteal implants (Astra Tech , ITI Bonefit , or Br
                nemark ) with chronic peri-implant lesions (Schwarz et al. 2007). The periodontal
                tissue probes were taken from teeth, either extracted for orthodontic reasons or due
                to carious lesions (healthy periodontium) or from teeth with generalized chronic
                periodontitis (Armitage 2004). Teeth with healthy PDL had no clinical signs of
                inflammation (no bleeding on probing), exhibited a probing depth of ?3,5 mm and had
                no radiographic detectable bone loss. In contrast, implants and teeth with
                generalized chronic inflammation exhibited obvious clinical signals of inflammation
                (bleeding on probing), exhibited a probing depth of &gt;4 mm and had
                radiographic evidence of bone loss (1 to 7 mm). A detailed anamnesis of each patient
                was explored. All patients were without a medical history, i.e. heart diseases or
                diabetes, and were not on medication. In addition, the tissue samples used in our
                study were only taken from non-smokers. The explanted implants and extracted teeth
                were immediately frozen and stored at -80 C. All patients who participated in the
                study were informed about the nature and aim of this project and gave their written
                informed consent. The study was approved according to the regulations of the Ethics
                Committee of the Medical Faculty of the University of Goettingen.</text>
        </description>
        <description>
            <id>1798651399</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Homo sapiens], using 2 arrays of array design [Affymetrix GeneChip Human
                Genome U133A 2.0 [HG-U133A_2]], producing 2 raw data files and 2 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="125">
        <id>1798654669</id>
        <accession>E-GEOD-17861</accession>
        <name>Transcription profiling of human heterogeneous renal allograft biopsies reveal
            conserved rejection signatures and molecular pathways I, partB</name>
        <releasedate>2009-09-14</releasedate>
        <species>Homo sapiens</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17861</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798656239</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798656241</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17861.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19017305</accession>
            <authors>Pierre Saint-Mezard, C line C Berthier, Hai Zhang, Alexandre Hertig, Sergio
                Kaiser, Martin Schumacher, Grazyna Wieczorek, Marc Bigaud, Jeanne Kehren, Eric
                Rondeau, Friedrich Raulf, Hans-Peter Marti</authors>
            <title>Analysis of independent microarray datasets of renal biopsies identifies a robust
                transcript signature of acute allograft rejection.</title>
        </bibliography>
        <provider>
            <contact>Dr Hans-Peter Marti</contact>
            <email>hans-peter.marti@insel.ch</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798654682</id>
            <text>Specific early diagnosis of renal allograft rejection is gaining importance in the
                current trend to minimize and individualize immunosuppression. Gene expression
                analyses could contribute significantly by defining molecular Banff signatures.
                Several previous studies have applied transcriptomics to distinguish different
                classes of kidney biopsies. However, the heterogeneity of microarray platforms,
                clinical samples and data analysis methods complicates the identification of robust
                signatures for the different types and grades of rejection. To address these issues,
                a comparative meta-analysis was performed across five different microarray datasets
                of heterogeneous sample collections from two published clinical datasets and three
                own datasets including biopsies for clinical indications, protocol biopsies, as well
                as comparative samples from non-human primates (NHP). This work identified conserved
                gene expression signatures that can differentiate groups with different
                histopathological findings in both human and NHP, regardless of the technical
                platform used. The marker panels comprise genes that clearly support the biological
                changes known to be involved in allograft rejection. A characteristic dynamic
                expression change of genes associated with immune and kidney functions was observed
                across samples with different grades of CAN. In addition, differences between human
                and NHP rejection were essentially limited to genes reflecting interstitial fibrosis
                progression. This data set comprises all renal allograft biopsies for clinical
                indications from patients at H pital Tenon, Paris (February 2003 until September
                2004) and few respective patients from H pital Bic tre, Paris, H pital Pellegrin,
                Bordeaux, and H pital Dupuytren, Limoges, plus control normal kidney samples from H
                pital Tenon, Paris, France (first batch). We used microarrays to identify different
                gene expression signatures of renal allograft biopsies that can classify them
                according to different types of allograft rejection or CAN. Experiment Overall
                Design: 16 renal allograft core biopsies for clinical indications with different
                histopathological diagnoses according to BANFF'97 criteria (additional samples
                associated with GSE9489)</text>
        </description>
        <description>
            <id>1798656421</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Homo sapiens], using 16 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 16 raw data files and 16
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="126">
        <id>1798655556</id>
        <accession>E-GEOD-17869</accession>
        <name>Transcription profiling of mouse C57BL/6 vs ERKO-alpha and ERKO-beta mice</name>
        <releasedate>2009-09-14</releasedate>
        <species>Mus musculus</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17869</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798656240</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798656242</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17869.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sridar Chittur</contact>
            <email>schittur@albany.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798655563</id>
            <text>These samples are part of the MMRRC study conducted at UAlbany Experiment Overall
                Design: Whole brains from C57BL/6 mice were compared to those from estrogen receptor
                knockout mice on the same background. Six samples (3 male and 3 female) from each
                strain (wild type B6, ERalphaKO, ERbetaKO) were compared in this study. These were
                processed on Affymetrix Mouse 430 plus 2.0 arrays to obtain expression data for each
                cell ine.</text>
        </description>
        <description>
            <id>1798656468</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Mus musculus], using 18 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 18 raw data files and 18 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="127">
        <id>1798656130</id>
        <accession>E-GEOD-9173</accession>
        <name>Transcription profiling of Xenopus embryos</name>
        <releasedate>2009-09-14</releasedate>
        <species>Xenopus laevis</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Xenopus laevis</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE9173</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>926019605</id>
            <accession>A-AFFY-62</accession>
            <name>Affymetrix GeneChip Xenopus laevis Genome Array [Xenopus_laevis]</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798656172</id>
            <name>Affymetrix:FeatureDimension:Xenopus_laevis</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>8</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798656173</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-9173.Xenopus_laevis.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19688031</accession>
            <authors>Andrea S Viczian, Eduardo C Solessio, Yung Lyou, Michael E Zuber</authors>
            <title>Generation of functional eyes from pluripotent cells.</title>
        </bibliography>
        <provider>
            <contact>Michael Zuber</contact>
            <email>zuberm@upstate.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798656138</id>
            <text>Xenopus laevis embryos were injected with mRNA for EFTFs at 2-cell stage. Animal
                caps collected at stage 9, cultured to the equivalent of stage 15 and RNA extracted.
                Four biological replicates of the EFTF-injected and GFP-injected (control) caps were
                used to profile transcript expression patterns using Affymetrix Xenopus Laevis
                GeneChip microarrays. Experiment Overall Design: Xenopus laevis embryos were
                injected with mRNA for EFTFs at 2-cell stage. Animal caps collected at stage 9,
                cultured to the equivalent of stage 15 and RNA extracted. Four biological replicates
                of the EFTF-injected and GFP-injected (control) caps were used to profile transcript
                expression patterns using Affymetrix Xenopus Laevis GeneChip microarrays.</text>
        </description>
        <description>
            <id>1798656174</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Xenopus laevis], using 8 arrays of array design [Affymetrix GeneChip
                Xenopus laevis Genome Array [Xenopus_laevis]], producing 8 raw data files and 8
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="128">
        <id>1798658787</id>
        <accession>E-TABM-787</accession>
        <name>Transcription profiling of pigmented and non-pigmented tubers of Solanum
            tuberosum</name>
        <releasedate>2009-09-14</releasedate>
        <species>Solanum tuberosum</species>
        <samples>2</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Solanum tuberosum</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>St clone CO97216-3P/PW</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>St clone CO97216-3P/PW purple</value>
            <value>St clone CO97216-3P/PW white</value>
        </experimentalfactor>
        <user>1561220012</user>
        <user>1798659389</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1798008119</id>
            <accession>A-MEXP-1117</accession>
            <name>POCI S tuberosum 44K v2</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798659274</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-787.A-MEXP-1117.1.FeatureDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>J Expt Bot</publication>
            <authors>Cecil Stushnoff, Laurence Ducreux, Rob Hancock, Pete Hedley, Gordon McDougall,
                Jenny Morris, Wayne Morris, Julie Sungurtas, Susan Verall, David Holm , Mark
                Taylor</authors>
            <title>Flavonol profiling and transcriptome analysis reveals new gene-metabolite
                correlations in tubers of Solanum tuberosum L.</title>
        </bibliography>
        <provider>
            <contact>Pete Hedley</contact>
            <email>pete.hedley@scri.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>dye swap</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798658793</id>
            <text>Transcriptional analysis of pigmented and non-pigmented potato tuber flesh using
                POCI 44k microarrays</text>
        </description>
        <description>
            <id>1798659378</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 2 samples of
                species [Solanum tuberosum], using 4 arrays of array design [POCI S tuberosum 44K
                v2], producing 4 raw data files and 0 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="129">
        <id>1798659231</id>
        <accession>E-TABM-788</accession>
        <name>Transcription profiling of pigmented and non-pigmented tubers of Solanum
            tuberosum</name>
        <releasedate>2009-09-14</releasedate>
        <species>Solanum tuberosum</species>
        <samples>4</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Solanum tuberosum</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>Purple Majesty</value>
            <value>Rio Grande Russett</value>
            <value>Russett Nugget</value>
            <value>St clone CO97216-3P/PW</value>
        </sampleattribute>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>Purple Majesty</value>
            <value>Rio Grande Russett</value>
            <value>Russett Nugget</value>
            <value>St clone CO97216-3P/PW</value>
        </experimentalfactor>
        <user>1561220012</user>
        <user>1798659402</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1798008119</id>
            <accession>A-MEXP-1117</accession>
            <name>POCI S tuberosum 44K v2</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798659379</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-788.A-MEXP-1117.1.FeatureDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>J Expt Bot</publication>
            <authors>Cecil Stushnoff, Laurence Ducreux, Rob Hancock, Pete Hedley, Gordon McDougall,
                Jenny Morris, Wayne Morris, Julie Sungurtas, Susan Verall, David Holm , Mark
                Taylor</authors>
            <title>Flavonol profiling and transcriptome analysis reveals new gene-metabolite
                correlations in tubers of Solanum tuberosum L.</title>
        </bibliography>
        <provider>
            <contact>Pete Hedley</contact>
            <email>pete.hedley@scri.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>dye swap</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798659239</id>
            <text>Transcriptional analysis of pigmented and non-pigmented potato tuber flesh using
                POCI 44k microarrays</text>
        </description>
        <description>
            <id>1798659386</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 4 samples of
                species [Solanum tuberosum], using 16 arrays of array design [POCI S tuberosum 44K
                v2], producing 16 raw data files and 0 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="130">
        <id>1798659347</id>
        <accession>E-MEXP-2349</accession>
        <name>Transcription profiling of Medicago truncatula responses to Colletotrichum
            species</name>
        <releasedate>2009-09-14</releasedate>
        <species>Medicago truncatula</species>
        <samples>36</samples>
        <assays>36</assays>
        <sampleattribute>
            <category>Age</category>
            <value>2 weeks</value>
        </sampleattribute>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>frozen_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>1dpi</value>
            <value>3dpi</value>
        </sampleattribute>
        <sampleattribute>
            <category>Genotype</category>
            <value>C. trifolii resistant line</value>
            <value>C. trifolii resistante line</value>
            <value>C. trifolii sensible line</value>
            <value>C. trifolli resistant line</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Medicago truncatula</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>leaf</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C. lindemuthianum</value>
            <value>C. trifolii</value>
            <value>noninoculated</value>
        </sampleattribute>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>1dpi</value>
            <value>3dpi</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Genotype</name>
            <value>C. trifolii resistant line</value>
            <value>C. trifolii resistante line</value>
            <value>C. trifolii sensible line</value>
            <value>C. trifolli resistant line</value>
            <value>Referenced Pool</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>StrainOrLine</name>
            <value>C. lindemuthianum</value>
            <value>C. trifolii</value>
            <value>noninoculated</value>
            <value>Referenced Pool</value>
        </experimentalfactor>
        <user>1719078069</user>
        <user>1798663316</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>391056805</id>
            <accession>A-MEXP-138</accession>
            <name>UNIBI-Mt16kOLI1Plus-Medicago truncatula-33k-Microarray</name>
            <count>36</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798659390</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2349.A-MEXP-138.1.FeatureDimension</name>
            <bioassaydatacubes>36</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>36</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798659399</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2349.A-MEXP-138.1.ReporterDimension</name>
            <bioassaydatacubes>36</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>36</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798659391</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-2349.A-MEXP-138.2.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography/>
        <provider>
            <contact>Bernard Dumas</contact>
            <email>dumas@scsv.ups-tlse.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>injury</experimentdesign>
        <experimentdesign>reference</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798659355</id>
            <text>We have previously showed a strong genetic determinant governing resistance of the
                M. truncatula A17 line to C. trifolii is located in a chromosomal region at the top
                of chromosome 4 (Ameline-torregrosa et al., 2008). This region also contains the
                RCT1 gene which has been shown to confer resistance to C. trifolii when transferred
                to a susceptible alfalfa plants (Zhu et al.), In order to evaluate the role of this
                region in the response to non-adapted Colletorichum species and to compare this
                response to those induce by C. trifolii, two M. truncatula near-isogenic lines
                differing only in this chromosomal region were used for transcript profiling
                experiments. These two lines were issued from a recombinant-inbred collection
                obtained from a A17-F83005.5 cross (Cazaux et al., in preparation). Plant
                inoculations were done on two-week-old entire plants by spraying a conidial
                suspension of C. trifolii or C. lindemuthianum to avoid possible artifacts which can
                be observed on detached leaves (Liu et al., 2007). RNA was extracted from leaves
                collected at 1dpi and 3dpi and transcript profiling was performed using
                Mt16kOLI1Plus chips (Thompson et al., 2005).</text>
        </description>
        <description>
            <id>1798659404</id>
            <text>(Generated description) Experiment with 36 hybridizations, using 36 samples of
                species [Medicago truncatula], using 36 arrays of array design
                [UNIBI-Mt16kOLI1Plus-Medicago truncatula-33k-Microarray], producing 36 raw data
                files and 37 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="131">
        <id>1798842014</id>
        <accession>E-MEXP-1434</accession>
        <name>Transcription profiling of human articular osteoarthritic chondrocytes after
            stimulation with IL-1beta and p38 MAPK inhibition with SB203580 or Birb 796</name>
        <releasedate>2009-09-14</releasedate>
        <species>Homo sapiens</species>
        <samples>13</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Age</category>
            <value>55 To 75 years</value>
            <value>58 To 77 years</value>
            <value>63 To 83 years</value>
        </sampleattribute>
        <sampleattribute>
            <category>DevelopmentalStage</category>
            <value>adult</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <sampleattribute>
            <category>OrganismPart</category>
            <value>cartilage</value>
        </sampleattribute>
        <sampleattribute>
            <category>Sex</category>
            <value>mixed_sex</value>
            <value>unknown_sex</value>
        </sampleattribute>
        <sampleattribute>
            <category>TargetedCellType</category>
            <value>chondrocyte</value>
        </sampleattribute>
        <experimentalfactor>
            <name>cell treatment</name>
            <value>10 ng/ml IL-1beta and 10 M Birb 796</value>
            <value>10 ng/ml IL-1beta, -- SB203580</value>
            <value>10 ng/ml IL-1beta, 10 M SB203580</value>
            <value>Control, -- IL-1beta, -- SB203580</value>
            <value>Reference</value>
        </experimentalfactor>
        <user>1352986007</user>
        <user>1798954256</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1352694151</id>
            <accession>A-MEXP-716</accession>
            <name>SBGB homo sapiens Operon Chip 21K v2.0</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1798869653</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-1434.A-MEXP-716.1.FeatureDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1798873291</id>
            <name>ebi.ac.uk:MAGETabulator:E-MEXP-1434.A-MEXP-716.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Joos Helga</contact>
            <email>helga.joos@uni-ulm.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>in vitro</experimentdesign>
        <experimentdesign>stimulated type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1798842041</id>
            <text>Effect of stimulation with IL-1beta and p38 MAPK inhibition with SB203580 or Birb
                796 on human articular osteoarthritic chondrocytes</text>
        </description>
        <description>
            <id>1798892880</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 13 samples of
                species [Homo sapiens], using 12 arrays of array design [SBGB homo sapiens Operon
                Chip 21K v2.0], producing 12 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="132">
        <id>1797833779</id>
        <accession>E-GEOD-11801</accession>
        <name>Re-sequencing of yeast to annotating low abundance and transient RNAs</name>
        <releasedate>2009-09-13</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE11801</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797669399</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-11801.VirtualArrayDesign</accession>
            <count>16</count>
        </arraydesign>
        <bibliography>
            <accession>19096707</accession>
            <authors>Albert Lee, Kasper Daniel Hansen, James Bullard, Sandrine Dudoit, Gavin
                Sherlock</authors>
            <title>Novel low abundance and transient RNAs in yeast revealed by tiling microarrays
                and ultra high-throughput sequencing are not conserved across closely related yeast
                species.</title>
        </bibliography>
        <provider>
            <contact>Gavin Sherlock</contact>
            <email>sherlock@genome.stanford.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797833786</id>
            <text>Annotating Low Abundance and Transient RNAs in Yeast using Tiling Microarrays and
                Ultra High-throughput Sequencing Reveals New Transcripts that are not Conserved
                Across Closely Related Yeast Species; A complete description of the transcriptome of
                an organism is crucial for a comprehensive understanding of how it functions, how
                its transcriptional networks are controlled, and may provide insights into the
                organism s evolution. Despite the status of Saccharomyces cerevisiae as arguably the
                most well studied model eukaryote, we still do not have a full catalog or
                understanding of all its genes. In order to interrogate the transcriptome of S.
                cerevisiae for low abundance or rapidly turned over transcripts, we deleted elements
                of the RNA degradation machinery with the goal of preferentially increasing the
                relative abundance of such transcripts. We then used high-resolution tiling
                microarrays and ultra high-throughput sequencing (UHTS) to identify, map and
                validate unannotated transcripts that are more abundant in the RNA degradation
                mutants relative to wild-type cells. We identified 365 currently unannotated
                transcripts, the majority presumably representing low abundance or short-lived RNAs,
                of which 185 are previously unknown and unique to this study. It is likely that many
                of these are cryptic unstable transcripts (CUTs), which are rapidly degraded and
                whose function(s) within the cell are still unclear, while others may be novel
                functional transcripts. Of the 185 transcripts we identified as novel to our study,
                greater than 80 percent come from regions of the genome that have lower conservation
                scores amongst closely related yeast species than 85 percent of the verified ORFs in
                S. cerevisiae. Such regions of the genome have typically been less well studied, and
                by definition transcripts from these regions will distinguish S. cerevisiae from
                these closely related species. Experiment Overall Design: Four samples, a wild-type
                reference and three mutants (1 containing 4 deletions and the other two containing 3
                each), were subjected to high salt shock, and total RNA was harvested. PolyA RNA was
                purified, and libraries were generated for the Solexa platform. Each library was run
                on 4 lanes of a Solexa flow cell.</text>
        </description>
        <description>
            <id>1797834293</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Saccharomyces cerevisiae], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-11801], producing 0 raw data files and 32 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="133">
        <id>1797718475</id>
        <accession>E-GEOD-14986</accession>
        <name>Transcription profiling of human MCF-7 cells treated with Fulvestrant (ICI 182,780)
            and vehicle reveals origins and phenotypic variations of antiestrogen resistance in
            breast cancer</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14986</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799390851</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799391041</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14986.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19706540</accession>
            <authors>Kathryn R Coser, Ben S Wittner, No l F Rosenthal, Sabrina C Collins, Antonia
                Melas, Shannon L Smith, Crystal J Mahoney, Keiko Shioda, Kurt J Isselbacher, Sridhar
                Ramaswamy, Toshi Shioda</authors>
            <title>Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived
                from a common monoclonal drug-resistant progenitor.</title>
        </bibliography>
        <provider>
            <contact>Ben Wittner</contact>
            <email>wittner.ben@mgh.harvard.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797718482</id>
            <text>Expression profiles of MCF-7 cells treated with Fulvestrant (ICI 182,780) and
                vehicle Experiment Overall Design: MCF7 cells were grown in DMEM supplemented with
                5% FCS (Hyclone, "Defined" grade). Growth medium was changed immediately before
                addition of 100 nM of ICI 182,780 or vehicle alone (0.1% ethanol) and cells
                incubated for 48h before they were harvested for profiling. Note that MCF7 cells
                show no signs of cell damage at this time point.</text>
        </description>
        <description>
            <id>1799391889</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="134">
        <id>1797719843</id>
        <accession>E-GEOD-1844</accession>
        <name>Transcription profiling of muscle sample biopsies on hyperCKemical subjects</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>3</samples>
        <assays>3</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE1844</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>3</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799390174</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>3</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799390248</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-1844.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Marco Crimi</contact>
            <email>Marco.Crimi@unimi.it</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797719850</id>
            <text>A cDNA microarray analysis of asymptomatic patients presenting moderately elevated
                serum Creatine Kinase levels</text>
        </description>
        <description>
            <id>1799390645</id>
            <text>(Generated description) Experiment with 3 hybridizations, using 3 samples of
                species [Homo sapiens], using 3 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 3 raw data files and 3 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="135">
        <id>1797719938</id>
        <accession>E-GEOD-13326</accession>
        <name>Transcription profiling of P. aeruginosa suspension cells of PA14 WT with and without
            NE (50 uM and 500 uM) for 7 h</name>
        <releasedate>2009-09-12</releasedate>
        <species>Pseudomonas aeruginosa UCBPP-PA14</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Pseudomonas aeruginosa UCBPP-PA14</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13326</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>260443237</id>
            <accession>A-AFFY-30</accession>
            <name>Affymetrix GeneChip P. aeruginosa Genome[Pae_G1a]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799388291</id>
            <name>Affymetrix:FeatureDimension:Pae_G1a</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799388316</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13326.Pae_G1a.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Manjunath Hegde</contact>
            <email>coolheggie@gmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797719948</id>
            <text>It has been proposed that the gastro-intestinal tract environment containing high
                levels of neuroendocrine hormones is important for gut-derived P. aeruginosa
                infections. In this study, we report that the hormone norepinephrine increases P.
                aeruginosa PA14 growth, virulence factor production, invasion of HCT-8 epithelial
                cells, and swimming motility in a concentration-dependent manner. Transcriptome
                analysis of P. aeruginosa exposed to 500 M, but not 50 M, norepinephrine for 7 h
                showed that genes involved in the regulation of the virulence determinants
                pyocyanin, elastase, and Pseudomonas quinolone signal (PQS,
                2-heptyl-3-hydroxy-4-quinolone) were up-regulated. The production of rhamnolipids,
                which are also important in P. aeruginosa infections, was significantly decreased on
                semi-solid surfaces, but not in planktonic cultures, upon exposure to
                norepinephrine. Swarming motility, a phenotype that is directly influenced by
                rhamnolipids, was also decreased upon 500 M norepinephrine exposure. The increase in
                the transcriptional activation of lasR, but not that of rhlR, suggest that the
                effects of norepinephrine are mediated primarily through the las quorum sensing
                pathway. Together, our data strongly suggests that norepinephrine can play an
                important role in gut-derived infections by increasing the pathogenicity of P.
                aeruginosa PA14. Experiment Overall Design: For growth rate measurements, a single
                colony of PA14 was grown overnight in Luria Bertini (LB) broth, and re-inoculated in
                serum-RPMI medium in the presence of 50 M and 500 M NE to an initial turbidity of ~
                0.05 at 600 nm. The turbidity of the cultures at 600 nm was monitored every hour and
                growth rate of the exponentially growing cultures was calculated. Growth curves were
                obtained in triplicate using three independent cultures, and the statistical
                significance of specific growth rate was determined using the unpaired Student s
                t-test. Total RNA isolation and microarray analysis PA14 was grown overnight in LB
                to turbidity at 600 nm of ~5.0 and diluted in 100 mL of serum-RPMI medium to an
                initial turbidity at 600 nm of 0.05. Different concentrations of NE (50 M or 500 M)
                were added and the cultures grown for 7 hours till late exponential phase (turbidity
                at 600 nm of ~0.5, 1.1 and 1.5 with 0 M, 50 M and 500 M NE, respectively). Cell
                pellets were prepared and RNA was isolated as described previously (Ren et al.
                2004a). The P. aeruginosa Genome Array (Affymetrix, P/N 510596) containing 5,500 of
                the 5,570 open reading frames of P. aeruginosa PA01, was used to analyze changes in
                the PA14 transcriptome. cDNA synthesis, fragmentation and hybridizations were as
                described previously (Gonzalez Barrios et al. 2006). Hybridization was performed for
                16 h at 50 C, and the total cell intensity was scaled to an average value of 500.
                The probe array images were inspected for any image artifact. Background values,
                noise values and scaling factors of all the arrays were examined and were
                comparable. The intensities of polyadenosine RNA control were used to monitor the
                labelling process. For each binary microarray comparison of differential genes
                expression, if the gene with the larger transcription rate did not have a consistent
                transcription rate based on the 13 probe pairs (P-value less than 0.05), these genes
                were discarded. A gene was considered differentially expressed when the P-value for
                comparing two chips was lower than 0.05 (to assure that the change in gene
                expression was statistically significant and that false positives arise less than
                5%), and the expression ratio (between cells treated with NE and control) was
                greater than 4.0 for the 50 M NE array and 2.0 for 500 M NE array (based on the
                standard deviation of fold-change values) (Ren et al. 2004b). Gene functions and
                locus tag numbers were obtained from the Pseudomonas Genome Database
                (http://www.pseudomonas.com/download.jsp).</text>
        </description>
        <description>
            <id>1799388643</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Pseudomonas aeruginosa UCBPP-PA14], using 4 arrays of array design
                [Affymetrix GeneChip P. aeruginosa Genome[Pae_G1a]], producing 4 raw data files and
                4 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="136">
        <id>1797720493</id>
        <accession>E-GEOD-10949</accession>
        <name>Transcription profiling of rat wild-type and (6) MRP2 deficient kidneys that had been
            transplanted in wild-type recipients reveals kidney-specific dysfunction of the organic
            anion transporter mrp2 (ABCC2): functional consequences for renal grafts</name>
        <releasedate>2009-09-12</releasedate>
        <species>Rattus norvegicus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE10949</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799391809</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799391967</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-10949.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sabine Ameling</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797720508</id>
            <text>Transplanting renal allografts represents the major curative treatment of chronic
                renal failure. Despite recent advances in immunosuppressive therapy, long-term
                survival of allografts remains a major clinical problem. Kidney function depends in
                part on transport proteins such as MRP2 (ABCC2) which facilitates renal secretion of
                amphiphilic exogenous and endogenous compounds. Inherited variants of genes not
                related to the immune system have been shown to modify the outcome after renal
                transplantation. We investigated whether ABCC2 gene variants in the donor kidney
                affect renal graft function. A congenic rat model was established carrying a single
                nucleotide deletion in the ABCC2 gene. Renal cross transplantations were performed
                with wild type rats. Renal excretion of the MRP2 substrates bilirubin glucuronide
                and p-aminohippuric acid, but not morphine-6-glucuronide, was affected by the donor
                genotype. Moreover, proteomic analyses and transcriptional profiling revealed
                modified expression patterns indicative of increased oxidative stress in renal
                grafts carrying the mutated gene. In the clinical part our study, we assessed ABCC2
                haplotypes in renal transplant patients and evaluated graft function. The
                3563T&gt;A gene polymorphism was significantly associated with delayed graft
                function. Together, both experimental and clinical data show that the ABCC2 genotype
                of the donor kidney affects renal graft function. Experiment Overall Design:
                Performed analyses of (6) wild-type and (6) MRP2 deficient kidneys that had been
                transplanted in wild-type recipients.</text>
        </description>
        <description>
            <id>1799392964</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Rattus norvegicus], using 12 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 12 raw data files and 12 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="137">
        <id>1797722533</id>
        <accession>E-GEOD-17824</accession>
        <name>Transcription profiling of Arabidopsis suspension cells after inhibition of cellulose
            synthesis by TA and IXB</name>
        <releasedate>2009-09-12</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17824</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799392547</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799392766</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17824.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19198845</accession>
            <authors>Isabelle Duval, Nathalie Beaudoin</authors>
            <title>Transcriptional profiling in response to inhibition of cellulose synthesis by
                thaxtomin A and isoxaben in Arabidopsis thaliana suspension cells.</title>
        </bibliography>
        <provider>
            <contact>Nathalie Beaudoin</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797722544</id>
            <text>Transcriptional profiling after inhibition of cellulose synthesis by thaxtomin A
                and isoxaben in Arabidopsis thaliana suspension cells; Perturbations in the
                cellulose content of the plant cell wall lead to global modifications in cellular
                homeostasis, as seen in cellulose synthase mutants or after inhibiting cellulose
                synthesis. In particular, application of inhibitors of cellulose synthesis such as
                thaxtomin A (TA) and isoxaben (IXB) initiates a programmed cell death (PCD) in
                Arabidopsis thaliana suspension cells that is dependent on de novo gene
                transcription. To further understand how TA and IXB activate PCD, a whole genome
                microarray analysis was performed on mRNA isolated from Arabidopsis suspension cells
                exposed to TA and IXB. More than 75% of the genes upregulated by TA were also
                upregulated by IXB, including genes encoding cell wall-related and calcium-binding
                proteins, defence/stress-related transcription factors, signalling components and
                cell death-related proteins. Comparisons with published transcriptional analyses
                revealed an important subset of genes generally induced in response to various
                biotic and abiotic stress. Experiment Overall Design: TA, IXB and methanol (control)
                were added to Arabidopsis thaliana suspension cells three days after sub-culture.
                Cells were harvested for RNA isolation and frozen in liquid nitrogen after 6 hours
                of contact with the inhibitors. Samples consisted of four replicates for each
                condition. A total of 12 Affymetrix GeneChips were used in this study, which
                correspond to 12 RNA samples from the four biological replicates for each of the TA,
                IXB or methanol addition.</text>
        </description>
        <description>
            <id>1799394670</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Arabidopsis thaliana], using 16 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 16 raw data files and 16 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="138">
        <id>1797722785</id>
        <accession>E-GEOD-14340</accession>
        <name>Transcription profiling of human neural crest cells</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>5</samples>
        <assays>5</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14340</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>5</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797735251</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>5</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797735823</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14340.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>5</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19666486</accession>
            <authors>Lo c de Pontual, Norann A Zaghloul, Sophie Thomas, Erica E Davis, David M
                McGaughey, H l ne Dollfus, Clarisse Baumann, Seneca L Bessling, Candice Babarit,
                Anna Pelet, Cecilia Gascue, Philip Beales, Arnold Munnich, Stanislas Lyonnet,
                Heather Etchevers, Tania Attie-Bitach, Jose L Badano, Andrew S McCallion, Nicholas
                Katsanis, Jeanne Amiel</authors>
            <title>Epistasis between RET and BBS mutations modulates enteric innervation and causes
                syndromic Hirschsprung disease.</title>
        </bibliography>
        <provider>
            <contact>Heather Etchevers</contact>
            <email>heather.etchevers@inserm.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797722792</id>
            <text>The expression profiles of five human trunk level neural crest cell lines were
                determined on Affymetrix chips HG U133 Plus 2.0. Experiment Overall Design: Total
                RNA was extracted from a confluent 10 cm dish of hNCC (lines N1-N5) from five human
                embryos at 26-32 dpf (Carnegie stages 12 &amp; 13).</text>
        </description>
        <description>
            <id>1797746947</id>
            <text>(Generated description) Experiment with 5 hybridizations, using 5 samples of
                species [Homo sapiens], using 5 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 5 raw data files and 5 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="139">
        <id>1797723166</id>
        <accession>E-GEOD-12840</accession>
        <name>Re-sequencing of Drosophila melanogaster late embryo, larval, pupal and adult head
            small RNA libraries</name>
        <releasedate>2009-09-12</releasedate>
        <species>Drosophila melanogaster</species>
        <samples>11</samples>
        <assays>11</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Drosophila melanogaster</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12840</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797668908</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12840.VirtualArrayDesign</accession>
            <count>11</count>
        </arraydesign>
        <provider>
            <contact>Nicolas Robine</contact>
            <email>robinen@mskcc.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797723173</id>
            <text>High-throughput sequencing of Drosophila melanogaster small RNAs. Total RNA,
                ~18-26nt RNAs isolated using PAGE, ligation to adapters requires 5' monophosphate
                and 3' OH; For data usage terms and conditions, please refer to
                http://www.genome.gov/27528022 and
                http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf
                Experiment Overall Design: Small RNAs were sequenced from D. melanogaster (Canton S)
                wandering late embryos, first instar larvae, third instar larvae or from 2-4 day old
                pupae and adult female heads or male heads. Raw sequences were clipped by 3' linker
                sequences recognition, and select clipped sequences longer than 18 nt.</text>
        </description>
        <description>
            <id>1799390582</id>
            <text>(Generated description) Experiment with 11 hybridizations, using 11 samples of
                species [Drosophila melanogaster], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-12840], producing 0 raw data files and 17 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="140">
        <id>1797725661</id>
        <accession>E-GEOD-12587</accession>
        <name>Transcription profiling of human peripheral lymphocytes after exposure to cigarette
            smoke - super series</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>39</samples>
        <assays>39</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12587</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>39</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799394389</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>39</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>39</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799393896</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12587.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>23</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>23</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799393860</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12587.HG-U133A.2.CompositeSequenceDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jinguo Chen</contact>
            <email>jinguochen@yahoo.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797725670</id>
            <text>This SuperSeries is composed of the following subset Series:; GSE12585: Expression
                data from healthy smokers; GSE12586: Alterations of gene expression in human
                peripheral lymphocytes after exposure to cigarette smoke condensate in vitro
                Experiment Overall Design: Refer to individual Series</text>
        </description>
        <description>
            <id>1799401327</id>
            <text>(Generated description) Experiment with 39 hybridizations, using 39 samples of
                species [Homo sapiens], using 39 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 39 raw data files and 39 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="141">
        <id>1797726029</id>
        <accession>E-GEOD-11686</accession>
        <name>Transcription profiling of human wrist muscles from cerebral palsy patients</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE11686</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804920525</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>16</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920583</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-11686.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>16</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>16</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19602279</accession>
            <authors>Lucas R Smith, Eva Pont n, Yvette Hedstr m, Samuel R Ward, Henry G Chambers,
                Shankar Subramaniam, Richard L Lieber</authors>
            <title>Novel transcriptional profile in wrist muscles from cerebral palsy
                patients.</title>
        </bibliography>
        <provider>
            <contact>Lucas Robert Smith</contact>
            <email>lrs001@ucsd.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797726040</id>
            <text>Cerebral palsy is caused be an upper motor neuron lesion which casues spasticity
                as well as secondary effects on muscle . Muscle from cerebral palsy patients is has
                been shown to be smaller, with more ECM and longer sarcomere lengths; We used
                microarrays to globally investigate the transcriptional adaptations of cerebral
                palsy muscle and research which muscle pathways are altered in the diseased state
                Experiment Overall Design: Muscle biopsies were taken from children undergoing
                surgery which exposed wrist muscle extensors (n=8) and flexors (n=8) in both
                cerebral palsy patients (n=6) and control patients (n=2) for RNA extraction and
                hybridization to Affymetrix GeneChips . Cerebral palsy patients were classified by a
                number of clinical scores.</text>
        </description>
        <description>
            <id>1799393629</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Homo sapiens], using 16 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 16 raw data files and 16 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1804920897</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Homo sapiens], using 16 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 16 raw data files and 16 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="142">
        <id>1797727581</id>
        <accession>E-GEOD-17795</accession>
        <name>Transcription profiling of mpuse normal and SMAR1 overexpressing B16F10 cells</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>2</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17795</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>373023407</id>
            <accession>A-AGIL-8</accession>
            <name>Agilent Mouse Microarray 011978 G4121A</name>
            <count>1</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799392566</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17795.A-AGIL-8.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AGIL</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>samit chattopadhyay</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797727588</id>
            <text>The present microarray studies the differential transcription levels of various
                genes upon overexpression of tumor suppressor protein SMAR1. The results will lead
                us to potential targets which are either up/downregulated by SMAR1. Experiment
                Overall Design: Agilent two-color experiment,Organism: Human ,Slides, Agilent s
                Human Microarray G4110B with 22000 features, Labeling kit: Agilents Low input RNA
                linear amplification Kit Cat # 5184-3523, Labeling Method: T7 promoter based-linear
                amplification to generate labeled complementary RNA</text>
        </description>
        <description>
            <id>1797734856</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 2 samples of
                species [Mus musculus], using 1 arrays of array design [Agilent Mouse Microarray
                011978 G4121A], producing 0 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1799392711</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 2 samples of
                species [Mus musculus], using 1 arrays of array design [Agilent Mouse Microarray
                011978 G4121A], producing 0 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="143">
        <id>1797729961</id>
        <accession>E-GEOD-12599</accession>
        <name>Transcription profiling of mouse glomerulus in lipopolysaccharide-induced proteinuria
            model</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>10</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12599</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393447</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799393592</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12599.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>ying sun</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797729977</id>
            <text>The pathogenic mechanisms of common kidney glomerular diseases, including the vast
                majority of cases of proteinuria, remain unknown. To gain insight into the
                pathogenesis of proteinuria development, we characterized the glomerular gene
                expression changes that accompany early stages of proteinuria induced by
                lipopolysaccharide (LPS) in mice. Experiment Overall Design: Nine-week-old female
                C57Bl6 mice were allocated to LPS-treated group (n=6) or PBS control group (n=4),
                and subsequently treated either by a single intraperitoneal injection LPS or control
                buffer.</text>
        </description>
        <description>
            <id>1799394807</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 10 samples of
                species [Mus musculus], using 10 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 10 raw data files and 10 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="144">
        <id>1797731995</id>
        <accession>E-GEOD-5845</accession>
        <name>Transcription profiling of human bladder cancer 40 cell lines</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>40</samples>
        <assays>40</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE5845</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>40</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393998</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-5845.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>40</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jae Lee</contact>
            <email>jaeklee@virginia.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797732003</id>
            <text>40 bladder cancer cell lines were profiled with their genome-wide gene expression
                patterns using Affymetrix HG-U133A chips. Experiment Overall Design: Total RNA
                sample of each of the 40 cell lines was obtained before the treatment of any
                anticancer compound.</text>
        </description>
        <description>
            <id>1799400282</id>
            <text>(Generated description) Experiment with 40 hybridizations, using 40 samples of
                species [Homo sapiens], using 40 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 0 raw data files and 40 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="145">
        <id>1797732794</id>
        <accession>E-GEOD-13071</accession>
        <name>Transcription profiling of mouse knee joint synovium from different grades of
            inflammation in mouse collagen induced arthritis (CIA)</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>15</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13071</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799392774</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>15</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799392995</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13071.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19690516</accession>
            <authors>Joosten Geurts, Arntz Takahashi, Bennink Gl ck, van de Loo van den
                Berg</authors>
            <title>Computational Design and Application of Endogenous Promoters for
                Transcriptionally Targeted Gene Therapy for Rheumatoid Arthritis.</title>
        </bibliography>
        <provider>
            <contact>Anton Gl ck</contact>
            <email>anton.glueck@novartis.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797732803</id>
            <text>Knee joint synovium was used for gene expression analysis of mouse collagen
                induced arthritis (CIA). Synovium was prepared at day 30 after initial sensitization
                from: healthy controls, CIA animals with no, with mild, with moderate, or with
                severe joint inflammation. Each sample group is represented by three replicates,
                each consisting of tissue collected from three to four animals. Experiment Overall
                Design: The data set consists of 15 samples: five groups with three replicates each.
                One sample group is from healthy controls, the other groups are from CIA animals
                with different degress of joint inflammation.</text>
        </description>
        <description>
            <id>1799394809</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 15 samples of
                species [Mus musculus], using 15 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 15 raw data files and 15 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="146">
        <id>1797732804</id>
        <accession>E-GEOD-17777</accession>
        <name>Transcription profiling of human HMVEC cells treated with vascular endothelial growth
            factor, anthrax edema toxin, and an Epac activator</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17777</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797751556</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17777.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>17491018</accession>
            <authors>Jia Hong, Robert C Doebele, Mark W Lingen, Lawrence A Quilliam, Wei-Jen Tang,
                Marsha Rich Rosner</authors>
            <title>Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and
                Rap1.</title>
        </bibliography>
        <provider>
            <contact>Robert Doebele</contact>
            <email>robert.doebele@ucdenver.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797754028</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1797732910</id>
            <text>Human microvascular endothelial cells (HMVEC) treated with vascular endothelial
                growth factor (VEGF), Antrhax Edema Toxin (ET), or the Epac activator,
                8-pCPT-2'-O-Me-cAMP (8CPT); Human microvascular endothelial cells (HMVEC) were
                treated with VEGF alone or VEGF in combination with either the the Epac-specific
                cAMP-mimetic, 8-pCPT-2'-O-Me-cAMP (8CPT), or anthrax edema toxin (ET), an adenylyl
                cyclase. ET or 8CPT can inhibit VEGF-mediated chemotaxis and angiogenesis. The goal
                of the study was to identify genes regulated by cAMP production (ET) or by
                activation of Epac/Rap (8CPT) that may mitigate the effects of VEGF treatment.
                Experiment Overall Design: Gene expression was measured 4 hours after treatment with
                VEGF, VEGF + 8CPT, VEGF + ET or mock treatment. Each sample contained one
                replicate.</text>
        </description>
    </experiment>
    <experiment textidx="147">
        <id>1797733273</id>
        <accession>E-GEOD-5266</accession>
        <name>Transcription profiling of normal atria and ventricles</name>
        <releasedate>2009-09-12</releasedate>
        <species>Rattus norvegicus</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE5266</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393472</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-5266.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19486520</accession>
            <authors>Monica Forero McGrath, Adolfo J de Bold</authors>
            <title>Transcriptional analysis of the mammalian heart with special reference to its
                endocrine function.</title>
        </bibliography>
        <provider>
            <contact>Adolfo de Bold</contact>
            <email>adebold@ottawaheart.ca</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797733280</id>
            <text>Pharmacological and gene ablation studies have demonstrated a crucial role of the
                cardiac natriuretic peptides (NP) hormones ANF and BNP in the maintenance of
                cardiovascular homeostasis. In addition, hypertension and chronic congestive heart
                failure are clinical entities that may be regarded as states of relative NP
                deficiency. Hence the study of the function of the endocrine heart is highly
                relevant. To identify genes that are related to the endocrine function of the heart
                we have conducted differential gene expression studies of the rat atria and
                ventricles using oligonucleotide arrays. Experiment Overall Design: The atrial
                appendages and the ventricular free walls were obtained from thirteen normal male
                Sprague Dawley rats. The total RNA was obtained from four pools of atrial and four
                pools of ventricular tissues. Four biological replicates for each muscle type were
                generated, i.e. 4 atrial replicates and 4 ventricular replicates.</text>
        </description>
        <description>
            <id>1799394328</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Rattus norvegicus], using 8 arrays of array design [Affymetrix GeneChip Rat
                Genome 230 2.0 [Rat230_2]], producing 0 raw data files and 8 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="148">
        <id>1797733632</id>
        <accession>E-GEOD-12548</accession>
        <name>Transcrription profiling of human retinal pigment epithelium (RPE) cell line (ARPE-19)
            in response to combination treatment of TGF and TNF</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>20</samples>
        <assays>20</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12548</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>20</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393989</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>20</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799394429</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12548.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>20</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>20</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Rui Ose</contact>
            <email>ruiose@kazusa.or.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797733639</id>
            <text>The purpose of this study is to determine the changes in gene expression by a
                human retinal pigment epithelium (RPE) cell line (ARPE-19) in response to
                combination treatment of TGF and TNF, which induces phenotypic changes in vitro that
                mimic the EMT (Epithelial-to-Mesenchymal Transition). For this purpose, total RNA
                was extracted from TGF and TNF-treated ARPE-19 cells and differential gene
                expression between each time point (0, 1, 6, 16, 24, 42, and 60 hours) was
                determined using genechip arrays (Affymetrix, Human Genome U133). Experiment Overall
                Design: ARPE19 cell lines treated with TGF and TNF for 0, 1, 6, 16, 24, 42, and 60
                hour. Each experiment were repeated three times. But 1 hour experiment was repeated
                two times.</text>
        </description>
        <description>
            <id>1799397511</id>
            <text>(Generated description) Experiment with 20 hybridizations, using 20 samples of
                species [Homo sapiens], using 20 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 20 raw data files and 20
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="149">
        <id>1797737936</id>
        <accession>E-GEOD-17782</accession>
        <name>Transcription profiling of human mesenchymal stem cells with and without TGF-B vs
            human annulus disc cells</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>13</samples>
        <assays>13</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17782</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>978204239</id>
            <accession>A-AFFY-54</accession>
            <name>Affymetrix GeneChip Human X3P Array [U133_X3P]</name>
            <count>13</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799392981</id>
            <name>Affymetrix:FeatureDimension:U133_X3P</name>
            <bioassaydatacubes>13</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>13</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799393150</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17782.U133_X3P.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>13</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>13</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Helen Gruber</contact>
            <email>Helen.Gruber@carolinashealthcare.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797737950</id>
            <text>Autologous stem cell therapy has potential for biologic treatment of disc
                degeneration. Due to ease of harvest and abundance, adipose-derived mesenchymal stem
                cells (AD-MSC) are readily available. Our objectives were: 1) To develop/validate
                methods to harvest AD-MSC and direct them to a disc-like phenotype by
                three-dimensional (3D) culture and TGF- 3 exposure; 2) To perform gene expression
                profiling for human AD-MSC and annulus cells in 3D culture; 3) To test whether disc
                cell-AD-MSC co-culture could augment proteoglycan production. Stem cell plasticity
                offers potential for future biologic therapies for disc degeneration. Data indicated
                that human AD-MSC can successfully be manipulated in 3D culture to express gene
                products important in the disc ECM (types I and II collagen, chondroitin sulfate,
                keratin sulfate, decorin), and that co-culture of annulus cells with AD-MSC enhances
                proteoglycan production. Studies defined gene expression patterns of AD-MSC and
                human annulus cells in 3D culture, important as we explore the potential of MSC in
                biologic therapies for disc degeneration. Experiment Overall Design: AD-MSC were
                extracted from human adipose tissue, and characterized as stem cells using accepted
                criteria (direction into osteoblasts or chondrocytes; and cell surface marker
                criteria). Three AD-MSC cultures were grown in 3D with or without TGF- 3 for 2-3
                weeks. Disc Tissue samples were obtained from surgical disc procedures performed on
                patients with herniated discs and degenerative disc disease. Seven disc cultures
                were also grown in 3-D for 2 weeks. RNA was harvested according to instructions with
                the Trizol isolation method, checked for quality using the 2100 Bioanalyzer (Agilent
                Technologies, Inc., Santa Clara, CA USA), reverse-transcribed to double-stranded
                cDNA, subjected to two rounds of transcription, and hybridized to the DNA microarray
                in the Affymetrix Fluidics Station 400. Affymetrix human U133 X3P arrays were used.
                Using Genesifter, gene expression in AD-MSC with and witout TGF-B3 was compared to
                annulus cells. Gene expression of stem cells with TGF- 3 was also compared to stem
                cells grown in the absence of TGF- 3.</text>
        </description>
        <description>
            <id>1799394603</id>
            <text>(Generated description) Experiment with 13 hybridizations, using 13 samples of
                species [Homo sapiens], using 13 arrays of array design [Affymetrix GeneChip Human
                X3P Array [U133_X3P]], producing 13 raw data files and 13 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="150">
        <id>1797740495</id>
        <accession>E-GEOD-12806</accession>
        <name>Transcription profiling of human Dendritic cells reveals inhibition of Chlamydia
            pneumoniae replication by TNF-alpha-Induced Indoleamine 2,3-Dioxygenase</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12806</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395247</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12806.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19643200</accession>
            <authors>Geffers Njau, Haller Thalmann, Wagner</authors>
            <title>Restriction of Chlamydia pneumoniae replication in human dendritic cell by
                activation of indoleamine 2,3-dioxygenase.</title>
        </bibliography>
        <provider>
            <contact>Robert Geffers</contact>
            <email>robert.geffers@helmholtz-hzi.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797740509</id>
            <text>Infection with Chlamydia pneumoniae, a human respiratory pathogen, has been
                associated with various chronic diseases such as asthma, coronary heart disease and
                importantly atherosclerosis. Possibly because the pathogen can exist in a persistent
                form. TNF-a has been reported to induce chlamydial persitence in epithelial cell
                lines, however the mechanism of TNF-a-induced persistence has not been reported.
                Moreover, C. pneumoniae persistently infect human dendritic cells (DCs) and activate
                DCs to produce cytokines including TNF-a. Induction of chlamydial persistence by
                other cytokines such as IFN-g is known to be due to indoleamine 2,3-dioxygenase
                (IDO) activity. The present study therefore, investigated whether C. pneumoniae
                infection can induce IDO activity in dendritic cells, and whether the restriction of
                chlamydial growth in the DCs by TNF-a is IDO-dependent. Our data indicate that
                infection of DCs with C. pneumoniae resulted in the induction of IDO expression.
                Reporting on our use of anti-TNF-a antibody adalimumab and varying concentrations of
                TNF-a, we further demonstrate that IDO induction following infection of DCs with C.
                pneumoniae is TNF-a-dependent. The anti-chlamydial activity induced by TNF-a and the
                expression of chlamydial 16S rRNA gene, euo, groEL1, ftsk and tal genes was
                correlated with the induction of IDO. Addition of excess amounts of tryptophan to
                the DC cultures resulted in abrogation of the TNF-a-mediated chlamydial growth
                restriction. These findings suggest that infection of DCs by C. pneumoniae induces
                production of functional IDO, which subsequently causes depletion of tryptophan.
                This may represent a potential mechanism for DCs to restrict bacterial growth in
                chlamydial infections. Experiment Overall Design: Human monocyte-derived DCs from
                five heathy donors were infected with C. pneumoniae at multiplicity of infection of
                5 for 72 h. Mock-infected (uninfected) DCs were used as a control for the infection.
                Total RNA from 72 h chlamydiae-infected or mock-infected DCs was isolated with
                RNeasy Mini Kit (Qiagen, Hilden, Germany) and DNA contamination was removed with RQ1
                DNase (Promega). Total RNA from all donors was pooled and the samples were processed
                and analyzed at the array facility of Helmholtz center for infection biology,
                Braunschweig. The integrity of the RNA was verified on the Agilent Bioanalyzer
                system. We used the Affymetrix Gene Chip Human Genome U133 2.0 Plus. Data were
                processed using Affymetrix software and signal intensity measured was normalized by
                the Affymetrix MAS5 algorithm. Data were filtered to exclude genes at background
                levels (non-expressors, signal intensity at 100).</text>
        </description>
        <description>
            <id>1799395848</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="151">
        <id>1797740903</id>
        <accession>E-GEOD-17385</accession>
        <name>Transcription profiling of human multiple myeloma cells ( MM1.S) cells with control or
            beta-catenin knockdown.</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17385</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393948</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799394215</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17385.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Daniel Ruben Carrasco</contact>
            <email>ruben_carrasco@dfci.harvard.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797740912</id>
            <text>MM1.S cells stably transduced with control or b-catenin shRNA were established.
                Total RNA was isolated from 5x 10^6 cells of each in triplicate. Experiment Overall
                Design: Comparative gene expression profiling in multiple myeloma.</text>
        </description>
        <description>
            <id>1799395225</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="152">
        <id>1797744718</id>
        <accession>E-GEOD-5846</accession>
        <name>Transcription profiling of human NCI-60 Cancer Cell Line</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>60</samples>
        <assays>60</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE5846</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>60</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799394235</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-5846.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>60</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>60</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jae Lee</contact>
            <email>jaeklee@virginia.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797744733</id>
            <text>NCI-60 cancer cell lines were profiled with their genome-wide gene expression
                patterns using Affymetrix HG-U133A chips. Experiment Overall Design: Total RNA
                sample of each of the NCI-60 cell lines was obtained before the treatment of any
                anticancer compound.</text>
        </description>
        <description>
            <id>1799404202</id>
            <text>(Generated description) Experiment with 60 hybridizations, using 60 samples of
                species [Homo sapiens], using 60 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 0 raw data files and 60 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="153">
        <id>1797745542</id>
        <accession>E-GEOD-15236</accession>
        <name>Transcription profiling of Arabidopsis Mediator complex mutant pft1/med25 and wildtype
            infected with Fusarium oxysporum</name>
        <releasedate>2009-09-12</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>16</samples>
        <assays>16</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15236</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>16</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395763</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19671879</accession>
            <authors>Edgar Kidd, Aitken Kumar, Manners Schenk, Kazan</authors>
            <title>The Mediator Complex Subunit PFT1 Is a Key Regulator of Jasmonate-Dependent
                Defense in Arabidopsis.</title>
        </bibliography>
        <provider>
            <contact>Brendan Kidd</contact>
            <email>brendan.kidd@csiro.au</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797745556</id>
            <text>The Mediator complex is an evolutionary conserved multiprotein complex that plays
                an essential role in initiating and regulating transcription. Its function is to act
                as a universal adaptor between RNA Polymerase II and DNA-bound transcription factors
                to translate regulatory information from activators and repressors to the
                transcriptional machinery. We have found that the PFT1 gene (which encodes the MED25
                subunit of the Mediator complex) is required for the uncompromised expression of
                both salicylic acid- and jasmonate-dependent defense genes as well as resistance to
                the leaf-infecting fungal pathogens, Alternaria brassicicola and Botrytis cinerea in
                Arabidopsis. Surprisingly, we found that the pft1/med25 mutant showed increased
                resistance to the root infecting pathogen Fusarium oxysporum and that this
                resistance was independent of classical defense genes. In addition, the
                over-expression of PFT1 led to increased susceptibility to F. oxysporum. Therefore,
                to explore this phenomenon further, we wished to use whole genome transcript
                profiling to identify which genes may be playing a role in pft1/med25-mediated
                resistance to F. oxysporum. Experiment Overall Design: We grew both WT and
                pft1/med25 plants for four weeks in soil. After four weeks we treated the plants by
                root-dipping in either water or a F. oxysporum spore suspension before replanting
                them back into soil. There were four independent replicates of each treatment and
                each replicate contained 20 plants each. The treatments were WT (mock): pft1 (mock):
                WT (infected): pft1 (infected). Each replicate (16 in total) was harvested after 48
                hours and the resulting RNA was used for hybridization to an Affymetrix ATH1
                chip.</text>
        </description>
        <description>
            <id>1797762289</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Arabidopsis thaliana], using 16 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 16 raw data files and 16 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1799398225</id>
            <text>(Generated description) Experiment with 16 hybridizations, using 16 samples of
                species [Arabidopsis thaliana], using 16 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 16 raw data files and 16 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="154">
        <id>1797748379</id>
        <accession>E-GEOD-12251</accession>
        <name>Transcription profiling of human ulcerative colitis samples reveals a predictive
            response signature to infliximab treatment in ulcerative colitis</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>23</samples>
        <assays>23</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12251</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>23</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804920472</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>23</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>23</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920549</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12251.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>23</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>23</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19700435</accession>
            <authors>Li Arijs, Quintens Toedter, Van Steen Van Lommel, De Hertogh Leemans, Ferrante
                Lemaire, Thorrez Schnitzler, Song Ma, Van Assche Marano, Geboes Vermeire, Baribaud
                Schuit, Rutgeerts</authors>
            <title>Mucosal gene signatures to predict response to infliximab in patients with
                ulcerative colitis.</title>
        </bibliography>
        <provider>
            <contact>K Li</contact>
            <email>kli@cntus.jnj.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1797748710</id>
            <text>Infliximab, an anti-TNFa monoclonal antibody, is an effective treatment for
                ulcerative colitis (UC) inducing over 60% of patients to respond to treatment.
                Consequently, about 40% of patients do not respond. This study analyzed mucosal gene
                expression from patients enrolled in ACT1 to provide a predictive response signature
                for infliximab treatment. Experiment Overall Design: Twenty-two patients underwent
                colonoscopy with biopsy before infliximab treatment. Response to infliximab was
                defined as endoscopic and histologic healing at week 8 (P2, 5, 9, 10, 14, 15, 16,
                17, 24, 27, 36, and 45 as responders; P3, 12, 13, 19, 28, 29, 32, 33, 34, and 47 as
                non-responders). Messenger RNA was isolated from pre-infliximab biopsies, labeled
                and hybridized to Affymetrix HGU133Plus_2.0 Array. The predictive response signature
                was verified by an independent data set.</text>
        </description>
        <description>
            <id>1804920984</id>
            <text>(Generated description) Experiment with 23 hybridizations, using 23 samples of
                species [Homo sapiens], using 23 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 23 raw data files and 23
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="155">
        <id>1797748692</id>
        <accession>E-GEOD-14810</accession>
        <name>Transcription profiling of mouse C3H/10T1/2 and 3T3 L1 adipocytes</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>71</samples>
        <assays>71</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14810</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>447429329</id>
            <accession>A-AFFY-36</accession>
            <name>Affymetrix GeneChip Mouse Genome 430A 2.0 [Mouse430A_2]</name>
            <count>71</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395022</id>
            <name>Affymetrix:FeatureDimension:MOE430A</name>
            <bioassaydatacubes>71</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>71</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799396627</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14810.Mouse430A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>71</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>71</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>James Rong</contact>
            <email>james.x.rong@gsk.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797749067</id>
            <text>Growing evidence indicates that PPAR agonists, such as rosiglitazone (RSG,),
                induce adipose mitochondrial biogenesis. Using microarrays, we systematically
                analyzed nucleus-encoded mitochondrial gene expression in two common murine
                adipocyte models, 3T3 L1 and C3H/10T1/2 adipocytes, and aimed to further establish
                the direct role of RSG, and capture the temporal changes in mitochondrial gene
                transcription during this process. Experiment Overall Design: Fully differentiated
                3T3 L1 and C3H/10T1/2 adipocytes were treated with RSG, or DMSO vehicle for 1, 2, 4,
                7, 24, and 48 hrs, and total RNA was extracted for microarray analysis.</text>
        </description>
        <description>
            <id>1799405598</id>
            <text>(Generated description) Experiment with 71 hybridizations, using 71 samples of
                species [Mus musculus], using 71 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430A 2.0 [Mouse430A_2]], producing 71 raw data files and 71 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="156">
        <id>1797750545</id>
        <accession>E-GEOD-17215</accession>
        <name>Transcription profiling of human HMLER breast cancer cells treated with paclitaxel and
            salinomycin-treated HMLER breast cancer cells</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17215</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1601694385</id>
            <accession>A-AFFY-113</accession>
            <name>Affymetrix GeneChip HT Human Genome U133A HT_HG-U133A </name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799393754</id>
            <name>Affymetrix:FeatureDimension:HT_HG-U133A</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799393875</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17215.HT_HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19682730</accession>
            <authors>Piyush B Gupta, Tamer T Onder, Guozhi Jiang, Kai Tao, Charlotte Kuperwasser,
                Robert A Weinberg, Eric S Lander</authors>
            <title>Identification of selective inhibitors of cancer stem cells by high-throughput
                screening.</title>
        </bibliography>
        <provider>
            <contact>Piyush Gupta</contact>
            <email>piyush@broadinstitute.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797750570</id>
            <text>Screens for agents that specifically kill epithelial cancer stem cells (CSCs) have
                not been possible due to the rarity of these cells within tumor cell populations and
                their relative instability in culture. We describe here an approach to screening for
                agents with epithelial CSC-specific toxicity. We implemented this method in a
                chemical screen and discovered compounds showing selective toxicity for breast CSCs.
                One compound, salinomycin, reduces the proportion of CSCs by &gt;100-fold
                relative to paclitaxel, a commonly used breast cancer chemotherapeutic drug.
                Treatment of mice with salinomycin inhibits mammary tumor growth in vivo and induces
                increased epithelial differentiation of tumor cells. In addition, global gene
                expression analyses show that salinomycin treatment results in the loss of
                expression of breast CSC genes previously identified by analyses of breast tissues
                isolated directly from patients. This study demonstrates the ability to identify
                agents with specific toxicity for epithelial CSCs Experiment Overall Design:
                Experimentally transformed HMLER breast cancer cells were treated in culture with
                either paclitaxel (10nM) or salinomycin (1uM) for one week. There were three
                biologic replicates for each treatment condition.</text>
        </description>
        <description>
            <id>1799394825</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip HT Human
                Genome U133A [HT_HG-U133A]], producing 6 raw data files and 6 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="157">
        <id>1797752230</id>
        <accession>E-GEOD-9545</accession>
        <name>Transcription profiling of mouse C57BL/6 Mouse Embryo Culture Model treated with
            ethanol</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>19</samples>
        <assays>19</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE9545</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>11</count>
        </arraydesign>
        <arraydesign>
            <id>447429329</id>
            <accession>A-AFFY-36</accession>
            <name>Affymetrix GeneChip Mouse Genome 430A 2.0 [Mouse430A_2]</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804920347</id>
            <name>Affymetrix:FeatureDimension:MOE430A</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>8</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920355</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>11</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920382</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-9545.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>11</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920385</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-9545.Mouse430A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>18366608</accession>
            <authors>Guohua Wang, Xin Wang, Yadong Wang, Jack Y Yang, Lang Li, Kenneth P Nephew,
                Howard J Edenberg, Feng C Zhou, Yunlong Liu</authors>
            <title>Identification of transcription factor and microRNA binding sites in responsible
                to fetal alcohol syndrome.</title>
        </bibliography>
        <provider>
            <contact>Feng Zhou</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797752240</id>
            <text>Mouse model for Fetal Alcohol Syndrome. Embryos exposed to alcohol in controlled
                environment to assess teratogenic effects. Fetal Alcohol Syndrome (FAS) is a leading
                developmental disorder. To date, a holistic view of molecular gene changes is
                largely unexplored. Using microarray analysis of whole embryo mouse culture with
                strict-control over alcohol-level, we found, directly related alcohol-metabolism, a
                reduction of retinol binding protein 1(Rbp1), and a, de novo expression of aldehyde
                dehydrogenase 1B1 (ALDH1B1). Remarkably, four key hemopoiesis genes (glycophorin A,
                adducin 2, beta-2 microglobulin, and ceruloplasmin) became absent, and many histone
                variants genes were reduced. Hypothesis-driven informatics analysis and intersection
                analysis of two independent experiments indicated that the altered genes are
                involved in cell growth, hemopoiesis, histone modification, eye and heart
                development, and a collective reduction in expression of growth factor genes (Igf1,
                Efemp1, Tieg, and Edil3) and neural specification genes (neurogenin, Sox 5, bHLHb5).
                Down-regulated neural specification phenotypes further supported the above findings.
                Further more, the gene expression profile indicated distinct subgroups which
                overlapped with the teratogenesis of the open- and the closed-neural tubes known in
                FAS. In summary, our data reveal genes alteration with causal potential for
                dysmorpology (e.g. retinoic acid, neuronal specification, and neurotrophic factors,
                and epigenetics related histone genes) and those downstream responsive genes related
                to alcohol metabolism, and developmental teratogenesis. Experiment Overall Design:
                Comparison of whole embryo gene expression after exposure to ethanol for 46 hours.
                Note 2 independent experiments completed.</text>
        </description>
        <description>
            <id>1799399636</id>
            <text>(Generated description) Experiment with 19 hybridizations, using 19 samples of
                species [Mus musculus], using 19 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2], Affymetrix GeneChip Mouse Genome 430A 2.0
                [Mouse430A_2]], producing 19 raw data files and 19 transformed and/or normalized
                data files.</text>
        </description>
        <description>
            <id>1804920731</id>
            <text>(Generated description) Experiment with 19 hybridizations, using 19 samples of
                species [Mus musculus], using 19 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2], Affymetrix GeneChip Mouse Genome 430A 2.0
                [Mouse430A_2]], producing 19 raw data files and 19 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="158">
        <id>1797752493</id>
        <accession>E-GEOD-15043</accession>
        <name>Transcription profiling of human herceptin-resistant breast cancer cells</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>10</samples>
        <assays>10</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15043</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>10</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799396610</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>10</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799396810</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15043.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>10</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>10</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19593441</accession>
            <authors>Long Gu, Sarah Waliany, Susan E Kane</authors>
            <title>Darpp-32 and its truncated variant t-Darpp have antagonistic effects on breast
                cancer cell growth and herceptin resistance.</title>
        </bibliography>
        <provider>
            <contact>Xiwei Wu</contact>
            <email>xwu@coh.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797752502</id>
            <text>Herceptin (trastuzumab) is a humanized monoclonal antibody targeted to the Her2
                receptor tyrosine kinase. Despite a robust response rate to Herceptin-based
                therapies in Her2-positive patients, resistance frequently arises within one year of
                the initial response. To address the mechanism of Herceptin resistance, we selected
                clonal variants of Her2-positive BT474 human breast cancer cells (BT/HerR) that are
                highly resistant to the anti-proliferative effects of Herceptin in the presence of
                0.2 uM or 1.0 uM Herceptin. Our original report on these cell lines demonstrated
                sustained PI3K/Akt signaling and sensitivity to PI3K inhibitors in BT/HerR cells in
                the presence of Herceptin, suggesting dysregulation of that pathway as an essential
                component of Herceptin-resistant proliferation. To address the mechanism by which
                BT/HerR cells and their PI3K/Akt signaling pathway became resistant to Herceptin, we
                analyzed gene expression profiles of two clones (BT/HerR1.0C and BT/HerR 1.0E) that
                were selected in 1.0 uM Herceptin and two clones (BT/HerR0.2D and BT/HerR 0.2J) that
                were selected in 0.2 uM Herceptin, in comparison to the Herceptin sensitive BT474
                parent cells. Experiment Overall Design: Total cellular RNAs were extracted from
                BT474 (control) and four BT/HerR subclones, two that were originally selected in 1.0
                uM Herceptin and two that were originally selected in 0.2 uM Herceptin. Two RNA
                samples independently prepared from each clone were analyzed.</text>
        </description>
        <description>
            <id>1799398544</id>
            <text>(Generated description) Experiment with 10 hybridizations, using 10 samples of
                species [Homo sapiens], using 10 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 10 raw data files and 10
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="159">
        <id>1797753681</id>
        <accession>E-GEOD-17708</accession>
        <name>Transcription profiling of human A549 lung adenocarcinoma cell line time Course of
            TGF-beta treatment</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>26</samples>
        <assays>26</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17708</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>26</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395803</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17708.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>26</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Rork Kuick</contact>
            <email>rork@umich.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797753689</id>
            <text>Time Course of TGF-beta treatment of A549 lung adenocarcinoma cell line on
                Affymetrix HG_U133_plus_2 arrays; triplicate experiments. The goal of the experiment
                is to profile temporal gene expression changes during TGF-beta-induced
                epithelial-mesenchymal transition (EMT). During EMT cancer cells loose their
                epithelial specifc proteins and gain mesenchymal proteins to acquire migratory and
                invasive phenotype essential for metastasis. Human A549 lung adenocarcinoma cell
                line was treated with 5 ng/mL TGF-beta for 0, 0.5, 1, 2, 4, 8, 16, 24, and 72 h to
                induce EMT. The experiment was repeated 3 times. Samples were assayed using
                Affymetrix HG_U133_plus_2 arrays with 54675 probe-sets, using standard techniques.
                We provide the raw .CEL files and a supplementary Excel spreadsheet with
                log-transformed data and selected results from a statistical analysis. Experiment
                Overall Design: Human A549 lung adenocarcinoma cell line was treated with 5 ng/mL
                TGF-beta for 0, 0.5, 1, 2, 4, 8, 16, 24, and 72 h. The experiment was repeated 3
                times. Samples were assayed using Affymetrix HG_U133_plus_2 arrays with 54675
                probe-sets, using standard techniques. The 2 h sample of the third experiment was
                not run on an array due to poor RNA, so that only 26 arrays were run.</text>
        </description>
        <description>
            <id>1799400627</id>
            <text>(Generated description) Experiment with 26 hybridizations, using 26 samples of
                species [Homo sapiens], using 26 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 26
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="160">
        <id>1797757624</id>
        <accession>E-GEOD-17743</accession>
        <name>Transcription profiling of human gastrointestinal stromal tumours according to KIT
            mutations and expression</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>29</samples>
        <assays>29</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17743</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>29</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804920412</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>29</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920486</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17743.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>29</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Krzysztof Goryca</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1797757631</id>
            <text>Gastrointestinal stromal tumours (GISTs) represent a heterogeneous group of
                tumours of mesenchymal origin characterized by gain-of-function mutations in KIT or
                PDGFRA of the type III receptor tyrosine kinase family. Although mutations in either
                receptor are thought to drive an early oncogenic event through similar pathways, two
                previous studies reported the mutation-specific gene expression profiles. However,
                their further conclusions were rather discordant. To clarify the molecular
                characteristics of differentially expressed genes according to GIST receptor
                mutations, we combined microarray-based analysis with detailed functional
                annotations. Experiment Overall Design: 29 samples: 15 with KIT mutation detected,
                11 with PDGFRA mutation detected, 3 with no mutation detected</text>
        </description>
        <description>
            <id>1804921018</id>
            <text>(Generated description) Experiment with 29 hybridizations, using 29 samples of
                species [Homo sapiens], using 29 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 29 raw data files and 29
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="161">
        <id>1797758585</id>
        <accession>E-GEOD-15269</accession>
        <name>Transcription profiling of Saccharomyces cerevisiae mutant delta-spe3 delta-fms1 after
            spermidine treatment</name>
        <releasedate>2009-09-12</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>13</samples>
        <assays>13</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15269</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>119528504</id>
            <accession>A-AFFY-27</accession>
            <name>Affymetrix GeneChip Yeast Genome S98 [YG_S98]</name>
            <count>13</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395290</id>
            <name>Affymetrix:FeatureDimension:YG_S98</name>
            <bioassaydatacubes>13</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>13</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799395629</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15269.YG_S98.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799395933</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15269.YG_S98.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19688718</accession>
            <authors>Chen Chattopadhyay, Cam Poy, Tabor Stiles</authors>
            <title>Microarray studies on the genes responsive to the addition of spermidine or
                spermine to a Saccharomyces cerevisiae spermidine synthase mutant.</title>
        </bibliography>
        <provider>
            <contact>WeiPing Chen</contact>
            <email>weipingChen@niddk.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797758603</id>
            <text>The naturally occurring polyamines putrescine, spermidine or spermine are
                ubiquitous in all cells. Although polyamines have prominent regulatory roles in cell
                division and growth, precise molecular and cellular functions are not well
                established in vivo. In this work we have performed a microarray experiment in a
                polyamine mutant (delta-spe3 delta-fms1) strain to investigate the responsiveness of
                yeast genes to supplementation with spermidine and spermine. Expression analysis
                identified genes responsive to the addition of either excess spermidine (10-5 M) or
                spermine (10-5 M) compared to a control culture containing 10-8 M spermidine. 247
                genes were up-regulated &gt;2-fold, and 11 genes were up-regulated more than
                10-fold after spermidine addition. Functional categorization of the genes showed
                induction of transport related genes, and genes involved in methionine, arginine,
                lysine, NAD and biotin biosynthesis. 268 genes were down-regulated more than 2-fold,
                and 6 genes were down-regulated more than 8-fold after spermidine addition. A
                majority of the down-regulated genes are involved in nucleic acid metabolism and
                various stress responses. In contrast, only few genes (18) were significantly
                responsive to spermine. Thus, results from global gene expression profiling
                demonstrate a more major role for spermidine in modulating gene expression in yeast
                than spermine. Experiment Overall Design: 5 control replicates vs. 3 spermine
                (SP)-treated or 5 spermidine (SPD)-treated samples.</text>
        </description>
        <description>
            <id>1799397777</id>
            <text>(Generated description) Experiment with 13 hybridizations, using 13 samples of
                species [Saccharomyces cerevisiae], using 13 arrays of array design [Affymetrix
                GeneChip Yeast Genome S98 [YG_S98]], producing 13 raw data files and 13 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="162">
        <id>1797758791</id>
        <accession>E-GEOD-17718</accession>
        <name>Transcription profiling of human CD4-positive HTLV-positive cell lines and from
            CD4-positive HTLV-negative primary cells.</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17718</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799399282</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799399400</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17718.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ralph Grassmann</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797758806</id>
            <text>We used microarrays to compare the global programme of gene expression in
                HTLV-positive, ATL-derived and HTLV-positive in vitro-transformed cell lines with
                that of uninfected primary CD4 T cells. Experiment Overall Design: Cells were
                harvested one day after splitting, in case of primary T cells, cells were harvested
                after reaching a postmitotic state.</text>
        </description>
        <description>
            <id>1797782493</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1799400389</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="163">
        <id>1797760279</id>
        <accession>E-GEOD-17032</accession>
        <name>Transcription profiling of human fibroblasts</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>36</samples>
        <assays>36</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17032</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>36</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799397553</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>36</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>36</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799398396</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17032.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>36</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>36</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ben Wittner</contact>
            <email>wittner.ben@mgh.harvard.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797760305</id>
            <text>Cancer cells interact with surrounding stromal fibroblasts during tumorigenesis,
                but the complex molecular rules that govern these interactions remain poorly
                understood, thus hindering the development of therapeutic strategies to target
                cancer stroma. We have taken a mathematical approach to begin defining these rules
                by performing large-scale quantitative analysis of fibroblast effects on cancer cell
                proliferation across more than four hundred heterotypic cell line pairings.
                Systems-level modeling of this complex dataset using singular value decomposition
                revealed that normal tissue fibroblasts variably express at least two functionally
                distinct activities, one which reflects transcriptional programs associated with
                activated mesenchyme, that act either coordinately or at cross-purposes to modulate
                cancer cell proliferation. To gain insight into the molecular identity of these
                fibroblast activities, we isolated RNA from 36 human skin and lung fibroblast cell
                line monocultures from Coriell Repositories or ATCC and performed microarray-based
                gene expression profiling using Affymetrix gene chips. Experiment Overall Design:
                Human skin and lung fibroblasts purchased from Coriell Repositories or ATCC were
                grown using standard cell culture conditions followed by flash freezing in liquid
                nitrogen, RNA isolation using Qiagen RNeasy kits, and microarray profiling</text>
        </description>
        <description>
            <id>1799404213</id>
            <text>(Generated description) Experiment with 36 hybridizations, using 36 samples of
                species [Homo sapiens], using 36 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 36 raw data files and 36
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="164">
        <id>1797762325</id>
        <accession>E-GEOD-16081</accession>
        <name>Transcription profiling of Gallus gallus bursal FAE and IFE</name>
        <releasedate>2009-09-12</releasedate>
        <species>Gallus gallus</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Gallus gallus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16081</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1526273951</id>
            <accession>A-AFFY-103</accession>
            <name>Affymetrix GeneChip Chicken Genome Array [Chicken]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797766701</id>
            <name>Affymetrix:FeatureDimension:Chicken</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797767679</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16081.Chicken.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19675110</accession>
            <authors>Gaku Nakato, Shinji Fukuda, Koji Hase, Ryo Goitsuka, Max D Cooper, Hiroshi
                Ohno</authors>
            <title>New approach for m-cell-specific molecules screening by comprehensive
                transcriptome analysis.</title>
        </bibliography>
        <provider>
            <contact>Shinji Fukuda</contact>
            <email>sfukuda@rcai.riken.jp</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797762332</id>
            <text>A minor population of M cells within the follicle-associated epithelium (FAE) of
                intestinal Peyer s patches (PP) serves as a major portal for entry of exogenous
                antigens. Characterization of the mammalian M cells, including identification of
                M-cell surface molecules used for bacterial uptake, has been hampered by their
                relative rarity. In contrast, M cells constitute virtually all of the FAE cells in
                the avian bursa of Fabricius. We therefore performed comparative gene expression
                profiling of chicken and murine FAE to identify commonly expressed genes by M cells
                in both species. The comprehensive transcriptome analysis revealed that 28 genes
                were commonly up-regulated in FAE from both species. In situ hybridization (ISH)
                revealed that annexin A10 (Anxa10) mRNA was scattered in FAE, and co-localized with
                Ulex europaeus agglutinin-1(UEA-1) that binds to M cells. Whole-mount immunostaining
                also revealed that cellular prion protein (PrPC) was expressed on the luminal side
                of the apical plasma membrane of M cells, and co-localized with grycoprotein2 (GP2)
                that recognizes only M cells in murine PP. Taken together, we found new
                M-cell-specific molecules by using comprehensive transcriptome analysis. These
                molecules conserved in M cells from both species might play critical roles in M-cell
                function and/or differentiation. Experiment Overall Design: Bursa of Fabricius were
                dissected from the rectum and soaked in Hank's Buffered Salt Solution (HBSS) (GIBCO)
                containing black ink for 5 min at room temperature to visualize FAE. After
                incubation, the tissue was treated with 40 mM EDTA/25 mM Hepes (pH 7.4) in HBSS for
                5min at room temperature to collect bursal FAE or 30 min at 37 C for bursal IFE.
                Bursal FAE and IFE were collected with a fine 29G needle under stereomicroscope
                monitoring (n=2)</text>
        </description>
        <description>
            <id>1797775584</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Gallus gallus], using 4 arrays of array design [Affymetrix GeneChip Chicken
                Genome Array [Chicken]], producing 4 raw data files and 4 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="165">
        <id>1797762807</id>
        <accession>E-GEOD-15465</accession>
        <name>Transcription profiling of Saccharomyces cerevisiae reveals the regulation of reserve
            carbohydrate metabolism in S cerevisiae in response to nutrient availability</name>
        <releasedate>2009-09-12</releasedate>
        <species>Saccharomyces cerevisiae</species>
        <samples>21</samples>
        <assays>21</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Saccharomyces cerevisiae</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15465</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>119528504</id>
            <accession>A-AFFY-27</accession>
            <name>Affymetrix GeneChip Yeast Genome S98 [YG_S98]</name>
            <count>21</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395483</id>
            <name>Affymetrix:FeatureDimension:YG_S98</name>
            <bioassaydatacubes>21</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>21</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799395954</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15465.YG_S98.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799395975</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15465.YG_S98.2.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jean-Marc Daran</contact>
            <email>j.g.daran@tudelft.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797762821</id>
            <text>In Saccharomyces cerevisiae, glycogen and trehalose are important reserve
                carbohydrates that accumulate under nutrient limitation in batch cultures. An
                inherent draw-back of batch studies is that specific growth rate and substrate and
                product concentrations are variable over time and between cultures. The aim of this
                present study was to identify the nutritional requirements associated with high
                accumulation of reserve carbohydrates at a fixed specific growth rate (0.10 h-1) in
                anaerobic chemostat cultures that were limited by one of five different nutrients
                (carbon, nitrogen, sulfur, phosphorus or zinc). Reserve carbohydrates accumulation
                is not a general response to nutrient limitation. Over the conditions tested,
                accumulation occurs essentially under nitrogen (and to a lesser extent carbon)
                limited conditions. This was confirmed by the transcriptional profile of the genes
                involved in trehalose biosynthesis. We show that the transcriptional induction of
                both glycogen and trehalose biosynthesis genes was to a large extent driven by the
                regulator Msn2/4. However, the main regulatory control of glycogen biosynthesis was
                post-translational. Under nitrogen limitation, the ratio of glycogen synthase over
                glycogen phosphorylase increased up to eight-fold, thus enabling an increased flux
                towards glycogen biosynthesis. Experiment Overall Design: We studied this in
                anaerobic chemostat cultures at a dilution rate of 0.10 h-1 where growth was limited
                by five different nutrients (carbon, nitrogen, sulfur, phosphorus or zinc
                limitations). In addition, we studied the expression of these pathways at
                transcriptional and post-transcriptional levels and assessed the role of Msn2/4 in
                mediating transcriptional induction of glycogen and trehalose genes in the absence
                of stress.</text>
        </description>
        <description>
            <id>1799399908</id>
            <text>(Generated description) Experiment with 21 hybridizations, using 21 samples of
                species [Saccharomyces cerevisiae], using 21 arrays of array design [Affymetrix
                GeneChip Yeast Genome S98 [YG_S98]], producing 21 raw data files and 21 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="166">
        <id>1797766663</id>
        <accession>E-GEOD-9175</accession>
        <name>Transcription profiling of Xenopus eye primordia vs. posterior neural plate vs.
            lateral endoderm normalized the whole embryos</name>
        <releasedate>2009-09-12</releasedate>
        <species>Xenopus laevis</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Xenopus laevis</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE9175</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>926019605</id>
            <accession>A-AFFY-62</accession>
            <name>Affymetrix GeneChip Xenopus laevis Genome Array [Xenopus_laevis]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799395888</id>
            <name>Affymetrix:FeatureDimension:Xenopus_laevis</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799396156</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-9175.Xenopus_laevis.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19688031</accession>
            <authors>Andrea S Viczian, Eduardo C Solessio, Yung Lyou, Michael E Zuber</authors>
            <title>Generation of functional eyes from pluripotent cells.</title>
        </bibliography>
        <provider>
            <contact>Michael Zuber</contact>
            <email>zuberm@upstate.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797766680</id>
            <text>Tissues from the eye primordia, lateral endoderm, and posterior; neural plate of
                stage 15 Xenopus laevis embryos were isolated and normalized to stage 15 whole
                embryos. Three biological replicates were prepared for each tissue and the
                expression patterns were profiled using Affymetrix Xenopus Laevis GeneChip
                microarrays. Experiment Overall Design: Tissues from the eye primordia, lateral
                endoderm, and posterior Experiment Overall Design: neural plate of stage 15 Xenopus
                laevis embryos were isolated and normalized to stage 15 whole embryos. Three
                biological replicates were prepared for each tissue and the expression patterns were
                profiled using Affymetrix Xenopus Laevis GeneChip microarrays.</text>
        </description>
        <description>
            <id>1799398005</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Xenopus laevis], using 12 arrays of array design [Affymetrix GeneChip
                Xenopus laevis Genome Array [Xenopus_laevis]], producing 12 raw data files and 12
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="167">
        <id>1797769170</id>
        <accession>E-GEOD-16333</accession>
        <name>Transcription profiling of Arabidopsis phytochrome interacting factors 4 and 5
            redundantly limit seedling de-etiolation in continuous far-red light.</name>
        <releasedate>2009-09-12</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16333</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799398562</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799398912</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16333.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19619162</accession>
            <authors>Trevisan Lorrain, Fankhauser Pradervand</authors>
            <title>Phytochrome interacting factors 4 and 5 redundantly limit seedling de-etiolation
                in continuous far-red light.</title>
        </bibliography>
        <provider>
            <contact>Sylvain Pradervand</contact>
            <email>Sylvain.Pradervand@unil.ch</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797769187</id>
            <text>Phytochromes are red/far red photosensors regulating numerous developmental
                programs in plants. Among them phytochrome A (phyA) is essential to enable seedling
                de-etiolation in continuous far-red (FR) light a condition mimicking the environment
                under a dense canopy. The ecological relevance of this response is demonstrated by
                the high mortality rate of phyA mutants germinating in deep vegetational shade. phyA
                signaling involves a direct interaction of the photoreceptor with members of the
                bHLH transcription factor family, PIF1 and PIF3 (Phytochrome Interacting Factor).
                Here we investigated the involvement of PIF4 and PIF5 in phyA signaling and found
                that they redundantly control de-etiolation in FR light. The pif4pif5 double mutant
                is hypersensitive to low fluence rates of FR light. This phenotype is dependent on
                FR light perception by phyA but does not rely on alterations of the phyA level. Our
                microarrays analysis shows that PIF4 and PIF5 are part of an inhibitory mechanism
                repressing the expression of some light-responsive genes in the dark and are also
                needed for full expression of several growth-related genes in the light. Unlike PIF1
                and PIF3, PIF4 and PIF5 are not degraded in response to FR light indicating that
                they are light-regulated by a different mechanism. Our genetic analysis suggests
                that this is achieved through the sequestration of these PIFs by the closely related
                bHLH transcription factor HFR1 (long Hypocotyl in FR light). Experiment Overall
                Design: he pif4pif5 double mutant were compared to wild-type plants when kept in the
                dark or subjected to 1 or 24 hours of 0.5 or 5 mol/m2/s far-red light
                respectively.</text>
        </description>
        <description>
            <id>1799402203</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Arabidopsis thaliana], using 18 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 18 raw data files and 18 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="168">
        <id>1797769572</id>
        <accession>E-GEOD-15913</accession>
        <name>Transcription profiling of human chronic lymphocytic leukemia (CLL) patients with a
            combined thalidomide/fludarabine regimen and monitored cellular and molecular changes
            induced by thalidomide in-vivo prior to fludarabine treatment - reveals thalidomide
            Exerts Distinct Molecular Antileukemic Effects</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>40</samples>
        <assays>40</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE15913</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>40</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799397739</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>40</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799398713</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-15913.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>40</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19440214</accession>
            <authors>Dmoszynska Giannopoulos, W sik-Szczepanek Kowal, Rolinski Bojarska-Junak,
                Stilgenbauer D hner, Bullinger</authors>
            <title>Thalidomide exerts distinct molecular antileukemic effects and combined
                thalidomide/fludarabine therapy is clinically effective in high-risk chronic
                lymphocytic leukemia.</title>
        </bibliography>
        <provider>
            <contact>Lars Bullinger</contact>
            <email>lars.bullinger@uniklinik-ulm.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797769592</id>
            <text>Thalidomide Exerts Distinct Molecular Antileukemic Effects and Combined
                Thalidomide/Fludarabine Therapy is Clinically Effective in High-Risk Chronic
                Lymphocytic Leukemia; Background: Thalidomide represents a promising
                immunomodulatory drug that targets both leukemia cells and the tumor
                microenvironment. Methods: We treated chronic lymphocytic leukemia (CLL) patients
                with a combined thalidomide/fludarabine regimen and monitored cellular and molecular
                changes induced by thalidomide in-vivo prior to fludarabine treatment. Thalidomide
                was given daily (100mg p.o./day) and fludarabine was administered on days 7-11 (25
                mg/m i.v./day) within each 4-week cycle (maximum of 6 cycles). Twenty patients
                received thalidomide/fludarabine as first line therapy and 20 patients were
                previously treated. Unmutated IgVH mutation status was found in 36 cases and 13 had
                high-risk cytogenetic aberrations (deletion of 17p13 or 11q22-q23). Results: The
                overall response rate was 80% and 25% for untreated and previously treated patients,
                respectively. While thalidomide effectively reduced the number of CLL cells, the
                number of CD3 lymphocytes showed no significant change, but the number of
                CD4+CD25hiFOXP3+ T-regulatory cells was significantly decreased. Gene expression
                profiling revealed a thalidomide induced signature containing both targets known to
                play a role in immunomodulatory drug action as well as novel candidate genes.
                Conclusions: Combined thalidomide/fludarabine therapy demonstrated efficacy in
                high-risk CLL patients. Furthermore, our study provides novel biological insights
                into thalidomide effect, which might act by enhancing apoptosis of CLL cells and
                reducing Tregs, thereby enabling T-cell dependent anti-tumor effect. Experiment
                Overall Design: Patients ("preTHAL") received thalidomide (100mg p.o./day) starting
                at day 0 and at day 7 Fludarabine therapy was added to the therapy. To evaluate the
                in-vivo influence of thalidomide on the transcriptome in CLL, paired GEP was
                performed in 20 cases at treatment start at day 0 (preTHAL) and prior to fludarabine
                treatment at day 7 (postTHAL) using HumanGenome U133 Plus2.0 Arrays according to the
                manufacturer's recommendations (Affymetrix; RNA was isolated from peripheral blood
                samples enriched for leukemic cells by Ficoll-density gradient centrifugation,
                percentage of leukemic cells &gt; 90%). Fluorescence ratios were evaluated by
                both the GCOS software and normalized by applying the RMA algorithm using the BRB
                Array Tools software.</text>
        </description>
        <description>
            <id>1799404600</id>
            <text>(Generated description) Experiment with 40 hybridizations, using 40 samples of
                species [Homo sapiens], using 40 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 40 raw data files and 40
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="169">
        <id>1797771532</id>
        <accession>E-GEOD-14973</accession>
        <name>Transcription profiling of human chronic lymphocytic leukemia cells treted with
            valproic acid</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>28</samples>
        <assays>28</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14973</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>28</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799399551</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>28</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>28</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799400236</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14973.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>28</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>28</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Basile Stamatopoulos</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797771542</id>
            <text>Epigenetic code modifications by histone deacetylase inhibitors (HDACi) have
                recently been proposed as potential new therapies for hematological malignancies.
                Chronic Lymphocytic Leukemia (CLL) remains incurable despite the introduction of new
                treatments. CLL cells are characterized by an apoptosis defect rather than excessive
                proliferation, but proliferation centers have been found in organs such as bone
                marrow and lymph nodes. Here, we investigated gene expression modifications in CLL
                cells following treatment with valproic acid (VPA), a well-tolerated anti-epileptic
                drug with HDAC inhibitory activity. Experiment Overall Design: CLL cells obtained
                from 14 patients were treated in vitro with a concentration of 1mM VPA for 4 hours.
                VPA effects on gene expression were thereafter studied using Affymetrix
                technology</text>
        </description>
        <description>
            <id>1799404366</id>
            <text>(Generated description) Experiment with 28 hybridizations, using 28 samples of
                species [Homo sapiens], using 28 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 28 raw data files and 28
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="170">
        <id>1797774287</id>
        <accession>E-GEOD-17709</accession>
        <name>Transcription profiling of mouse podocyte specific PTIP deletion in mouse glomerular
            preparations at 1 month of age</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17709</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799398244</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>18</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799398695</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17709.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Greg Dressler</contact>
            <email>dressler@umich.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797774314</id>
            <text>Glomerular RNA comparison between wild-type and podocyte specific deletion of the
                PTIP gene in 1 month old kidneys. The PTIP gene was deleted using a floxed allele
                and a Podocin-Cre driver strain. These mice develop protein urea by 3 months of age.
                This study was designed to find gene expression differences prior to the onset of
                the phenotype. Experiment Overall Design: A ptip floxed allele was crossed into the
                Podocin-Cre expressing strain to generate ptip fl/fl homozygous mice or ptip fl/-
                transheterozygous mice with or without the Cre expressing transgene. Animals were
                genotyped and assigend into two groups: Mutants with PTIP deletion (PTIP-) with the
                genotype ptip fl/fl:Pod-Cre or ptip fl/-:Pod-Cre or control mice (PTIP+) with either
                ptip fl/fl or ptip fl/-. Note that the floxed allele produced normal levels of
                wild-type PTIP protein. Experiment Overall Design: Kidneys were excised at 1 month
                of age. Glomeruli enriched fractions were generated by sieving of the tissue
                homogenates. RNA was prepared from glomerular enriched fractions.</text>
        </description>
        <description>
            <id>1799401664</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Mus musculus], using 18 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 18 raw data files and 18 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="171">
        <id>1797775653</id>
        <accession>E-GEOD-16060</accession>
        <name>Re-sequencing of human MCF7 cell isolated small RNAs reveals the non-coding RNA of the
            multidrug resistance-linked vault particle encodes multiple regulatory small RNAs</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16060</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797774821</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-16060.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <provider>
            <contact>Helena Persson</contact>
            <email>Helena.Persson@med.lu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797775666</id>
            <text>Vault particles are conserved organelles that have been implicated in multidrug
                resistance and intracellular transport. They are formed by three different proteins
                and the non-coding vault RNAs (vRNAs). Here we show that human vRNAs produce several
                small RNAs (svRNAs) by mechanisms different from the canonical microRNA (miRNA)
                pathway. At least one of these svRNAs, we named svRNAb, associates with Argonaute
                proteins to guide sequence-specific cleavage and regulate gene expression in a
                manner similar to miRNAs. We demonstrate that svRNAb downregulates CYP3A4, a key
                enzyme in drug metabolism. Our findings expand the repertoire of small regulatory
                RNAs and assign, for the first time, a function to vRNAs that may help explain the
                observed association between vaults and drug resistance. Experiment Overall Design:
                Small RNAs 18-35 nt were isolated from MCF7 cell total RNA and sequenced on the
                Illumina Genome Analyzer</text>
        </description>
        <description>
            <id>1799397049</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-16060], producing 0 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="172">
        <id>1797776243</id>
        <accession>E-GEOD-12843</accession>
        <name>Transcription profiling of human mesenchymal stem cells derived from adult adipose and
            lipoma tissues</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12843</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799400525</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799400624</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12843.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Sung-Liang Yu</contact>
            <email>slyu@ntu.edu.tw</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797776253</id>
            <text>Human mesenchymal stem cells (MSCs) have been isolated from adult adipose tissues,
                and were shown to have ability to differentiate into multiple mesodermal lineages as
                well as non-mesodermal lineages. MSC had also been isolated from lipoma, and the
                lipoma-derived MSCs (LM6) showed very similar stem cell characteristics to
                adipose-derived MSCs (AM3). However, LM6 cells exhibited a higher cumulative
                population doubling levels as compared with AM3 cells. The expression profiles of
                both mRNAs and microRNAs (miRNAs) from AM3 and LM6 cells were compared to find
                considerable similarities except that miRNAs miR-99a and miR-152 were abundantly
                expressed in AM3, but absent in LM6 cells. The abundantly differentially expressed
                genes HAS2, VNN1, SLC16A6 and COL11A1 in LM6 cells were shown to be targets of
                miRNAs miR-99a and/or miR-152. Several additional genes were also found to be
                targets of miRNAs miR-99a and miR-152, as well as let-7g, let-7i, miR-199a, mir-134
                and miR-374. The highly up-regulated expression of miRNA target genes such as
                SLC16A6, COL11A1 and TRHDE, as well as several other genes such as sushi domain
                containing 2, keratin associated proteins and tumor necrosis factor family, may
                explain the higher proliferation potential in LM6 cells compared with AM3 cells.
                SUBMITTER_CITATION: "Comparative Profiling of mRNA and microRNA in Human Mesenchyman
                Stem Cells Derived from Adult Adipose and Lipoma Tissues. The Open Stem Cell
                Journal, Vol 1, pp.1-9 (9) 2009 Experiment Overall Design: The expression profiles
                of both mRNAs and miRNAs from the same RNA samples of AM3 and LM6 cells were
                determined and compared in order to understand the genetic bases for their
                similarities and differences.</text>
        </description>
        <description>
            <id>1799401289</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 4 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="173">
        <id>1797778273</id>
        <accession>E-GEOD-10393</accession>
        <name>Transcription profiling of human hepatocellular carcinoma reveals common molecular
            subtypes</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE10393</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1601694385</id>
            <accession>A-AFFY-113</accession>
            <name>Affymetrix GeneChip HT Human Genome U133A HT_HG-U133A </name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799397232</id>
            <name>Affymetrix:FeatureDimension:HT_HG-U133A</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799397345</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-10393.HT_HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19723656</accession>
            <authors>Nijman Hoshida, Chan Kobayashi, Chiang Brunet, Newell Villanueva, Hashimoto
                Ikeda, Gabriel Watanabe, Kumada Friedman, Golub Llovet</authors>
            <title>Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human
                Hepatocellular Carcinoma.</title>
        </bibliography>
        <provider>
            <contact>Yujin Hoshida</contact>
            <email>hoshida@broad.mit.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797778288</id>
            <text>Hepatocellular carcinoma (HCC) is a common malignancy with high mortality due to a
                lack of effective therapies. HCC represents a collection of highly heterogeneous
                tumor types but a general molecular classification of HCC is lacking. Here, we
                define three molecular subtypes of HCC that are observed across various independent
                patient cohorts and profiling platforms. Analysis of the expression signatures
                indicates that a limited number of pathways and processes drive the clustering of
                these subtypes. Notably, TGF-beta signaling is a critical factor that distinguishes
                two subtypes of high-grade tumors, and is associated with early tumor recurrence.
                Furthermore, both bioinformatics and functional analyses reveal molecular crosstalk
                between TGF-beta and WNT signaling pathways. These findings suggest that TGF-beta
                plays a critical role in a subclass of HCC tumors and may enhance WNT pathway
                activation in the absence of activating mutations in canonical pathway components.
                This study is an example of how robust molecular subclassification can be used to
                interrogate molecular abnormalities in the context of human cancer. Experiment
                Overall Design: Four hepatocellular carcinoma (HCC) cell line samples treated or
                untreated by TGF-beta</text>
        </description>
        <description>
            <id>1799398085</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip HT Human
                Genome U133A [HT_HG-U133A]], producing 4 raw data files and 4 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="174">
        <id>1797779259</id>
        <accession>E-GEOD-16070</accession>
        <name>Transcription profiling of human MCF7 breast cancer cells resistant to
            methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16070</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799400939</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799401162</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16070.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797779281</id>
            <text>A summary of the work associated to these microarrays is the following:; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are MCF7 breast cancer cells sensitive to methotrexate and MCF7
                cells resistant to 10e-6M methotrexate. Six samples are provided which correspond to
                tripicates of each cell line. The samples provided were analyzed using the specific
                software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799402206</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="175">
        <id>1797779957</id>
        <accession>E-GEOD-14554</accession>
        <name>Transscription profiling of rat primary hepatocytes toxicogenomic comparison of TCDD
            and PCB 126 responsiveness</name>
        <releasedate>2009-09-12</releasedate>
        <species>Rattus norvegicus</species>
        <samples>26</samples>
        <assays>26</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14554</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>114147931</id>
            <accession>A-AFFY-18</accession>
            <name>Affymetrix GeneChip Rat Genome U34A [RG_U34A]</name>
            <count>26</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799398774</id>
            <name>Affymetrix:FeatureDimension:RG_U34A</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>26</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799399437</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14554.RG_U34A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>26</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Erik Carlson</contact>
            <email>carlson@ge.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797779974</id>
            <text>(Abstract) Toxicogenomics has great potential for enhancing our understanding of
                environmental chemical toxicity, hopefully leading to better-informed human health
                risk assessments. This study employed toxicogenomic technology to reveal species
                differences in response to two prototypical aryl hydrocarbon receptor (AHR)
                agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the polychlorinated
                biphenyl (PCB) congener PCB 126. Dose responses of primary cultures of rat and human
                hepatocytes were determined using species-specific microarrays sharing over 4,000
                gene orthologs. Forty-seven human and 79 rat genes satisfied dose response criteria
                for both chemicals and were subjected to further analysis including the calculation
                of EC50 and the relative potency (REP) of PCB 126 for each gene. Only 5 responsive
                orthologous genes were shared between the two species, yet the geometric mean of the
                REPs for all rat and human modeled responsive genes were 0.06 (95% Confidence
                Interval (CI); 0.03-0.1) and 0.002 (95% CI; 0.001-0.005), respectively, suggesting
                broad species differences in the initial events that follow AHR activation but
                precede toxicity. This indicates that there are species differences in both the
                specific genes that responded and the agonist potency and relative potency for those
                genes. This observed insensitivity of human cells to PCB 126 is consistent with more
                traditional measurements of AHR activation (i.e., CYP1A1 enzyme activity) and
                suggests that the species difference in PCB 126 sensitivity is likely due to certain
                aspects of AHR function. That a species divergence also exists in this expanded
                AHR-regulated gene repertoire is a novel finding and should help when extrapolating
                animal data to humans. Experiment Overall Design: Primary hepatocyte cultures,
                separated into 2 pools of 3 female Sprague Dawley rats each, were treated with
                vehicle (0.5% DMSO), TCDD (-14 to -6.5 log10 M) , or PCB 126 (-12 to -5 log10 M) for
                48h. Total RNA was extracted and screened with RG-U34A microarrays for dose
                response.</text>
        </description>
        <description>
            <id>1799404056</id>
            <text>(Generated description) Experiment with 26 hybridizations, using 26 samples of
                species [Rattus norvegicus], using 26 arrays of array design [Affymetrix GeneChip
                Rat Genome U34A [RG_U34A]], producing 26 raw data files and 26 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="176">
        <id>1797780203</id>
        <accession>E-GEOD-16085</accession>
        <name>Transcription profiling of human K562 erythroblastic leukemia cells sensitive to
            methotrexate and K562 cells resistant to 10e-5M methotrexate. - networking of
            differentially expressed genes in human K562 erythtoblastic leukemia cells resistant to
            methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16085</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799400806</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799400916</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16085.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>5</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799401059</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16085.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797780214</id>
            <text>A summary of the work associated to these microarrays is the following:; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are K562 erythroblastic leukemia cells sensitive to methotrexate and
                K562 cells resistant to 10e-5M methotrexate. Six samples are provided which
                correspond to triplicates of each cell line. The samples provided were analyzed
                using the specific software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799401791</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="177">
        <id>1797780553</id>
        <accession>E-GEOD-16066</accession>
        <name>Transcription profiling of human CaCo2 colon cancer cells resistant to
            methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16066</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799400199</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799400356</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16066.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797780562</id>
            <text>A summary of the work associated to these microarrays is the following:; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are Caco2 colon cancer cells sensitive to methotrexate and Caco2
                cells resistant to 10e-5M MTX. Six samples are provided, which correspond to
                triplicates of each cell line. The samples provided were analyzed using the specific
                software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799401242</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="178">
        <id>1797780560</id>
        <accession>E-GEOD-16082</accession>
        <name>Transcription profiling of human MIA PaCa2 pancreatic cancer cells resistant to
            methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16082</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799399745</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799399905</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16082.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797780583</id>
            <text>A summary of the work associated to these microarrays is the following: ; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are MIA PaCa2 pancreatic cancer cells sensitive to methotrexate and
                MIA PaCa2 cells resistant to 10e-6M MTX. Six samples are provided which correspond
                to triplicates of each cell line. The samples provided were analyzed using the
                specific software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799400986</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="179">
        <id>1797780633</id>
        <accession>E-GEOD-12037</accession>
        <name>ChIP-seq of Arabidopsis ARGONAUTE-small RNA interactions in Arabidopsis thaliana
            identified by high-throughput sequencing</name>
        <releasedate>2009-09-12</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12037</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797668739</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12037.VirtualArrayDesign</accession>
            <count>4</count>
        </arraydesign>
        <bibliography>
            <accession>18342362</accession>
            <authors>Taiowa A Montgomery, Miya D Howell, Josh T Cuperus, Dawei Li, Jesse E Hansen,
                Amanda L Alexander, Elisabeth J Chapman, Noah Fahlgren, Edwards Allen, James C
                Carrington</authors>
            <title>Specificity of ARGONAUTE7-miR390 interaction and dual functionality in TAS3
                trans-acting siRNA formation.</title>
        </bibliography>
        <provider>
            <contact>James Carrington</contact>
            <email>carrington@cgrb.oregonstate.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>ChIP-seq</experimenttype>
        <description>
            <id>1797780649</id>
            <text>The goal of this study was to identify small RNA-ARGONAUTE interactions in
                Arabidopsis. Co-immunoprecipitation assays followed by high-throughput sequencing
                were done to identify small RNA associated with HA-AGO2 and HA-AGO7. Experiment
                Overall Design: Sequencing-by-synthesis technology was used to sequence small RNA
                from input and co-immunoprecipitation fractions from cell lysates of inflorescence
                tissue from Arabidopsis plants transformed with HA epitope-tagged AGO2 or AGO7
                constructs. Meaningful intepretation requires comparison between the input and
                co-immunoprecipitation datasets. Experiment Overall Design: Note: Raw data files
                requested, however, the submitter declined to provide them.</text>
        </description>
        <description>
            <id>1799399812</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Arabidopsis thaliana], using 1 arrays of array design [Virtual Array Design
                for E-GEOD-12037], producing 0 raw data files and 8 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="180">
        <id>1797782235</id>
        <accession>E-GEOD-14710</accession>
        <name>Transcription profiling of mouse muscle mutant to reveals skeletal muscle growth and
            fiber composition in mice are regulated through the transcription factors
            STAT5a/b</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14710</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799402141</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799402509</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14710.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>11</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799402590</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14710.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19417088</accession>
            <authors>Peter Klover, Weiping Chen, Bing-Mei Zhu, Lothar Hennighausen</authors>
            <title>Skeletal muscle growth and fiber composition in mice are regulated through the
                transcription factors STAT5a/b: linking growth hormone to the androgen
                receptor.</title>
        </bibliography>
        <provider>
            <contact>WeiPing Chen</contact>
            <email>weipingChen@niddk.nih.gov</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797782249</id>
            <text>In skeletal muscle, STAT5a/b transcription factors are critical for normal
                postnatal growth, whole-animal glucose homeostasis, and local IGF-1 production.
                These observations have led us to hypothesize that STAT5a/b are critical for
                maintenance of normal muscle mass and function. To investigate this, mice with a
                skeletal muscle-specific deletion of the Stat5a/b genes (Stat5MKO) were used.
                Stat5MKO mice displayed reduced muscle mass, altered fiber-type distribution and
                reduced activity. On a molecular level, gene expression in skeletal muscle of
                Stat5MKO and control mice was analyzed by microarrays and real-time PCR, both in the
                presence and absence of growth hormone (GH) stimulation. Several genes involved in
                muscle growth, fiber-type and metabolism were significantly changed. Specifically in
                the quadriceps, a muscle almost exclusively composed of type II fibers, the absence
                of STAT5a/b led to increased expression of several genes associated with type I
                fibers and the de novo appearance of type I fibers. Additionally, it is shown here
                that expression of the androgen receptor gene (Ar) is controlled by GH through
                STAT5a/b. The link between STAT5a/b and Ar gene is likely through direct
                transcriptional regulation, as chromatin immunoprecipitaion of the Ar promoter
                region in C2C12 myoblasts was accomplished by antibodies against STAT5a. These
                experiments demonstrate an important role for STAT5a/b in skeletal muscle physiology
                and they provide a direct link to androgen signaling. Experiment Overall Design:
                Total 6 WT controls and 6 stat5a/b KO mice, treated or w/o GH</text>
        </description>
        <description>
            <id>1799404399</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 12 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="181">
        <id>1797790612</id>
        <accession>E-GEOD-17908</accession>
        <name>Transcription profiling of human EBV infected EBNA-3 positive and negative human B
            lymphocytes</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>14</samples>
        <assays>14</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17908</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>458263473</id>
            <accession>A-AFFY-37</accession>
            <name>Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2]</name>
            <count>14</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797798113</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17908.HG-U133A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>14</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>14</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Roland Lang</contact>
            <email>Roland.Lang@lrz.tum.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797790632</id>
            <text>The genome of Epstein-Barr virus (EBV) encodes 86 proteins but only a limited set
                is expressed in EBV-growth transformed B cells, termed lymphoblastoid cell lines
                (LCLs). These cells proliferate via the concerted action of EBV nuclear antigens
                (EBNAs) and latent membrane proteins (LMPs), some of which are rate limiting to
                establish a stable homeostasis of growth promoting and anti-apoptotic activities. We
                show here that EBV mutants, which lack the EBNA-3A gene, are impaired but can still
                initiate cell-cycle entry and proliferation of primary human B cells in contrast to
                an EBNA-2-deficient mutant virus. Surprisingly and in contrast to previous reports,
                these viral mutants are attenuated in growth transformation assays but give rise to
                permanently growing EBNA-3A negative B cell lines which exhibit reduced
                proliferation rates and elevated levels of apoptosis. Expression profiles of EBNA-3A
                deficient LCLs are characterized by 129 upregulated and 167 downregulated genes,
                which are significantly enriched for genes involved in apoptotic processes or cell
                cycle progression like the tumor suppressor gene p16/INK4A or might contribute to
                essential steps in the viral life cycle. In addition EBNA-3A cellular target genes
                remarkably overlap with previously identified targets of EBNA-2. Experiment Overall
                Design: Comparison of gene expression profiles from lymphoblastoid cell lines (LCLs)
                infected with EBNA-3A positive or negative EBV. LCLs were generated from three
                donors. A total of five EBNA-3A positive and nine negative LCLs were
                analysed.</text>
        </description>
        <description>
            <id>1797805967</id>
            <text>(Generated description) Experiment with 14 hybridizations, using 14 samples of
                species [Homo sapiens], using 14 arrays of array design [Affymetrix GeneChip Human
                Genome U133A 2.0 [HG-U133A_2]], producing 0 raw data files and 14 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="182">
        <id>1797790825</id>
        <accession>E-GEOD-17509</accession>
        <name>Transcription profiling of mouse spleen from animals exposed to Ebola virus reveals
            reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects
            of Ebola virus infection</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>57</samples>
        <assays>57</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17509</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>57</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799401837</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>57</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>57</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799403291</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17509.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>57</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>57</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19683682</accession>
            <authors>Rekha G Panchal, Steven B Bradfute, Brian D Peyser, Kelly L Warfield, Gordon
                Ruthel, Douglas Lane, Tara A Kenny, Arthur O Anderson, William C Raschke, Sina
                Bavari</authors>
            <title>Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal
                effects of Ebola virus infection.</title>
        </bibliography>
        <provider>
            <contact>Brian Peyser</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797790850</id>
            <text>To gain insight into the changes in gene expression pattern upon Ebola infection,
                CD45+/+ (100% protein level) and CD45+/- (62% protein level) mice were challenged
                with mouse adapted Ebola virus. At time-points day 0, 1, 3, 5, 7, 9, 11 and 13,
                spleen tissue was harvested and splenocytes isolated. Total RNA was isolated for
                mRNA expression analysis. The mouse genome 430 2.0 array (Affymetrix, Inc.), which
                consists of over 39,000 genes in a single array, was used. Based on gene expression
                patterns, the variable genes were grouped into sixteen clusters. Each cluster
                contained genes associated with cellular immune processes, signaling, cell-cycle,
                complement coagulation cascade, biosynthesis/metabolism, ubiquitous genes involved
                in several cascades, and genes of unknown function. Interestingly, gene expression
                in clusters 2 and 3 were significantly downregulated by day 1 following EBOV
                challenge in CD45100% mice. In contrast, at day 1 following EBOV infection, the CD45
                62% mice maintained gene expression patterns similar to day 0. The differences in
                gene expression patterns between the CD45 100% and CD45 62% splenocytes were less
                apparent at day 3 following infection and by days 5 and 7 they became very similar.
                At day 9, when wild-type mice had succumbed to the disease, the pattern in CD45 62%
                mice remained similar to the day 7 patterns of CD45 100% and CD45 62% mice. The
                pattern at days 11 and 13 in the CD45 62% mice had returned to that of day 0 CD45
                100% or CD45 62% mice. These results suggested that in CD45 100% mice, subversion of
                the cell transcriptional machinery during the early stages of EBOV infection (day 1)
                might represent a major factor leading to death of the mice. In CD45 62% mice, early
                control of gene regulation likely provided the appropriate antiviral responses
                leading to regulated inflammation, immune co-stimulation, and survival. Experiment
                Overall Design: RNA expression in CD45 100% and 62% mice were compared at each time
                point: days 0, 1, 3, 5, and 7, using an empirical Bayes procedure. From 3 to 8
                biological replicates were in each group. Samples for days 9, 11, and 13 (4
                biological replicates each) were also available for only CD45 62%. Median expression
                values for highly variable genes within each group were clustered using
                agglomerative nesting over all available time points.</text>
        </description>
        <description>
            <id>1799406099</id>
            <text>(Generated description) Experiment with 57 hybridizations, using 57 samples of
                species [Mus musculus], using 57 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 57 raw data files and 57 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="183">
        <id>1797791480</id>
        <accession>E-GEOD-14553</accession>
        <name>Transcription profiling of primary human hepatocytes - toxicogenomic comparison of
            TCDD and PCB 126 responsiveness in primary human hepatocytes</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>40</samples>
        <assays>40</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14553</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>40</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1804920341</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>40</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1804920420</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14553.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>40</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Erik Carlson</contact>
            <email>carlson@ge.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <description>
            <id>1797791501</id>
            <text>(Abstract) Toxicogenomics has great potential for enhancing our understanding of
                environmental chemical toxicity, hopefully leading to better-informed human health
                risk assessments. This study employed toxicogenomic technology to reveal species
                differences in response to two prototypical aryl hydrocarbon receptor (AHR)
                agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and the polychlorinated
                biphenyl (PCB) congener PCB 126. Dose responses of primary cultures of rat and human
                hepatocytes were determined using species-specific microarrays sharing over 4,000
                gene orthologs. Forty-seven human and 79 rat genes satisfied dose response criteria
                for both chemicals and were subjected to further analysis including the calculation
                of EC50 and the relative potency (REP) of PCB 126 for each gene. Only 5 responsive
                orthologous genes were shared between the two species, yet the geometric mean of the
                REPs for all rat and human modeled responsive genes were 0.06 (95% Confidence
                Interval (CI); 0.03-0.1) and 0.002 (95% CI; 0.001-0.005), respectively, suggesting
                broad species differences in the initial events that follow AHR activation but
                precede toxicity. This indicates that there are species differences in both the
                specific genes that responded and the agonist potency and relative potency for those
                genes. This observed insensitivity of human cells to PCB 126 is consistent with more
                traditional measurements of AHR activation (i.e., CYP1A1 enzyme activity) and
                suggests that the species difference in PCB 126 sensitivity is likely due to certain
                aspects of AHR function. That a species divergence also exists in this expanded
                AHR-regulated gene repertoire is a novel finding and should help when extrapolating
                animal data to humans. Experiment Overall Design: Primary hepatocyte cultures
                derived from 3 human donors were treated with vehicle (0.5% DMSO), TCDD (-14 to -6.5
                log10 M) , or PCB 126 (-12 to -5 log10 M) for 48h. Total RNA was extracted and
                screened with HG-U133A microarrays for dose response.</text>
        </description>
        <description>
            <id>1804921130</id>
            <text>(Generated description) Experiment with 40 hybridizations, using 40 samples of
                species [Homo sapiens], using 40 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 40 raw data files and 40 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="184">
        <id>1797791585</id>
        <accession>E-GEOD-17987</accession>
        <name>Transcription profiling of human pancreatic cancer treated with masitinib combined
            with standard gemcitabine chemotherapy</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17987</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799399617</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CEL_AGCC</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799399666</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17987.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Pascal FINETTI</contact>
            <email>finettip@marseille.fnclcc.fr</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797791605</id>
            <text>Masitinib is a tyrosine kinase inhibitor of c-Kit, PDGFR and , and to some extent
                Lyn of the Src kinase family. We evaluated the therapeutic potential of masitinib in
                vitro on human pancreatic tumour cell lines and in vivo in a mouse model of human
                pancreatic cancer. Experiment Overall Design: Expression patterns of masitinib
                tyrosine kinase targets including c-Kit, PDGFR and PDGFR were determined in four
                pancreatic tumour cell lines by PCR. Proliferation assays were performed with
                masitinib alone or in combination with gemcitabine. To determine the in vivo effects
                of masitinib, Nog-SCID mice were injected subcutaneously with MiaPaca 2 cells,
                randomised 28 days later and received one of the following treatments: vehicle
                control p.o., masitinib p.o., gemcitabine i.p., or a combination of masitinib plus
                gemcitabine. Additionally, the transcriptome of MiaPaca 2 cells for each of these
                conditions was determined with Affymetrix arrays.</text>
        </description>
        <description>
            <id>1799400378</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Homo sapiens], using 4 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 4 raw data files and 4 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="185">
        <id>1797792205</id>
        <accession>E-GEOD-16089</accession>
        <name>Transcription profiling of human Saos-2 osteosarcoma cells resistant to
            methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16089</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799402484</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799402632</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16089.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797792222</id>
            <text>A summary of the work associated to these microarrays is the following:; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are Saos-2 osteosarcoma cells sensitive to methotrexate and Saos-2
                cells resistant to 10e-6M methotrexate. Six samples are provided which correspond to
                triplicates of each cell line. The samples provided were analyzed using the specific
                software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799403457</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="186">
        <id>1797792781</id>
        <accession>E-GEOD-17806</accession>
        <name>Transcription profiling of neocortical fast-spiking GABAergic interneurons</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>15</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17806</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799402337</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17806.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ken Sugino</contact>
            <email>sugino@brandeis.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797792796</id>
            <text>Fast-spiking (FS) interneurons are important elements of neocortical circuitry
                that constitute the primary source of synaptic inhibition in adult cortex and impart
                temporal organization on ongoing cortical activity. The highly specialized intrinsic
                membrane and firing properties that allow cortical FS interneurons to perform these
                functions are attributable to equally specialized gene expression, which is
                ultimately coordinated by cell-type-specific transcriptional regulation. Although
                embryonic transcriptional events govern the initial steps of cell-type specification
                in most cortical interneurons, including FS cells, the electrophysiological
                properties that distinguish adult cortical cell types emerge relatively late in
                postnatal development, and the transcriptional events that drive this maturational
                process are not known. To address this, we used mouse whole-genome microarrays and
                whole-cell patch clamp to characterize the transcriptional and electrophysiological
                maturation of cortical FS interneurons between postnatal day 7 (P7) and P40. We
                found that the intrinsic and synaptic physiology of FS cells undergoes profound
                regulation over the first 4 postnatal weeks and that these changes are correlated
                with primarily monotonic but bidirectional transcriptional regulation of thousands
                of genes belonging to multiple functional classes. Using our microarray screen as a
                guide, we discovered that upregulation of two-pore K leak channels between P10 and
                P25 contributes to one of the major differences between the intrinsic membrane
                properties of immature and adult FS cells and found a number of other candidate
                genes that likely confer cell-type specificity on mature FS cells. Experiment
                Overall Design: We characterized the transcriptional maturation of genetically
                labeled FS interneurons in mouse S1 cortex using whole-genome microarrays.mRNA was
                harvested from manually sorted GFPexpressing neurons dissociated from acutely
                prepared brain slices at a range of developmental time points (P7, P10, P15, P25,
                and P40) and subsequently reverse transcribed, amplified, labeled, and hybridized to
                Affymetrix 430 2.0 whole-genome microarrays (three microarrays from three different
                animals per condition). We used the G42 transgenic mice described by Chattopadhyaya
                et al. (2004) for all experiments.</text>
        </description>
        <description>
            <id>1799404470</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 15 samples of
                species [Mus musculus], using 15 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 0 raw data files and 15 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="187">
        <id>1797793051</id>
        <accession>E-GEOD-16080</accession>
        <name>Transcription profiling of human cancer cell lines - networking of differentially
            expressed genes in human MDA-MB-468 breast cancer cells resistant to methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16080</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799402277</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799402399</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16080.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797793059</id>
            <text>A summary of the work associated to these microarrays is the following:; The need
                for an integrated view of all data obtained from high-throughput technologies gave
                rise to network analyses. These are especially useful to rationalize phenomena in
                terms of how external perturbations propagate through the expression of genes. To
                address this issue in the case of drug resistance, we constructed Biological
                Association Networks of genes differentially expressed in cell lines resistant to
                methotrexate (MTX). Seven cell lines representative of different types of cancer
                including colon cancer (HT29 and Caco2), breast cancer (MCF7 and MDA-MB-468),
                pancreatic cancer (MIA PaCa-2), erythroblastic leukemia (K562) and osteosarcoma
                (Saos-2), were used. The differential expression pattern between sensitive and
                MTX-resistant cells was determined by microarrays covering the whole human genome
                and analyzed with the GeneSpring GX software package, v.7.3.1. Genes deregulated in
                common in the two colon cancer cell lines studied, were subject of Biological
                Association Networks construction. Dikkopf homolog-1 (DKK1) was a clear node of this
                network, and functional validations of this target using a siRNA showed a
                chemosensitization toward MTX. Members of the UDP-glucuronosyltransferase 1A (UGT1A)
                family formed a network of differentially expressed genes in the two breast cancer
                cell lines studied. siRNA treatment against UGT1A showed also an increase in MTX
                sensitivity. Eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) was a gene
                overexpressed in common among the pancreatic cancer, leukemia and osteosarcoma cell
                lines, and siRNA treatment against EEF1A1 produced a chemosensitization toward MTX.
                Biological Association Networks identified DKK1, UGT1As and EEF1A1 as important gene
                nodes in MTX-resistance. Treatments using iRNA technology against these three genes
                show chemosensitization toward MTX. Experiment Overall Design: Two cell lines are
                compared, which are MDA-MB-468 breast cancer cells sensitive to methotrexate and
                MDA-MB-468 cells resistant to 10e-6M methotrexate. Six samples are provided which
                correspond to tripicates of each cell line. The sample provided were analyzed using
                the specific software GeneSpring GX.</text>
        </description>
        <description>
            <id>1799403316</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 6 raw data files and 6 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="188">
        <id>1797795328</id>
        <accession>E-GEOD-12675</accession>
        <name>Transcription profiling of chicken embryonic hears from Tibetan Chicken, Dwarf
            Recessive White Chicken and Shouguang Chicken</name>
        <releasedate>2009-09-12</releasedate>
        <species>Gallus gallus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Gallus gallus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12675</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1526273951</id>
            <accession>A-AFFY-103</accession>
            <name>Affymetrix GeneChip Chicken Genome Array [Chicken]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1799402367</id>
            <name>Affymetrix:FeatureDimension:Chicken</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1799402714</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12675.Chicken.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>mei li</contact>
            <email>meili.emily@gmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797795339</id>
            <text>Adaptation to hypoxia is a complicated and important physiological course for
                organisms, but the genetic mechanism underlying the adaptation is not fully
                understood yet. Tibetan Chicken (T), an indigenous chicken breed in China which
                inhabit in high areas with an altitude above 2,900 meters. Shouguang Chicken(S) and
                Dwarf Recessive White Chicken (DRW), two lowland chicken breeds, were used as
                control groups. The heart was the first functional organ to develop during the
                embryonic development. Furthermore, the heart is an efficient energy converter
                utilizing the most appropriate fuel for a given environment. Therefore, GeneChip
                Chicken Genome Array was employed to identify the differentially expressed genes in
                embryonic hearts of Tibetan Chicken and two lowland chicken breeds in both hypoxic
                and normoxic incubating environments with a genome wide profile. Experiment Overall
                Design: To obtain general expression profiles of embryonic hearts in Tibetan
                Chicken(T), Dwarf Recessive White Chicken (DRW)and Shouguang Chicken (S)in hypoxia
                and normoxia, the fertilized full sib eggs of all the three chicken breeds were
                incubated under two different conditions. The heart was isolated from all the three
                chicken breeds under the two different conditions for RNA extraction and
                hybridization on Affymetrix microarrays.</text>
        </description>
        <description>
            <id>1799404458</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Gallus gallus], using 12 arrays of array design [Affymetrix GeneChip
                Chicken Genome Array [Chicken]], producing 12 raw data files and 12 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="189">
        <id>1797796830</id>
        <accession>E-GEOD-17962</accession>
        <name>Transcription profiling of regulatory T cells with Stat3 ablation</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17962</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>2</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797806022</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>2</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797806042</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17962.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>2</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>2</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ashutosh Chaudhry</contact>
            <email>chaudha1@mskcc.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797796847</id>
            <text>We used microarrays to detail the global programme of gene expression dependent
                upon Stat3 in regulatory T cells Experiment Overall Design: Regulatory T cells
                isolated from Foxp3&lt;Cre/wtS&gt; Stat3&lt;fl/wt&gt; or Foxp3
                &lt;Cre/wt&gt; Stat3 &lt;fl/fl&gt; were isolated using FACS based
                sorting followed by RNA extraction, amplification, labeling and hybridization on
                Affymatrix Microarray</text>
        </description>
        <description>
            <id>1797806188</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Mus musculus], using 2 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 2 raw data files and 2 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="190">
        <id>1797799439</id>
        <accession>E-GEOD-17929</accession>
        <name>Transcription profiling of rat (Sprague Dawley) brain subjected to MCAo.</name>
        <releasedate>2009-09-12</releasedate>
        <species>Rattus norvegicus</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17929</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>114147931</id>
            <accession>A-AFFY-18</accession>
            <name>Affymetrix GeneChip Rat Genome U34A [RG_U34A]</name>
            <count>4</count>
        </arraydesign>
        <arraydesign>
            <id>232122446</id>
            <accession>A-AFFY-25</accession>
            <name>Affymetrix GeneChip Rat Expression Array RAE230A [RAE230A]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797804166</id>
            <name>Affymetrix:FeatureDimension:RAE230A</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797804103</id>
            <name>Affymetrix:FeatureDimension:RG_U34A</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797804710</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17929.RAE230A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797804534</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17929.RG_U34A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Kandiah Jeyaseelan</contact>
            <email>bchjeya@nus.edu.sg</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797799455</id>
            <text>Middle cerebral artery occlusion (MCAo) in rat represent the ischemic stroke in
                human. Rodents subjected to MCAo and treated with venom phospholipase A2 showed
                reduction in infarct volume after 24hours of stroke. We studied the global gene
                expression of the reduction in infarct volume using Affymetrix Gene Chips. We
                analysed all the genes that were up or down regulated in the study. Experiment
                Overall Design: Total RNA isolated from sham, MCAo and MCAo+nPLA rat brains, was
                pooled to minimize inter-individual variation and hybridized to each array of the
                RAE-230A or U34A GeneChipTM according to protocols described in the GeneChipTM
                expression analysis package (Affymetrix, CA).</text>
        </description>
        <description>
            <id>1797805929</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Rattus norvegicus], using 8 arrays of array design [Affymetrix GeneChip Rat
                Expression Array RAE230A [RAE230A], Affymetrix GeneChip Rat Genome U34A [RG_U34A]],
                producing 8 raw data files and 8 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="191">
        <id>1797800099</id>
        <accession>E-GEOD-17550</accession>
        <name>Transcription profiling of bone marrow derived macrophages in vitro-infected
            (Leishmania major) vs uninfected</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17550</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>25874048</id>
            <accession>A-AFFY-6</accession>
            <name>Affymetrix GeneChip Murine Genome U74Av2 [MG_U74Av2]</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797801847</id>
            <name>Affymetrix:FeatureDimension:MG_U74Av2</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>8</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797804126</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17550.MG_U74Av2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Gordon Smyth</contact>
            <email>smyth@wehi.edu.au</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797800113</id>
            <text>Gene expression profiles of in vitro-infected (Leishmania major) and uninfected
                bone-marrow-derived macrophages from BALB/c, C57BL/6, C.B6-(lmr1, lmr2) and
                B6.c-(lmr1, lmr2) mouse strains. We utilised microarrays to investigate a number of
                issues. Firstly, we determined which genes were differentially regulated in
                macrophages in response to infection with Leishmania major. Secondly, we hoped to
                gain some insight into the differences between C-B6-(lmr1, lmr2) congenic mice and
                their parental control BALB/c, as well as differences between B6-c-(lmr1, lmr2) and
                their parental control C57BL/6. This would aid us in the search for the genes
                underlying our loci, since the only genomic regions differing between the two
                strains are those of the two congenic intervals on chromosomes 9 and 17. Any genes
                differentially regulated would be contributing to the experimental infection
                differences observed between the congenic mice and their parental controls.
                Experiment Overall Design: L. major-infected and uninfected bone marrow-derived
                macrophages from C57BL/6, BALB/c, B6.c-(lmr1, lmr2) and C.B6-(lmr1, lmr2) mice were
                analyzed. Macrophages from 6 mice were pooled for each sample.</text>
        </description>
        <description>
            <id>1797805917</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Mus musculus], using 8 arrays of array design [Affymetrix GeneChip Murine
                Genome U74Av2 [MG_U74Av2]], producing 8 raw data files and 8 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="192">
        <id>1797800665</id>
        <accession>E-GEOD-13908</accession>
        <name>Transcription profiling of nouse intestinal epithelial cells of germ-free versus
            wildtype mice</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13908</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>4</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797809915</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>4</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797809957</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13908.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>4</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>4</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Knut Kotarsky</contact>
            <email>Knut.Kotarsky@med.lu.se</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797800678</id>
            <text>Gene expression was analyzed in intestinal epithelial cells of germ-free and
                wildtype mice. Experiment Overall Design: Ileums and proximal colons of 4 C57/Bl6
                control and 4 C57/BL6 germ-free mice were collected and embedded in OCT. Tissue
                sectioned (10 mikroM) and laser capture microscopy was performed using a Zeiss/Palm
                laser capture system. Total RNA was extracted from about 16000 cells of the
                catapulted samples using RNA microprep kit (Stratagene). These 16 000 cells derive
                from all 4 animals (pooled approx. 4 000 cells from each mouse). We retrieved
                between 50 and 150 ng total RNA. Fourty ng total RNA was expanded by two rounds of
                in vitro cRNA amplification and affymetrix genechip Moe403 were probed at the
                Swegene Resource Center Lund, Sweden. Array data analysis was performed using
                dCHIP2004 software.</text>
        </description>
        <description>
            <id>1797810452</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Mus musculus], using 4 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 4 raw data files and 4 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="193">
        <id>1797801155</id>
        <accession>E-GEOD-17153</accession>
        <name>Re-sequencing of RNAs from C. elegans embryos</name>
        <releasedate>2009-09-12</releasedate>
        <species>Caenorhabditis elegans</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Caenorhabditis elegans</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17153</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797783523</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-17153.VirtualArrayDesign</accession>
            <count>6</count>
        </arraydesign>
        <provider>
            <contact>Jonas Maaskola</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797801193</id>
            <text>Caenorhabditis elegans is one of the most prominent model systems to study
                embryogenesis. However, it has been impractical to collect large amounts of
                precisely staged embryos. Thus, early C. elegans embryogenesis has not been amenable
                to most modern high-throughput genomics or biochemistry assays. To overcome this
                problem, we devised a method to collect large amounts of cleanly staged C. elegans
                embryos by Fluorescent Activated Cell Sorting (termed eFACS). eFACS can in principle
                be applied to all embryonic developmental stages up to hatching. As a proof of
                principle we show that a single eFACS run routinely yields tens of thousands of
                almost perfectly staged one-cell embryos. Since in animals the earliest embryonic
                events are driven by post-transcriptional regulation, we combined eFACS with
                next-generation sequencing technology to systematically profile the embryonic
                expression of small, non-coding RNAs. We discovered a wealth of complex and
                orchestrated changes in the expression between and within almost all classes of
                small RNAs, including miRNAs, during embryogenesis. Our data indicate that half of
                all known miRNAs are already expressed in the one-cell stage embryo and we also shed
                light on the expression and genomic organization of the previously under-appreciated
                26G-RNAs. Together, our eFACS data suggest that the complexity of small RNA
                expression dynamics in animals is comparable to the expression dynamics of protein
                encoding genes. Experiment Overall Design: Various C. elegans embryo samples were
                generated: mixed embryos by traditional bleaching (Brenner, 1974), early embryos by
                eFACS (Stoeckius et al., in press). RNA was extracted and length fractionated. Small
                RNA was subjected to a 5'-dependent ligation protocol to add sequencing adapters.
                The small RNA samples were sequenced using the Illumina GA I &amp; II.</text>
        </description>
        <description>
            <id>1799403244</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Caenorhabditis elegans], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-17153], producing 0 raw data files and 6 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="194">
        <id>1797802447</id>
        <accession>E-GEOD-17923</accession>
        <name>Transcription profiling of mouse white Adipose Tissue of KSR2-/- vs wild type
            mice</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17923</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797809928</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797809982</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17923.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Robert Lewis</contact>
            <email>kfisher@unmc.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797802470</id>
            <text>The goal of this study was to define the gene expression changes that take place
                in the white adipose tissue of KSR2-/- mice at 6 months of age. Experiment Overall
                Design: Three wild type mice and three KSR2-/- mice were used for total RNA
                extraction from white adipose tissue. The RNA from each mouse was analyzed on one
                Affymetrix gene chip and the differences were compared using Gene Set Enrichment
                Analysis.</text>
        </description>
        <description>
            <id>1797810552</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Mus musculus], using 6 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 6 raw data files and 6 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="195">
        <id>1797802529</id>
        <accession>E-GEOD-17959</accession>
        <name>Transcription profiling of rats treated with nandrolone with denervation</name>
        <releasedate>2009-09-12</releasedate>
        <species>Rattus norvegicus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17959</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797814460</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797814609</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17959.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Weiping Qin</contact>
            <email>weiping.qin@mssm.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797802547</id>
            <text>We showed that nandrolone attenuated subacute, but not acute, denervation atrophy
                and upregulation of MAFbx. The present study explored the molecular determinants for
                this time-dependent effect using microarray analysis to identify genes that were
                differentially regulated by administration of nandrolone for 7 days beginning either
                concomitantly with denervation (7 days) or 29 days later (35 days) Experiment
                Overall Design: The analysis used gastrocnemius muscle from male Wistar-Hannover
                rats that had undergone left sciatic nerve transaction followed by the
                administration of nandrolone or vehicle beginning either on the day of surgery or 29
                days thereafter. Animals had been sacrificed 7 days after starting nandrolone (Nan)
                or vehicle (Veh) (e.g, at days 7 or 35).</text>
        </description>
        <description>
            <id>1797815678</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Rattus norvegicus], using 12 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 12 raw data files and 12 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="196">
        <id>1797802755</id>
        <accession>E-GEOD-16873</accession>
        <name>Transcription profiling of human patient-matched histologically normal (HN), ADH, and
            DCIS from 12 patients with ER+ sporadic breast cancer - early dysregulation of cell
            adhesion and extracellular matrix pathways in breast cancer progression</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>40</samples>
        <assays>40</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16873</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>40</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797808086</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>40</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797808157</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16873.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>40</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19700746</accession>
            <authors>Lyndsey A Emery, Anusri Tripathi, Chialin King, Maureen Kavanah, Jane Mendez,
                Michael D Stone, Antonio de las Morenas, Paola Sebastiani, Carol L
                Rosenberg</authors>
            <title>Early dysregulation of cell adhesion and extracellular matrix pathways in breast
                cancer progression.</title>
        </bibliography>
        <provider>
            <contact>Lyndsey Emery</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797802776</id>
            <text>Proliferative breast lesions, such as simple ductal hyperplasia (SH) and atypical
                ductal hyperplasia (ADH), are candidate precursors to ductal carcinoma in situ
                (DCIS) and invasive cancer. To better understand their relationship to more advanced
                disease, we used microdissection and DNA microarrays to profile the gene expression
                of patient-matched histologically normal (HN), ADH, and DCIS from 12 patients with
                ER+ sporadic breast cancer. SH were profiled from a subset of cases. We found 837
                differentially expressed genes between DCIS-HN and 447 between ADH-HN, with
                &gt;90% of the ADH-HN genes also present among the DCIS-HN genes. Only 61 genes
                were identified between ADH-DCIS. Expression differences were reproduced in an
                independent cohort of patient-matched lesions by qRT-PCR. Many breast cancer-related
                genes and pathways were dysregulated in ADH and maintained in DCIS. Particularly,
                cell adhesion and extracellular matrix (ECM) interactions were overrepresented.
                Focal adhesion was the top pathway in each gene set. We conclude that ADH and DCIS
                share highly similar gene expression and are distinct from HN. In contrast, SH
                appear more similar to HN. These data provide genetic evidence that ADH (but not SH)
                are often precursors to cancer and suggest cancer-related genetic changes,
                particularly adhesion and ECM pathways, are dysregulated prior to invasion and even
                before malignancy is apparent. These findings could lead to novel risk
                stratification, prevention, and treatment approaches. Patient-matched (HN, SH, ADH,
                DCIS) samples were isolated from within patients with ER+ sporadic breast cancers
                via laser capture microdissection. Use of patient-matched samples decreases between
                patient variations. Experiment Overall Design: Forty total samples were analyzed via
                Affymetrix U133A. Patient age ranged from 48-92. Case numbers correspond to
                individual patients. Each sample is identified by case number, histologic lesion and
                corresponding microarray ID.</text>
        </description>
        <description>
            <id>1797808939</id>
            <text>(Generated description) Experiment with 40 hybridizations, using 40 samples of
                species [Homo sapiens], using 40 arrays of array design [Affymetrix GeneChip Human
                Genome HG-U133A [HG-U133A]], producing 40 raw data files and 40 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="197">
        <id>1797803530</id>
        <accession>E-GEOD-17925</accession>
        <name>Transcription profiling of primary mouse hepatocytes either TCDD treated C57BL6/J and
            or expressing human Aryl hydrocarbon Receptor</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17925</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797809931</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797810123</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17925.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Gary Perdew</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797803546</id>
            <text>The human and mouse aryl hydrocarbon receptor (hAHR and mAHRb) share limited (58%)
                transactivation domain sequence identity. Compared to the mAHRb allele, the hAHR
                displays 10-fold lower relative affinity for prototypical ligands such as 2,3,7,8
                tetrachlorodibenzo-p-dioxin (TCDD). However, in previous studies we have
                demonstrated that the hAHR can display a higher relative ligand binding affinity
                than the mAHRb for specific AHR ligands such as indirubin. Each receptor has also
                been shown to differentially recruit LXXLL co-activator-motif proteins and to
                utilize different TAD subdomains in gene transactivation. Using hepatocytes isolated
                from C57BL6/J mice (Ahrb/b) and AHRTtr transgenic mice which express hAHR protein
                specifically in hepatocytes, we investigated whether the hAHR and mAHRb
                differentially regulate genes. Microarray and quantitative-PCR analysis of Ahrb/b
                and AHRTtr primary-mouse hepatocytes treated with 10 nM TCDD revealed that a number
                of established AHR target genes such as Cyp1a1 and Cyp1b1 are significantly induced
                by both receptors. Remarkably, of the 1752 genes induced by mAHRb and 1186 genes
                induced by hAHR, only 265 genes (&lt;10%) were significantly activated by both
                receptors in response to TCDD. Conversely of the 1100 and 779 genes significantly
                repressed in mAHRb and hAHR hepatocytes respectively, only 462 (&lt;25%) genes
                were significantly repressed by both receptors in response to TCDD treatment. Genes
                identified as differentially expressed are known to be involved in a number of
                biological pathways, including cell proliferation and inflammatory response which
                suggests that compared to the mAHRb, the hAHR may play contrasting roles in
                TCDD-induced toxicity and endogenous AHR-mediated gene regulation. Experiment
                Overall Design: Isolated mouse hepatocytes from wild type and treated with 10nM TCDD
                for 6h were analyzed. 1 array per mouse (3 mice per treatment group) was
                used.GeneChip Operating Software (Affymetrix) was utilized to preprocess CAB/CEL
                files generated from the 12 scanned microarrays which represented hepatocytes
                isolated from one mouse each. Data quality was initially assessed by checking the
                array image, B2 oligo performance, average background to noise ratios, poly-A
                controls, hybridization controls and the 3' to 5' probe-set ratios for control genes
                (e.g. -actin or GAPDH). Microarray data was normalized using Probe Logarithmic
                Intensity Error Approximation PLIER-MM algorithm (Affymetrix Expression Console
                Software 1.1). Normalized microarray data outputs from TCDD and control treated
                Ahrb/band AHRTtr hepatocytes were compared for differential expression using
                Significance Analysis of Microarrays (SAM, version 2.23A (Pan 2002; Tusher et al.
                2001)) with 100 permutations, KNN-10.</text>
        </description>
        <description>
            <id>1797810685</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 12 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="198">
        <id>1797803597</id>
        <accession>E-GEOD-17254</accession>
        <name>Transcription profiling of human and moise primary hepatocytes from 12 donors were
            treated with PPARI? agonist Wy14643</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <species>Mus musculus</species>
        <samples>48</samples>
        <assays>48</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17254</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>24</count>
        </arraydesign>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>24</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797819917</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17254.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797819908</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17254.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>24</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>24</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19710929</accession>
            <authors>Maryam Rakhshandehroo, Guido Hooiveld, Michael M ller, Sander Kersten</authors>
            <title>Comparative analysis of gene regulation by the transcription factor PPARalpha
                between mouse and human.</title>
        </bibliography>
        <provider>
            <contact>Guido Hooiveld</contact>
            <email>guido.hooiveld@wur.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797821250</id>
            <text>(Generated description) Experiment with 48 hybridizations, using 48 samples of
                species [Homo sapiens, Mus musculus], using 48 arrays of array design [Affymetrix
                GeneChip Mouse Genome 430 2.0 [Mouse430_2], Affymetrix GeneChip Human Genome U133
                Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 48 transformed and/or
                normalized data files.</text>
        </description>
        <description>
            <id>1797803607</id>
            <text>Studies in mice have shown that PPAR is an important regulator of hepatic lipid
                metabolism and the acute phase response. However, little information is available on
                the role of PPAR in human liver. Here we set out to compare the function of PPAR in
                mouse and human hepatocytes via analysis of target gene regulation. Primary
                hepatocytes from 6 human and 6 mouse donors were treated with PPAR agonist Wy14643
                and gene expression profiling was performed using Affymetrix GeneChips followed by a
                systems biology analysis. Baseline PPAR expression was similar in human and mouse
                hepatocytes. Depending on species and time of exposure, Wy14643 significantly
                induced the expression of 362-672 genes. Surprisingly minor overlap was observed
                between the Wy14643-regulated genes from mouse and human, although more substantial
                overlap was observed at the pathway level. Xenobiotics metabolism and apolipoprotein
                synthesis were specifically regulated by PPAR in human hepatocytes, whereas
                glycolysis-gluconeogenesis was regulated specifically in mouse hepatocytes. Most of
                the genes commonly regulated in mouse and human were involved in lipid metabolism
                and many represented known PPAR targets, including CPT1A, HMGCS2, FABP, ACSL, and
                ADFP. Several genes were identified that were specifically induced by PPAR in human
                (MBL2, ALAS1, CYP1A1, TSKU) or mouse (Fbp2, lgals4, Cd36, Ucp2, Pxmp4). Furthermore,
                several putative novel PPAR targets were identified that were commonly regulated in
                both species, including CREB3L3, KLF10, KLF11 and MAP3K8. Our results suggest that
                PPAR activation has a major impact on gene regulation in human hepatocytes.
                Importantly, the role of PPAR as master regulator of hepatic lipid metabolism is
                generally well-conserved between mouse and human. Overall, however, PPAR regulates a
                mostly divergent set of genes in mouse and human hepatocytes. GSE17250: Comparative
                analysis of gene regulation by the transcription factor PPAR _mouse; GSE17251:
                Comparative analysis of gene regulation by the transcription factor PPAR _human
                Experiment Overall Design: Refer to individual Series</text>
        </description>
    </experiment>
    <experiment textidx="199">
        <id>1797805216</id>
        <accession>E-GEOD-17817</accession>
        <name>Transcription profiling of mouse cancer associated fibroblasts (CAFs) reveals are
            activation in incipient neoplasia to orchestrate tumor promoting inflammation in an
            NF-I?B-dependent manner.</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17817</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797809904</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797809967</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17817.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Neta Erez</contact>
            <email>nerez@diabetes.ucsf.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797805233</id>
            <text>Full title: Cancer Associated Fibroblasts are activated in incipient neoplasia to
                orchestrate tumor promoting inflammation in an NF- B-dependent manner. Cancer
                Associated Fibroblasts (CAFs) support tumorigenesis by stimulating angiogenesis,
                cancer cell proliferation, and invasion. We demonstrate that CAFs also mediate
                tumor-enhancing inflammation. Using a mouse model of squamous skin cancer, we found
                a pro-inflammatory gene signature in CAFs isolated from dysplastic skin. This
                signature was also evident in CAFs from skin as well as mammary and pancreatic
                tumors in mice, and in human cancer. Surprisingly, the inflammatory signature was
                already activated in CAFs isolated from the incipient hyperplastic stage in
                multistep tumorigenesis. CAFs from this pathway functioned to promote macrophage
                recruitment, neovascularization and tumor growth in vivo, activities abolished when
                NF- B signaling was inhibited. Additionally, we show that normal dermal fibroblasts
                can be educated by carcinoma cells to express pro-inflammatory genes. Experiment
                Overall Design: We performed expression profiling analysis of dermal fibroblasts
                sorted from dysplastic skin tissue of K14-HPV16 mice, and from age matched non
                transgenic controls. This array analysis was repeated in triplicate. Amplified RNA
                was hybridized to the 430 2.0 Affymetrix mouse genome arrays.</text>
        </description>
        <description>
            <id>1797810563</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Mus musculus], using 6 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 6 raw data files and 6 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="200">
        <id>1797805428</id>
        <accession>E-GEOD-16464</accession>
        <name>Transcription profiling of human Articular chondrocytes from patients with OA
            undergoing total knee replacement (Mankin Score &gt;3, Ahlb??ck Score &gt;2) and
            from patients undergoing ACT</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16464</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797816975</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16464.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Tilo Dehne</contact>
            <email>tilo.dehne@charite.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797805444</id>
            <text>Autologous chondrocyte transplantation (ACT) is a routine technique to regenerate
                focal cartilage lesions. However, patients with osteoarthritis (OA) are lacking an
                appropriate long-lasting treatment alternative, partly since it is not known if
                chondrocytes from OA patients have the same chondrogenic differentiation potential
                as chondrocytes from donors not affected by OA. Articular chondrocytes from patients
                with OA undergoing total knee replacement (Mankin Score &gt;3, Ahlb ck Score
                &gt;2) and from patients undergoing ACT, here referred to as normal donors (ND),
                were isolated applying protocols used for ACT. Their chondrogenic differentiation
                potential was evaluated both in high-density pellet and scaffold (Hyaff-11) cultures
                by histological proteoglycan assessment (Bern Score) and immunohistochemistry for
                collagen types I and II. Chondrocytes cultured in monolayer and scaffolds were
                subjected to gene expression profiling using genome-wide oligonucleotide
                microarrays. Expression data were verified by using quantitative RT-PCR.
                Chondrocytes from ND and OA donors demonstrated accumulation of comparable amounts
                of cartilage matrix components, including sulphated proteoglycans and collagen types
                I and II. The mRNA expression of cartilage markers (COL2A1, COMP, aggrecan, CRTL1,
                SOX9) and genes involved in matrix synthesis (biglycan, COL9A2, COL11A1, TIMP4,
                CILP2) was highly induced in 3D cultures of chondrocytes from both donor groups.
                Genes associated with hypertrophic or OA cartilage (COL10A1, RUNX2, periostin, ALP,
                PTHR1, MMP13, COL1A1, COL3A1) were not significantly regulated between the two
                groups of donors. The expression of 661 genes, including COMP, FN1, and SOX9, were
                differentially regulated between OA and ND chondrocytes cultured in monolayer.
                During scaffold culture, the differences diminished between the OA and ND
                chondrocytes, and only 184 genes were differentially regulated. Only few genes were
                differentially expressed between OA and ND chondrocytes in Hyaff-11 culture. The
                risk of differentiation into hypertrophic cartilage does not seem to be increased
                for OA chondrocytes. Our findings suggest that the chondrogenic capacity is not
                significantly affected by OA and OA chondrocytes fulfill the requirements for
                matrix-associated ACT. Experiment Overall Design: Gene expression profiles of
                monolayer cultures (ML; passage 2) and Hyaff-11 scaffold cultures (3D; 14 days in
                vitro) of chondrocytes from 3 normal donors (ND; underwent ACT treatment) and 3
                donors suffering from Osteoarthritis (OA; underwent knee replacement surgery) were
                determined. Comparative analyses between 3D and ML cultures (3D vs. ML) were
                performed to assess differentiation capacity of ND and OA chondrocytes. Furthermore,
                OA-related differences were determined comparing OA and ND monolayers as well as
                scaffold cultures (each OA vs. ND).</text>
        </description>
        <description>
            <id>1797817172</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Homo sapiens], using 12 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 0 raw data files and 12
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="201">
        <id>1797812101</id>
        <accession>E-GEOD-17307</accession>
        <name>Transcription profiling of human GRE specific DNA-binding polyamide effect on
            dexamethasone-stimulated lung adenocarcinoma cell line</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>15</samples>
        <assays>15</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17307</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>15</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797820128</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>15</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797820165</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17307.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>15</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>15</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Peter Dervan</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797812112</id>
            <text>Analysis of dexamethasone-stimulated A549 lung adenocarcinoma epithelial cells
                treated with a glucocorticoid response (GR) element (GRE) specific DNA binding
                polyamide. Polyamide designed to target the sequence 5'-WGWWCW-3' and disrupt
                GR-mediated gene expression. Effects of the GR antagonist mifepristone also
                examined. Experiment Overall Design: A549 cells were treated with compounds for 48
                hours before RNA extraction and hybridization on Affymetrix microarrays.</text>
        </description>
        <description>
            <id>1797820789</id>
            <text>(Generated description) Experiment with 15 hybridizations, using 15 samples of
                species [Homo sapiens], using 15 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 15 raw data files and 15
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="202">
        <id>1797815029</id>
        <accession>E-GEOD-13933</accession>
        <name>Transcription profiling of human trachea epithelium in smokers and non smokers</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>87</samples>
        <assays>87</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13933</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>87</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797820297</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>87</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>87</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797820824</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13933.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>87</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>87</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Jacqueline Salit</contact>
            <email>jas2038@med.cornell.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797815042</id>
            <text>The initial site of smoking-induced lung disease is the small airway epithelium,
                which is difficult and time consuming to sample by fiberoptic bronchoscopy. We
                developed a rapid, office-based procedure to obtain trachea epithelium without
                conscious sedation from healthy nonsmokers (n=26) and healthy smokers (n=19, 27 15
                pack-yr). Gene expression differences [fold-change &gt;1.5, p&lt; 0.01,
                Benjamini-Hochberg correction] were assessed with Affymetrix microarrays. 1,057
                probe sets were differentially expressed in healthy smokers vs nonsmokers,
                representing &gt;500 genes. Trachea gene expression was compared to an
                independent group of small airway epithelial samples (n=23 healthy nonsmokers, n=19
                healthy smokers, 25 12 pack-yr). The trachea epithelium is more sensitive to
                smoking, responding with 3-fold more differentially-expressed genes than small
                airway epithelium. The trachea transcriptome paralleled the small airway epithelium,
                with 156 of 167 (93%) genes that are significantly up- and down-regulated by smoking
                in the small airway epithelium showing similar direction and magnitude of response
                to smoking in the trachea. Trachea epithelium can be obtained without conscious
                sedation, representing a less invasive surrogate canary for smoking-induced changes
                in the small airway epithelium. This should prove useful in epidemiologic studies
                correlating gene expression with clinical outcome in assessing smoking-induced lung
                disease. Experiment Overall Design: Tracheal gene expression: matched group of small
                airway epithelial samples (n=23 healthy non-smokers, n= 19 healthy smokers)</text>
        </description>
        <description>
            <id>1797822750</id>
            <text>(Generated description) Experiment with 87 hybridizations, using 87 samples of
                species [Homo sapiens], using 87 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 87 raw data files and 87
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="203">
        <id>1797816558</id>
        <accession>E-GEOD-17781</accession>
        <name>Re-sequencing of C. elegans to produce an encyclopedia of C. elegans 3 prime UTRs and
            their regulatory elements - ModEncode</name>
        <releasedate>2009-09-12</releasedate>
        <species>Caenorhabditis elegans</species>
        <samples>17</samples>
        <assays>17</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Caenorhabditis elegans</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17781</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797805302</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-17781.VirtualArrayDesign</accession>
            <count>17</count>
        </arraydesign>
        <provider>
            <contact>Kristin Gunsalus</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797816566</id>
            <text>The 3' untranslated region (3'UTR) constitutes a major site of
                post-transcriptional regulation of gene expression. Sequence elements in the 3'UTR
                interact with trans-acting regulators such as microRNAs that affect translation and
                stability. The overall aim is to use a 3'RACE cloning-sequencing stragety to
                identify the 3'UTRs of C. elegans transcripts and explore their heterogeneity in
                different developmental stages and tissues. For data usage terms and conditions,
                please refer to http://www.genome.gov/27528022 and
                http://www.genome.gov/Pages/Research/ENCODE/ENCODEDataReleasePolicyFinal2008.pdf
                Experiment Overall Design: pilot study [GSM443959..GSM443964]: N2 wildtype worms
                staged at embryo, L1, L2, L3, L4, and adult Experiment Overall Design: full
                experiment [GSM446651..GSM446661]: N2 wildtype worms staged at embryo, L1, L2, L3,
                L4, dauer, and adult.</text>
        </description>
        <description>
            <id>1797816866</id>
            <text>(Generated description) Experiment with 17 hybridizations, using 17 samples of
                species [Caenorhabditis elegans], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-17781], producing 0 raw data files and 17 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="204">
        <id>1797817010</id>
        <accession>E-GEOD-17703</accession>
        <name>Transcription profiling of human bone marrow gene expression of pediatric acute
            lymphoblastic leukemia (ALL)</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>101</samples>
        <assays>101</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17703</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>458263473</id>
            <accession>A-AFFY-37</accession>
            <name>Affymetrix GeneChip Human Genome U133A 2.0 [HG-U133A_2]</name>
            <count>101</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797823518</id>
            <name>Affymetrix:FeatureDimension:HG-U133A_2</name>
            <bioassaydatacubes>101</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>101</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797823833</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17703.HG-U133A_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>101</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>101</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Nan Qiao</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797817027</id>
            <text>Pediatric acute lymphoblastic leukemia (ALL) contains cytogenetically distinct
                subtypes that respond differently to cytotoxic drugs. Subtype classification can be
                also achieved through gene expression profiling. However, how to apply such
                classifiers to a single patient and correctly diagnose the disease subtype in an
                independent patient group has not been addressed. Furthermore, the underlying
                regulatory mechanisms responsible for the subtype-specific gene expression patterns
                are still largely unknown. Here, by combining three published microarray datasets
                (PMIDs: 12086872, 12730115, 17002788) on 535 Caucasian samples and generating a new
                dataset on 100 Chinese children ALL samples, we were able to 1) identify a 62-gene
                classifier with 97.6% accuracy from the Caucasian samples and validated it on the
                completely independent set of 100 Chinese samples, 2) to uncover potential
                regulatory networks of ALL subtypes. The classifier we identified was so far the
                only one that could be applied directly to a single sample and sustained validation
                in a large independent patient group. Our results also suggest that the etiology of
                ALL is largely the same among different ethnic groups, and that the transcription
                factor hubs in the predicted regulatory network might play important roles in
                regulating gene expression and development of ALL. Experiment Overall Design: A
                total of 100 Chinese pediatric acute lymphoblastic leukemia bone marrow (BM) samples
                were analyzed, together with five non-ALL BM samples as negative control (the five
                samples were combined to generate one control, see details in Li et al. Blood,
                2009). The diagnosis of ALL was based on morphology, immunology, cytogenetic and
                molecular (MICM) classification. Cytogenetic ALL subtypes were identified
                experimentally by G-banding karyotype and multiplex nested RT-PCR. Among the 100 ALL
                patients, eleven relapsed within five years. All the samples, including those
                relapsed afterward, were from patients treated on BCH-2003 protocol and were
                extracted at their initial diagnosis. The five non-ALL BM samples were taken from
                the removed bones of patients who had plastic surgery for their bone deformity in
                Beijing Children s Hospital. And the informed consent was obtained from parents,
                guardians, or patients (as appropriate). More details are available in Li et al.
                Gene expression-based classification and regulatory networks of pediatric acute
                lymphoblastic leukemia, Blood, 2009. Experiment Overall Design: We have generated
                these ALL and control samples to validate that a high accuracy subtype classifier
                that we identified could be applied directly to a single sample and sustained
                validation in a large independent patient group.</text>
        </description>
        <description>
            <id>1797831000</id>
            <text>(Generated description) Experiment with 101 hybridizations, using 101 samples of
                species [Homo sapiens], using 101 arrays of array design [Affymetrix GeneChip Human
                Genome U133A 2.0 [HG-U133A_2]], producing 101 raw data files and 101 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="205">
        <id>1797817036</id>
        <accession>E-GEOD-14555</accession>
        <name>Transcription profiking of rat and human primary hepatocytes response to aryl
            hydrocarbon receptor agonists </name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <species>Rattus norvegicus</species>
        <samples>66</samples>
        <assays>66</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14555</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>114147931</id>
            <accession>A-AFFY-18</accession>
            <name>Affymetrix GeneChip Rat Genome U34A [RG_U34A]</name>
            <count>26</count>
        </arraydesign>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>40</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797820296</id>
            <name>Affymetrix:FeatureDimension:RG_U34A</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>26</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797820348</id>
            <name>Affymetrix:FeatureDimension:HG-U133A</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>40</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797820730</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14555.RG_U34A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>26</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>26</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797820719</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14555.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>40</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>40</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Erik Carlson</contact>
            <email>carlson@ge.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797817047</id>
            <text>This SuperSeries is composed of the following subset Series:; GSE14553:
                Toxicogenomic Comparison of TCDD and PCB 126 Responsiveness in Primary Human
                Hepatocytes; GSE14554: Toxicogenomic Comparison of TCDD and PCB 126 Responsiveness
                in Primary Rat Hepatocytes Experiment Overall Design: Refer to individual
                Series</text>
        </description>
        <description>
            <id>1797822412</id>
            <text>(Generated description) Experiment with 66 hybridizations, using 66 samples of
                species [Homo sapiens, Rattus norvegicus], using 66 arrays of array design
                [Affymetrix GeneChip Rat Genome U34A [RG_U34A], Affymetrix GeneChip Human Genome
                HG-U133A [HG-U133A]], producing 66 raw data files and 66 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="206">
        <id>1797818869</id>
        <accession>E-GEOD-16648</accession>
        <name>Transcription profiling of human cancer cell lines resistant to methotrexate</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>42</samples>
        <assays>42</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE16648</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>42</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797822401</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>42</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>42</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797822570</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16648.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>29</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797822596</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-16648.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>13</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>13</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19732436</accession>
            <authors>Oleaga Selga, de Almagro Ramirez, Ciudad Noe</authors>
            <title>Networking of differentially expressed genes in human cancer cells resistant to
                methotrexate.</title>
        </bibliography>
        <provider>
            <contact>carlos ciudad</contact>
            <email>cciudad@ub.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797818878</id>
            <text>This SuperSeries is composed of the following subset Series:; GSE11440: Role of
                Caveolin 1, E-Cadherin, Enolase 2 and PKCa on resistance to methotrexate in human
                HT29 colon cancer cells; GSE16066: Networking of differentially expressed genes in
                CaCo2 human colon cancer cells resistant to methotrexate; GSE16070: Networking of
                differentially expressed genes in human MCF7 breast cancer cells resistant to
                methotrexate; GSE16080: Networking of differentially expressed genes in human
                MDA-MB-468 breast cancer cells resistant to methotrexate; GSE16082: Networking of
                differentially expressed genes in human MIA PaCa2 pancreatic cancer cells resistant
                to methotrexate; GSE16085: Networking of differentially expressed genes in human
                K562 erythtoblastic leukemia cells resistant to methotrexate; GSE16089: Networking
                of differentially expressed genes in human Saos-2 osteosarcoma cells resistant to
                methotrexate Experiment Overall Design: Refer to individual Series</text>
        </description>
        <description>
            <id>1797823270</id>
            <text>(Generated description) Experiment with 42 hybridizations, using 42 samples of
                species [Homo sapiens], using 42 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 42 raw data files and 42
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="207">
        <id>1797822016</id>
        <accession>E-GEOD-13319</accession>
        <name>Transcription profiling of human and rat uterine leiomyoma: identification of a
            dysregulated mTOR pathway</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <species>Rattus norvegicus</species>
        <samples>106</samples>
        <assays>106</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13319</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>29</count>
        </arraydesign>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>77</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797828246</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>29</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797828253</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>77</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>77</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797828680</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13319.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>29</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>29</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797828655</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13319.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>77</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>77</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19622772</accession>
            <authors>Judy S Crabtree, Scott A Jelinsky, Heather A Harris, Sung E Choe, Monette M
                Cotreau, Michelle L Kimberland, Ewa Wilson, Kathryn A Saraf, Wei Liu, Adrienne S
                McCampbell, Bhuvanesh Dave, Russell R Broaddus, Eugene L Brown, Wenling Kao, Jerauld
                S Skotnicki, Magid Abou-Gharbia, Richard C Winneker, Cheryl L Walker</authors>
            <title>Comparison of human and rat uterine leiomyomata: identification of a dysregulated
                mammalian target of rapamycin pathway.</title>
        </bibliography>
        <provider>
            <contact>Scott Jelinsky</contact>
            <email>sjelinsky@wyeth.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797822025</id>
            <text>Uterine leiomyomata, or fibroids, are benign tumors of the uterine myometrium that
                significantly affect up to 30% of reproductive-age women. Despite being the primary
                cause of hysterectomy in the United States, accounting for up to 200,000 procedures
                annually, the etiology of leiomyoma remains largely unknown. Due to the lack of an
                effective medicinal therapy for these tumors, this disease continues to have a
                tremendous negative impact on women s health. As a basis for understanding leiomyoma
                pathogenesis and identifying targets for pharmacotherapy, we conducted
                transcriptional profiling of leiomyoma and unaffected myometrium from humans and
                Eker rats, the best characterized preclinical model of leiomyoma. A global
                comparison of mRNA from leiomyoma versus myometrium in human and rat identified a
                highly significant overlap of dysregulated gene expression in leiomyoma. An unbiased
                pathway analysis using a method of gene set enrichment based on the Sigpathway
                algorithm detected the mammalian target of rapamycin (mTOR) pathway as one of the
                most highly upregulated pathways in both human and rat tumors. Activation of this
                pathway was confirmed in both human and rat leiomyomata at the protein level via
                Western. Inhibition of mTOR in female Eker rats with the rapamycin analog WAY-129327
                for 2 weeks decreased mTOR signaling and cell proliferation in tumors, and treatment
                for 4 months significantly decreased tumor incidence, multiplicity and size. These
                results identify dysregulated mTOR signaling as a component of leiomyoma etiology
                across species and directly demonstrate the dependence of these tumors on mTOR
                signaling for growth in the Eker rat. Modulation of this pathway warrants additional
                investigation as a potential therapy for uterine leiomyoma. Experiment Overall
                Design: We analyzed 1-3 leiomyoma or normal myometrium biopsies from each 23 woman
                undergoing hysterectomy for the treatment of uterine fibroids. tment and compared it
                leiomyoma and normal myometrium from the Eker rat model of uterine fibroids
                (N=14-15)</text>
        </description>
        <description>
            <id>1797831401</id>
            <text>(Generated description) Experiment with 106 hybridizations, using 106 samples of
                species [Homo sapiens, Rattus norvegicus], using 106 arrays of array design
                [Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2], Affymetrix GeneChip Human Genome
                U133 Plus 2.0 [HG-U133_Plus_2]], producing 106 raw data files and 106 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="208">
        <id>1797824774</id>
        <accession>E-GEOD-17951</accession>
        <name>Transcription profiling of prostate cancer samples using Affymetrix U133Plus2
            array</name>
        <releasedate>2009-09-12</releasedate>
        <species>Homo sapiens</species>
        <samples>154</samples>
        <assays>154</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17951</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>154</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797828504</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>154</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>154</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797829171</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17951.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>154</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>154</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Yipeng Wang</contact>
            <email>ywang@skcc.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797824783</id>
            <text>Over one million prostate biopsies are performed in the U.S. every year. However,
                pathology examination is not definitive in a significant percentage of cases due
                limited diagnostic tumor. We have observed that the microenvironment of prostate
                tumor cells exhibits numerous differential gene expression changes and have asked
                whether such information can be used to distinguish tumor from nontumor . We
                initially compared expression analysis data (Affymetrix U133plus2) from 18 volunteer
                biopsy specimens to 17 specimens containing largely tumor-adjacent stroma and
                identified 964 significant (p_adj &lt; 0.01 and B &gt; 0) expression
                changes. These genes were filtered to eliminate possible aging-related genes and
                genes expressed in tumor cells &gt; 10% of the stroma cell expression level
                leading to 23 candidate genes (28 Affymetrix probe sets). A classifier based on the
                28 probe sets was tested on 289 independent cases, including 195 tumor-bearing
                cases, 99 nontumor cases (normal biopsies, normal autopsies, remote stroma as well
                as pure tumor adjacent stroma) all with accuracies &gt;85%, sensitivities
                &gt;90% and specificities &gt;85%. These results indicate that the prostate
                cancer microenvironment exhibits reproducible changes useful for categorization as
                tumor and nontumor . For inquires please contact dmercola@uci.edu. Experiment
                Overall Design: Prostate cancer gene expression profiles were studied in this
                project. Total RNA from 154 prostate sample with various amount of different cell
                types were hybridized to Affymetrix U133Plus2 array. The percentage of different
                cell types were determined by a pathologist.</text>
        </description>
        <description>
            <id>1797832954</id>
            <text>(Generated description) Experiment with 154 hybridizations, using 154 samples of
                species [Homo sapiens], using 154 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 154 raw data files and 154
                transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="209">
        <id>1797827191</id>
        <accession>E-GEOD-12757</accession>
        <name>Methylation profiling of mouse embryogenesis reveals a piRNA pathway primed by
            individual transposons is linked to de novo DNA methylation in mice</name>
        <releasedate>2009-09-12</releasedate>
        <species>Mus musculus</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12757</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797667925</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12757.VirtualArrayDesign</accession>
            <count>9</count>
        </arraydesign>
        <bibliography>
            <accession>18922463</accession>
            <authors>Alexei A Aravin, Ravi Sachidanandam, Deborah Bourc'his, Christopher Schaefer,
                Dubravka Pezic, Katalin Fejes Toth, Timothy Bestor, Gregory J Hannon</authors>
            <title>A piRNA pathway primed by individual transposons is linked to de novo DNA
                methylation in mice.</title>
        </bibliography>
        <provider>
            <contact>Alexei Aravin</contact>
            <email>aravin@cshl.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>methylation profiling</experimenttype>
        <description>
            <id>1797827198</id>
            <text>We examined the construction of the piRNA system in the restricted developmental
                window in which methylation patterns are set during mammalian embryogenesis. We find
                robust expression of two Piwi family proteins, MIWI2 and MILI. Their associated
                piRNA profiles reveal differences from Drosophila wherein large piRNA clusters act
                as master regulators of silencing. Instead, in mammals, dispersed transposon copies
                initiate the pathway, producing primary piRNAs, which predominantly join MILI in the
                cytoplasm. MIWI2, whose nuclear localization and association with piRNAs depend upon
                MILI, is enriched for secondary piRNAs antisense to the elements that it controls.
                The Piwi pathway lies upstream of known mediators of DNA methylation, since piRNAs
                are still produced in Dnmt3L mutants, which fail to methylate transposons. This
                implicates piRNAs as specificity determinants of DNA methylation in germ cells.
                Experiment Overall Design: Examination of total small RNA and MILI associated piRNAs
                in embryonic and post-birth mouse testes, MIWI2-associated piRNAs in embryonic
                testes.</text>
        </description>
        <description>
            <id>1797827366</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Mus musculus], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12757], producing 0 raw data files and 18 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="210">
        <id>1797624484</id>
        <accession>E-MEXP-2353</accession>
        <name>Transcription profiling of human hepatoma Hep3B cells following irradiation to
            investigate the effects of DNA damage</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>CellLine</category>
            <value>Hep3B</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>Irradiate</name>
            <value>40J/m2 UV</value>
            <value>none</value>
        </experimentalfactor>
        <user>1</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1792922888</id>
            <accession>A-MEXP-1622</accession>
            <name>Splicing factors And pathways CRG</name>
            <count>6</count>
        </arraydesign>
        <bibliography>
            <title>DNA damage regulates alternative splicing through inhibition of RNA polymerase II
                elongation</title>
        </bibliography>
        <provider>
            <contact>Claudia Ben-Dov</contact>
            <email>claudia.bendov@crg.es</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>dye swap</experimentdesign>
        <experimentdesign>replicate</experimentdesign>
        <experimentdesign>stimulus or stress</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797624492</id>
            <text>To monitor the changes in transcription and alternative splicing upon UV
                irradiation, human hepatoma Hep3B cells were Hep3B cells were washed two times with
                PBS and then irradiated with 40J/m2 UV light; fresh medium was immediately added
                after the irradiation and the cells were incubated at 37 C and collected 6 hours
                after the treatment for the RNA preparation. RNAs from three biological replicates
                of control or irradiated cells were purified, reverse transcribed into cDNA,
                labelled with Cy5 or Cy3 fluorochromes, and hybridized to a custom
                splicing-sensitive microarray&lt;br&gt;cDNA and Cy5-Cy3 labelled cRNA were
                generated from the total RNA using the Agilent Low RNA Input Fluorescent Linear
                Amplification kit; the cRNA was purified with the RNeasy Mini kit (Qiagen). 8?g of
                each cRNA were used for the hybridization with the arrays (Agilent In situ
                hybridization kit plus). After hybridization, arrays were washed, and scanned images
                analyzed. Three biological replicates were hybridized, with both direct and
                dye-reversal hybridizations. General gene expression values represent the average of
                log2 ratios for all the probes in constitutive exones of a locus. Statystical
                analyses were carried out with Linear Models for Microarray Data (Limma;
                Bioconductor Project; Dudoit, et al., 2003). The background correction method used
                in the analysis was Normexp (Ritchie, et al., 2007). Locally weighted linear
                regression (LOWESS) analysis was used as a normalization method (Yang, et al.,
                2002).&lt;br&gt;</text>
        </description>
        <description>
            <id>1797624659</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Homo sapiens], using 6 arrays of array design [Splicing factors And
                pathways CRG], producing 6 raw data files and 6 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="211">
        <id>1797631509</id>
        <accession>E-GEOD-995</accession>
        <name>Transcription profiling of human acute myeloid leukemia cells to identify compounds
            inducing the differentiation of acute myeloid leukemia cells</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>115</samples>
        <assays>115</assays>
        <sampleattribute>
            <category>BioSourceType</category>
            <value>fresh_sample</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellLine</category>
            <value>HL-60</value>
        </sampleattribute>
        <sampleattribute>
            <category>CellType</category>
            <value>monocyte</value>
            <value>neutrophil</value>
        </sampleattribute>
        <sampleattribute>
            <category>DiseaseState</category>
            <value>acute myeloid leukemia</value>
            <value>acute promyelocytic leukemia</value>
            <value>normal</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <experimentalfactor>
            <name>CellLine</name>
            <value>HL-60</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>CellType</name>
            <value>monocyte</value>
            <value>neutrophil</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Compound</name>
            <value>1,10-phenanthroline</value>
            <value>1,25-dihydroxyvitamin D3</value>
            <value>16-ketoestradiol</value>
            <value>4,5-dianilinophthalimide</value>
            <value>5-fluorouracil</value>
            <value>5-fluorouridine</value>
            <value>8-(3-chlorostyryl) caffeine</value>
            <value>a-methyl-L-p-tyrosine</value>
            <value>all-trans retinoic acid</value>
            <value>control</value>
            <value>cyclazosin HCl</value>
            <value>dimethyl sulfoxide</value>
            <value>erythro-9-(2-hydroxy-3-nonyl)adenine HCl</value>
            <value>none</value>
            <value>pergolide methanesulfonate</value>
            <value>phorbol 12-myristate 13-acetate</value>
            <value>R-(-)-apomorphine HCl</value>
            <value>scopolamine methyl bromide</value>
            <value>sulmazole</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>DiseaseState</name>
            <value>acute myeloid leukemia</value>
            <value>acute promyelocytic leukemia</value>
            <value>normal</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Dose</name>
            <value>0.1 %</value>
            <value>0.1 uM</value>
            <value>0.8 uM</value>
            <value>1 uM</value>
            <value>10 nM</value>
            <value>100 uM</value>
            <value>1uM</value>
            <value>25 uM</value>
            <value>30 uM</value>
            <value>5 uM</value>
            <value>50 uM</value>
            <value>7.5 uM</value>
            <value>70 uM</value>
            <value>75 uM</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Time</name>
            <value>0</value>
            <value>12 hours</value>
            <value>120 hours</value>
            <value>24 hours</value>
            <value>4 hours</value>
            <value>72 hours</value>
        </experimentalfactor>
        <user>1</user>
        <secondaryaccession>GSE995</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>119901743</id>
            <accession>A-AFFY-32</accession>
            <name>Affymetrix GeneChip HuGeneFL Array [HuGeneFL]</name>
            <count>28</count>
        </arraydesign>
        <arraydesign>
            <id>302382080</id>
            <accession>A-AFFY-33</accession>
            <name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name>
            <count>87</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797633050</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-995.Hu6800.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>28</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>28</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797633037</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-995.HG-U133A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>87</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>87</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>14770183</accession>
            <authors>Kimberly Stegmaier, Kenneth N Ross, Sierra A Colavito, Shawn O'Malley, Brent R
                Stockwell, Todd R Golub</authors>
            <title>Gene expression-based high-throughput screening(GE-HTS) and application to
                leukemia differentiation.</title>
        </bibliography>
        <provider>
            <contact>Ken Ross</contact>
            <email>kross@broad.mit.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>cell type comparison</experimentdesign>
        <experimentdesign>co-expression</experimentdesign>
        <experimentdesign>compound treatment</experimentdesign>
        <experimentdesign>time series</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797631516</id>
            <text>We developed a general approach to small molecule library screening called GE-HTS
                (Gene Expression-Based High Throughput Screening) in which a gene expression
                signature is used as a surrogate for cellular states and applied it to the
                identification of compounds inducing the differentiation of acute myeloid leukemia
                cells. In screening 1,739 compounds, we identified 8 that reliably induced the
                differentiation signature, and furthermore yielded functional evidence of bona fide
                differentiation. This SuperSeries is composed of the following subset Series:;
                GSE976: Gene Expression-Based High Throughput Screening: APL Treatment with
                Candidate Compounds; GSE982: Gene Expression-Based High Throughput Screening: HL-60
                Cell Treatment with Candidate Compounds; GSE983: Gene Expression-Based High
                Throughput Screening: Primary Patient AML Blasts, Normal Neutrophils, and Normal
                Monocytes; GSE985: Gene Expression-Based High Throughput Screening: HL-60 Cells
                Treated with ATRA and PMA Experiment Overall Design: Refer to individual
                Series</text>
        </description>
        <description>
            <id>1797634369</id>
            <text>(Generated description) Experiment with 115 hybridizations, using 115 samples of
                species [Homo sapiens], using 115 arrays of array design [Affymetrix GeneChip
                HuGeneFL Array [HuGeneFL], Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]],
                producing 0 raw data files and 115 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="212">
        <id>1797645521</id>
        <accession>E-TABM-786</accession>
        <name>Transcription profiling of mouse embryonic fibroblasts wild-type and DNA
            repair-deficient Rad54/Rad54B cells</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>1</samples>
        <assays>50</assays>
        <sampleattribute>
            <category>GeneticModification</category>
            <value>none</value>
            <value>Rad54/Rad54B</value>
        </sampleattribute>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <sampleattribute>
            <category>StrainOrLine</category>
            <value>C57BL/6</value>
        </sampleattribute>
        <experimentalfactor>
            <name>GeneticModification</name>
            <value>none</value>
            <value>Rad54/Rad54B</value>
        </experimentalfactor>
        <experimentalfactor>
            <name>Treatment</name>
            <value>Bleomycin</value>
            <value>Control</value>
            <value>MitomycinReferenceC</value>
            <value>N-acetoxy-2-acetylaminofluorene</value>
            <value>N-ethyl-N-mitrosourea</value>
            <value>Reference</value>
        </experimentalfactor>
        <user>1797649988</user>
        <user>1797654779</user>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1149254583</id>
            <accession>A-MEXP-542</accession>
            <name>RIVM MAD mouse 22K v1</name>
            <count>50</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797645742</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645749</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645754</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645757</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645762</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645767</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645770</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645775</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645780</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645783</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645788</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645793</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645796</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645801</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645804</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645809</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645814</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645817</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645822</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645827</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645830</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645835</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645838</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645843</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645848</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645851</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645856</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645859</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645864</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645867</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645872</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645877</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645880</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645885</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645888</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645893</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645898</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645901</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645906</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645909</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645914</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645919</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645928</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645933</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645936</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645941</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645944</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645949</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645954</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645957</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>1</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797645962</id>
            <name>ebi.ac.uk:Tab2MAGE:E-TABM-786.A-MEXP-542.1.ReporterDimension</name>
            <bioassaydatacubes>1</bioassaydatacubes>
            <arraydesignprovider>MEXP</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>50</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <publication>Submitted</publication>
            <authors>Anuska Mahabir, Mirjam Schaap, Jeroen Pennings, Jan van Benthem, Coenraad
                Hendriksen, and Harry van Steeg</authors>
            <title>Comparison of clastogen-induced gene expression profiles in wild-type and DNA
                repair-deficient Rad54/Rad54B cells</title>
        </bibliography>
        <provider>
            <contact>Anuska Mahabir</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>reference</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797645527</id>
            <text>Transcriptional responses in mouse embryonic fibroblasts to clastogens, mutagens,
                and control</text>
        </description>
        <description>
            <id>1797646807</id>
            <text>(Generated description) Experiment with 50 hybridizations, using 1 samples of
                species [Mus musculus], using 50 arrays of array design [RIVM MAD mouse22K v1],
                producing 50 raw data files and 1 transformed and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="213">
        <id>1797666808</id>
        <accession>E-GEOD-12053</accession>
        <name>Re-sequencing of Turnip mosaic virus siRNAs 15-29 nucleotides long with 100 percent
            hit to Turnip mosaic virus clone GBR98</name>
        <releasedate>2009-09-11</releasedate>
        <species>Turnip mosaic virus</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Turnip mosaic virus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12053</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666516</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12053.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <provider>
            <contact>Thien Xuan Ho</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797666825</id>
            <text>Mustard (Brassica juncea) was tested for Turnip mosaic virus infection. Small RNA
                of the plant was extracted and converted to DNA according to Ho, T., et al. (2006)
                Journal of Virological Methods 136:217-223, with primers modified to contain 454
                adapter nucleotide sequences. The DNA then passed quality control through
                Bioanalyzer and Nanodrop before sequenced by 454 Life Sciences. Experiment Overall
                Design: One sample analyzed by 454 high-throughput sequencing technology</text>
        </description>
        <description>
            <id>1797666917</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Turnip mosaic virus], using 1 arrays of array design [Virtual Array Design
                for E-GEOD-12053], producing 0 raw data files and 1 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="214">
        <id>1797666809</id>
        <accession>E-GEOD-12052</accession>
        <name>Re-sequencing of Cocksfoot streak virus siRNAs 15-29 nucleotides long with 100 percent
            hit to Cocksfoot streak virus</name>
        <releasedate>2009-09-11</releasedate>
        <species>Cocksfoot streak virus</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Cocksfoot streak virus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12052</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666517</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12052.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <provider>
            <contact>Thien Xuan Ho</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797666824</id>
            <text>Cocksfoot grass (Dactylis glomerata) collected from Wytham, Oxford, UK, was tested
                for Cocksfoot streak virus infection. Small RNA of the grass was extracted and
                converted to DNA according to Ho, T., et al. (2008) Biochem Biophys Res Commun.
                368:433-7, with primers modified to contain 454 adapter nucleotide sequences. The
                DNA then passed quality control through Bioanalyzer and Nanodrop before sequenced by
                454 Life Sciences. Experiment Overall Design: One sample analyzed by 454
                high-throughput sequencing technology</text>
        </description>
        <description>
            <id>1797666918</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Cocksfoot streak virus], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-12052], producing 0 raw data files and 1 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="215">
        <id>1797666834</id>
        <accession>E-GEOD-13370</accession>
        <name>ChIP-Seq of human endogenous small RNAs associated to Argonaute 1 and 2</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13370</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666627</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-13370.VirtualArrayDesign</accession>
            <count>2</count>
        </arraydesign>
        <bibliography>
            <accession>19026782</accession>
            <authors>Christine Ender, Azra Krek, Marc R Friedl nder, Michaela Beitzinger, Lasse
                Weinmann, Wei Chen, S bastien Pfeffer, Nikolaus Rajewsky, Gunter Meister</authors>
            <title>A human snoRNA with microRNA-like functions.</title>
        </bibliography>
        <provider>
            <contact>Gunter Meister</contact>
            <email>meister@biochem.mpg.de</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>ChIP-seq</experimenttype>
        <description>
            <id>1797666841</id>
            <text>Small non-coding RNAs function in concert with Argonaute (Ago) proteins to
                regulate gene expression at the level of transcription, mRNA stability or
                translation. Ago proteins bind small RNAs and form the core of silencing complexes.
                Here we report the analysis of small RNAs associated with human Ago1 and Ago2
                revealed by immunoprecipitation and deep sequencing. Among the reads we find small
                RNAs originating from the small nucleolar RNA (snoRNA) ACA45. Moreover, processing
                of ACA45 requires Dicer activity but is independent of Drosha/DGCR8. Using
                bio-informatic prediction algorithms and luciferase reporter assays, we uncover the
                mediator subunit CDC2L6 as one potential mRNA target of ACA45 small RNAs suggesting
                a role for ACA45 processing products in post-transcriptional gene silencing. We
                further identify a number of human snoRNAs with microRNA (miRNA)- like processing
                signatures. We have therefore identified a novel class of small RNAs in human cells
                that originate from snoRNAs and can function like miRNAs. Experiment Overall Design:
                Two samples examined. Small RNAs associated to human Argonaute 1 and human Argonaute
                2</text>
        </description>
        <description>
            <id>1797667221</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-13370], producing 0 raw data files and 2 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="216">
        <id>1797666857</id>
        <accession>E-GEOD-12527</accession>
        <name>Re-sequencing of Drosophila small RNA from S2 cell infected with FHV deltaB2
            particle</name>
        <releasedate>2009-09-11</releasedate>
        <species>Drosophila melanogaster</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Drosophila melanogaster</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12527</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666584</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12527.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <bibliography>
            <accession>18854242</accession>
            <authors>Roghiyh Aliyari, Qingfa Wu, Hong-Wei Li, Xiao-Hong Wang, Feng Li, Lance D
                Green, Cliff S Han, Wan-Xiang Li, Shou-Wei Ding</authors>
            <title>Mechanism of induction and suppression of antiviral immunity directed by
                virus-derived small RNAs in Drosophila.</title>
        </bibliography>
        <provider>
            <contact>Qingfa Wu</contact>
            <email>qingfawu@ucr.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797666864</id>
            <text>S2 cells were infected with FHV deltaB2 particle and the S2 cells were harvested
                to isolate total RNA at 96 hpi. Small RNAs were separated on a denaturing 15%
                polyacrylamide gel. Ligation to adapters requires 5' monophosphate and 3' OH. Note:
                The base quality (.qual) file corresponding to the fasta format (.fna) file linked
                to Sample GSM306489 is unavailable. Experiment Overall Design: Small RNAs were
                sequenced from S2 cell after virus infection.</text>
        </description>
        <description>
            <id>1797667086</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Drosophila melanogaster], using 1 arrays of array design [Virtual Array
                Design for E-GEOD-12527], producing 0 raw data files and 2 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="217">
        <id>1797667511</id>
        <accession>E-GEOD-13483</accession>
        <name>Re-sequencing of Small RNA cloning and deep sequencing from human embryonic stem
            cells, derived neural progenitors and neurons reveals divergent transcription from
            active promoters</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>3</samples>
        <assays>3</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13483</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797667359</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-13483.VirtualArrayDesign</accession>
            <count>3</count>
        </arraydesign>
        <bibliography>
            <accession>19056940</accession>
            <authors>Amy C Seila, J Mauro Calabrese, Stuart S Levine, Gene W Yeo, Peter B Rahl, Ryan
                A Flynn, Richard A Young, Phillip A Sharp</authors>
            <title>Divergent transcription from active promoters.</title>
        </bibliography>
        <provider>
            <contact>Gene Yeo</contact>
            <email>geneyeo@ucsd.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797667519</id>
            <text>Here we describe a novel class of short RNAs that indicate widespread divergent
                transcription at mammalian promoters Experiment Overall Design: Small RNA cloning
                and deep sequencing from human embryonic stem cells, derived neural progenitors and
                neurons</text>
        </description>
        <description>
            <id>1797667950</id>
            <text>(Generated description) Experiment with 3 hybridizations, using 3 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-13483], producing 0 raw data files and 3 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="218">
        <id>1797668639</id>
        <accession>E-GEOD-12081</accession>
        <name>Re-sequencing of Solanum lycopersicum endogenous small RNAs from leaf and fruit</name>
        <releasedate>2009-09-11</releasedate>
        <species>Solanum lycopersicum</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Solanum lycopersicum</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12081</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666759</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12081.VirtualArrayDesign</accession>
            <count>2</count>
        </arraydesign>
        <bibliography>
            <accession>18653800</accession>
            <authors>Simon Moxon, Runchun Jing, Gyorgy Szittya, Frank Schwach, Rachel L Rusholme
                Pilcher, Vincent Moulton, Tamas Dalmay</authors>
            <title>Deep sequencing of tomato short RNAs identifies microRNAs targeting genes
                involved in fruit ripening.</title>
        </bibliography>
        <provider>
            <contact>Frank Schwach</contact>
            <email>f.schwach@uea.ac.uk</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797668647</id>
            <text>Comparison of the endogenous small RNA content of tomato leaves and fruits.
                Experiment Overall Design: Size fractionated small RNA from total RNA extracts was
                ligated to adapters, purified again and reverse transcribed. After PCR amplification
                the sample was subjected to 454 high throughput pyrosequencing. Please see
                www.454.com for details of the sequencing technology. Experiment Overall Design:
                Note: Raw data files were not available from 454 at the time this experiment was
                carried out.</text>
        </description>
        <description>
            <id>1797668894</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Solanum lycopersicum], using 1 arrays of array design [Virtual Array Design
                for E-GEOD-12081], producing 0 raw data files and 2 transformed and/or normalized
                data files.</text>
        </description>
    </experiment>
    <experiment textidx="219">
        <id>1797669092</id>
        <accession>E-GEOD-13152</accession>
        <name>Re-sequencing of rice unique small RNA populations from grain</name>
        <releasedate>2009-09-11</releasedate>
        <species>Oryza sativa</species>
        <samples>4</samples>
        <assays>4</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Oryza sativa</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13152</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797667527</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-13152.VirtualArrayDesign</accession>
            <count>4</count>
        </arraydesign>
        <bibliography>
            <accession>18716673</accession>
            <authors>Sara E Heisel, Yuanji Zhang, Edwards Allen, Liang Guo, Tracey L Reynolds, Xiao
                Yang, David Kovalic, James K Roberts</authors>
            <title>Characterization of unique small RNA populations from rice grain.</title>
        </bibliography>
        <provider>
            <contact>Sara Elizabeth Heisel</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797669421</id>
            <text>(Generated description) Experiment with 4 hybridizations, using 4 samples of
                species [Oryza sativa], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-13152], producing 0 raw data files and 4 transformed and/or normalized data
                files.</text>
        </description>
        <description>
            <id>1797669099</id>
            <text>Small RNAs (~20 to 24 nucleotides) function as naturally occurring molecules
                critical in developmental pathways in plants and animals. Here we analyze small RNA
                populations from mature rice grain and seedlings by pyrosequencing. Using a
                clustering algorithm to locate regions producing small RNAs, we classified hotspots
                of small RNA generation within the genome. Hotspots here are defined as 1 kb regions
                within which small RNAs are significantly overproduced relative to the rest of the
                genome. Hotspots were identified to facilitate characterization of different
                categories of small RNA regulatory elements. Included in the hotspots, we found
                known members of 23 miRNA families representing 92 genes, one trans acting siRNA
                (ta-siRNA) gene, novel siRNA-generating coding genes and phased siRNA generating
                genes. Interestingly, over 20% of the small RNA population in grain came from a
                single foldback structure, which generated eight phased 21-nt siRNAs. This is
                reminiscent of a newly arising miRNA derived from duplication of progenitor genes.
                Our results provide data identifying distinct populations of small RNAs, including
                phased small RNAs, in mature grain to facilitate characterization of small
                regulatory RNA expression in monocot species. Experiment Overall Design: In an
                attempt to gain a broader understanding of gene expression in rice grain, we
                characterized small RNA populations from Oryza sativa spp. japonica cv. Nipponbare
                utilizing a deep sequencing approach. Small RNA libraries were constructed from
                three pools of mature, dormant rice grain and three-week post germination seedlings
                utilizing RNA-adapter mediated ligation. Each of the four libraries were
                independently sequenced using high-throughput pyrosequencing. We obtained a total of
                679,146 sequences from the three rice grain libraries and 257,394 from one rice
                seedling library.</text>
        </description>
    </experiment>
    <experiment textidx="220">
        <id>1797669550</id>
        <accession>E-GEOD-11672</accession>
        <name>ChIP-Seq of human H1299 lung carcinoma cells - genomic location data for ectopic
            p73</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>1</samples>
        <assays>1</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE11672</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797669490</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-11672.VirtualArrayDesign</accession>
            <count>1</count>
        </arraydesign>
        <bibliography>
            <accession>18678646</accession>
            <authors>Jennifer M Rosenbluth, Deborah J Mays, Maria F Pino, Luo Jia Tang, Jennifer A
                Pietenpol</authors>
            <title>A gene signature-based approach identifies mTOR as a regulator of p73.</title>
        </bibliography>
        <provider>
            <contact>Jennifer Pietenpol</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>ChIP-seq</experimenttype>
        <description>
            <id>1797669562</id>
            <text>The integral role of p53 in tumor suppression has promted many laboratories to
                perform extensive analyses of signaling pathways downstream of the p53 family of
                sequence-specific DNA binding transcription factors (p53 and its homologs p63 and
                p73). Despite the ability of p73 to regulate many p53 family target genes, little is
                known about the specific pathways that modulate p73 during development,
                tumorigenesis and tumor therapy. In this study we present a gene signature-based
                approach for connecting signaling pathways to transcription factors, as exemplified
                by p73. We generated a p73 gene signature by integrating whole-genome chromatin
                immunoprecipitation and expression profiling. Experiment Overall Design: H1299 lung
                carcinoma cells were transduced with TAp73beta or GFP expressing adenoviruses.
                Microarray analysis (on the GFP and TAp73beta samples) and ChIPSeq analysis (on the
                TAp73beta sample) were performed to identify candidate p73 target genes.</text>
        </description>
        <description>
            <id>1797669951</id>
            <text>(Generated description) Experiment with 1 hybridizations, using 1 samples of
                species [Homo sapiens], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-11672], producing 0 raw data files and 1 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="221">
        <id>1797673125</id>
        <accession>E-GEOD-17825</accession>
        <name>Transcription profiling of mouse fracture healing</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>18</samples>
        <assays>18</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17825</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>18</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797685969</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17825.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>18</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>18</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Winnie Liang</contact>
            <email>wliang@tgen.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797673136</id>
            <text>Time-point expression analysis of fractures calluses at 1, 3, and 5 days
                post-fracture in young and old BALB/c mice. Experiment Overall Design: Femur
                fractures were generated on female c57BI6 mice in triplicate: 8 month old retired
                breeders (old mice) and 6 week old mice (young mice) were used. 1, 3, and 5 days
                post-fracture, fracture calluses were dissected and total RNA isolated. Expression
                profiling was performed using Affymetrix's Mouse Genome 430 2.0 array.</text>
        </description>
        <description>
            <id>1797690819</id>
            <text>(Generated description) Experiment with 18 hybridizations, using 18 samples of
                species [Mus musculus], using 18 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 0 raw data files and 18 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="222">
        <id>1797673560</id>
        <accession>E-GEOD-12911</accession>
        <name>Transcription profiling of Arabidopsis wild type (Col) and stomata mutant</name>
        <releasedate>2009-09-11</releasedate>
        <species>Arabidopsis thaliana</species>
        <samples>3</samples>
        <assays>3</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Arabidopsis thaliana</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12911</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>13851999</id>
            <accession>A-AFFY-2</accession>
            <name>Affymetrix GeneChip Arabidopsis Genome [ATH1-121501]</name>
            <count>3</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797682910</id>
            <name>Affymetrix:FeatureDimension:ATH1-121501</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>3</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797682939</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12911.ATH1-121501.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>3</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>3</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Zidian Xie</contact>
            <email>xzd482@yahoo.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797683051</id>
            <text>(Generated description) Experiment with 3 hybridizations, using 3 samples of
                species [Arabidopsis thaliana], using 3 arrays of array design [Affymetrix GeneChip
                Arabidopsis Genome [ATH1-121501]], producing 3 raw data files and 3 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1797673567</id>
            <text>As the gate for gas exchange and water vapor, stomata play an essential role in
                plant development. It has been a long time that many research focus on how the
                opening and closing of stomata is controlled. Until recently, studies on how stomata
                are formed in Arabidopsis just emerge. With a cluster of guard cells in one stomate
                in flp-1/myb88 mutant, it will be great interest to understand how FLP/MYB88 control
                stomata development. By taking advantaging of microarray technology, we intend to
                study a set of genes regulated by FLP/MYB88, which will facilitate us to better
                explore the biological functions of FLP/MYB88 in stomata development, even in the
                biotic or abiotic stresses. Experiment Overall Design: By comparing the gene
                expression differences between the wild type and stomata mutant--flp-1/myb88, we are
                trying to see which genes' transcripts are affected in flp-1/myb88 mutant.</text>
        </description>
    </experiment>
    <experiment textidx="223">
        <id>1797679485</id>
        <accession>E-GEOD-12547</accession>
        <name>Re-sequencing of Zebrafish Zili- and Ziwi-interacting small RNAs</name>
        <releasedate>2009-09-11</releasedate>
        <species>Danio rerio</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Danio rerio</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12547</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797668268</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12547.VirtualArrayDesign</accession>
            <count>6</count>
        </arraydesign>
        <bibliography>
            <accession>18833190</accession>
            <authors>Saskia Houwing, Eugene Berezikov, Ren F Ketting</authors>
            <title>Zili is required for germ cell differentiation and meiosis in zebrafish.</title>
        </bibliography>
        <provider>
            <contact>Eugene Berezikov</contact>
            <email>e.berezikov@niob.knaw.nl</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797679492</id>
            <text>Small RNAs exert an effect through diverse RNA interference pathways to
                transcriptionally or post-transcriptionally silence their targets. The
                Piwi-interacting RNAs (piRNAs) represent a germline-specific small RNA pathway where
                Piwi proteins themselves are thought to mediate piRNA biosynthesis. Here, we provide
                strong evidence for a piRNA amplification loop in zebrafish, in which Ziwi and Zili
                bind piRNAs of opposite polarity. Furthermore, we describe a function for Zili in
                transposon defense and germ cell differentiation, as well as a crucial function in
                meiosis, significantly extending the function of Piwi proteins beyond the control of
                transposable elements in vertebrates. Experiment Overall Design: small RNA from
                total gonads or Argonaute IPs were cloned and sequenced using 454 GS FLX
                system.</text>
        </description>
        <description>
            <id>1797680715</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Danio rerio], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12547], producing 0 raw data files and 12 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="224">
        <id>1797679630</id>
        <accession>E-GEOD-12521</accession>
        <name>Re-sequencing of mouse ild type, dgcr8delta/delta, and dicer1delta/delta ES cell
            derived endogenous shRNAs, siRNAs, and other microprocessor-independent, Dicer-dependent
            Small RNAs</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>5</samples>
        <assays>5</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12521</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797667534</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12521.VirtualArrayDesign</accession>
            <count>5</count>
        </arraydesign>
        <bibliography>
            <accession>18923076</accession>
            <authors>Joshua E Babiarz, J Graham Ruby, Yangming Wang, David P Bartel, Robert
                Blelloch</authors>
            <title>Mouse ES cells express endogenous shRNAs, siRNAs, and other
                Microprocessor-independent, Dicer-dependent small RNAs.</title>
        </bibliography>
        <provider>
            <contact>James Graham Ruby</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797679645</id>
            <text>Canonical microRNAs (miRNAs) require two processing steps: the first by the
                Microprocessor, a complex of DGCR8 and Drosha, and the second by Dicer.
                dgcr8delta/delta mouse embryonic stem cells (mESCs) have less severe phenotypes than
                dicer1delta/delta mESCs, suggesting a physiological role for
                Microprocessor-independent, Dicer-dependent small RNAs. To identify these small RNAs
                with unusual biogenesis, we performed high-throughput sequencing from wild type,
                dgcr8delta/delta, and dicer1delta/delta mESCs. Several of the DGCR8-independent,
                Dicer-dependent RNAs were non-canonical miRNAs. These derived from mirtrons and a
                newly identified subclass of miRNA precursors, which appears to be the endogenous
                counterpart of short hairpin RNAs (shRNAs). Our analyses also revealed endogenous
                siRNAs resulting from Dicer cleavage of long hairpins, the vast majority of which
                originated from one genomic locus with tandem, inverted short interspersed nuclear
                elements (SINEs). Our results extend the known diversity of mammalian small-RNA
                generating pathways and show that mammalian siRNAs exist in tissues outside of
                oocytes. Experiment Overall Design: Small RNAs were sequenced from wt, dgcr8(-), and
                dicer(-) mouse ES cells and the frequencies of small RNA types compared between the
                three. This record includes Illumina-platform-generated datasets from all three
                samples and 454-platform-generated datasets from wt and dgcr8(-) samples. Experiment
                Overall Design: [raw data files are unavailable]</text>
        </description>
        <description>
            <id>1797680059</id>
            <text>(Generated description) Experiment with 5 hybridizations, using 5 samples of
                species [Mus musculus], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12521], producing 0 raw data files and 5 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="225">
        <id>1797681701</id>
        <accession>E-GEOD-13252</accession>
        <name>Transcription profiling of Pseduomonas aeruginosa PAO1 exposed to subinhibitory
            colistin</name>
        <releasedate>2009-09-11</releasedate>
        <species>Pseudomonas aeruginosa PAO1</species>
        <samples>6</samples>
        <assays>6</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Pseudomonas aeruginosa PAO1</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13252</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>260443237</id>
            <accession>A-AFFY-30</accession>
            <name>Affymetrix GeneChip P. aeruginosa Genome[Pae_G1a]</name>
            <count>6</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797682561</id>
            <name>Affymetrix:FeatureDimension:Pae_G1a</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>6</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797682595</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13252.Pae_G1a.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>6</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>6</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Fergal O'Gara</contact>
            <email>f.ogara@ucc.ie</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797682899</id>
            <text>(Generated description) Experiment with 6 hybridizations, using 6 samples of
                species [Pseudomonas aeruginosa PAO1], using 6 arrays of array design [Affymetrix
                GeneChip P. aeruginosa Genome[Pae_G1a]], producing 6 raw data files and 6
                transformed and/or normalized data files.</text>
        </description>
        <description>
            <id>1797681720</id>
            <text>Colistin is an important cationic antimicrobial peptide (CAMP) in the fight
                against Pseudomonas aeruginosa infection within the cystic fibrosis (CF) lungs. The
                effects of sub-inhibitory colistin on gene expression in P. aeruginosa were
                investigated by transcriptome microarray and functional analysis. Analysis revealed
                an alteration in the expression of 60 genes in total from a variety of pathways.
                Genes associated with bacterial chronic colonisation and virulence such as response
                to osmotic stress, motility, and biofilm formation, as well as those associated with
                LPS modification and quorum sensing are the most highly represented. Most striking
                among these is the upregulation of the PQS biosynthesis operon including pqsH, pqsE,
                and the anthranilate biosynthetic genes phnAB. Early activation of this central
                component of the QS-network may represent a switch to a more robust population, with
                increased fitness in the competitive environment of the CF-lung. Experiment Overall
                Design: Three independent cultures of the P. aeruginosa strain PAO1 were exposed to
                0.15 g colistin ml 1. The untreated and treated samples were grown from OD600 0.05
                to 0.8 and subsequently total RNA was extracted using the Ambion RiboPureTm-
                Bacteria kit according to the manufacturer s instructions.</text>
        </description>
    </experiment>
    <experiment textidx="226">
        <id>1797682364</id>
        <accession>E-GEOD-17513</accession>
        <name>Transcription profiling of mouse embryonic stem cell derived cardiac
            progenitors</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17513</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797685933</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17513.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Ibrahim Domian</contact>
            <email>idomian@partners.org</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797682371</id>
            <text>Mamamlian cardiogenesis occurs through the development of discreate populations of
                first and second heart field progenitors. We have used a dual transgenic color
                reproter system to isolate purified populations of these progenitors. We used
                microarrays to detail the global programme of gene expression underlying cardiac
                development in mouse; All four populations of cells are derived from embryonic stem
                cells differentiating in vitro (day 6 of in vitro differentaition). The stem cell
                line has two transgenic reporters as follows:; 1. The second heart field (SHF)
                specific reporter of the Mef2C gene (E. Dodou, S. M. Xu, B. L. Black, Mech Dev 120,
                1021 (Sep, 2003)) driving the expression of dsRed; 2. The cardiac specific enhancer
                ( C. L. Lien et al., Development 126, 75 (Jan, 1999)) driving the expression of
                eGFP. Thus, the red cells are SHF specific, the green cells are cardiac specific,
                and the red/green are SHF and cardiac specific. These cells are compared to the
                double negative cells which serve as a control. Experiment Overall Design: Embryonic
                stem cell derived progenitors were isolated into four distinct populations by FACS
                purifying these progenitors based on a two color reporter system. Four populations
                were then compared to each other by transcriptional profiling.</text>
        </description>
        <description>
            <id>1797690394</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Mus musculus], using 12 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 0 raw data files and 12 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="227">
        <id>1797685895</id>
        <accession>E-GEOD-7836</accession>
        <name>Transcription profiling of rat REF52 cells expressing SV40 T antigens</name>
        <releasedate>2009-09-11</releasedate>
        <species>Rattus norvegicus</species>
        <samples>5</samples>
        <assays>5</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE7836</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>114147931</id>
            <accession>A-AFFY-18</accession>
            <name>Affymetrix GeneChip Rat Genome U34A [RG_U34A]</name>
            <count>5</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797686402</id>
            <name>Affymetrix:FeatureDimension:RG_U34A</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv3</dataformat>
            <bioassays>5</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797686544</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-7836.RG_U34A.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>5</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>5</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <bibliography>
            <accession>19201438</accession>
            <authors>Paul G Cantalupo, Maria Teresa S enz-Robles, Abhilasha V Rathi, Rebecca W
                Beerman, William H Patterson, Robert H Whitehead, James M Pipas</authors>
            <title>Cell-type specific regulation of gene expression by simian virus 40 T
                antigens.</title>
        </bibliography>
        <provider>
            <contact>Paul Cantalupo</contact>
            <email>pcantalupo@gmail.com</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797685904</id>
            <text>SV40 transforms cells through the action of two oncoproteins, large T antigen and
                small t antigen. Small t antigen targets phosphatase PP2A, while large T antigen
                stimulates cell proliferation and survival by action on multiple proteins, including
                the tumor suppressors Rb and p53. Large T antigen also binds components of the
                transcription initiation complex and several transcription factors. We examine
                global gene expression in SV40-transformed REF52 cells. SV40 transformation alters
                the expression of approximately 480 cellular genes. Much of this regulation is
                consistent with T antigen action on the Rb-E2F pathway. Experiment Overall Design:
                We used the Affymetrix RGU34A microarrays to probe the global mRNA expression from
                two wild-type REF52neo and three REF52neoT stable cell lines. Cells were grown to
                two days post-confluence and harvested.</text>
        </description>
        <description>
            <id>1797689783</id>
            <text>(Generated description) Experiment with 5 hybridizations, using 5 samples of
                species [Rattus norvegicus], using 5 arrays of array design [Affymetrix GeneChip Rat
                Genome U34A [RG_U34A]], producing 5 raw data files and 5 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="228">
        <id>1797686535</id>
        <accession>E-GEOD-12173</accession>
        <name>Re-sequencing of maize small RNA SBS signatures identified using Illuminas SBS
            technology</name>
        <releasedate>2009-09-11</releasedate>
        <species>Zea mays</species>
        <samples>2</samples>
        <assays>2</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Zea mays</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12173</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1797666662</id>
            <accession>ebi.ac.uk:MAGETabulator:E-GEOD-12173.VirtualArrayDesign</accession>
            <count>2</count>
        </arraydesign>
        <bibliography>
            <accession>18815367</accession>
            <authors>Kan Nobuta, Cheng Lu, Roli Shrivastava, Manoj Pillay, Emanuele De Paoli, Monica
                Accerbi, Mario Arteaga-Vazquez, Lyudmila Sidorenko, Dong-Hoon Jeong, Yang Yen,
                Pamela J Green, Vicki L Chandler, Blake C Meyers</authors>
            <title>Distinct size distribution of endogeneous siRNAs in maize: Evidence from deep
                sequencing in the mop1-1 mutant.</title>
        </bibliography>
        <provider>
            <contact>Blake Meyers</contact>
            <email>meyers@dbi.udel.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>re-sequencing</experimenttype>
        <description>
            <id>1797686542</id>
            <text>Most endogenous siRNAs in Arabidopsis are dependent on RNA-DEPENDENT RNA
                POLYMERASE 2 (RDR2) for their biogenesis. Recent work has demonstrated that the
                maize MEDIATOR OF PARAMUTATION1 (mop1) gene is a predicted ortholog of the
                Arabidopsis RDR2 gene. The mop1 gene is required for establishment of paramutation
                and maintenance of transcriptional silencing of transposons and transgenes,
                suggesting the potential involvement of small RNAs. We analyzed small RNAs in
                wildtype maize and in the isogenic mop1-1 loss-of-function mutant using Illumina s
                sequencing-by-synthesis (SBS) technology, which allowed us to characterize the
                complement of maize small RNAs to considerable depth. Similar to rdr2 in
                Arabidopsis, in mop1-1, the 24 nt (nucleotide) endogenous heterochromatic
                short-interfering siRNAs were dramatically reduced resulting in an enrichment of
                miRNAs and trans-acting siRNAs (ta-siRNAs). In contrast to the Arabidopsis rdr2
                mutant, the mop1-1 plants retained a highly abundant heterochromatic ~22 nt class of
                small RNAs. These data suggest that maize, unlike Arabidopsis, has a second
                mechanism for heterochromatic siRNA production. The enrichment of miRNAs and loss of
                24 nt heterochromatic siRNAs in mop1-1 should be advantageous for miRNA discovery as
                the maize genome becomes more fully sequenced. Experiment Overall Design: This
                library was derived from maize variety K55 wild-type and mop1 mutant. Immature ears
                were harvested from plants grown outdoors in Tuscon, AZ. The material was harvested
                from plants 68 days after germination, with the floral tissue including young
                tassels 2-3 cm long. Total RNA was isolated using a standard TRIZOL-based method and
                the small RNA libraries were generated as described by Lu et al. (Methods 2007,
                43:110), followed by sequencing with Illumina's SBS method. The adapter sequences
                were removed, and the abundance of each distinct small RNA was determined.
                Experiment Overall Design: Raw data are unavailable from Illumina</text>
        </description>
        <description>
            <id>1797688167</id>
            <text>(Generated description) Experiment with 2 hybridizations, using 2 samples of
                species [Zea mays], using 1 arrays of array design [Virtual Array Design for
                E-GEOD-12173], producing 0 raw data files and 2 transformed and/or normalized data
                files.</text>
        </description>
    </experiment>
    <experiment textidx="229">
        <id>1797686559</id>
        <accession>E-GEOD-12639</accession>
        <name>Transcription profiling of rat with induced diabetes mellitus to investigate the
            progression of post-infarction genetic regulatory expression</name>
        <releasedate>2009-09-11</releasedate>
        <species>Rattus norvegicus</species>
        <samples>12</samples>
        <assays>12</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Rattus norvegicus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE12639</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>383811809</id>
            <accession>A-AFFY-43</accession>
            <name>Affymetrix GeneChip Rat Genome 230 2.0 [Rat230_2]</name>
            <count>12</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797690559</id>
            <name>Affymetrix:FeatureDimension:Rat230_2</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>12</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797690714</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-12639.Rat230_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>12</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>12</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>guangyuan song</contact>
            <email>canghailinghu@yahoo.com.cn</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797691948</id>
            <text>(Generated description) Experiment with 12 hybridizations, using 12 samples of
                species [Rattus norvegicus], using 12 arrays of array design [Affymetrix GeneChip
                Rat Genome 230 2.0 [Rat230_2]], producing 12 raw data files and 12 transformed
                and/or normalized data files.</text>
        </description>
        <description>
            <id>1797686566</id>
            <text>OBJECTIVE: To study the genetic regulatory mechanisms in the remote zone of left
                ventricular (LV) free wall in order to partly explain the more frequent progression
                to heart failure after acute myocardial infarction (AMI) in diabetic rats. METHODS:
                10 weeks after diabetes mellitus (DM) induction with Streptozotocin (STZ), the left
                anterior descending coronary arteries of uncontrolled diabetic Sprague-Dawley (SD)
                rats and non-diabetic ones were ligated without reperfusion. Then, the remote zone
                tissues of LV free wall were taken as samples at day 1, 7, 14, 28, and 56 post AMI.
                Significant different expression genes were filterd from Affymetrix Genechip U230
                2.0 array by GCOS software. Genetic changes post myocardial infarction were
                classified by hierarchical clustering of 10 gene chips. And then, the differential
                expressions of 10 selected transcripts identified by the microarray were examined in
                greater detail by Real Time-PCR. RESULTS: According to hierarchical clustering, we
                find that the molecular regulatory expression related to cardiac remodeling in the
                remote zone to myocardial infarction is quite different as time elapses in both
                diabetic and non-diabetic rats. The gene expression at day 1 and 7 post AMI in both
                groups is similar, while the genetic changes at day 14 post AMI in diabetic rats and
                the ones at day 14 and 28 in non-diabetic rats are classified into the same cluster.
                And then the genetic changes at day 28 and 56 post AMI in diabetic rats and the ones
                at day 56 in non-diabetic rats are classified into the same cluster. (Figure.1) The
                patterns of numerous products of genes expression were used in the cluster,
                including 118 genes, such as leucine-rich PPR-motif containing (IL-6 signaling
                pathway), procollagen type I, VI, VIII, and XV, fibronectin1, RT1, and TIMP-1, etc.
                CONCLUSION: The genetic findings in this study might be the possible mechanism that
                diabetes mellitus can accerate the progression of post-infarction genetic regulatory
                expression. Experiment Overall Design: All studies were performed with male SD rats
                (200-220g), aged 8 weeks, which were obtained from laboratorial animal center of
                Chinese University of Agriculture. DM was induced with a singleintraperitoneal
                injection of STZ (65 mg/kg in 0.1mmol/L, pH 4.5 sodium citrate buffer) . Age and
                body weight matched rats that used as non-diabetic controls were injected with the
                same dose of sodium citrate buffer (0.1mmol/L, pH 4.5). Ultrastructure changes of
                myocardium were observed 10 weeks after DM induction by TEM. 10 weeks after DM
                induction,both diabetic and non-diabetic rats were subjected to left anterior
                descending coronary artery (LADCA) ischemia for 1-56 days without reperfusion.
                Two-dimensional echocardiography was utilized to obtain LV dimensions and LV percent
                fractional shortening at baseline, DM 10weeks, and at 1d, 7d, 14d, 28d, 56d after
                AMI; the remote zone tissues of LV free wall were taken as samples at day 1, 7, 14,
                28, and 56 post AMI for gene chip microarray analysis (10 samples from 30 rats); in
                addition, heart-to-body weight and heart to tibial length ratios and masson's
                trichrome staining was measured as an index of cardiac hypertrophy and fibrosis at
                baseline, DM 10weeks, and at 1d, 7d, 14d, 28d, 56d after AMI.</text>
        </description>
    </experiment>
    <experiment textidx="230">
        <id>1797689348</id>
        <accession>E-GEOD-17353</accession>
        <name>Transcription profiling of human hypoxia exposed normal human esophageal epithelial
            cells</name>
        <releasedate>2009-09-11</releasedate>
        <species>Homo sapiens</species>
        <samples>8</samples>
        <assays>8</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Homo sapiens</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE17353</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>405156763</id>
            <accession>A-AFFY-44</accession>
            <name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name>
            <count>8</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797692070</id>
            <name>Affymetrix:FeatureDimension:HG-U133_Plus_2</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>8</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797692094</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-17353.HG-U133_Plus_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>8</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>8</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Hiroshi Nakagawa</contact>
            <email>nakagawh@mail.med.upenn.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797689355</id>
            <text>To delineate the role of hypoxia in esophageal epithelial biology, we carried out
                gene array experiments using a non-transformed immortalized diploid human esophageal
                cell line, EPC2-hTERT (Mol Cancer Res. 2003;1:729-38). Unlike cancer cell lines,
                EPC2-hTERT has no genetic alterations at early passages that may affect the cellular
                response to hypoxia. Experiment Overall Design: EPC2-hTERT cells were exposed to
                moderate (1% O2) hypoxia in experiment 1 (Exp1) or severe (0.2% O2) hypoxia in
                experiment 2 (Exp2). Normoxia (21% O2) served as a control in both
                experiments.</text>
        </description>
        <description>
            <id>1797692665</id>
            <text>(Generated description) Experiment with 8 hybridizations, using 8 samples of
                species [Homo sapiens], using 8 arrays of array design [Affymetrix GeneChip Human
                Genome U133 Plus 2.0 [HG-U133_Plus_2]], producing 8 raw data files and 8 transformed
                and/or normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="231">
        <id>1797690422</id>
        <accession>E-GEOD-10730</accession>
        <name>Transcription profiling of Soybean iron deficiency in soybean leaf tissue</name>
        <releasedate>2009-09-11</releasedate>
        <species>Glycine max</species>
        <samples>11</samples>
        <assays>11</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Glycine max</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE10730</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>1134087197</id>
            <accession>A-AFFY-59</accession>
            <name>Affymetrix GeneChip Soybean Genome Array</name>
            <count>11</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797692163</id>
            <name>Affymetrix:FeatureDimension:Soybean</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>11</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797692274</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-10730.Soybean.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>11</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>11</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Randy Shoemaker</contact>
            <email>rcsshoe@iastate.edu</email>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797690429</id>
            <text>This study was designed to identify candidate genes associated with iron
                efficiency in soybeans. Two genotypes, Clark (PI548553) and IsoClark (PI547430),
                were grown in both iron sufficient (100uM Fe(NO3)3) and iron deficient (50uM
                Fe(NO3)3) hydroponics conditions. The second trifoliate was harvested for RNA
                extraction for the microarray experiment. Candidate genes were identified by
                comparing gene expression profiles within genotypes between the two iron growth
                conditions. Experiment Overall Design: This experiment was designed to compare
                expression profiles of Clark grown in iron sufficient and deficient iron conditions
                and of IsoClark grown in the same conditions. Plants grown in iron sufficient
                conditions were used as controls and plants grown in iron deficient conditions were
                considered experimental. For the Clark genotype, There were two biological
                replicates of iron deficient plants, and three biological replicates of iron
                sufficient plants. The IsoClark genotype had three biological replicates for both
                iron sufficient and deficient conditions.</text>
        </description>
        <description>
            <id>1797694457</id>
            <text>(Generated description) Experiment with 11 hybridizations, using 11 samples of
                species [Glycine max], using 11 arrays of array design [Affymetrix GeneChip Soybean
                Genome Array [Soybean]], producing 11 raw data files and 11 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="232">
        <id>1797690591</id>
        <accession>E-GEOD-13408</accession>
        <name>Transcription profiling of mouse Rb family triple knock-out (TKO) embryonic stem cells
            as they differentiate in vivo</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>14</samples>
        <assays>14</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE13408</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>14</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797692125</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>14</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>14</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797692237</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-13408.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>14</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>14</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Stacey Wirt</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797690598</id>
            <text>The retinoblastoma cell cycle regulator pRb and the two related proteins p107 and
                p130 are thought to suppress cancer development both by inhibiting the G1/S
                transition of the cell cycle in response to growth-arrest signals and by promoting
                cellular differentiation. Here, we investigated the phenotype of Rb family triple
                knock-out (TKO) embryonic stem cells as they differentiate in vivo and in culture.
                Confirming the central role of the Rb gene family in cell cycle progression, TKO
                mouse embryos did not survive past mid-gestation and differentiating TKO cells
                displayed increased proliferation and cell death. However, patterning and cell fate
                determination were largely unaffected in these TKO embryos. Furthermore, a number of
                TKO cells, including in the neural lineage, were able to exit the cell cycle in G1
                and terminally differentiate. This ability of Rb family TKO cells to undergo cell
                cycle arrest was associated with the repression of target genes for the E2F6
                transcription factor, uncovering a pRb-independent control of the G1/S transition of
                the cell cycle. These results show that the Rb gene family is required for proper
                embryonic development but is not absolutely essential to induce G1 arrest and
                differentiation in certain lineages. Experiment Overall Design: Genome-wide gene
                expression was analyzed for wild-type and TKO ESC and EB cells. Three biological
                replicates were isolated for wild-type ESCs, TKO ESCs, and wild-type EBs, while five
                biological replicates were isolated for TKO EBs.</text>
        </description>
        <description>
            <id>1797694751</id>
            <text>(Generated description) Experiment with 14 hybridizations, using 14 samples of
                species [Mus musculus], using 14 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 14 raw data files and 14 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
    <experiment textidx="233">
        <id>1797691739</id>
        <accession>E-GEOD-14270</accession>
        <name>Transcription profiling of mouse cornea from three strains reveal central corneal
            thickness is a genetic dependent trait among inbred strains of mice</name>
        <releasedate>2009-09-11</releasedate>
        <species>Mus musculus</species>
        <samples>9</samples>
        <assays>9</assays>
        <sampleattribute>
            <category>Organism</category>
            <value>Mus musculus</value>
        </sampleattribute>
        <user>1</user>
        <secondaryaccession>GSE14270</secondaryaccession>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <miamescores>
            <overallscore>0</overallscore>
        </miamescores>
        <arraydesign>
            <id>417942717</id>
            <accession>A-AFFY-45</accession>
            <name>Affymetrix GeneChip Mouse Genome 430 2.0 [Mouse430_2]</name>
            <count>9</count>
        </arraydesign>
        <bioassaydatagroup>
            <id>1797692596</id>
            <name>Affymetrix:FeatureDimension:Mouse430_2</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>CELv4</dataformat>
            <bioassays>9</bioassays>
            <isderived>0</isderived>
        </bioassaydatagroup>
        <bioassaydatagroup>
            <id>1797692924</id>
            <name>ebi.ac.uk:MAGETabulator:E-GEOD-14270.Mouse430_2.1.CompositeSequenceDimension</name>
            <bioassaydatacubes>9</bioassaydatacubes>
            <arraydesignprovider>AFFY</arraydesignprovider>
            <dataformat>tab delimited</dataformat>
            <bioassays>9</bioassays>
            <isderived>1</isderived>
        </bioassaydatagroup>
        <provider>
            <contact>Markus Kuehn</contact>
            <role>submitter</role>
        </provider>
        <experimentdesign>unknown experiment type</experimentdesign>
        <experimenttype>transcription profiling</experimenttype>
        <description>
            <id>1797691746</id>
            <text>Central corneal thickness (CCT) exhibits broad variability. We determined the
                corneal gene expression profile three mouse strains with distinct corneal thickness:
                C57BLKS/J (88.6 um), SJL/J (123.5 um), and C57BL/6J (100.1 um). Experiment Overall
                Design: Enucleated eyes from 4 month old mice were dissected in phosphate-buffered
                saline and a punch of central cornea was collected utilizing a 2-mm biopsy punch.
                Two central corneal punches (left and right eyes) were pooled from each mouse to
                form one sample; three samples were analyzed per strain.</text>
        </description>
        <description>
            <id>1797695048</id>
            <text>(Generated description) Experiment with 9 hybridizations, using 9 samples of
                species [Mus musculus], using 9 arrays of array design [Affymetrix GeneChip Mouse
                Genome 430 2.0 [Mouse430_2]], producing 9 raw data files and 9 transformed and/or
                normalized data files.</text>
        </description>
    </experiment>
</experiments>
